ATI Templates
The eight standardized ATI Active Learning templates from Maternal Newborn Edition 11 (book pages A1–A16). Click a template to expand it, then switch tabs to study each worked example. Track your study progress with the checkboxes — single tap = reviewed, double tap = mastered.
Related Content
Skin changes:
- Hyperpigmentation
- Linea nigra — dark vertical line from umbilicus to pubic area
- Chloasma (mask of pregnancy) on the face
- Striae gravidarum — stretch marks, most pronounced on abdomen and thighs
Breast changes:
- Darkening of the areola
- Enlarged Montgomery's glands
- Increase in size and heaviness
- Increased sensitivity
- Visible vascularization (veins)
Underlying Principles
Increase in estrogen and progesterone occurring during pregnancy drives both the skin and breast changes.
- Estrogen: stimulates melanocyte activity (hyperpigmentation), increases vascularization, supports breast ductal growth
- Progesterone: supports breast lobule and alveolar development, contributes to glandular tissue enlargement
- Skin stretching from rapid uterine and breast growth produces striae as collagen and elastic fibers tear
Nursing Interventions
Who, when, why, how:
- Acknowledge the client's concerns about pregnancy and encourage sharing of feelings (judgment-free atmosphere)
- Educate that these changes are expected, not pathological
- Discuss timeline for return to prepregnant state after delivery (most fade gradually)
- Recommend sun protection for chloasma — sunscreen, hats, avoiding peak sun
- Reassure about striae — they fade to silvery white over time; no proven prevention via topicals
- Encourage well-fitted supportive bra for breast comfort
- Refer to counseling if body image concerns affect the pregnancy
- Set goals with the client for postpartum self-care and newborn care
Related Content
Why UTIs are common in pregnancy:
- Renal pelvis & ureteral dilation from progesterone
- Urinary stasis from displaced bladder
- Glycosuria provides bacterial growth medium
- Vaginal flora more alkaline (normally acidic)
- Asymptomatic bacteriuria can progress to pyelonephritis if untreated
Risk: untreated UTI → preterm labor, low birth weight, pyelonephritis (high fever, flank pain, sepsis).
Underlying Principles
- UTIs are common during pregnancy because of renal changes (smooth muscle relaxation by progesterone, dilated ureters, urinary stasis)
- Vaginal flora become more alkaline during pregnancy, allowing bacterial overgrowth
- The shorter female urethra is in close proximity to anal flora
- Mechanical pressure from gravid uterus on the bladder promotes incomplete emptying
Nursing Interventions
Decrease UTI risk by — When? Why? How?
- How, When: Wipe perineum front to back after voiding (prevents anal flora migration)
- How: Avoid bubble baths (irritate urethra)
- How: Wear cotton underpants; avoid tight pants (allow airflow, reduce moisture)
- How: Drink ≥ 8 glasses of water/day (mechanical flushing)
- How, Why: Urinate before and after intercourse — flushes bacteria present or introduced
- How, Why: Urinate as soon as urge occurs — retention provides bacterial growth medium
- When, Why: Notify provider if urine is foul-smelling, contains blood, or appears cloudy — early treatment prevents pyelonephritis
Related Content
Why nutrition matters in pregnancy:
- Adequate nutrition supports fetal growth and maternal physiologic adaptations
- Recommended weight gain (single pregnancy): 11.3–15.9 kg (25–35 lb)
- Pace: 1–2 kg in 1st trimester, ~0.5 kg/week in 2nd–3rd
- Insufficient gain → low birth weight, IUGR, preterm birth
- Excessive gain → macrosomia, labor complications, GDM, gestational HTN
Underlying Principles
Age-related:
- Adolescents may have poor nutritional habits (low vitamins/protein, may not take iron supplements)
Culture / lifestyle:
- Vegetarians may be low in protein, calcium, iron, zinc, vitamin B12
- Excessive weight gain → macrosomia and labor complications
Socioeconomic:
- Inability to purchase or access foods limits adequate nutrition
Dietary complications during pregnancy:
- Nausea and vomiting
- Anemia
- Eating disorders (anorexia, bulimia)
- Pica (craving nonfood substances — dirt, red clay)
- Inability to gain weight
Nursing Interventions
Federal nutrition support:
WIC (Women, Infants, and Children) — federally funded state program providing nutritional support to pregnant clients and their children up to 5 years old.
Other nursing actions:
- Assess client's diet via food journal at each prenatal visit
- Provide education on nutritional benefits to mother and newborn
- Monitor weight gain pattern; identify deviations from target
- Refer to registered dietitian for tailored counseling
- Screen for eating disorders, pica, food insecurity, financial barriers
- Counsel adolescents on age-specific risks and supplement adherence
- Address vegetarian-specific gaps with B12, iron, zinc supplementation guidance
Related Content
Sensory stimulation strategies:
- Aromatherapy
- Breathing techniques (Lamaze, patterned breathing)
- Imagery
- Music
- Use of focal points
- Subdued lighting
Cutaneous stimulation strategies:
- Therapeutic touch & massage; back rubs
- Effleurage (light circular abdominal stroking)
- Sacral counterpressure (heel of hand or fist on sacral area)
- Heat or cold therapy
- TENS
- Hydrotherapy (whirlpool, shower) — ↑ endorphins
- Acupressure
- Walking, rocking
Cognitive strategies: childbirth education, doulas, hypnosis, biofeedback.
Underlying Principles
Gate-control theory of pain:
The sensory nerve pathways that pain sensations use to travel to the brain allow only a limited number of sensations to travel at any given time. By sending alternate signals through these pathways (touch, sound, image), pain signals can be blocked from ascending the neurologic pathway, inhibiting the brain's perception and sensation of pain.
Fear-tension-pain cycle: anxiety/fear → ↑ muscle tension → ↑ pain perception → slowed labor. Reducing anxiety is itself analgesic.
Endorphin release: hydrotherapy and movement promote endogenous endorphin release, contributing to natural pain modulation.
Nursing Interventions
Who, when, why, how:
- How: teach methods during prenatal childbirth education classes (3rd trimester ideal)
- When: apply during 1st-stage latent and active phases — when comfort techniques are most effective
- Why: reduce anxiety, fear, tension — major contributors to labor pain; minimize need for pharmacological interventions; improve birth experience
- How: involve partner/doula in providing massage, counterpressure, encouragement
- How: encourage frequent position changes — semi-sitting, squatting, kneeling, supine ONLY with hip wedge
- Why: position changes promote relaxation, fetal descent, and pain relief
- How: assess for hyperventilation (low PCO₂ → numbness, tingling) → breathe into paper bag or oxygen mask
- When: if a client requests pharmacological intervention, offer continued nonpharmacological methods alongside (combined approach optimizes pain management)
- How: document strategies attempted and their effectiveness
Related Content
Definition: Begins with delivery of the placenta; includes at least the first 2 hr after birth.
Maternal characteristics:
- Maternal stabilization of vital signs
- Achievement of homeostasis
- Lochia: scant to moderate rubra (expected)
Assessment priorities:
- Maternal vital signs
- Fundus (firmness, location)
- Lochia (color, amount, clots)
- Urinary output / bladder distention
- Perineum (episiotomy/laceration repair for erythema)
- Baby-friendly activities
Monitoring schedule:
- BP and pulse every 15 min for first 2 hr
- Temperature at start of recovery; q4h × 8 hr; then q8h
- Fundus and lochia every 15 min for first hour, then per facility protocol
Underlying Principles
The focus of care in the fourth stage is to maintain uterine tone and prevent hemorrhage.
Why uterine tone matters: The placental site is a large, raw wound. Uterine muscle fibers must contract around the maternal blood vessels supplying that site — this physiologic ligature is the primary mechanism preventing postpartum hemorrhage.
What disrupts uterine tone:
- Bladder distention — pushes the uterus up and to the side, prevents adequate contraction
- Retained placental fragments
- Uterine atony
- General anesthesia agents
- Prolonged labor or rapid labor
- Multifetal pregnancy or hydramnios (overdistention)
Endogenous oxytocin: Skin-to-skin contact and breastfeeding stimulate oxytocin release, which contracts the uterus and supports hemostasis — bonding activities are clinical interventions, not just emotional ones.
Nursing Interventions
Core four (per ALS):
- Assess vital signs, fundus, and lochia every 15 min for the first 2 hr, then per facility protocol
- Massage the uterus — and/or administer oxytocics as prescribed to maintain uterine tone and prevent hemorrhage
- Encourage voiding to prevent bladder distention (a full bladder displaces the uterus and impairs contraction)
- Promote parental-newborn bonding — facilitates endogenous oxytocin release and supports attachment
Additional interventions:
- Assess episiotomy or laceration repair for erythema, swelling, hematoma
- Apply ice pack to perineum for comfort and edema reduction
- Provide perineal hygiene; clean perineal pad
- Facilitate skin-to-skin contact immediately following birth
- Allow private time; encourage breastfeeding initiation
- After bonding and eating, support a nap or quiet rest period
- Document all assessments and interventions
Related Content
Anatomic context: Postpartum perineum can be erythematous, edematous, with episiotomy or laceration. Hematomas and hemorrhoids may be present. Healing: initial 2–3 weeks; complete 4–6 months.
Risk factors for perineal injury/poor healing:
- Episiotomy (median or mediolateral)
- Perineal lacerations (1st–4th degree)
- Operative vaginal birth (forceps, vacuum)
- Macrosomia, prolonged 2nd stage
- Maternal diabetes (impaired wound healing)
Assessment using REEDA:
- Redness
- Edema
- Ecchymosis
- Discharge
- Approximation of edges
A bright red trickle of blood from the episiotomy site in the early postpartum period is a normal finding.
Underlying Principles
Three core principles for perineal hygiene:
- Increase tissue perfusion — promotes oxygen delivery and waste removal at the wound site, accelerating healing
- Prevent infection — the perineum is in proximity to the urethra, vagina, and anus; bacteria from each can contaminate the wound. Hand hygiene, front-to-back wiping, and squeeze bottle cleansing minimize cross-contamination
- Promote comfort — perineal pain reduces ambulation, voiding, bonding, and breastfeeding success. Adequate comfort is a clinical priority, not just emotional support
Why front to back? The urethra (clean) is anterior; the anus (contaminated) is posterior. Wiping back to front transfers bacteria from anus to urethra/vagina/wound → ↑ UTI and wound infection.
Why blot, not wipe? Friction can disrupt sutures and traumatize edematous tissue. Blotting cleans without mechanical injury.
Nursing Interventions
Client actions to prevent infection (4):
- Wash hands thoroughly before and after voiding
- Use a squeeze bottle (peri bottle) with warm water or antiseptic solution after each voiding
- Clean the perineal area from front to back (urethra to anus)
- Blot dry — do not wipe
- Use topical antiseptic cream or spray sparingly
- Change perineal pad from front to back after voiding/defecating
- Avoid tampons (↑ infection risk)
Nurse actions to promote comfort (4):
- Apply ice or cold packs to the perineum (first 24 hr; never directly to skin)
- Encourage sitz baths at least twice a day (≥ 20 min, hot or cool temperature)
- Administer analgesics as prescribed (acetaminophen, ibuprofen, opioids if needed)
- Apply topical anesthetics (benzocaine spray) to perineal area
- Apply witch hazel compresses to rectal area for hemorrhoids
- Heat therapy / moist heat after first 24 hr to ↑ circulation and healing
Documentation & teaching:
- Document REEDA findings each shift
- Teach signs to report: increased pain, foul-smelling discharge, separation of suture line, fever > 38°C
- Reinforce hygiene and pad-change technique at every patient encounter
Related Content
Three ways the father develops a parent-infant bond:
- Touching, holding, skin-to-skin contact, and maintaining eye-to-eye contact
- Recognizing personal features in the infant and validating his claim to the infant
- Talking, reading, singing, and verbally interacting with the newborn
Context — what the father may experience:
- Initially has preconceived expectations of fatherhood
- May feel sadness, frustration, or jealousy when reality doesn't match expectations
- May feel unable to talk with the other parent (consumed with caregiving)
- Eventually decides to actively engage in care
- Reaps rewards: infant smiles, completeness, meaning
Underlying Principles
Three stages of paternal transition to parenthood:
- Expectations: having preconceived ideas about fatherhood
- Reality: recognizing that expectations might not be met, facing these feelings, and embracing the need to become actively involved in parenting
- Transition to mastery: taking an active role in parenting
Three stages of father-infant bond development:
- Making a commitment and assuming responsibility for parenting
- Becoming connected and having feelings of attachment to the newborn
- Modifying lifestyle to make room to care for the newborn
Why this matters: Co-parents face a transition that can include emotional challenges similar to but distinct from the birthing parent's. Acknowledging the legitimacy of paternal adaptation supports family-centered care and improves long-term parental engagement.
Nursing Interventions
Three actions to assist in the father-infant bonding process:
- Provide education about newborn care when the father is present (don't deliver teaching only when the birthing parent is present)
- Encourage the father to take a hands-on role in care when present
- Provide guidance as the father builds skill and confidence
Additional interventions:
- Involve the father as a full partner, not a helper, in the parenting process
- Encourage the couple to verbalize concerns and expectations about newborn care
- Facilitate skin-to-skin opportunities for the father (especially in cases of cesarean recovery or maternal complications)
- Validate paternal experiences and emotions; normalize ambivalence and adjustment difficulty
- Connect to peer support groups for new fathers when available
- Document paternal-infant interactions and any concerns
Related Content
Lactation suppression for the nonlactating client:
- Wear well-fitting, supportive bra continuously for first 72 hours
- Avoid breast stimulation and warm water over breasts
- Cold compresses 15 min on, 45 min off for engorgement
- Cabbage leaves inside the bra
- Mild analgesics for engorgement pain
Activity:
- Pelvic tilt and Kegel exercises
- Vaginal: limit stair climbing first few weeks
- Cesarean: 4–6 weeks before strenuous exercise; 1 flight stairs/day; < 10 lb lifting × 2 weeks
- Plan ≥ 1 daily rest period
Contraception:
- Menses may resume 4–10 weeks; ovulation as early as 1 month
- Contraception needed before resuming sexual activity
Follow-up: 4–6 weeks after vaginal birth · 2 weeks after cesarean
Underlying Principles
Nutrition:
- Eat a diet that includes all food groups and higher protein content
- Drink fluids to satisfy thirst
- Consume 1,800–2,200 kcal/day
Resumption of sexual intercourse:
- Safely resume by 2nd to 4th week after birth, when bleeding has stopped and perineum has healed
- OTC lubricants might be needed
- Physiological reactions to sexual activity can be slower and less intense for the first 3 months
Why teach all of this: Discharge instructions support self-care competence, infection prevention, recovery progression, and recognition of complications. Verifying understanding via teach-back / return demonstration ensures actionable retention.
Nursing Interventions — Indications of Complications to Report
The client should report the following to the provider:
- Chills or fever > 38°C (100.4°F) for 2 or more days
- Change in vaginal discharge: increased amount, large clots, change to previous lochia color, foul odor
- Episiotomy, laceration, or incisional pain not resolving with analgesics; foul-smelling drainage; redness; edema
- Pain or tenderness in abdominal or pelvic area not resolving with analgesics
- Localized breast pain + heat + swelling; nipple cracks or fissures (mastitis)
- Calves with localized pain, tenderness, redness, swelling; lower extremity redness/warmth (DVT)
- Burning, pain, frequency, urgency on urination (UTI)
- Indications of possible depression: apathy toward infant, cannot provide self/infant care, feelings of harming self or infant
Documentation: ensure client has the date and time of follow-up appointment in writing and a number to call with concerns.
Related Content
Why airway clearance matters in newborns:
- Newborns have small airways and produce mucus during transition to extrauterine life
- Cesarean newborns are more susceptible to retained fluid in lungs than vaginally delivered (no thoracic squeeze during birth)
- Newborns are obligate nose breathers until ~3 weeks → nasal blockage causes flaring, cyanosis, asphyxia
- The 2nd period of reactivity (2–8 hr after birth) is when newborns commonly gag/choke on accumulated mucus
Signs of respiratory distress requiring intervention:
- Bradypnea (RR ≤ 30) or tachypnea (RR ≥ 60)
- Expiratory grunting
- Crackles, wheezes
- Nasal flaring
- Retractions
- Gasping, labored breathing
- Apnea > 15 seconds
Family teaching: bulb syringe should remain with newborn at all times. Family demonstrates technique back to nurse before discharge.
Underlying Principles — 3 mechanisms that promote airway clearance
- Infant's cough reflex
- Newborn is able to clear most secretions in air passages by the cough reflex
- The cough reflex is part of normal newborn physiology and the first-line clearance mechanism
- Mechanical suctioning
- If bulb suctioning is unsuccessful, mechanical suction is used for clearing the airway
- Emergency procedures instituted if airway does not clear
- Use of the bulb syringe for suctioning
- Routine use to remove excess mucus in the respiratory tract
- Performed on mouth first, then nasal passages
Why mouth before nose? When the nose is suctioned first, the stimulation can trigger a gasp reflex that aspirates whatever is pooled in the mouth. Suctioning mouth first ensures no oral secretions are present to be aspirated when nasal stimulation occurs.
Nursing Interventions — Bulb Syringe Technique
Stepwise technique:
- Compress (depress) bulb BEFORE insertion
- Inserting an uncompressed bulb forces air into the airway, which can push secretions deeper
- Insert syringe into the side of the mouth
- Avoid the center of the mouth — prevents stimulating the gag reflex
- Aspirate mouth first, then one nostril, then second nostril
- Mouth before nose prevents aspiration when nasal stimulation triggers a gasp
- Release bulb to draw secretions in
- Remove bulb from mouth/nose; expel secretions onto a clean tissue or cloth by compressing bulb sharply
- Repeat as needed; observe respiratory pattern after each pass
- Clean bulb syringe per facility policy
Family teaching points:
- Demonstrate technique to family
- Have family return-demonstrate before discharge
- Keep bulb syringe with newborn (in bassinet, diaper bag)
- Use only when needed (mucus visible, gagging, distress) — NOT routinely after every feeding
- Notify provider if bulb suctioning doesn't relieve respiratory difficulty
Related Content — Types & Use
Three types of breast pumps:
- Manual
- Electric
- Battery-operated
Use of the pump:
- Pumping of one or both breasts
- Adjustable suction for comfort
- Pumped directly into a bottle or freezer bag
- Used to obtain breast milk for storage and later feeding
Why pump?
- Allows continued BF when separated from infant (work, illness)
- Maintains supply during temporary cessation of direct BF
- Provides expressed milk if supplementation is needed (preferred over formula)
- Relieves engorgement
Nursing Interventions — Storage & Freezing
Breast milk must be stored according to guidelines for proper containers, labeling, refrigerating, and freezing.
Storage durations:
- Room temperature under very clean conditions: up to 8 hours
- Refrigerated in sterile bottles: use within 8 days
- Frozen in freezer compartment of refrigerator in sterile containers: up to 6 months
- Deep freezer: up to 12 months
Container/labeling tips:
- Use sterile containers
- Label with date and amount
- Use oldest stored milk first ("first in, first out")
- Don't fill containers more than ¾ full (allow for expansion when frozen)
Nursing Interventions — Thawing
Procedures for thawing milk:
- Thaw milk in the refrigerator for 24 hr — best method (preserves immunoglobulins)
- Hold container under running lukewarm water OR place in container of lukewarm water
- Bottle should be rotated, but NOT shaken (shaking can damage milk components)
- DO NOT thaw in microwave
- Destroys immune factors and lysozymes
- Creates hot spots due to uneven heating → can burn newborn
After thawing:
- Do NOT refreeze thawed milk
- Discard unused portions after thawing or warming
- Use within 24 hr of thawing in refrigerator
Why these rules matter: Breast milk's immune-protective properties (IgA, lysozymes, leukocytes, macrophages, lactoferrin) are heat-sensitive. Refrigerator thawing preserves these factors; microwave heating destroys them and creates burn risk from uneven heating. The "no shaking" rule preserves the lipid structure of the milk.
Skin Care & Safety Interventions
Skin care:
- The eyes are cleaned using a clean portion of the wash cloth (use a different section of cloth for each eye)
- The newborn should be washed, rinsed, and dried with no soap left on the skin
- Apply fragrance-free, hypoallergenic, moisturizing emollient immediately after bathing to prevent dry skin
Infant safety:
- Do not leave the newborn unattended during the bath (single most important safety rule)
- Hot water heater should be set at 49°C (120.2°F) or less to prevent scalding
- Room should be warm; bath water 36.6–37.2°C (98–99°F)
- Bath water should be tested on the inner wrist (or elbow) prior to use
- Organize all equipment so the newborn isn't left unattended to retrieve supplies
Order of Giving the Bath
Move from the cleanest to the dirtiest areas of the newborn's body:
- Eyes — clean portion of the wash cloth; use clear water; move from inner canthus to outer canthus; new cloth section for each eye
- Face and head — wash gently; rinse
- Chest, arms, legs — wash, rinse, dry; ensure no soap is left on skin
- Groin LAST — perineal area is the dirtiest; saving it for last prevents transferring bacteria to cleaner areas
Why this order matters: Bathing cleanest to dirtiest prevents bacteria from the perineum from being spread to the eyes, face, or other body parts. Working systematically also reduces risk of missing areas and shortens total bath time (less heat loss).
Other technique points:
- Wrap newborn in a towel; swaddle in a football hold to shampoo the head
- Rinse shampoo and dry to avoid chilling
- Expose only the body part being bathed; dry thoroughly
Preventing Complications
Key prevention measures:
- Bathing by immersion is NOT done until the umbilical cord falls off and the circumcision is healed
- Until then: sponge bath only
- Wash around cord; do not get cord wet
- Do NOT bathe newborn immediately after feeding — prevents spitting up and vomiting
- Uncircumcised newborn: foreskin should NOT be forced back — constriction can result; clean what is exposed only
- Female newborns: wash the vulva by wiping from front to back — prevents contamination of the vagina or urethra from rectal bacteria
Genital cleansing summary:
- Uncircumcised penis: soap and water; rinse; do NOT retract foreskin
- Circumcised penis (post-procedure): warm water only; NO soap until healed
- Vulva: front to back, every diaper change and bath
Risk to monitor: chilling and heat loss → cold stress. Keep room warm, expose only the part being washed, and dry thoroughly between body areas.
Related Content
Standardized assessment at 1 and 5 minutes after birth — repeated every 5 min if score < 7 until 20 min or score normalizes. Evaluates 5 parameters, each scored 0–2 (max 10).
Five parameters (mnemonic APGAR):
- Appearance (color): 2 = pink all over · 1 = body pink, extremities blue (acrocyanosis) · 0 = pale or blue
- Pulse (HR): 2 = > 100 · 1 = < 100 · 0 = absent
- Grimace (reflex irritability to stimulus): 2 = cry, sneeze, cough · 1 = grimace · 0 = no response
- Activity (muscle tone): 2 = active motion, flexed · 1 = some flexion · 0 = limp
- Respirations: 2 = strong cry, regular · 1 = weak, irregular · 0 = absent
Underlying Principles
Score interpretation:
- 7–10 = good condition (most newborns; routine care)
- 4–6 = moderate distress (stimulation, supplemental O₂, possible bag/mask)
- 0–3 = severe distress (resuscitation required immediately)
Key principles:
- Resuscitation does NOT wait for Apgar score
- 5-min score correlates more closely with neurologic outcome than 1-min
- Score may be affected by gestational age, maternal medications, congenital anomalies
- Apgar score is not a predictor of long-term outcomes alone
- Color (Appearance) most subjective — acrocyanosis common and normal first 24 hr
Nursing Interventions
Score 7–10 (normal):
- Dry, warm, position
- Skin-to-skin with mother if stable
- Initiate feeding within 1 hour
Score 4–6 (moderate):
- Stimulate by drying, rubbing back
- Supplemental oxygen via blow-by
- Suction airway if obstructed
- Consider PPV (positive pressure ventilation) with bag-mask
- Reassess every 30 sec
Score 0–3 (severe):
- Immediate PPV with 100% O₂
- Chest compressions if HR < 60 after 30 sec PPV
- Call neonatal resuscitation team / code
- Establish IV access for medications
- Consider intubation, epinephrine, volume expansion
Document score, time of assessment, and any interventions performed.
Related Content
Primitive reflexes present at birth indicate intact neurological function. Most disappear in early infancy. Absence, asymmetry, or persistence beyond expected age may indicate neurologic dysfunction.
Major reflexes assessed (and disappearance age):
- Sucking — disappears 3–4 months
- Rooting — disappears 3–4 months
- Palmar grasp — disappears 3–4 months
- Plantar grasp — disappears 8 months
- Moro (startle) — disappears 3–4 months
- Babinski — disappears 12 months (toes fan up normally)
- Tonic neck (fencing) — disappears 3–4 months
- Step / dance — disappears 3–4 weeks
- Galant (truncal incurvation) — disappears 4 weeks
Underlying Principles
How to elicit each reflex:
- Sucking: stroke lips or insert nipple — infant sucks rhythmically
- Rooting: stroke cheek/corner of mouth — infant turns head toward stimulus and opens mouth
- Palmar grasp: place finger in palm — infant tightly grasps
- Plantar grasp: place finger at base of toes — toes curl down
- Moro: sudden change of position or loud noise — symmetric abduction/extension of arms, hands open, then flexion ('hugging')
- Babinski: stroke lateral sole heel to toe — toes fan and dorsiflex (positive in infant — abnormal in adult)
- Tonic neck: turn head to one side while supine — same-side arm extends, opposite arm flexes ('fencing position')
- Step: hold upright, feet touching surface — infant makes stepping motions
- Galant: stroke one side of back along spine — trunk curves toward stimulated side
Significance of findings:
- Absent reflexes may indicate CNS depression (asphyxia, sedation), neurologic damage, or prematurity
- Asymmetric reflexes may indicate brachial plexus injury, fracture, hemiparesis
- Persistent reflexes beyond expected disappearance — cerebral palsy, neurological disorder
Nursing Interventions
Who to assess:
- All newborns at initial assessment
- Daily during nursery stay
- At well-child visits per pediatric schedule
How to assess:
- Perform when infant is calm, alert (best 30–60 min after feed)
- Test all reflexes systematically
- Test bilaterally and compare sides
- Avoid testing immediately after feeding (regurgitation risk with Moro)
Why it matters:
- Documents neurologic status at birth
- Identifies need for further evaluation
- Baseline for comparison over time
- Reassurance to parents
Document findings: present/absent, symmetric/asymmetric, strength of response.
Report any abnormalities (absent, asymmetric, or weak reflexes) to provider for further evaluation.
Related Content
Decelerations are decreases in fetal heart rate from baseline. Classification based on timing relative to contractions, depth, and shape. Use the VEAL CHOP MINE mnemonic:
- Variable decels — Cord compression — Move (reposition mother)
- Early decels — Head compression — Identify labor progress (no intervention needed)
- Accelerations — Okay — No intervention (reassuring)
- Late decels — Placental insufficiency — Execute interventions (intrauterine resuscitation)
Each pattern characteristics:
- Early decel: gradual decrease & return, mirror image of contraction, nadir at peak of contraction, depth usually < 30 BPM. Benign.
- Variable decel: abrupt decrease (< 30 sec to nadir), ≥ 15 BPM below baseline, ≥ 15 sec but < 2 min. Shape and timing vary.
- Late decel: gradual decrease, nadir AFTER peak of contraction, return to baseline AFTER contraction ends. Concerning.
- Prolonged decel: decrease > 15 BPM below baseline lasting 2–10 min. Concerning if recurrent or severe.
Underlying Principles
Physiologic basis of each pattern:
- Early — Head compression: vagal stimulation from fetal head compression during contraction. Normal in active labor.
- Variable — Cord compression: umbilical cord compression intermittently impairs umbilical blood flow. May occur with oligohydramnios, cord around neck, prolapsed cord.
- Late — Placental insufficiency: contraction reduces uteroplacental blood flow; if insufficient placental reserve, fetus experiences transient hypoxia. Ominous sign of fetal hypoxia/acidosis.
- Prolonged — Multiple causes: tetanic contraction, maternal hypotension (epidural), cord prolapse, abruption, uterine rupture, vagal stimulation.
FHR categories (ACOG):
- Category I (Normal): baseline 110–160, moderate variability, accelerations present, no late or variable decels
- Category II (Indeterminate): not Cat I or Cat III; requires evaluation and intervention
- Category III (Abnormal): absent variability with recurrent late decels, recurrent variable decels, bradycardia, OR sinusoidal pattern. Urgent intervention or delivery required.
Intrauterine resuscitation interventions (LION mnemonic):
- Lateral position (left side first)
- IV fluid bolus (LR 500 mL)
- Oxygen 10 L/min via nonrebreather mask
- Notify provider; discontinue oxytocin
Nursing Interventions
Early decels — NO intervention needed:
- Document and continue monitoring
- Reassure client these are normal
- Identify cervical dilation if not recently checked
Variable decels — REPOSITION:
- Reposition mother (left lateral first, then right, then hands-knees if persistent)
- Consider amnioinfusion if persistent and oligohydramnios suspected
- Vaginal exam to rule out cord prolapse if severe
- Discontinue oxytocin if running
- Document interventions and response
Late decels — INTRAUTERINE RESUSCITATION:
- Discontinue oxytocin immediately
- Reposition mother (left lateral)
- IV fluid bolus (LR 500–1,000 mL)
- Oxygen 10 L/min via face mask
- Notify provider STAT
- Treat hypotension if present (ephedrine if epidural-related)
- Consider tocolysis (terbutaline 0.25 mg SC) if tachysystole
- Prepare for delivery if persistent (cesarean if no response)
Prolonged decels — RAPID ASSESSMENT:
- All interventions above
- Vaginal exam for cord prolapse, rapid cervical change, abruption signs
- Assess maternal VS for hypotension
- Stop oxytocin
- Prepare for emergency cesarean if not resolving
- Document interventions, timing, and FHR response carefully
Related Content
Recommended weight gain in pregnancy is based on PRE-PREGNANCY BMI per the Institute of Medicine (IOM) guidelines. Inadequate weight gain → IUGR, low birth weight, preterm birth. Excessive weight gain → macrosomia, gestational diabetes, hypertension, cesarean delivery, postpartum weight retention.
IOM Weight Gain Recommendations (Singleton)
- Underweight (BMI < 18.5): 28–40 lb (12.7–18.1 kg)
- Normal weight (BMI 18.5–24.9): 25–35 lb (11.3–15.9 kg)
- Overweight (BMI 25.0–29.9): 15–25 lb (6.8–11.3 kg)
- Obese (BMI ≥ 30): 11–20 lb (5.0–9.1 kg)
Distribution of Weight Gain
- First trimester: 1–4.4 lb (0.5–2 kg) total
- Second/third trimester: weekly gain depending on BMI
- Normal BMI: 0.8–1.0 lb/week
- Underweight: 1.0–1.3 lb/week
- Overweight: 0.5–0.7 lb/week
- Obese: 0.4–0.6 lb/week
Multifetal Gestation Weight Gain
- Twins (normal BMI): 37–54 lb
- Twins (underweight): 50–62 lb
- Twins (overweight): 31–50 lb
- Twins (obese): 25–42 lb
Underlying Principles
Where the weight goes (~25-35 lb total):
- Fetus: 7–8 lb (3.2–3.6 kg)
- Placenta: 1–2 lb (0.5–1 kg)
- Amniotic fluid: 2 lb (1 kg)
- Uterine enlargement: 2 lb (1 kg)
- Maternal breast tissue: 1–3 lb (0.5–1.4 kg)
- Maternal blood volume: 3–4 lb (1.4–1.8 kg)
- Body fluids (increased): 2–3 lb (1–1.4 kg)
- Maternal fat stores: 5–9 lb (2.3–4.1 kg) — energy reserves for breastfeeding
Pattern of Weight Gain
- Most weight gain occurs in 2nd and 3rd trimesters
- Slow or no gain in 1st trimester is normal (nausea, vomiting)
- Steady weekly weight gain expected from 2nd trimester onward
- Sudden weight gain (> 2 lb/week, > 6 lb/month) → assess for preeclampsia (fluid retention)
Caloric Requirements by Trimester
- 1st trimester: No increase needed (~2,000 cal/day for average)
- 2nd trimester: +340 cal/day
- 3rd trimester: +452 cal/day
- Lactation: +450–500 cal/day (per AAP)
Consequences of Inappropriate Weight Gain
- Inadequate gain: IUGR, low birth weight, preterm birth, increased perinatal mortality
- Excessive gain: macrosomia (> 4,000 g), shoulder dystocia, cesarean, gestational diabetes, preeclampsia, postpartum obesity, future childhood obesity in offspring
Nursing Interventions
Assessment at every prenatal visit:
- Calculate pre-pregnancy BMI from history
- Weigh at each visit (consistent scale, similar clothing)
- Plot weight on appropriate growth chart
- Compare to expected gain trajectory
- Assess for symmetry (steady gain vs sudden gain)
Nutrition Counseling
- Provide BMI-specific recommendations to client
- Encourage variety: fruits, vegetables, whole grains, lean protein, low-fat dairy
- Discourage empty calories: sugary drinks, processed foods, fast food
- Adequate fluid intake (2.3 L/day)
- Address cravings, food aversions, pica
- Refer to dietitian if significantly off trajectory
- Refer to WIC if food insecurity
For Inadequate Weight Gain
- Assess for nausea/vomiting, hyperemesis, eating disorder
- Dietary counseling: small frequent meals, calorie-dense foods
- Address underlying medical conditions
- Treat eating disorders
- Monitor fetal growth (serial ultrasounds)
For Excessive Weight Gain
- Never recommend weight loss during pregnancy
- Aim to slow rate of gain to appropriate weekly target
- Increase moderate exercise (walking 30 min/day)
- Limit added sugars, fats, processed foods
- Portion control education
- Screen for gestational diabetes
- Monitor BP for preeclampsia
Sudden Weight Gain — Red Flag
- Gain > 2 lb/week → assess for preeclampsia
- Check BP, urine protein
- Assess for face/hand edema (vs dependent edema, which is normal)
- Ask about headache, visual changes, RUQ pain
Related Content
The Bishop Score is a system used to predict the likelihood of successful induction of labor based on cervical readiness. Higher scores indicate the cervix is more favorable ("ripe") for induction.
Bishop Score Parameters (Total 0-13)
| Parameter | 0 | 1 | 2 | 3 |
|---|---|---|---|---|
| Dilation (cm) | Closed | 1–2 | 3–4 | ≥ 5 |
| Effacement (%) | 0–30 | 40–50 | 60–70 | ≥ 80 |
| Station | -3 | -2 | -1 / 0 | +1 / +2 |
| Consistency | Firm | Medium | Soft | — |
| Position | Posterior | Mid | Anterior | — |
Score Interpretation
- Score ≥ 8 (favorable): cervix is ripe; induction likely successful with similar duration to spontaneous labor
- Score 6–7 (intermediate): induction may proceed; consider cervical ripening for better success
- Score < 6 (unfavorable): cervical ripening agents recommended before induction; higher failure rate
Underlying Principles
Why Bishop Score Matters:
- Predicts duration of induction
- Predicts likelihood of cesarean delivery
- Identifies clients who would benefit from cervical ripening before oxytocin
- Helps with clinical decision-making and patient counseling
Understanding Each Parameter
- Dilation: how open the cervical os is (closed → 10 cm)
- Effacement: thinning of cervix (0-100%)
- Station: relationship of presenting part to ischial spines (-5 to +5; 0 = engaged)
- Consistency: firm (like nose) → medium → soft (like lip)
- Position: posterior → mid → anterior (anterior more favorable)
When Bishop Score is Used
- Before elective induction of labor
- To assess cervical readiness for VBAC
- To decide between cervical ripening agents vs direct oxytocin
- To counsel about likelihood of successful vaginal delivery
Cervical Ripening Options for Low Bishop Scores
- Prostaglandins:
- Dinoprostone (Cervidil 10 mg vaginal insert; Prepidil 0.5 mg gel)
- Misoprostol (Cytotec) 25 mcg PO/PV q4hr — contraindicated in prior cesarean
- Mechanical methods:
- Foley balloon catheter (30-60 mL)
- Cook balloon (double-balloon)
- Laminaria (hygroscopic dilators)
- Membrane stripping
Nursing Interventions
Assessment of Bishop Score:
- Performed via sterile vaginal exam
- Score each parameter individually
- Add all parameters for total score
- Document time, score, indication for assessment
- Combine with patient history and overall clinical picture
Nursing Care for Cervical Ripening
- Pre-procedure:
- Verify informed consent
- NPO if procedure may lead to delivery
- Baseline FHR and contraction monitoring
- IV access
- Empty bladder
- During/After Cervical Ripening Agent:
- Continuous EFM × 30 min to 2 hours post-insertion
- Lie supine or lateral × 30 min post-insertion
- Monitor for tachysystole (> 5 contractions in 10 min)
- Monitor for non-reassuring FHR pattern
- Watch for ROM
- If Cervidil: can remove immediately if complications
- If misoprostol: cannot be removed
- Begin oxytocin no sooner than 4 hr after last dinoprostone dose
Mechanical Methods (Foley Balloon)
- Safe in clients with prior cesarean
- Insert via sterile vaginal exam
- Inflate balloon with 30-60 mL saline
- Apply gentle traction (taped to leg)
- Falls out when dilation reaches 3-4 cm
- Maximum 24 hr placement
- Less risk of tachysystole than prostaglandins
Patient Education
- Explain the procedure and expectations
- Mild cramping is expected
- Goal is to soften and open the cervix before active induction
- May take 12-24 hours to achieve favorable cervix
- Once cervix is favorable, oxytocin may be started
- Report: severe pain, heavy bleeding, ROM, decreased fetal movement
Related Content
Pregnancy produces a wide range of physiologic discomforts from hormonal changes, growing uterus, increased blood volume, and changes in body mechanics. Most are normal but require management to maintain quality of life. Some require differentiation from pathologic conditions.
First Trimester (Weeks 1-12)
- Nausea and vomiting (50-80% of clients; "morning sickness")
- Fatigue, sleepiness (high progesterone)
- Urinary frequency (uterine pressure on bladder)
- Breast tenderness and enlargement
- Increased vaginal discharge (leukorrhea)
- Nasal stuffiness, epistaxis
- Ptyalism (excessive salivation)
Second Trimester (Weeks 13-26)
- Heartburn / GERD
- Constipation, hemorrhoids
- Round ligament pain (sharp groin pain)
- Backache (especially low back)
- Leg cramps (especially nocturnal)
- Varicose veins
- Skin changes (chloasma, linea nigra, striae gravidarum)
Third Trimester (Weeks 27-40)
- Shortness of breath (diaphragm elevation)
- Dependent edema
- Insomnia, sleep disturbances
- Braxton-Hicks contractions
- Returning urinary frequency
- Pelvic pressure
- Carpal tunnel syndrome
- Lightening (descent of presenting part)
Underlying Principles
Pathophysiology of Pregnancy Discomforts:
- Hormonal effects: hCG, progesterone, and estrogen affect smooth muscle, GI motility, vasculature
- Mechanical effects: growing uterus displaces organs, alters posture and gait
- Hemodynamic changes: increased blood volume, decreased peripheral resistance affect venous return
- Metabolic changes: increased nutrient demands, altered glucose metabolism
When Discomforts Become Red Flags
- Severe nausea/vomiting → hyperemesis gravidarum (weight loss > 5%, ketonuria, dehydration)
- Severe headache + visual changes → preeclampsia (NOT a normal pregnancy discomfort)
- Sudden weight gain, facial/hand edema → preeclampsia
- Painful, unilateral leg swelling → DVT
- Vaginal bleeding → abruption, previa, preterm labor
- Sudden gush of fluid → ROM
- Regular painful contractions before 37 wk → preterm labor
- Severe abdominal pain → abruption, ectopic, uterine rupture
- Decreased fetal movement → fetal distress
Pharmacologic Considerations
- Most OTC medications avoided unless approved by HCP
- Safe in pregnancy: acetaminophen, certain antacids (calcium-based), pyridoxine (B6), doxylamine, certain antihistamines (diphenhydramine, loratadine), simethicone
- Avoid: aspirin (3rd tri), ibuprofen/NSAIDs, decongestants with phenylephrine/pseudoephedrine, bismuth subsalicylate, sodium bicarbonate antacids
Nursing Interventions
First Trimester Management:
- Nausea/vomiting: small frequent meals; dry crackers before getting up; ginger 250 mg QID; pyridoxine (B6) 25 mg TID; doxylamine-pyridoxine (Diclegis) if severe; acupressure bands; avoid empty stomach
- Fatigue: 8-10 hr sleep, naps, prioritize rest, light exercise
- Urinary frequency: continue fluid intake during day, decrease evening fluids, void completely
- Breast tenderness: supportive bra (sports bra), gentle warm shower
- Leukorrhea: cotton underwear, panty liners, NO douching, good hygiene
- Nasal stuffiness: humidifier, saline nasal spray, avoid decongestants
Second Trimester Management
- Heartburn: small frequent meals, no eating before bed, head of bed elevated, calcium-based antacids (Tums), AVOID sodium bicarbonate
- Constipation: 25-30 g fiber/day, 2.3 L fluid/day, exercise, docusate sodium, NO stimulant laxatives, NO mineral oil
- Hemorrhoids: stool softeners, witch hazel pads (Tucks), sitz baths, topical hydrocortisone (short-term), avoid prolonged sitting
- Round ligament pain: slow position changes, bend knees toward abdomen, support belt, warm compress (NOT hot)
- Backache: pelvic tilt exercises, proper body mechanics, low-heeled shoes, support pillow, prenatal massage
- Leg cramps: dorsiflex foot with knee extended, calcium and magnesium intake, avoid pointing toes, warm bath
- Varicose veins: elevate legs frequently, compression stockings, avoid prolonged standing, NO crossing legs
Third Trimester Management
- Dyspnea: semi-Fowler position, extra pillows when sleeping, slow movements
- Edema: elevate feet, left lateral position, compression stockings, adequate hydration; differentiate from preeclampsia
- Insomnia: side-lying with pillow between legs, warm bath, no caffeine, relaxation techniques
- Braxton-Hicks: hydration, position change, walking; assess for preterm labor if regular/painful
- Carpal tunnel: wrist splints (especially night), ice, NSAIDs only with HCP approval
- Pelvic pressure: normal with engagement; reposition, pelvic rocking exercises
Related Content
TORCH is a mnemonic for a group of infections that can cross the placenta and cause significant congenital infection, fetal anomalies, or stillbirth. Often asymptomatic in the mother but devastating to the fetus.
TORCH Components
- T — Toxoplasmosis (Toxoplasma gondii)
- O — Other (HBV, HIV, syphilis, parvovirus B19, varicella, Zika, listeria)
- R — Rubella
- C — Cytomegalovirus (CMV)
- H — Herpes Simplex Virus (HSV)
Common Congenital Effects Across TORCH
- Intrauterine growth restriction (IUGR)
- Microcephaly
- Hepatosplenomegaly
- Jaundice
- Petechiae, purpura ("blueberry muffin rash")
- Hearing/vision impairment
- Neurodevelopmental delays
- Cardiac defects
Underlying Principles
Specific Infections in Detail:
Toxoplasmosis
- Source: raw/undercooked meat, unwashed produce, cat litter (oocysts)
- Maternal symptoms: often asymptomatic; flu-like illness
- Fetal effects: chorioretinitis, hydrocephalus, intracranial calcifications, hepatosplenomegaly, mental retardation
- Treatment: Spiramycin (1st tri); pyrimethamine + sulfadiazine + folinic acid (after 16 wk)
Rubella (German Measles)
- Source: respiratory droplets
- Maternal symptoms: low-grade fever, rash, lymphadenopathy
- Fetal effects (Congenital Rubella Syndrome): deafness, cataracts, cardiac defects (PDA), microcephaly, IUGR — worst if infected 1st trimester (50%)
- Vaccine: LIVE — give postpartum if non-immune; avoid pregnancy × 4 weeks
- No specific treatment — supportive only
Cytomegalovirus (CMV)
- Most common congenital infection
- Source: body fluids (saliva, urine, sexual contact); often acquired from toddlers
- Maternal symptoms: usually asymptomatic; may have mono-like illness
- Fetal effects: hearing loss (MOST COMMON sequela), microcephaly, intracranial calcifications, hepatosplenomegaly, learning disabilities
- No vaccine or effective treatment
- Prevention: hand hygiene around children, avoid sharing utensils/cups
Herpes Simplex Virus (HSV)
- HSV-2 (genital) and HSV-1 (oral, increasingly genital)
- Risk to fetus highest with PRIMARY maternal infection during pregnancy
- Neonatal HSV: skin/eye/mouth disease, CNS disease (encephalitis), disseminated disease (50% mortality)
- Active genital lesions at time of labor → cesarean delivery
- Suppressive therapy: acyclovir 400 mg TID from 36 weeks for recurrent HSV
Nursing Interventions
Screening at First Prenatal Visit:
- Rubella titer — IgG (immunity); if non-immune, vaccinate postpartum
- HSV history — primary or recurrent outbreaks?
- CMV — not routine; consider in high-risk (childcare workers, parents of toddlers)
- Toxoplasmosis — IgG/IgM if exposure history; not routine in US
- Other: HIV, HBsAg, syphilis (RPR), varicella history/titer
Prevention Education
- Toxoplasmosis:
- Avoid raw/undercooked meat (cook to 165°F)
- Wash all fruits and vegetables thoroughly
- Avoid cat litter changing (if must, wear gloves; have someone else change litter daily)
- Gardening with gloves
- Avoid contact with cat feces or stray cats
- CMV:
- Frequent hand hygiene, especially after diapering, feeding, wiping noses
- Don't share utensils, cups, food, toothbrushes with young children
- Don't kiss children on the mouth
- Clean toys, surfaces frequently
- Rubella:
- Pre-conception vaccination if non-immune
- Avoid contact with anyone with viral rash illness
- Avoid travel to areas with rubella outbreaks
- HSV:
- Disclose history at first prenatal visit
- Use condoms with partner who has HSV
- Avoid oral sex with partner who has cold sores
- Suppressive therapy from 36 weeks for recurrent genital HSV
- Inspect for lesions at labor onset
Management of Suspected/Confirmed Infection
- Document specific organism and gestational age at infection
- Maternal serology (IgG, IgM)
- Consider amniocentesis for fetal diagnosis (PCR)
- Detailed ultrasound for fetal abnormalities
- Fetal MRI in selected cases
- Genetic counseling and pediatric infectious disease consultation
- Postpartum: newborn evaluation with cultures, PCR, ophthalmology, audiology
Related Content
BUBBLE-HE is a systematic head-to-toe mnemonic for postpartum assessment. Performed at intervals: q15 min × 1 hr after delivery, q30 min × 1 hr, q4 hr × 24 hr, then per institutional protocol. Identifies complications early.
The BUBBLE-HE Mnemonic
- B — Breasts
- U — Uterus (fundus)
- B — Bladder
- B — Bowel
- L — Lochia
- E — Episiotomy / Epidural site / Edema
- H — Homans sign / Hemorrhoids
- E — Emotions / Education
Some versions include "Lower extremities" for the second L position; principles are the same.
Underlying Principles
What to Assess in Each Component:
B — Breasts
- Day 1-2: soft, colostrum production
- Day 3-5: milk "comes in" — full, firm, possibly tender (engorgement)
- Assess: shape, symmetry, nipples (everted/inverted/flat/cracked), tenderness, redness, warmth, masses
- Latch and feeding (if breastfeeding)
- Watch for: mastitis (unilateral redness, warmth, fever), plugged duct, severe engorgement
U — Uterus (Fundus)
- Assess: location (above/at/below umbilicus), midline vs deviated (deviation = full bladder), firmness (firm/boggy)
- Expected involution: 1 cm below umbilicus each day; non-palpable by day 10-14
- If boggy: massage firmly; if doesn't firm → uterotonics, notify provider
- If deviated: have client void, then reassess
B — Bladder
- Assess: ability to void, void volume, postvoid residual
- First void within 6-8 hours postpartum (catheterize if not)
- Distended bladder displaces uterus → atony, hemorrhage
- Risk of retention from epidural, bladder hypotonia, edema
B — Bowel
- Bowel sounds, last BM, flatus
- Expected: first BM by day 2-3
- Often delayed by perineal pain, opioids, slow peristalsis
- Stool softener (docusate) for prevention of constipation
L — Lochia
- Assess: amount, color, odor, presence of clots
- Quantification: Scant (< 2.5 cm) → Light (2.5-10 cm) → Moderate (> 10 cm, < pad) → Heavy (full pad in 2 hr)
- Progression: Rubra (days 1-3) → Serosa (days 4-10) → Alba (days 11-21+)
- Reassessment after voiding (full bladder can mask blood)
- Saturating pad < 1 hr → hemorrhage
E — Episiotomy / Epidural / Edema
- REEDA: Redness, Edema, Ecchymosis, Discharge, Approximation
- Epidural site: hematoma, redness, drainage
- Perineal edema: ice × 12-24 hr, then sitz baths
- Hematomas: severe pain, perineal mass, hypotension out of proportion to visible blood loss
H — Homans Sign / Hemorrhoids
- Assess legs for: warmth, redness, swelling, tenderness, asymmetry
- Homans sign: calf pain on dorsiflexion (controversial; low sensitivity)
- Postpartum has 5× DVT risk in pregnancy, 20× in immediate postpartum
- Hemorrhoids: assess size, tenderness, bleeding; topical agents, sitz baths
E — Emotions / Education
- Mood, attachment behaviors, family interaction
- Screen for postpartum blues vs depression (EPDS)
- Concerns or questions
- Sleep quality and amount
- Identify learning needs: newborn care, self-care, return to activity
Nursing Interventions
Documentation:
- Date, time of each assessment
- Each component of BUBBLE-HE documented
- Fundal height (in fingerbreadths or cm), position, consistency
- Lochia: amount, color, odor, clots
- Any abnormal findings + interventions + response
Frequency of Assessment
- 1st hour: every 15 minutes
- 2nd hour: every 30 minutes
- Next 22 hours: every 4 hours
- After 24 hours: every shift or per protocol
- More frequent if abnormalities
Red Flags Requiring Immediate Action
- Boggy fundus that doesn't firm with massage → uterotonics, notify provider
- Saturated pad in < 1 hr → hemorrhage protocol
- Heavy bleeding with firm fundus → cervical/vaginal laceration
- Fever > 38°C after first 24 hr → infection workup
- Severe headache, BP > 140/90 → late-onset preeclampsia
- Unilateral calf swelling, redness, pain → DVT workup
- SOB, chest pain → PE workup (medical emergency)
- Foul lochia + abdominal pain → endometritis
- Inability to void after 6-8 hr → catheterize
- Suicidal ideation or self-harm thoughts → emergency mental health evaluation
Patient Education During Assessment
- Normal vs abnormal findings
- When to call provider after discharge
- Self-fundal massage if home use
- Lochia changes over time
- Perineal care, breast care
- Signs of postpartum depression
Related Content
Maternal role attainment is the process of becoming a mother — taking on the maternal role and developing maternal identity. Reva Rubin (1961) described three classic phases of psychological adaptation in the postpartum period.
Rubin's Three Phases of Maternal Role Attainment
- Taking-In (Days 1-2): Passive, dependent, focused on own physical recovery
- Taking-Hold (Days 2-10): Increased autonomy, eager to learn newborn care
- Letting-Go (1+ weeks): Integration of newborn into family unit, redefinition of self
While Rubin's original timeline has been updated (modern practice notes phases overlap and progress faster with shorter hospital stays), the framework remains useful for understanding postpartum adaptation.
Underlying Principles
Taking-In Phase (Days 1-2)
- Maternal focus: her own needs (food, fluid, rest, physical recovery)
- Passive, dependent on others for care
- Talks about birth experience repeatedly (processing)
- Needs nurturing and reassurance
- Limited interest in newborn care initially
- Difficulty integrating new information — teaching is poorly retained
- Tearfulness may occur
- Sleep needs are high
Taking-Hold Phase (Days 2-10)
- Maternal focus: increasing focus on newborn and learning to mother
- Becomes more independent
- Eager to learn newborn care
- Optimal time for teaching — high motivation, better retention
- Concerned with body image, bladder/bowel function
- May feel inadequate or anxious about caring for newborn
- Often coincides with "baby blues" (50-80% incidence)
- Mother regains energy and engagement
Letting-Go Phase (1+ weeks)
- Maternal focus: family unit and accepting newborn as separate individual
- Integration of newborn into family
- Reestablishment of relationships (partner, other children)
- Acceptance of changes in lifestyle and self-image
- Letting go of expectations about birth and motherhood
- Adapting to reality of motherhood
- Resumption of pre-pregnancy activities (modified)
Healthy Attachment Behaviors
- En face position: face-to-face eye contact (~8 inches distance)
- Calling newborn by name
- Parentese: high-pitched, slow, melodic speech
- Progressive touch: fingertip → palmar → enfolding
- Identifying specific features ("She has my nose")
- Skin-to-skin contact
- Responding to newborn cues
- Engrossment (in partner): intense preoccupation with newborn
Warning Signs of Impaired Attachment
- Negative comments about newborn
- Avoiding eye contact or refusing to hold
- Inappropriate handling (rough, distant)
- Lack of interest in newborn's care
- Using generic terms only ("it," "the baby" — never name)
- Refusing to name newborn
- Crying, withdrawal, or hostility
Nursing Interventions
Nursing Interventions for Taking-In Phase:
- Provide nurturing care and meet basic needs (food, fluid, rest, comfort)
- Allow mother to talk about birth experience — validate feelings
- Avoid extensive teaching during this phase
- Provide pain management for postpartum discomfort
- Encourage skin-to-skin contact even if mother is tired
- Support partner's involvement in newborn care
- Brief, simple education only
- Don't be alarmed by passivity or self-focus — this is normal
Nursing Interventions for Taking-Hold Phase
- Prime time for teaching:
- Newborn care: diapering, bathing, cord care, swaddling, soothing
- Feeding (breastfeeding latch, formula prep, burping)
- Recognizing newborn cues
- Self-care (perineal care, breast care, lochia, activity)
- Warning signs for self and newborn
- Postpartum depression awareness
- Build maternal confidence — praise efforts
- Allow mother to provide care while you observe
- Refer to lactation consultant if needed
- Address body image and bladder/bowel concerns
- Provide written materials for later reference
- Screen for postpartum blues vs depression
Nursing Interventions for Letting-Go Phase
- Encourage involvement of partner and family
- Discuss sibling adaptation
- Address concerns about returning to work
- Refer to support groups, lactation support, mommy groups
- Postpartum depression screening at 6-week visit
- Resume sexual activity counseling
- Contraception planning
- Discuss self-care and rest
Promoting Attachment
- Facilitate immediate skin-to-skin contact at delivery (golden hour)
- Rooming-in
- Encourage breastfeeding
- Support family-centered care (visitors as desired)
- Identify and support cultural practices
- Document attachment behaviors
- Identify risk factors for impaired attachment (PPD, abuse history, unwanted pregnancy)
Risk Factors for Delayed/Impaired Role Attainment
- Difficult or traumatic birth experience
- Newborn complications (NICU admission, prematurity)
- Postpartum depression
- Lack of social support
- Adolescent mother
- Unwanted/unplanned pregnancy
- Substance abuse
- History of childhood trauma
- Domestic violence
- Major life stressors (financial, housing)
Related Content
Motor vehicle crashes are the leading cause of death in children > 1 year old. Proper car seat installation and use reduce death by 71% for infants. Most parents install car seats incorrectly without instruction. Car seat education and installation verification are essential before hospital discharge.
AAP Recommendations (2018 Update)
- Rear-facing until at least age 2 OR maximum weight/height for the seat (whichever comes first)
- Forward-facing with harness after rear-facing limit, until reaches harness limit (40-65 lb)
- Booster seat until adult seat belt fits properly (typically age 8-12)
- Back seat until at least age 13
Types of Car Seats for Newborns
- Infant-only seats (rear-facing only):
- Designed for newborns up to 22-35 lb (varies)
- Carrier-style with detachable base
- Most common for newborns
- Convertible seats:
- Can be used rear-facing then forward-facing
- Higher weight limits (rear: 35-50 lb)
- Stay in the vehicle
- All-in-one seats: Rear-facing → forward-facing → booster
Underlying Principles
Critical Installation Principles:
Position
- ALWAYS rear-facing for newborns
- NEVER place rear-facing seat in front seat with active airbag — fatal head injury risk if airbag deploys
- Center rear seat is statistically safest position
- Side window seat acceptable if center can't accommodate
Recline Angle
- 30-45° recline angle for newborns (head shouldn't slump forward — airway compromise)
- Use built-in level indicators
- May need pool noodle or rolled towel under base to achieve angle (only if manufacturer permits)
Installation Tightness
- Use either LATCH (Lower Anchors and Tethers for Children) system OR vehicle seat belt — NEVER both
- LATCH weight limit varies (typically 65 lb for combined weight of child + seat)
- Car seat should not move more than 1 inch front-to-back or side-to-side at the belt path
- Press knee firmly into seat while tightening to compress and secure
Harness Position
- Rear-facing: harness straps at or BELOW shoulders
- Forward-facing: harness at or ABOVE shoulders
- Chest clip AT ARMPIT LEVEL (over the collarbones, level with armpits)
- Harness should be snug — cannot pinch a fold of webbing at the shoulder
- No twists in the harness
What NOT to Use
- NO bulky coats or blankets BEHIND/UNDER the harness — compresses in crash, harness too loose
- NO aftermarket products not approved by manufacturer: mirrors, head supports, harness covers, snuggle pads, swaddle wraps for car seat
- NO sleep positioners or wedges
- Approved: head support that comes WITH the seat
Special Considerations for Newborns
- Verify weight is appropriate for seat (most seats > 4 lb minimum; some have lower limits)
- Preterm/low birth weight infants: Car Seat Challenge required before discharge
Nursing Interventions
Before Discharge Education:
- Verify family has car seat available
- Confirm understanding of:
- Rear-facing requirement
- Back seat placement
- NO airbag rule
- Harness adjustment
- Chest clip position
- Demonstrate proper installation if possible
- Provide written materials
- Refer to certified Child Passenger Safety Technician (CPST) for installation check
- Discuss: NHTSA inspection stations are free
Car Seat Challenge (for Preterm/LBW Infants)
- Required before discharge for: infants < 37 weeks gestation, < 2.5 kg birth weight, low APGAR, or known cardiopulmonary issues
- Procedure: place infant in their own car seat at the recline angle that will be used
- Monitor with pulse oximetry × 90-120 minutes (or duration of typical car trip)
- Fail criteria:
- Desaturation < 90% (or per institutional protocol)
- Apnea > 20 seconds
- Bradycardia < 80 bpm
- If fails: car bed (lie-flat) used until follow-up assessment
Common Parent Questions
- "Can I use a coat in cold weather?" Buckle baby in with thin clothing first, THEN place blanket over harness
- "How long can the baby be in the car seat?" Limit to 2 hours when possible; take breaks for tummy time
- "What if my baby falls asleep in the car seat?" Safe in the car; transfer to crib for sleep at home — car seat is NOT a sleep surface
- "When can I face forward?" Rear-facing until at least age 2 (longer is safer)
- "What about used car seats?" Only safe if: no crash history, no expiration date passed (typically 6 years from manufacture), no recalls, all parts present, instructions available
Resources for Parents
- NHTSA (nhtsa.gov) — free car seat inspection locations
- Local fire/police stations often have CPSTs
- AAP HealthyChildren.org car seat finder
- SafeKids.org
- Manufacturer's instruction manual and vehicle owner's manual
Reporting and Replacement
- Replace car seat after ANY crash (per NHTSA)
- Check for recalls (registered with manufacturer)
- Verify expiration date (typically 6 years)
Related Content
The Five P's are factors affecting the labor process:
- Powers — uterine contractions (primary) and maternal pushing efforts (secondary in second stage)
- Passenger — the fetus: size, lie, presentation, position, attitude
- Passage — the pelvis (true and false), pelvic outlet, soft tissues
- Position — maternal positioning during labor
- Psyche/Psychological response — maternal anxiety, fear, coping, support
1. Powers:
- Primary: involuntary uterine contractions
- Frequency, duration, intensity, resting tone
- Effective contractions cause cervical effacement and dilation
- Secondary: maternal pushing in second stage
2. Passenger:
- Lie: longitudinal (normal), transverse (abnormal), oblique
- Presentation: cephalic (vertex normal; brow/face abnormal), breech (frank, complete, footling), shoulder
- Position: relationship of presenting part to maternal pelvis (e.g., LOA, ROA, LOP)
- Attitude: degree of flexion (full flexion = vertex, optimal)
- Station: level of presenting part relative to ischial spines (-5 to +5)
- Size: macrosomia complicates
3. Passage:
- True pelvis: inlet, midpelvis, outlet
- Pelvis types: gynecoid (most favorable), android (heart-shaped, poor), anthropoid (oval), platypelloid (flat, very narrow)
- Soft tissues: cervix, vagina, perineum (elasticity)
- CPD (cephalopelvic disproportion) can prevent vaginal birth
4. Position (maternal):
- Upright positions (walking, standing, squatting): use gravity, may shorten labor
- Hands and knees: helps OP rotation
- Side-lying: rest, can help slow labor
- Supine: NOT ideal (supine hypotension, slower)
- Encouraged to change positions frequently
5. Psyche:
- Anxiety, fear → ↑ catecholamines → ↓ contractions, ↓ progress
- Support persons, doula, environment, prior experiences
- Cultural beliefs
- Coping mechanisms
- Confidence in ability to birth
Underlying Principles
All five P's must work in harmony for normal labor progress. Imbalance in any can cause dystocia (dysfunctional labor).
Powers depend on:
- Uterine integrity, gestational age, hormones (oxytocin, prostaglandins)
- Position, hydration, fatigue
Passenger depends on:
- Fetal head plasticity (molding allows passage)
- Diameters of presenting part
- Optimal: vertex, full flexion, occiput anterior
Passage depends on:
- Bony pelvis: largely fixed, but soft tissue gives
- Pelvic types affect labor mechanics
- Soft tissues: estrogen, relaxin soften connective tissue
Position effects:
- Upright: gravity assists descent, larger pelvic diameter
- Pelvic openings 30% larger in squatting/hands and knees
Psyche effects:
- Fight-or-flight (stress) → catecholamines inhibit oxytocin and contractions
- Relaxation → endorphins, oxytocin support labor
Nursing Interventions
Assess each P:
- Powers: monitor contractions (frequency, duration, intensity)
- Passenger: Leopold maneuvers, ultrasound; cervical exam for position/station
- Passage: history of prior births, pelvic assessment, fetal size estimate
- Position: encourage frequent changes, ambulation
- Psyche: continuous emotional support, doula/family involvement
Optimize each P:
- Powers: Hydration, position changes, oxytocin if augmentation needed; rest if exhausted
- Passenger: Encourage optimal positioning (hands and knees for OP); ECV for breech; cesarean for malpresentation
- Passage: Position changes to maximize pelvic outlet; avoid lithotomy
- Position: Walking, squatting, hands and knees, peanut ball, side-lying
- Psyche: Continuous support, breathing techniques, environment (quiet, dim lights), pain management, education and reassurance
Documentation:
- Contraction pattern
- Cervical changes
- Fetal position, station
- Maternal positioning
- Coping, support
When P's are not working:
- Identify which P
- Targeted intervention
- Sometimes intervention needed (augmentation, position change, cesarean)
Related Content
First Stage: onset of regular contractions → full cervical dilation (10 cm)
- Latent phase (0-6 cm): contractions mild to moderate, less frequent; many women can sleep, eat lightly, ambulate; can last hours-days for primips
- Active phase (6-10 cm): contractions stronger, more frequent (every 2-3 min); rapid dilation; intense; ~1-2 cm/hour
- Transition (8-10 cm): peak intensity; brief but intense; may feel "out of control"
Second Stage: full dilation → birth of baby
- Pushing stage
- Primigravida: up to 2-3 hours (longer with epidural)
- Multigravida: minutes to 1 hour
- Cardinal movements: engagement, descent, flexion, internal rotation, extension, external rotation, expulsion
Third Stage: birth of baby → delivery of placenta
- 5-30 minutes typically
- Active management with oxytocin
- Signs of placental separation: lengthening cord, gush of blood, uterine contraction, uterus becomes globular
Fourth Stage: 1-4 hours postpartum
- Recovery stage
- Hemodynamic stabilization
- Bonding, breastfeeding initiation
- Watch for hemorrhage
Underlying Principles
Why staged? Each stage has distinct physiologic events, risks, and nursing care priorities.
First stage:
- Cervical effacement and dilation occur
- Effacement (thinning) is %
- Dilation (opening) is in cm (0-10)
- Primip: effacement before dilation
- Multip: simultaneous
Second stage:
- Ferguson reflex (oxytocin surge with stretching of vagina)
- Cardinal movements: passive descent through pelvis
- Crowning: largest diameter of head emerges
Third stage:
- Uterine contractions continue → placental shearing from uterine wall
- Uterotonic effect of oxytocin
- Schultz mechanism (shiny side first) vs Duncan (dirty/maternal side first)
Fourth stage:
- Uterine contraction prevents hemorrhage
- Cardiovascular shift: ↑ cardiac output (auto-transfusion from uterus)
- Risk of: PPH, hematomas, eclampsia
Nursing Interventions
First stage nursing care:
- Vital signs Q1h (active labor) or Q4h (latent)
- Fetal monitoring (continuous or intermittent based on risk)
- Contraction assessment
- Cervical exams (limit to minimize infection)
- Position changes, ambulation in latent/early active
- Pain management — non-pharm and pharm
- Hydration (IV or oral)
- Empty bladder Q2h
- Emotional support, education
Second stage:
- Vital signs Q15-30 minutes
- FHR Q15 minutes (with each push)
- Coach pushing (open vs closed glottis based on preference)
- Allow descent (delayed pushing OK)
- Position changes (squat, hands and knees, side-lying)
- Encourage rest between pushes
- Prepare for delivery
- Time second stage
Third stage:
- Watch for signs of separation
- Avoid traction until separation
- Active management (oxytocin)
- Examine placenta for completeness
- Document time of placental delivery
- Skin-to-skin with mother
Fourth stage:
- Vital signs Q15 min × 1 hour, then Q30 min × 1, then Q1h
- Fundal checks (firm, midline, at umbilicus level)
- Lochia assessment (amount, color)
- Perineum assessment
- Bladder (encourage void, watch for retention)
- Bonding facilitation
- Breastfeeding initiation
- Pain management
- Watch for hemorrhage
Related Content
True labor:
- Regular contractions that become progressively closer, longer, stronger
- Cause cervical change (effacement, dilation)
- Pain typically starts in back, radiates to abdomen
- Walking increases or doesn't change intensity
- Not relieved by hydration, rest, or position changes
- Bloody show may be present
- Membranes may rupture
False labor (Braxton Hicks):
- Irregular contractions, don't progress
- No cervical change
- Pain in abdomen only (not back)
- Walking, rest, or hydration often relieves contractions
- Position changes relieve
- No bloody show typically
- Common in late pregnancy
Other signs that labor is starting:
- Lightening (baby drops)
- Loss of mucus plug (bloody show)
- Spontaneous rupture of membranes (water breaking)
- Energy burst (nesting)
- Backache, pelvic pressure
- Diarrhea (some)
- Cervical changes on exam
Underlying Principles
Physiology:
- True labor: oxytocin surge, increased prostaglandins, uterine sensitivity → coordinated effective contractions
- False labor: uterine activity without sufficient prostaglandins/oxytocin → uncoordinated, ineffective
5-1-1 rule:
- Contractions every 5 minutes
- Lasting 1 minute each
- For 1 hour
- → Time to go to hospital (low-risk multips: 4-1-1)
Important distinction:
- Only cervical change definitively confirms true labor
- Contraction pattern is suggestive
- Some women have prodromal labor (irregular but causing some changes) — frustrating
SROM (spontaneous rupture of membranes):
- Gush or trickle of clear fluid
- Cannot be controlled (vs urine)
- Watch for: color (greenish = meconium, concerning), amount, time of rupture, contractions
- Bring to hospital even if no contractions
Nursing Interventions
Education on signs of labor:
- Prenatal classes
- Discuss 5-1-1 rule for nullipara
- 4-1-1 for multipara
- Bloody show OK; trickle of blood OK
- Significant bleeding → ER immediately
- SROM: come to hospital
Assessment at admission:
- Contraction pattern (frequency, duration, intensity)
- Cervical exam (dilation, effacement, station, position)
- Compare to prior exam if available
- Determine: true labor, prodromal, or false labor
If false labor:
- Reassurance
- Hydration
- Walking
- Discharge to home with instructions
- Return precautions: bleeding, ROM, regular intense contractions, decreased fetal movement, severe headache/visual changes (preeclampsia)
If true labor:
- Admit
- Initiate labor care
- Continuous fetal monitoring as indicated
- Family support
Watch for and report (during pregnancy late 3rd tri):
- Regular contractions in true labor pattern
- SROM
- Bleeding
- Decreased fetal movement
- Severe headache, visual changes, RUQ pain (preeclampsia)
- Persistent vomiting
Related Content
National Institute of Child Health and Human Development (NICHD) three-tier system for interpreting fetal heart rate (FHR) tracings:
Category I (Normal):
- Baseline 110-160 bpm
- Moderate variability (6-25 bpm)
- Accelerations: present or absent
- Late or variable decelerations ABSENT
- Early decelerations: present or absent
- Reassuring — normal acid-base status; continue routine care
Category II (Indeterminate):
- Everything NOT Category I or III
- Most tracings fall here
- Variable: absent or minimal variability with no decelerations; absent variability with recurrent variable or late decelerations; tachycardia; bradycardia without absent variability
- Recurrent variable or late decelerations with moderate variability
- Not predictive of abnormal fetal acid-base status, but warrants evaluation, continued surveillance, intrauterine resuscitation
Category III (Abnormal):
- Absent variability AND any of:
- - Recurrent late decelerations
- - Recurrent variable decelerations
- - Bradycardia
- OR sinusoidal pattern
- Predictive of abnormal acid-base status — requires prompt evaluation and intervention; may require immediate delivery
Underlying Principles
Components of FHR assessment:
- Baseline rate: 110-160 bpm (over 10 min, excluding accels/decels)
- Variability: beat-to-beat fluctuations
- - Absent: undetectable
- - Minimal: ≤ 5 bpm
- - Moderate: 6-25 bpm (NORMAL — best indicator of fetal well-being)
- - Marked: > 25 bpm
- Accelerations: abrupt ↑ > 15 bpm above baseline, lasting ≥ 15 seconds (10 bpm/10 sec if < 32 wks); GOOD SIGN
- Decelerations:
- - Early: gradual onset, mirrors contraction (head compression — benign)
- - Variable: abrupt onset, V/U/W shape (cord compression)
- - Late: gradual, AFTER contraction peak (uteroplacental insufficiency — concerning)
- - Prolonged: ≥ 2 minutes but < 10 minutes
- - Sinusoidal: smooth sine-wave (severe fetal anemia — concerning)
Why three-tier:
- Provides framework for communication and decision-making
- Most tracings (~80%) are Category II — requires clinical judgment
- Category III rare but indicates urgent intervention needed
VEAL CHOP mnemonic:
- Variable decels = Cord compression
- Early decels = Head compression
- Accelerations = OK (well-oxygenated)
- Late decels = Placental insufficiency
Nursing Interventions
Category I:
- Continue routine care
- Documentation
- Reassure mother
Category II:
- Continued surveillance, more frequent monitoring
- Intrauterine resuscitation:
- - Position change (left side-lying, then right if no improvement)
- - O2 by face mask 10 L/min
- - IV fluid bolus (LR 500 mL)
- - Stop oxytocin if running
- - Correct hypotension (epidural-related)
- - Treat hyperstimulation (terbutaline)
- - Internal monitoring (FSE, IUPC) if external inadequate
- Notify provider
- Reassess after interventions
- If not improving → may need Category III workup
Category III:
- Notify provider immediately
- Intrauterine resuscitation (as above)
- Prepare for emergent delivery (likely cesarean)
- OR ready
- Pediatric/neonatal team to attend
- Document interventions and response
- Communicate clearly with team
- Family support
Documentation:
- Document FHR strip every 15-30 min in active labor
- Note: baseline, variability, accelerations, decelerations
- Tier/category
- Interventions and response
- Provider notifications
Communication:
- SBAR format
- Provider must see strip
- Closed-loop communication
- Document conversations
Related Content
First stage: onset of regular contractions to full cervical dilation (10 cm). Subdivided:
Latent phase (0-6 cm):
- Contractions: mild to moderate, every 5-30 min, lasting 30-45 sec
- Cervical change slow
- Patient often able to talk, walk, eat lightly
- Duration: 6-8+ hours primip; 4-5 hours multip
Active phase (6-10 cm):
- Contractions: stronger, every 2-3 min, lasting 60-90 sec
- Dilation 1-1.5 cm/hour (primip); faster (multip)
- More intense pain
Transition phase (8-10 cm):
- Contractions: every 2-3 min, lasting 60-90 sec, intense
- Bloody show
- Possible vomiting, trembling
- Often feels "out of control"
- Brief but intense
Key assessments:
- Vital signs
- Contraction pattern (frequency, duration, intensity)
- Fetal heart rate
- Cervical exam
- Pain assessment
- Coping, support
Underlying Principles
Goals of first stage:
- Effacement and dilation (mechanical changes of cervix)
- Fetal descent begins
- Establish coping and support patterns
- Manage pain
- Monitor mother and fetus safely
- Identify complications early
Cervical changes:
- Effacement: cervix thins from approximately 2 cm thick to paper-thin
- Measured 0-100%
- Dilation: cervix opens from 0 cm to 10 cm
- Primip: effacement happens before dilation; multip: simultaneous
Powers (contractions) characteristics:
- Frequency: from start of one to start of next
- Duration: from start to end of one contraction
- Intensity: mild, moderate, strong (palpation or IUPC in mmHg)
- Resting tone: relaxed uterus between contractions
Hydration and nutrition:
- Latent: clear liquids and light foods often OK
- Active: typically clear liquids, ice chips
- IV fluids if NPO or for hydration
Nursing Interventions
Vital signs:
- BP, HR, RR Q1h in active labor; Q4h latent
- Temperature Q4h (Q2h after ROM)
Contraction assessment:
- Q30 min in active labor
- Q1h latent
- External tocodynamometer or palpation
- IUPC for accurate intensity if needed
Fetal monitoring:
- Low-risk: intermittent auscultation Q30 min active labor; Q1h latent
- High-risk: continuous external or internal monitoring
- Document Category I, II, or III
- Note baseline, variability, accelerations, decelerations
Cervical exam:
- Limit to minimize infection (especially after ROM)
- Performed at admission, periodically with progress, before pain medication
- Document: dilation, effacement, station, position, membranes intact or ruptured
Comfort measures:
- Position changes Q30 min (walking, side-lying, hands and knees, ball)
- Breathing techniques
- Massage, counter-pressure
- Warm compresses, ice
- Hydrotherapy (shower, tub)
- Music, dim lights
- Aromatherapy
- Continuous labor support (doula, family)
Pain management:
- Non-pharm first
- Pharm: IV opioids (nubain, butorphanol — note opioid timing for newborn respiratory depression), epidural, spinal
Hydration:
- Encourage clear liquids, ice chips
- IV LR or NS
- Empty bladder Q2h
Watch for:
- Fetal distress (Category III)
- Hyperstimulation
- Bleeding
- Maternal fever
- Hypertension
- Inadequate progress (consider dystocia)
- ROM (note time, color, amount)
Family-centered care:
- Involve support person
- Continuous emotional support
- Updates on progress
Related Content
Second stage: full cervical dilation (10 cm) → birth of baby. Pushing stage.
Duration:
- Primigravida without epidural: up to 2 hours (3 hours with epidural)
- Multigravida without epidural: up to 1 hour (2 hours with epidural)
- Beyond these → arrest of descent
Phases:
- Latent (laboring down): 10 cm but no urge to push; fetus descending passively; allowed with epidural
- Active pushing: ferguson reflex, Valsalva pushing
- Birth: crowning to expulsion
Cardinal movements:
- Engagement (largest diameter through inlet)
- Descent
- Flexion
- Internal rotation (occiput to anterior)
- Extension (head delivers)
- External rotation (restitution + shoulders rotate)
- Expulsion
Signs of imminent birth:
- Bulging perineum
- Crowning (presenting part visible at perineum)
- Strong urge to push
- Bloody show ↑
- "Burning" or "stretching" sensation
Underlying Principles
Ferguson reflex:
- Stretching of vagina by presenting part → oxytocin release → stronger contractions and urge to push
Pushing technique:
- Open-glottis (physiological): push when urge, brief efforts, breathe through contractions — preferred
- Closed-glottis (directed/Valsalva): 10-second sustained pushes — traditional, but may cause maternal fatigue and reduce fetal oxygenation
- Evidence supports patient-led, open-glottis pushing
Why delayed pushing OK:
- Allows passive descent through cardinal movements
- Reduces maternal exhaustion
- Especially helpful with epidural
Crowning:
- Head no longer recedes between contractions
- Largest diameter of head emerging
- Critical moment — controlled delivery prevents lacerations
Maternal physiologic changes:
- ↑ BP, ↑ HR with pushing
- Hyperventilation
- Possible vomiting
- Trembling
Nursing Interventions
Vital signs:
- BP Q5-15 min
- HR Q5-15 min
- Continuous fetal monitoring (Q5-15 min with each push)
Coaching pushing:
- Encourage spontaneous pushing first
- If directed pushing needed: deep breath, push with contraction
- 3 pushes per contraction typically
- Rest between contractions
- Allow downward grunting (physiological)
Positioning:
- Variety of positions — patient preference
- Side-lying, semi-Fowler, hands and knees, squatting, lithotomy
- Upright positions may shorten second stage
- Change positions if not progressing
- Avoid lithotomy if possible (reduces pelvic outlet)
Perineal care:
- Warm compresses to perineum (may reduce tears)
- Gentle massage if desired
- Support perineum during crowning to control delivery
Comfort:
- Cool cloth to forehead
- Ice chips
- Encouragement
- Mirror so patient can see (some)
Watch for fetal distress:
- Variable decels common (cord compression)
- Late decels concerning (placental insufficiency)
- Continuous monitoring
Prepare for delivery:
- Sterile delivery field
- Resuscitation equipment ready
- Identification bands
- Skin-to-skin plan
- Time of birth
Delivery of baby:
- Provider controls head emergence (slow)
- Suction nose, mouth if needed
- Check for cord around neck (nuchal cord)
- Anterior shoulder, then posterior, then body
- Place baby on mother (skin-to-skin)
- Dry, stimulate, suction PRN
- Clamp cord (delayed if possible — 1-3 minutes)
- Apgar score at 1 and 5 minutes
Watch for arrest of descent:
- No descent in 1 hour active pushing
- Notify provider
- Position changes
- May need vacuum, forceps, or cesarean
Related Content
Third stage: birth of baby → delivery of placenta. Usually 5-30 minutes; concerning if > 30 min.
Mechanisms of placental separation:
- Schultze mechanism (most common): shiny side (fetal) presents first, looks like inverted umbrella
- Duncan mechanism: dirty/maternal side presents first, irregular surface
Signs of placental separation:
- Uterus rises in abdomen
- Uterus becomes globular (round, firm)
- Sudden gush of blood
- Cord lengthens (lengthens at vulva)
- Patient may feel urge to push again
Active management of third stage (recommended for all):
- Oxytocin administration with anterior shoulder or after birth
- Controlled cord traction (with countertraction on uterus)
- Uterine massage after placental delivery
- Reduces postpartum hemorrhage
Underlying Principles
Physiology:
- Uterine contractions continue after birth
- Placental site shrinks → placenta separates from uterine wall
- Living ligature (uterine muscle fibers) clamps blood vessels → controls bleeding
- Oxytocin (endogenous or exogenous) supports contraction
Why active management:
- Reduces postpartum hemorrhage risk by 50%
- Standard of care
- Shortens third stage
Placenta examination importance:
- Detect retained fragments (cause of late PPH)
- Check completeness (intact cotyledons, intact membranes)
- Number of vessels in cord (normally 2 arteries, 1 vein — single artery may suggest anomalies)
- Note any abnormalities (calcifications, infarcts, abnormal insertion)
Bleeding considerations:
- Average blood loss: 500 mL vaginal birth, 1000 mL cesarean
- PPH: > 500 mL vaginal or > 1000 mL cesarean (or any amount causing hemodynamic compromise)
- Most common cause of PPH: uterine atony
Nursing Interventions
Active management protocol:
- Administer oxytocin (10 units IM or IV in fluid bag) at delivery of anterior shoulder or immediately after birth
- Controlled cord traction with countertraction (provider responsibility — guard uterus)
- Don't pull on cord without contraction
- Fundal massage after placental delivery
Watch for separation signs:
- Uterus rises and globular
- Cord lengthens
- Gush of blood
- Time placental delivery (concerning if > 30 min)
After placental delivery:
- Inspect placenta for completeness
- - Cotyledons intact?
- - Membranes intact?
- - Vessels: 2 arteries, 1 vein
- - Abnormalities (calcifications, infarcts)
- - Insertion (central, marginal, velamentous)
- Document findings
Examine for lacerations:
- Perineum (1st-4th degree)
- Vagina, sidewalls
- Cervix (with bleeding despite firm fundus)
- Periurethral
Maternal status:
- Vital signs Q15 min
- Bleeding assessment
- Fundal massage
- Pain management for repair
Newborn care:
- Skin-to-skin contact
- Initial assessment
- Vitamin K, erythromycin eye prophylaxis (delay 1 hour for bonding/breastfeeding)
- Apgar at 1 and 5 minutes
- Identification bands matched
Breastfeeding initiation:
- Within first hour optimal
- Skin-to-skin facilitates
- Hand expression to colostrum
If retained placenta:
- Wait up to 30 min if not bleeding
- Try emptying bladder, breastfeeding (oxytocin)
- If continued: manual removal under anesthesia
- Watch for PPH
Documentation:
- Time of placental delivery
- Mechanism (Schultze or Duncan)
- Placenta complete or not
- Cord vessels
- Estimated blood loss
- Medications given
- Lacerations
Related Content
The initial prenatal visit (8-12 weeks gestation, ideally) establishes baseline data, identifies risk factors, and sets up the plan of care.
Components:
1. Detailed history:
- Demographics: age, ethnicity, occupation
- Menstrual history: menarche, cycle pattern, LMP (for dating)
- Obstetric history:
- - GTPAL: Gravida (total pregnancies), Term (≥ 37 weeks), Preterm (20-36+6), Abortions/losses (< 20 weeks), Living children
- - Prior pregnancy outcomes (vaginal/cesarean, complications)
- - Postpartum complications
- - Infant outcomes
- Gynecologic history: STIs, infections, surgeries, abnormal Paps
- Medical history: chronic conditions (DM, HTN, asthma, autoimmune, cardiac), surgeries, hospitalizations
- Family history: chronic disease, genetic disorders, pregnancy outcomes
- Genetic screening: ethnicity-specific risks (sickle cell, Tay-Sachs, thalassemia)
- Medications, allergies
- Substance use: tobacco, alcohol, drugs (illicit and prescription)
- Social: housing, finances, support, IPV screening, mental health
- Current pregnancy: symptoms, complications, intentional/unintentional
2. Physical exam:
- Vital signs, height, weight, BMI
- Head-to-toe exam
- Breast exam (changes in pregnancy)
- Pelvic exam: speculum (cervix, vagina), bimanual
- Pelvic adequacy assessment
- Fetal heart tones (after 10-12 weeks via Doppler)
3. Labs/diagnostics (see Routine Prenatal Labs template)
4. Risk stratification:
- Low-risk vs high-risk pregnancy
- Referrals as needed (MFM, genetics)
Underlying Principles
Naegele's rule for EDD calculation:
- LMP + 7 days - 3 months + 1 year = EDD
- Example: LMP June 1, 2024 → EDD March 8, 2025
- Assumes 28-day cycle
- Ultrasound dating preferred for irregular cycles or unsure LMP
Pregnancy terminology:
- Gravida: total pregnancies including current
- Para: pregnancies that reached viability (20 weeks) regardless of outcome
- Term: ≥ 37 weeks
- Preterm: 20-36+6
- Abortions: < 20 weeks (spontaneous or elective)
- Living: number of currently living children
Why thorough history:
- Identify risk factors for complications
- Plan appropriate level of care
- Genetic counseling if indicated
- Schedule appropriate testing
- Establish baseline for comparison
- Build therapeutic relationship
Risk stratification examples:
- Low-risk: healthy, no complications
- High-risk: chronic conditions, prior complications, advanced age, substance use, multiple gestation, congenital concerns
Nursing Interventions
Establishing relationship:
- Welcoming, non-judgmental approach
- Cultural sensitivity
- Privacy
- Adequate time for questions
Comprehensive history-taking:
- Use structured interview (medical, obstetric, social)
- Explore in detail; don't assume
- Document carefully
- Update at each visit
Calculate GTPAL:
- Example: Pregnant woman with 1 prior term birth, 1 preterm birth (currently living), 1 miscarriage
- G3 (current is 3rd pregnancy if counting), T1 P1 A1 L2
Confirm pregnancy:
- Urine hCG
- Serum hCG if needed
- Ultrasound for dating, viability
Assess for IPV:
- Routine screening (private, every visit)
- Safety planning
- Resources
Substance use screening:
- Routine, non-judgmental
- Tobacco, alcohol, illicit drugs, prescription misuse
- Refer for treatment
Mental health screening:
- Edinburgh Postpartum Depression Scale or PHQ-9
- Anxiety screening
- Suicidality
Establish plan of care:
- Visit schedule (monthly to 28 weeks, biweekly to 36 weeks, weekly after)
- Provider for delivery
- Birth setting
- Lab schedule
- Genetic testing offered
Education:
- Diet, exercise, weight gain
- Prenatal vitamins (with folate)
- Avoid: alcohol, tobacco, illicit drugs, certain meds, raw meat/fish, unpasteurized dairy, deli meat, high-mercury fish
- Caffeine limits (< 200 mg/day)
- Hot tubs, saunas avoided
- Travel, sex generally safe
- Warning signs to report
Schedule:
- Next visit
- Labs
- Ultrasound (dating, anatomy ~20 weeks)
- Genetic screening offered
Watch for and report:
- Vaginal bleeding
- Severe abdominal/pelvic pain
- Severe headache
- Visual disturbances
- Persistent vomiting
- Fever
- Severe edema (especially face/hands)
- Decreased fetal movement (after 28 weeks)
- ROM
- Signs of preterm labor
Related Content
Naegele's rule: standard method for calculating estimated date of delivery (EDD/EDC) based on last menstrual period (LMP).
Formula:
- First day of LMP + 7 days - 3 months + 1 year = EDD
Example:
- LMP: June 1, 2024
- Add 7 days → June 8
- Subtract 3 months → March 8
- Add 1 year → March 8, 2025 = EDD
Pregnancy terms by gestational age:
- Pregnancy = 40 weeks (280 days) from LMP
- Term: 37-42 weeks
- Early term: 37-38+6/7 weeks
- Full term: 39-40+6/7 weeks
- Late term: 41+0/7 to 41+6/7
- Post-term: ≥ 42 weeks
- Preterm: 20-36+6/7
- Trimesters:
- - First: 0-12+6/7 weeks
- - Second: 13-27+6/7 weeks
- - Third: 28-40+ weeks
Underlying Principles
Assumptions in Naegele's rule:
- Regular 28-day menstrual cycle
- Ovulation at day 14
- Conception within 24 hours of ovulation
Limitations:
- Less accurate with irregular cycles
- Less accurate if patient doesn't recall LMP
- Different cycle lengths affect accuracy
- Only ~5% of women deliver on EDD
Adjustments for cycle length:
- If cycle ≠ 28 days: subtract or add days based on cycle length
- Example: 32-day cycle → add 4 days to EDD calculated by Naegele's
Ultrasound dating:
- First trimester ultrasound is most accurate for dating (especially < 14 weeks)
- Crown-rump length (CRL) accuracy ± 5-7 days
- If ultrasound discrepancy from LMP-based EDD is > 5 days in 1st trimester, ultrasound prevails
- If discrepancy > 14 days in 2nd trimester, ultrasound prevails
- If discrepancy > 21 days in 3rd trimester, ultrasound prevails
Why accurate dating matters:
- Schedule appropriate screening tests
- Genetic screening timing
- Detect IUGR vs SGA
- Detect macrosomia
- Determine prematurity
- Timing of induction
- Postdates management
Nursing Interventions
Initial dating:
- Obtain LMP at first prenatal visit
- Confirm with patient — first day of last period
- Use Naegele's rule to calculate EDD
- Document menstrual history
- Order first-trimester ultrasound for dating if uncertain
Cycle considerations:
- Note typical cycle length
- Note prior pregnancies, contraception
- Adjust EDD for irregular cycles or known ovulation date
Confirming dates:
- First-trimester ultrasound for confirmation (most accurate)
- If discrepancy: usually adjust to ultrasound
- Document decision
Communication:
- Explain EDD is an estimate
- Most births are within 2 weeks of EDD (37-42 weeks)
- Only ~5% deliver exactly on EDD
- Term pregnancy is 37-42 weeks
Calculate gestational age at each visit:
- From LMP or adjusted EDD
- Document weeks + days (e.g., 28+3 weeks)
- Useful for screening test scheduling
- Useful for detecting IUGR/macrosomia
Special situations:
- IVF pregnancy: dating from transfer (most accurate)
- Conception while on contraception or breastfeeding: ultrasound essential
- No LMP: ultrasound for dating
Related Content
Pregnancy signs are classified by their certainty:
Presumptive signs (subjective — felt by woman):
- Amenorrhea (missed period)
- Nausea/vomiting ("morning sickness")
- Breast tenderness, enlargement
- Fatigue
- Urinary frequency (early due to enlarging uterus pressing bladder)
- Quickening (first perception of fetal movement — 16-20 weeks)
- Food cravings, aversions
Probable signs (objective — observed by examiner):
- Goodell sign (cervical softening — 5 weeks)
- Chadwick sign (bluish-purple cervical/vaginal color — 6-8 weeks)
- Hegar sign (softening of uterine isthmus — 6-12 weeks)
- Uterine enlargement
- Positive pregnancy test (hCG in urine or serum)
- Ballottement (passive fetal movement on examination — 16-28 weeks)
- Braxton Hicks contractions
- Pigmentation: linea nigra, chloasma
Positive signs (diagnostic — fetal origin):
- Fetal heart tones heard by Doppler (10-12 weeks) or fetoscope (17-19 weeks)
- Visualization of fetus by ultrasound
- Fetal movement palpated by examiner
Underlying Principles
Why three categories:
- Presumptive signs: caused by hormonal changes; can be from other conditions (e.g., breast tenderness from PMS, amenorrhea from stress)
- Probable signs: more specific to pregnancy but can have other causes (e.g., uterine fibroids, hCG-producing tumors — molar pregnancy, ectopic, GTD)
- Positive signs: confirm pregnancy because they can only originate from fetus
hCG (human chorionic gonadotropin):
- Produced by trophoblast after implantation (8-10 days after ovulation)
- Detectable in serum days before missed period
- Detectable in urine around time of missed period
- Peaks at 9-10 weeks, then declines
- Doubles approximately every 48 hours in early pregnancy
- Used for: confirming pregnancy, ectopic monitoring, molar pregnancy detection
Differential diagnosis to consider:
- Ectopic pregnancy
- Gestational trophoblastic disease
- Pseudocyesis
- Tumors (some produce hCG)
- Other gynecologic conditions
Earliest detectable signs/tests:
- Serum hCG: 7-10 days after conception
- Urine hCG: ~14 days after conception (around missed period)
- Ultrasound: gestational sac visible at ~4.5-5 weeks transvaginally; fetal pole at ~6 weeks; cardiac activity ~6-7 weeks
Nursing Interventions
Pregnancy confirmation:
- Take history (LMP, cycle, symptoms)
- Obtain pregnancy test (urine or serum hCG)
- Physical exam (note probable signs)
- Ultrasound for positive signs (visualization, cardiac activity)
- Document carefully
Patient education:
- Distinguish presumptive vs probable vs positive
- Explain why positive signs are needed
- Address any concerns about other conditions
If pregnancy desired and confirmed:
- Discuss prenatal care
- Initiate prenatal vitamins with folate
- Avoid teratogens (alcohol, tobacco, certain meds)
- Provide first prenatal visit scheduling
- Address danger signs
If pregnancy unintended:
- Non-directive counseling
- Options counseling: continue, adoption, termination
- Patient choice
- Resources for each option
- Mental health support
If positive test but ectopic/molar suspected:
- Workup: serial hCG, ultrasound
- Refer appropriately
If pregnancy test negative but signs present:
- Repeat test in 1 week (may be too early)
- Quantitative serum hCG (more sensitive)
- Consider other causes
Educate about:
- Early pregnancy symptoms (presumptive)
- When to take pregnancy test (day of missed period or later)
- How home tests work
- Importance of dating
- Establishing prenatal care
Related Content
Lochia is the vaginal discharge after birth as the uterus involutes and the placental site heals. Progresses through three stages over 4-6 weeks.
Lochia Rubra (red):
- Days 1-3 postpartum
- Bright red blood with small clots (less than nickel-sized OK)
- Heaviest flow
- Composition: blood, decidua, mucus, small clots
Lochia Serosa (pink/brown):
- Days 4-10 postpartum
- Pink-brown, watery
- Decreasing amount
- Composition: serous fluid, older blood, WBCs, microorganisms
Lochia Alba (white/yellow):
- Days 10-14 to 4-6 weeks
- Yellowish-white
- Light amount
- Composition: leukocytes, mucus, epithelial cells
Volume descriptors:
- Scant: < 1 inch (2.5 cm) on pad in 1 hour
- Light/small: < 4 inches (10 cm)
- Moderate: < 6 inches (15 cm)
- Large/heavy: > 6 inches OR saturating pad in 1 hour
Underlying Principles
Physiology:
- After placental delivery, exposed uterine vessels close off via uterine contraction (living ligature)
- Lochia is the result of healing of placental site
- Uterine involution: rapid decrease in uterine size
- Endometrial regeneration occurs (3 weeks for placental site; 6 weeks for rest)
Why three stages:
- Reflects progressive healing
- Color and amount changes indicate normal involution
- Deviations suggest complications (infection, hemorrhage)
Abnormal findings:
- Heavy bleeding or large clots (early postpartum hemorrhage)
- Persistent rubra beyond 3-4 days (subinvolution, retained fragments)
- Return to rubra after progressed to serosa (subinvolution, infection)
- Foul-smelling lochia (endometritis)
- Excessive amount, saturating > 1 pad/hour (hemorrhage)
- Continued bleeding after expected duration
Influencing factors:
- Breastfeeding: ↑ oxytocin → ↑ uterine contraction → less bleeding
- Activity: brief increase with ambulation, position changes normal
- Position: ↑ flow when standing up after lying down (pooled blood)
- Cesarean: slightly less lochia (some removed surgically)
Nursing Interventions
Routine assessment (BUBBLE-HE):
- Assess lochia at every postpartum check
- Inspect pad: color, amount, odor, clots
- Note time of last pad change (gauge rate of bleeding)
- Document quantitatively when possible
- Increasing flow when getting up may indicate hemorrhage
Fundal assessment with lochia:
- Position: have woman empty bladder first
- Supine, knees flexed
- Palpate fundus: firmness (firm = good), level (at umbilicus level immediately postpartum; descends 1 fingerbreadth/day), midline (vs deviated)
- Massage if boggy
- Watch lochia during massage
Watch for warning signs:
- Saturating pad < 1 hour
- Passing large clots (> egg-sized or persistent grape-sized)
- Foul odor
- Persistent bright red blood after expected progression
- Return to rubra after serosa
- Continued lochia past 6 weeks
- Fever, chills, tachycardia (infection)
- Boggy fundus
Educate patient:
- Normal progression of lochia stages
- What's normal vs abnormal
- Hygiene: change pads regularly, peri bottle after voiding
- Wash hands
- No tampons (infection risk)
- Report excessive bleeding, foul odor, clots, fever
- Continued flow up to 6 weeks normal
- Increased flow with standing, breastfeeding (oxytocin) is normal
- Resume periods 6-8 weeks postpartum if not breastfeeding; longer if breastfeeding
Documentation:
- Color, amount, odor
- Number of pads used
- Time intervals
- Trends over shift
Related Content
Signs and symptoms that require immediate evaluation during pregnancy. All pregnant women should be educated on these from the first prenatal visit.
By trimester (some common to all):
First trimester:
- Severe abdominal/pelvic pain (ectopic, miscarriage)
- Vaginal bleeding (miscarriage, ectopic)
- Severe nausea/vomiting unable to keep fluids (hyperemesis)
- Fever > 38°C (infection)
- Dysuria, frequency (UTI)
Second trimester:
- Vaginal bleeding (placenta previa, abruption)
- Severe abdominal pain (preterm labor, abruption)
- Cervical pressure, low backache (preterm labor)
- Decreased fetal movement after quickening
- Persistent vomiting
- Visual disturbances, severe headache (preeclampsia)
- Severe edema, especially face/hands
- Fever, signs of infection
Third trimester:
- Vaginal bleeding (always concerning)
- Regular contractions before 37 weeks (preterm labor)
- Rupture of membranes (PROM)
- Decreased fetal movement (kick counts < 10 in 2 hours)
- Severe headache, visual changes, RUQ pain (severe preeclampsia)
- Sudden severe edema
- Sudden weight gain (3+ lbs/week)
- Persistent abdominal pain
- Decreased urine output
- Itching especially palms/soles (cholestasis)
- Signs of true labor at term
Underlying Principles
Why early recognition matters:
- Many pregnancy complications progress rapidly
- Early intervention improves outcomes
- Some conditions (preeclampsia, abruption) can be life-threatening within hours
- Reduces maternal and fetal mortality
Key emergencies and their signs:
Ectopic pregnancy:
- Severe unilateral lower abdominal pain
- Vaginal bleeding (often light)
- Shoulder pain (referred from blood irritating diaphragm)
- Signs of shock
- Positive pregnancy test
Placental abruption:
- Vaginal bleeding (may be concealed)
- Severe constant abdominal pain
- Rigid, board-like abdomen
- Frequent contractions
- Fetal distress
Placenta previa:
- Painless bright red bleeding
- Usually no contractions
Preeclampsia/eclampsia:
- BP ≥ 140/90 after 20 weeks
- Severe headache
- Visual disturbances (blurring, scotoma, photophobia)
- RUQ or epigastric pain
- Decreased urine output
- Severe edema
- Hyperreflexia, clonus
- Seizure = eclampsia
Preterm labor:
- Regular contractions before 37 weeks
- Low backache
- Pelvic pressure
- Vaginal discharge changes
- Cervical change
PROM:
- Gush or trickle of clear fluid
- Continuous
- Cannot be controlled (vs urine)
Nursing Interventions
Education at every prenatal visit:
- Review signs appropriate to gestational age
- Provide written instructions
- Emergency contact information
- "What to do" plan
- Repeat in late pregnancy
When to go where:
- Office hours: call provider for guidance
- After hours: on-call provider or L&D
- Emergency: severe bleeding, severe pain, suspected ROM, seizure → 911 or ER
Specific instructions:
- Decreased fetal movement: lie down, focused count, drink cold liquid, if < 10 movements in 2 hours → L&D
- SROM: come to L&D, don't put anything in vagina
- Contractions in true labor pattern: 5-1-1 (every 5 min, 1 min long, for 1 hour)
- Severe headache: dim lights, rest, take acetaminophen; if not relieved or with visual changes → call provider/ER
- RUQ pain: call provider immediately
Triage:
- Assess vital signs
- Fetal heart rate
- Symptoms in detail
- Risk factors
- Determine acuity
Document and report:
- Patient assessment
- Vital signs
- Fetal status
- Provider notification
- Interventions and response
Empower patient:
- Trust her instincts
- Don't dismiss concerns
- "When in doubt, get it checked"
- Address fears, anxiety
Related Content
Comprehensive education for the breastfeeding postpartum client at discharge. Covers maternal recovery, breastfeeding establishment, infant care, and recognition of complications.
Maternal physical recovery:
- Lochia progression and pad use
- Perineal care (sitz baths, peri bottle)
- Cesarean wound care (if applicable)
- Pain management — acetaminophen, ibuprofen safe with breastfeeding
- Constipation prevention — fluids, fiber, stool softeners
- Hemorrhoid care
- Pelvic floor exercises (Kegels)
- Activity progression — gradual
- Sleep when baby sleeps
- Nutrition: balanced diet, adequate calories (~500 extra/day breastfeeding)
- Adequate fluids — drink to thirst, urine pale yellow
Breastfeeding establishment:
- Frequent feedings — 8-12 times/24 hours
- On demand (baby-led)
- Latch: cross-cradle, football, side-lying, cradle
- Breast care: hand expression, lanolin for soreness
- Engorgement management: frequent feeding, warm compress before, cold after
- Mastitis prevention: empty breasts, complete feeds, address blocked ducts
- Watch for: nipple cracks, severe pain, infection signs
- Lactation consultant if struggling
Newborn care:
- Feeding cues: rooting, hand-to-mouth, lip smacking, fussiness
- Wet/soiled diaper counts
- Skin-to-skin contact
- Safe sleep (back to sleep, firm surface, no soft bedding)
- Cord care (clean, dry)
- Bathing
- Temperature (axillary 97.7-99.5°F)
- Jaundice
- Umbilical and circumcision care
Emotional adaptation:
- Postpartum blues — common, transient
- Postpartum depression — warning signs
- Bonding
- Partner involvement
- Sibling adjustment
Underlying Principles
Postpartum recovery physiology:
- Uterus involutes over 6 weeks
- Lochia 4-6 weeks (typically)
- Hormonal changes affect mood
- Lactation establishes over first 2-4 weeks
Why thorough teaching:
- Reduces complications
- Improves breastfeeding success
- Identifies issues early
- Empowers mother
- Improves bonding
Breastfeeding success factors:
- Early initiation (within 1 hour)
- Skin-to-skin contact
- Frequent feedings
- Effective latch
- Adequate hydration, nutrition
- Rest
- Support system
- Avoiding bottles/pacifiers initially (nipple confusion)
Watch for and treat:
- Engorgement
- Sore/cracked nipples
- Plugged ducts
- Mastitis
- Insufficient milk concerns
- Poor latch
Nursing Interventions
Pre-discharge:
- Verify breastfeeding established
- Lactation consultant if needed
- Provide written instructions
- Demonstrate care techniques
- Have mother demonstrate
- Address questions
Education topics:
Maternal:
- Lochia: rubra → serosa → alba (over 4-6 weeks)
- Pad use, no tampons, no douching
- Perineal/cesarean care
- Pain management: acetaminophen, ibuprofen, avoid aspirin (Reye's)
- Sitz baths after first 24 hours
- Adequate hydration (drink to thirst)
- Nutritional support — extra 500 calories
- Constipation prevention
- Sleep when baby sleeps
- Activity: gradual return, avoid heavy lifting
- No intercourse, tampons, douching until cleared (6 weeks)
- Family planning options
- Pelvic floor exercises
Breastfeeding:
- Frequent feedings 8-12/24 hours
- Both breasts if possible
- Latch correctly: open mouth wide, areola in mouth, lips flanged
- Recognize good latch: rhythmic suck-swallow, audible swallowing, no pain
- Burping after each side
- Hand expression, manual pumping technique
- Milk storage if pumping
- Engorgement: warm compress before, cold after
- Sore nipples: air dry, lanolin, correct latch
- Watch for: severe pain, fever, redness, hot/cold areas, hard areas → mastitis signs
- Avoid bottles/pacifiers first 4 weeks (if exclusive BF goal)
- Lactation consultant contact
Newborn:
- Feeding cues
- Diaper counts: 6+ wet, 3+ soiled by day 4 (varies)
- Sleeping back, firm surface
- Temperature taking
- Bathing, cord care
- Holding, swaddling
- Signs of illness: fever > 38°C, poor feeding, lethargy, color changes
- Pediatrician follow-up 2-3 days after discharge
- Vaccinations
- Car seat use
Mental health:
- Postpartum blues OK days 3-10
- If symptoms persist > 2 weeks or worsen → postpartum depression — call provider
- Warning signs: anhedonia, hopelessness, thoughts of harming self/baby
- Support resources
Warning signs to report:
- Excessive bleeding (saturating pad < 1 hour)
- Foul-smelling lochia
- Fever > 38°C
- Severe pain
- Signs of mastitis
- Wound issues
- Calf pain (DVT)
- Severe headache, visual changes (late-onset preeclampsia)
- Mental health concerns
Follow-up:
- Postpartum visit at 6 weeks (or earlier per protocol)
- Pediatric appointment
- Lactation support
- Mental health resources
Related Content
Newborn CPR (Infant CPR < 1 year):
- Recognize emergency: unresponsive, not breathing
- Call 911 (or have someone call)
- Begin chest compressions if no pulse or HR < 60 bpm
- Compression rate: 100-120 per minute
- Compression depth: 1.5 inches (about 1/3 chest depth)
- Compression location: Just below nipple line
- Compression technique: Two fingers (single rescuer) or two thumbs encircling chest (two rescuers)
- Ratio: 30 compressions : 2 breaths (single rescuer); 15:2 (two rescuers, healthcare)
- Allow chest to fully recoil
- Continue until help arrives or baby responds
Choking infant:
- Mild obstruction (coughing, gagging) — allow to clear
- Severe (silent, blue, can't breathe) → action needed
- 5 back blows between shoulder blades
- 5 chest thrusts (just below nipple line)
- Alternate until object expelled or unresponsive
- If unresponsive: start CPR
Safe Sleep (AAP recommendations):
- Back to sleep — always supine
- Firm mattress, fitted sheet — no soft surfaces, sofas, pillows
- No bedding or soft items in crib — no blankets, bumpers, toys, pillows
- Room-sharing without bed-sharing — crib/bassinet in parents' room for first 6-12 months
- Smoke-free environment
- Avoid overheating — sleep clothing not too heavy
- Pacifier at sleep (after breastfeeding established)
- Tummy time when awake and supervised
- Breastfeed if possible — reduces SIDS
- Routine immunizations
- No commercial devices claiming to reduce SIDS (positioners, wedges)
Underlying Principles
Why infant CPR differs from adult:
- Smaller compression depth
- Faster compression rate
- Different technique (fingers vs hands)
- Most pediatric arrests are respiratory in origin
- Quick rescue breaths and oxygenation often resolves
SIDS (Sudden Infant Death Syndrome):
- Unexplained death in infants < 1 year
- Peak: 2-4 months
- Risks: prone sleep, soft bedding, smoking, overheating, prematurity
- Protective: back sleep, breastfeeding, pacifier use, room sharing
- Significant decline in SIDS rates with "Back to Sleep" campaign
Sleep environment safety:
- Crib or bassinet meeting current safety standards
- Firm mattress (don't test by softness — should be firm enough that head doesn't indent)
- No gap > 2 fingers between mattress and crib
- Crib slats no more than 2-3/8 inches apart
- Avoid hand-me-down cribs (may not meet current standards)
Bed-sharing risks:
- Increased risk of SIDS, suffocation, falls
- Especially dangerous: sofa, recliner, soft surfaces, adult bed with bedding, parent who smoked, drank alcohol, used drugs
- Bed-sharing not recommended
- Room-sharing IS recommended
Nursing Interventions
Pre-discharge teaching:
- Demonstrate infant CPR (mannequin if possible)
- Have parent return demonstrate
- Provide written/visual materials
- Refer to community CPR class (AHA Family & Friends or HealthCare Provider)
- Encourage all caregivers to learn
CPR teaching points:
- Recognize: unresponsive, not breathing, blue
- Call 911 first if alone (or send someone)
- Begin CPR (no pulse or HR < 60)
- Position infant on back on firm surface
- Compressions: 2 fingers, just below nipple line, 1.5 inches deep
- Rate 100-120/min
- Ratio 30:2 (single rescuer)
- Open airway: head-tilt chin-lift (don't hyperextend in infant)
- 2 breaths: cover mouth and nose with rescuer mouth, gentle puffs
- Continue until EMS arrives
Choking infant teaching:
- Recognize severe choking (silent, blue, can't breathe)
- Position face-down on forearm, head lower than body
- 5 back blows between shoulder blades
- Turn over, face up
- 5 chest thrusts (just below nipple line)
- Alternate until object expelled or unresponsive
- If unresponsive: start CPR; check mouth for visible object before each set of breaths
Safe sleep teaching:
- ABC: Alone, on Back, in Crib
- Demonstrate proper sleep position
- Demonstrate proper crib setup
- Address questions and barriers
- Show videos if available
- Provide handouts
Common questions:
- "What if baby spits up on back?" — natural mechanism protects airway; less choking risk on back actually
- "What about head flat spots?" — supervised tummy time prevents
- "What about cold?" — wearable blanket/sleep sack instead of loose blankets
- "Bed-sharing is cultural" — discuss risks, alternatives like cosleeper
Address environment:
- Crib safety (current standards)
- Mattress firmness
- Smoke-free environment
- Bedroom temperature
- Pacifier at sleep (once BF established)
Resources:
- Local CPR classes
- Safe Kids USA
- AAP safe sleep resources
- Hospital lactation/safety education
Related Content
Fertility awareness-based methods (FABM): tracking signs of ovulation and avoiding intercourse during fertile window OR using protection. Methods range from less effective to more effective with correct use.
Common methods:
- Calendar/rhythm method: tracking cycle length over months; identify fertile window (typical: day 8 to day 19 of cycle assuming 28-day)
- Basal Body Temperature (BBT): daily temperature on waking; rise of 0.5-1°F indicates ovulation has occurred
- Cervical mucus (Billings): egg-white, stretchy, slippery = fertile
- Symptothermal: combines BBT, cervical mucus, calendar — more accurate
- Cervical position: high, soft, open during ovulation
- Ovulation predictor kits (OPK): detect LH surge in urine
- Lactational amenorrhea method (LAM): exclusive breastfeeding < 6 months postpartum with amenorrhea — 98% effective if all conditions met
Effectiveness:
- Perfect use: 1-5% failure rate
- Typical use: 12-24% failure rate
- Symptothermal method most effective among NFP
Underlying Principles
Female menstrual cycle:
- Follicular phase: variable length
- Ovulation: ~14 days before next period
- Luteal phase: 10-16 days (more consistent)
- Sperm can survive up to 5 days; egg viable 24 hours
- Fertile window: ~6 days (5 days before to 1 day after ovulation)
Signs of fertility:
- Cervical mucus changes: dry → sticky → creamy → stretchy/clear (most fertile) → dry
- Cervical position: low/firm/closed (non-fertile) → high/soft/open (fertile)
- BBT: drop just before ovulation, then rise 0.5-1°F after ovulation
- Mittelschmerz (ovulation pain — some women)
- Breast tenderness, libido changes
- LH surge: detectable in urine 24-36 hours before ovulation
Why NFP appeals:
- No medications or devices
- Compatible with religious beliefs
- No side effects
- Increased body awareness
- Inexpensive (long-term)
- Can be used to achieve pregnancy
- Reversible immediately
Limitations:
- Requires daily tracking
- Irregular cycles make less reliable
- Doesn't protect against STIs
- Requires partner cooperation
- Less effective with poor adherence
- Stress, illness, travel affect cycle
- Postpartum, perimenopausal women less reliable
- Requires training/coaching
Nursing Interventions
Pre-counseling:
- Assess motivation, commitment
- Partner involvement
- Regular cycle history
- Discuss effectiveness rates
- Discuss STI prevention (this doesn't protect)
- Compare to other methods
- Refer to FABM educator/instructor
Calendar/rhythm method teaching:
- Track 6+ cycles to determine cycle length
- Shortest cycle - 18 = first fertile day
- Longest cycle - 11 = last fertile day
- Avoid sex during fertile window
BBT teaching:
- Special BBT thermometer (sensitive to 0.1°F)
- Take same time each morning before getting up
- Chart daily for 3-4 months
- Identify thermal shift (rise of 0.5-1°F sustained 3 days)
- Ovulation occurred 1-2 days before rise
- Avoid sex from period to 3 days after thermal shift
Cervical mucus teaching:
- Check daily (before urinating)
- Wipe with toilet paper, observe
- Document: dry, sticky, creamy, stretchy/clear
- Most fertile = clear, stretchy (egg-white)
- Avoid sex during stretchy mucus through 3 days after peak
Symptothermal:
- Combine BBT + cervical mucus + calendar
- More accurate than single method
LAM (lactational amenorrhea method):
- Must meet ALL: exclusive breastfeeding, no formula/water, less than 6 months postpartum, amenorrheic
- 98% effective if all met
- Plan transition to another method by 6 months
Considerations:
- Cervical mucus affected by infections, medications
- BBT affected by illness, sleep, alcohol
- Stress affects cycle
- Multiple methods more reliable
If pregnancy occurs:
- Earlier than expected EDD calculation
- Use ultrasound for dating
Combine with backup method:
- Condom during fertile days
- Increases overall effectiveness
- Adds STI protection
Resources:
- NFP educators (Couple to Couple League, Creighton Model, etc.)
- Apps for tracking
- Books, online resources
- Healthcare provider consultation
Related Content
Barrier methods prevent sperm from reaching the egg. Some also reduce STI transmission. Include male/female condoms, diaphragms, cervical caps, sponge, spermicide.
Male condoms:
- Most common barrier
- Latex (most common; some allergies), polyurethane, polyisoprene, lambskin (doesn't prevent STIs)
- Single use, fitted over penis before contact
- Effectiveness: ~85% typical use, ~98% perfect use
- Protects against STIs
- Available OTC
Female (internal) condoms:
- Nitrile pouch with rings
- Inserted into vagina before sex (can place hours before)
- Effectiveness: ~79% typical use, ~95% perfect use
- Protects against STIs
- Available OTC
Diaphragm:
- Silicone or latex dome with flexible rim
- Inserted with spermicide before sex; left in 6 hours after
- Effectiveness: ~88% typical use, ~94% perfect use
- Reusable
- Requires prescription, fitting
- Refit after weight changes, pregnancy
- NO STI protection
Cervical cap (FemCap):
- Smaller than diaphragm, fits over cervix
- Used with spermicide
- Effectiveness: ~71% typical use parous; ~86% nulliparous
- Less effective in women who have given birth
- Prescription needed
- NO STI protection
Contraceptive sponge:
- OTC
- Contains spermicide
- Effectiveness: ~76% parous; ~88% nulliparous
- Less effective in women who have given birth
- NO STI protection
Spermicide alone:
- OTC
- Foam, gel, film, suppository, cream
- Effectiveness: ~72% typical use
- Less effective alone
- NO STI protection
- Can irritate (especially nonoxynol-9)
Underlying Principles
Mechanism:
- Physical: prevent sperm from entering uterus/tubes
- Chemical (spermicide): kills sperm
- STI protection (condoms): physical barrier to microorganisms
Why use barrier methods:
- Hormone-free
- Available OTC (most)
- Use only when needed (no daily compliance)
- Effective immediately
- Compatible with breastfeeding
- STI protection (condoms only)
Limitations:
- Must be used correctly every time
- Can interrupt spontaneity
- Latex allergies possible
- Spermicide may cause irritation, increase HIV transmission (with nonoxynol-9 frequent use)
- Some methods less effective in parous women
- Most don't protect against STIs
Allergies:
- Latex allergy: use polyurethane or polyisoprene condoms
- Spermicide sensitivity: try different brands or methods
Storage:
- Condoms: cool, dry place (not wallets, glove boxes — heat damages)
- Check expiration dates
- Don't use damaged packaging
Nursing Interventions
Patient counseling:
- Discuss all options
- Patient values and lifestyle
- STI risk
- Effectiveness
- Comfort with method
- Partner involvement
Condom teaching (key points):
- Use new condom for each act
- Check expiration date
- Open package carefully (no fingernails, scissors)
- Pinch tip to leave space for ejaculate
- Roll down to base of erect penis BEFORE any contact
- Hold base when withdrawing
- Use water- or silicone-based lube (not oil-based with latex)
- Dispose properly
- If breaks or slips: emergency contraception, STI screening
Diaphragm teaching:
- Wash hands
- Apply spermicide inside dome
- Insert into vagina, fit over cervix
- Check placement (cervix covered)
- Leave in 6 hours after sex
- Don't leave > 24 hours (TSS risk)
- Reapply spermicide if more than one act of sex
- Clean after use
- Refit after: weight change > 10 lbs, pregnancy, surgery
Cervical cap teaching:
- Similar to diaphragm
- Smaller learning curve
- Can leave in 48 hours
- Spermicide
Sponge:
- Wet with water before insertion (activates spermicide)
- Insert against cervix
- Leave 6 hours after sex (up to 30 hours total)
Spermicide:
- Use 10-15 minutes before sex (allow to disperse)
- Reapply for each act
- Most effective combined with another barrier
Combine with other methods:
- Condoms + diaphragm/spermicide for additional protection
- Backup for fertility awareness
- Always backup if missed pill
STI prevention emphasis:
- Condoms only barrier that protects against STIs
- Use condoms with new partners
- Use condoms even with hormonal contraception for STI protection
Emergency contraception:
- If condom breaks: emergency contraception within 5 days
- OTC: levonorgestrel
- Rx: ulipristal acetate, copper IUD
Description of Procedure
Outpatient radiological procedure in which a radiopaque contrast dye is instilled through the cervix into the uterus and fallopian tubes. X-ray imaging follows the dye's path to assess fallopian tube patency and detect uterine cavity abnormalities. Used in the infertility workup.
Indications
- Infertility workup — assess tubal patency
- Suspected tubal occlusion (e.g., post-PID, post-ectopic pregnancy)
- Uterine cavity defects (fibroids, polyps, septum, adhesions)
- Recurrent pregnancy loss
- Post-tubal sterilization confirmation
Interpretation of Findings
- Patent tubes — dye spills freely into the peritoneal cavity bilaterally
- Occluded tubes — dye stops at the blockage
- Uterine cavity defects visualized as filling defects
- Mild therapeutic effect — tubal flushing may temporarily increase fertility
Nursing Interventions (pre, intra, post)
Pre: Screen for iodine/seafood/shellfish allergy (contrast dye contraindication). Verify pregnancy is not present (urine hCG). Confirm no active pelvic infection (elevated temperature/HR could signal infection — contraindication). Confirm informed consent. Schedule procedure 2–5 days after the end of menses (avoids interference with possible pregnancy and reduces infection risk). Bowel prep may be ordered. Encourage NSAID/analgesic 30–60 min before procedure.
Intra: Position lithotomy. Speculum exam to visualize cervix. Catheter inserted; dye instilled slowly. X-ray images taken. Monitor pain; provide reassurance.
Post: Monitor vital signs. Assess for bleeding, severe cramping, fever, allergic reaction. Provide perineal pad — vaginal spotting is expected. Educate on post-procedure expectations and red flags.
Client Education
- Expect cramping during and shortly after the procedure (similar to menstrual cramps)
- Vaginal spotting and dye discharge for 1–2 days is normal
- Notify provider for: heavy bleeding, severe cramping, fever, foul-smelling discharge, allergic symptoms (rash, dyspnea, pruritus)
- Resume normal activities the same day unless instructed otherwise
- Wear a pad — avoid tampons × 24 hr
- NSAIDs prior to procedure reduce discomfort
- Mild therapeutic effect: tubal flushing may temporarily improve fertility post-HSG
Potential Complications
- Allergic reaction to contrast dye (most concerning) — anaphylaxis possible
- Pelvic infection (PID) — especially with active untreated cervicitis
- Uterine perforation (rare)
- Vasovagal reaction (light-headedness, nausea, hypotension)
- Persistent or severe cramping
- Pregnancy disruption if HSG performed in early pregnancy
Nursing Interventions
- Allergy screen first (iodine, seafood, shellfish, prior contrast reactions)
- Confirm absence of pregnancy and active infection
- Schedule 2–5 days post-menses
- Provide pre-procedure analgesic per orders
- Monitor for allergic reaction during/after procedure
- Teach red-flag symptoms requiring follow-up
- Document allergies, vital signs, procedure tolerance
- Provide perineal pad; explain expected discharge
Description of Procedure
Most widely used technique for antepartum evaluation of fetal well-being. Performed in the 3rd trimester. Noninvasive — monitors FHR response to fetal movement using a Doppler transducer (FHR) and tocotransducer (uterine contractions) attached externally. Client pushes a button each time fetal movement is felt, marking the tracing. Typically completed within 20–30 minutes.
Indications
- Assessment for intact fetal CNS during 3rd trimester
- Rule out fetal death in client with DM — used 2×/wk starting at 28–32 wks
- Decreased fetal movement
- Intrauterine growth restriction
- Postmaturity
- Hx of gestational HTN or DM
- SLE, kidney disease, intrahepatic cholestasis
- Oligohydramnios, multiple gestation
Interpretation of Findings
Reactive (NORMAL): FHR accelerates ≥ 15/min for ≥ 15 sec, occurring ≥ 2 times in a 20-min period.
Before 32 weeks: ≥ 10/min for ≥ 10 sec is acceptable.
Nonreactive (ABNORMAL): Does NOT demonstrate ≥ 2 qualifying accelerations in a 20-min window. Further assessment with CST or BPP is indicated.
Nursing Interventions (pre, intra, post)
Preprocedure:
- Seat client in reclining chair, semi-Fowler's, or left-lateral position
- Apply conduction gel to abdomen
- Apply two belts with FHR + uterine contraction monitors
Intraprocedure:
- Instruct client to depress event marker button each time fetus moves
- If fetus is sleeping, use vibroacoustic stimulation (laryngeal stimulator) for 3 sec on maternal abdomen over fetal head
Postprocedure: Document tracing, communicate findings to provider, prepare for CST/BPP if nonreactive.
Client Education
- Eat a meal beforehand — fetal activity often increases after maternal food intake
- Empty bladder before the test for comfort
- Press the button every time you feel the fetus move
- The test is painless and takes 20–30 minutes
- If nonreactive, additional testing will be needed
Potential Complications
- False-nonreactive results (most common limitation) — caused by fetal sleep, fetal immaturity, maternal medications, nicotine use
- None inherent to the test itself — noninvasive, safe
Nursing Interventions
- Position to avoid supine hypotension (semi-Fowler's or left-lateral)
- Monitor FHR baseline and pattern
- Identify and document accelerations with movement
- Use vibroacoustic stimulation if fetus appears asleep
- Communicate reactive vs nonreactive result to provider
- Prepare client for follow-up testing if nonreactive
Description of Procedure
Uses real-time ultrasound to visualize physical and physiological characteristics of the fetus and observe biophysical responses to stimuli. Combines FHR monitoring (NST) + fetal ultrasound. Five variables scored 0 (abnormal) or 2 (normal) — maximum total = 10.
Indications
- Nonreactive NST
- Suspected oligohydramnios or polyhydramnios
- Suspected fetal hypoxemia or hypoxia
- Premature rupture of membranes
- Maternal infection
- Decreased fetal movement
- Intrauterine growth restriction
Interpretation of Findings
The 5 variables (each scored 0 or 2):
- FHR: reactive NST = 2 · nonreactive = 0
- Fetal breathing: ≥ 1 episode > 30 sec in 30 min = 2 · absent or < 30 sec = 0
- Gross body movements: ≥ 3 extensions w/ flexion in 30 min = 2 · < 3 = 0
- Fetal tone: ≥ 1 extension w/ return to flexion = 2 · slow/absent = 0
- Amniotic fluid: ≥ 1 pocket ≥ 2 cm in 2 perpendicular planes = 2 · < 2 cm = 0
Total score:
- 8–10: normal, low risk of chronic asphyxia
- 4–6: abnormal, suspect chronic asphyxia
- < 4: abnormal, strongly suspect chronic asphyxia
Nursing Interventions (pre, intra, post)
Pre: Same nursing management as ultrasound. Explain the procedure (combines NST + ultrasound). Position semi-Fowler's or left-lateral to avoid supine hypotension. Apply transducers for the NST component.
Intra: Monitor each of the 5 variables. Allow up to 30 minutes for fetal observation. Use vibroacoustic stimulation if fetus is sleeping.
Post: Document each variable score and total. Communicate to provider — abnormal scores typically prompt further evaluation or delivery planning.
Client Education
- The test combines an ultrasound with fetal heart rate monitoring
- Painless and noninvasive
- Takes about 30 minutes
- 5 fetal characteristics will be assessed and scored
- Results will be discussed with provider; further testing may be needed
Potential Complications
- None inherent to the test itself — noninvasive
- Limitation: subjective scoring of variables in some interpretations
Nursing Interventions
- Position to prevent supine hypotension
- Coordinate ultrasound and NST equipment
- Document each of the 5 variable scores accurately
- Calculate and report total score
- Communicate findings — alert provider for scores ≤ 6
- Prepare client for next steps based on findings
Description of Procedure
20-min painless procedure using high-frequency sound waves to visualize the fetus and maternal structures. Three types: external abdominal (transducer on abdomen, full bladder needed, useful after 1st trimester), transvaginal (probe inserted vaginally, no full bladder, more accurate especially in 1st trimester or obese clients), and Doppler (assesses maternal-fetal blood flow). Image types: 2D (standard), 3D (lifelike still images), 4D (movement video).
Indications
- Confirm pregnancy & gestational age (biparietal diameter)
- Identify multifetal pregnancy
- Determine site of fetal implantation (uterine vs ectopic)
- Assess fetal growth, viability, position
- Locate placental attachment, grade placental maturation
- Determine amniotic fluid volume
- Observe fetal heartbeat, breathing, movement
- Vaginal bleeding, questionable fundal height, decreased fetal movement
- Preterm labor, questionable rupture of membranes
- Adjunct for amniocentesis or BPP
Interpretation of Findings
- Visualization of fetus, gestational age estimation
- Detection of fetal abnormalities, multifetal pregnancies, ectopic location
- Confirmation of viability or fetal death
- Assessment of placental position (rule out previa)
- Adequate vs inadequate amniotic fluid volume
- Doppler: normal blood flow vs IUGR/poor placental perfusion patterns
Nursing Interventions (pre, intra, post)
Abdominal ultrasound — pre:
- Explain procedure — no known risk to self or fetus
- Have client drink 1 quart of water before the procedure (full bladder lifts uterus, displaces bowel, acts as echolucent)
- Supine position with small pillow under head and knees
Abdominal ultrasound — intra/post:
- Apply ultrasonic gel — room temperature or warmer
- Allow client to empty bladder when done
- Provide tissues to wipe gel
Transvaginal ultrasound — pre/intra:
- NO full bladder needed
- Lithotomy position
- Probe covered with protective device (condom), water-soluble gel
- Inserted by client or examiner
- Probe position or table tilt may change for complete pelvic view
Client Education
- Painless, no known risks to mother or fetus
- Identify fetal and maternal structures during the procedure (engages client)
- Abdominal: drink water beforehand; you may feel pressure on bladder
- Transvaginal: you may feel pressure as the probe is moved
- Doppler: a swooshing sound is normal — that's fetal blood flow
Potential Complications
- None inherent — ultrasound has no known risk
- Transvaginal: minor discomfort from probe
Nursing Interventions
- Verify the type of ultrasound ordered and prepare accordingly
- Bladder protocol — full for abdominal, empty/no requirement for transvaginal
- Warm conducting gel before applying
- Position appropriately (supine vs lithotomy)
- Provide privacy and emotional support
- Document procedure, indications, findings
Description of Procedure
Aspiration of amniotic fluid for analysis via a needle inserted transabdominally into the uterus and amniotic sac under direct ultrasound guidance. The placenta is located and the fetus's position is determined. Performed after 14 weeks of gestation. AFP measured 15–20 weeks (ideal: 16–18). Used to assess for genetic disorders, neural tube defects, and fetal lung maturity.
Indications
- Previous birth with chromosomal anomaly
- Parent who is a carrier of a chromosomal anomaly
- Family Hx of neural tube defects
- Prenatal diagnosis of genetic disorder/congenital anomaly
- AFP level for fetal abnormalities
- Fetal lung maturity assessment
- Fetal hemolytic disease
Interpretation of Findings
AFP:
- HIGH: neural tube defects (anencephaly, spina bifida, omphalocele); also normal multifetal
- LOW: chromosomal disorders (Down syndrome) or gestational trophoblastic disease
Fetal lung maturity:
- L/S ratio 2:1 = lung maturity (2.5:1 or 3:1 in clients with DM)
- PG (phosphatidylglycerol) absent → respiratory distress risk
Nursing Interventions (pre, intra, post)
Preprocedure:
- Explain procedure; obtain informed consent
- Educate client to EMPTY bladder before procedure (reduces size, prevents inadvertent puncture)
Intraprocedure:
- Obtain baseline vital signs and FHR
- Supine with wedge under right hip to displace uterus off vena cava
- Drape, exposing only abdomen
- Prepare client for ultrasound to locate placenta
- Cleanse abdomen with antiseptic before provider gives local anesthetic
- Educate: feel slight pressure as needle inserted; continue breathing (holding breath shifts intrauterine contents)
Postprocedure:
- Monitor FHR
- Administer Rho(D) immune globulin if Rh-negative (standard after every amnio for Rh-neg clients)
Client Education
- Empty bladder before procedure
- Continue normal breathing during the procedure
- You'll feel pressure when the needle is inserted
- Report immediately: fever, chills, fluid leakage or bleeding from insertion site, decreased fetal movement, vaginal bleeding, uterine contractions
- Limit activity for 24 hr after procedure
Potential Complications
- Amniotic fluid emboli
- Maternal or fetal hemorrhage
- Fetomaternal hemorrhage with Rh isoimmunization
- Maternal or fetal infection
- Inadvertent fetal damage (limb anomalies)
- Fetal death
- Inadvertent maternal intestinal or bladder damage
- Miscarriage or preterm labor
- Premature rupture of membranes
- Leakage of amniotic fluid
Nursing Interventions
- Confirm gestational age > 14 weeks
- Verify informed consent obtained
- Empty bladder before procedure
- Position supine with right-hip wedge
- Monitor maternal vital signs and FHR throughout and after
- Always check Rh status — give RhoGAM if Rh-negative
- Teach red-flag symptoms requiring follow-up
- Document procedure tolerance, fluid obtained, results pending
Description of Procedure
Universal screening of all newborns for genetic, metabolic, hormonal, and cardiac disorders that, if undetected, can cause significant morbidity or death. Required by all 50 US states (specific panels vary). Performed before hospital discharge, typically at 24-48 hours of life.
Indications
- All newborns — universal screening regardless of risk
- Detection of treatable conditions in asymptomatic newborns
- Conditions screened may include > 30 disorders depending on state
Client Preparation
- Educate parents about each screening test and rationale
- Obtain consent (informed refusal documented if declined)
- Verify newborn has been feeding × 24+ hours (PKU/galactosemia screening accuracy)
- Gather supplies: heel warmer, alcohol pads, lancet, filter paper card, gauze, bandage
Nursing Actions
- METABOLIC SCREEN (Heel Stick):
- Performed at 24-48 hours of life (must be feeding × 24+ hr for accuracy)
- Warm heel × 5-10 min (improves blood flow)
- Use the lateral aspect of the heel (avoid medial/center — risk of injury to calcaneus)
- Cleanse with alcohol, allow to dry
- Pierce skin with sterile lancet
- Wipe away first drop, then allow drops to fill all circles on filter paper
- Do NOT touch circles or squeeze area
- Apply pressure to stop bleeding; gauze and bandage
- Comfort newborn (sucrose, breastfeeding, swaddling)
- Document time, site, sample appearance, newborn tolerance
- Send to state lab
- HEARING SCREEN:
- Performed in quiet environment with newborn sleeping
- Otoacoustic Emissions (OAE): small probe in ear, measures inner ear response to sound
- Auditory Brainstem Response (ABR): electrodes on scalp, measures brainstem electrical activity to sound
- Pass or refer result; if refer, repeat in 4 weeks; if still refer, referral to audiologist
- CCHD SCREEN (Pulse Oximetry):
- Performed at ≥ 24 hours of life
- Place oximeter on RIGHT hand (pre-ductal) and either foot (post-ductal)
- Both must be ≥ 95% AND difference between them ≤ 3%
- Pass criteria: SpO₂ ≥ 95% in right hand AND foot AND difference < 3%
- Fail → echocardiogram
- BILIRUBIN SCREEN:
- Transcutaneous (TcB) or serum bilirubin before discharge
- Plot on Bhutani nomogram to assess risk
- Repeat as needed based on risk zone
Potential Complications
- Heel bruising or bleeding (minor)
- Newborn discomfort during procedure
- False positives (more common than false negatives)
- False negatives if test done before 24 hr of feeds
- Parental anxiety during waiting period
- Need for repeat testing if inadequate sample
- Cellulitis or osteomyelitis if improper heel stick technique (very rare)
Client Education
- Metabolic screen tests for > 30 disorders including:
- PKU (phenylketonuria)
- Congenital hypothyroidism
- Galactosemia
- Sickle cell disease
- Cystic fibrosis
- Congenital adrenal hyperplasia
- Maple syrup urine disease
- Biotinidase deficiency
- Severe combined immunodeficiency (SCID)
- MCAD deficiency (fatty acid oxidation)
- Hearing screen: universal, helps identify hearing loss EARLY for intervention
- CCHD screen: detects critical heart defects before they become life-threatening
- Bilirubin screen: identifies newborns at risk for severe hyperbilirubinemia
- Results typically available in 1-2 weeks for metabolic
- Hearing and CCHD results immediate
- If positive screen: NOT a diagnosis — requires confirmatory testing
- Pediatrician will follow up on results
- Schedule first newborn visit at 3-5 days after discharge
- Right of refusal: some states allow opt-out for religious/personal reasons; significant risks if undiagnosed; document refusal carefully
Interprofessional Care
- Pediatrician/neonatologist — primary follow-up
- Audiologist — hearing screen follow-up
- Pediatric cardiologist — CCHD evaluation
- Geneticist — metabolic disorder confirmation
- Endocrinologist — hypothyroidism, CAH
- Hematologist — sickle cell
- Pulmonologist — cystic fibrosis
- Social work — connect families to resources
- Public health nurse — state screening programs
Description of Procedure
Test to assess fetal response to uterine contractions — evaluates uteroplacental function. Contractions stress the placenta — if fetus is well-oxygenated, no late decelerations. Used in high-risk pregnancies or after non-reactive NST. Less commonly performed today (BPP and Doppler often preferred). Two types: spontaneous (using natural contractions) or induced (using IV oxytocin or nipple stimulation).
Indications
- Non-reactive NST that requires further evaluation
- Suspected uteroplacental insufficiency
- Decreased fetal movement
- IUGR
- Postdates pregnancy
- Maternal chronic disease (diabetes, hypertension)
- Decreased fluid (oligohydramnios)
- Sometimes used in late preterm/term for high-risk surveillance
Contraindications:
- Preterm labor risk (contractions could induce labor)
- Placenta previa
- Prior classical cesarean (uterine rupture risk)
- Multiple cesareans
- Prior uterine rupture
- PPROM
- Multiple gestation
Interpretation of Findings
Goal: Three contractions of moderate intensity, lasting 40-60 seconds, in 10-minute window.
Results:
- Negative (NORMAL/REASSURING): NO late decelerations with contractions; placenta functioning well; suggests fetal well-being
- Positive (ABNORMAL): Late decelerations with > 50% of contractions; suggests uteroplacental insufficiency; may need delivery
- Equivocal-suspicious: intermittent late decels or significant variables; needs repeat or additional testing
- Equivocal-hyperstimulatory: late decels with contractions every 2 min or lasting > 90 sec
- Unsatisfactory: inadequate contractions or uninterpretable tracing
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Verify gestational age (typically > 32-34 weeks)
- Check for contraindications
- Informed consent
- Patient empties bladder
- Side-lying position (avoid supine hypotension)
- Baseline vital signs, FHR baseline
- External fetal monitor (tocodynamometer + FHR)
- Establish IV access (if oxytocin will be used)
Intra-procedure:
- Nipple stimulation method: warm cloth over one nipple, massage for 2 min; rest; repeat as needed
- Oxytocin method: begin at 0.5-1 mU/min IV, double every 15-20 min until adequate contraction pattern (max 10 mU/min)
- Monitor FHR continuously
- Monitor maternal vital signs Q15 min
- Watch for hyperstimulation (contractions every < 2 min or lasting > 90 seconds)
- Stop stimulation if adequate pattern achieved or for hyperstim
Post-procedure:
- Continue monitoring until contractions subside
- Vital signs
- Discharge planning based on results
- If positive: prepare for further evaluation/delivery
Client Education
- Procedure takes 1-2 hours
- Monitors will be on belly
- Goal is to have a few contractions
- You'll feel mild to moderate cramping
- Nipple stimulation may be used (less invasive) or IV oxytocin
- Important to lie on your side
- Tell us if you have severe pain, vaginal bleeding, or fluid leakage
- Most often results are reassuring
- If positive — additional testing or delivery may be recommended
- Don't eat heavy meal beforehand
- Empty bladder before
Potential Complications
- Induction of preterm labor (in susceptible patients)
- Hyperstimulation (excessive contractions) → fetal distress
- Uterine rupture (especially with prior cesarean)
- Fetal distress requiring emergent delivery
- Cord prolapse if membranes rupture during test
- Maternal hypotension
- Equivocal results requiring repeat testing
- Anxiety
Nursing Interventions
- Pre-procedure: confirm gestational age, check contraindications, IV access, informed consent
- Side-lying position to prevent supine hypotension
- Continuous fetal monitoring
- Vital signs Q15 min
- Watch for hyperstimulation — stop stimulation if occurs
- Treat hyperstimulation: terbutaline 0.25 mg SQ
- Document contraction pattern and FHR response
- Recognize positive result and notify provider
- Post: continue monitoring until uterus quiet
- Educate on results and next steps
- Discharge with follow-up plan
Description of Procedure
Maternal serum screening for fetal abnormalities. MSAFP (single marker) and the more comprehensive Quad Screen (four markers) detect risk of neural tube defects (NTDs), Down syndrome, and Trisomy 18. Performed at 15-20 weeks gestation (ideally 16-18 weeks). Screening test only — not diagnostic.
Quad markers:
- AFP (alpha-fetoprotein)
- hCG (human chorionic gonadotropin)
- Estriol
- Inhibin A
Indications
- Routine offering at 15-20 weeks (ideally 16-18 weeks)
- All pregnant women offered, regardless of age
- Especially recommended for: advanced maternal age (35+), family history of genetic disorders, prior child with NTD or chromosomal abnormality, abnormal first-trimester screen
- Often combined with first-trimester screening as "sequential" or "integrated"
Interpretation of Findings
Reported as risk (e.g., 1 in 100):
- Results compared with age-adjusted population risk
- "Positive" or "increased risk" — does NOT mean fetus is affected; just indicates need for further testing
- "Negative" or "screen negative" — risk lower than threshold, doesn't guarantee normal fetus
Interpretation patterns:
- ↑ AFP: NTD (spina bifida, anencephaly); abdominal wall defects (gastroschisis, omphalocele); multiple gestation; underestimated gestational age; intrauterine fetal death
- ↓ AFP: Down syndrome, Trisomy 18, overestimated gestational age
- Down syndrome pattern: ↓ AFP, ↑ hCG, ↓ estriol, ↑ inhibin A
- Trisomy 18 pattern: ↓ AFP, ↓ hCG, ↓ estriol, normal/↑ inhibin A
Sensitivity/specificity:
- Quad screen: ~80% sensitivity for Down syndrome with 5% false positive rate
- MSAFP alone: ~80% sensitivity for open NTDs
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Informed consent — woman should understand it's a screening test, not diagnostic
- Verify accurate gestational age (critical — gestational age error causes false positives)
- Documentation of LMP, ultrasound dating
- Identification confirmed
- Pre-test counseling on possible results and next steps
Intra-procedure:
- Simple venipuncture for maternal serum
- Standard blood draw technique
Post-procedure:
- Results in 1-2 weeks typically
- Communicate results to patient
- If positive screen: offer counseling and additional testing
- Provide genetic counseling referral
- Discuss options for confirmatory testing: amniocentesis, detailed ultrasound, NIPT (cell-free DNA)
Client Education
- Voluntary test — your choice
- It's a screening test, not diagnostic — tells us the risk, not whether your baby has the condition
- Positive screen does NOT mean your baby is affected — about 1 in 20 women have positive results but most have normal babies
- Negative screen doesn't guarantee a normal baby — false negatives possible
- Detects: spinal cord defects (spina bifida), Down syndrome, Trisomy 18
- Requires accurate dating — your provider may do ultrasound to confirm gestational age
- Performed at 15-20 weeks, ideal 16-18
- Simple blood test, results in 1-2 weeks
- If positive: additional testing options will be discussed (detailed ultrasound, amniocentesis, NIPT) — your decision
- Genetic counseling available
- Decisions about what to do with results are yours to make
Potential Complications
- False positive results causing anxiety
- Maternal anxiety waiting for results
- Decisions about further invasive testing
- Limited sensitivity — misses some affected fetuses
- Confused interpretation if gestational age inaccurate
- Multiple gestation may alter results
- Maternal diabetes affects AFP
- Decisions about continuing pregnancy if confirmed abnormal
- Ethical considerations
Nursing Interventions
- Educate that screening is optional
- Provide accurate, balanced information
- Ensure informed consent
- Verify accurate dating
- Coordinate blood draw at appropriate gestational age
- Document results in chart
- Communicate results clearly
- Provide emotional support
- Refer to genetic counseling if needed
- Discuss further testing options non-directively
- Respect patient's decisions
- Note: newer NIPT (cell-free fetal DNA) is more accurate for chromosomal screening
Description of Procedure
Both are invasive diagnostic procedures with small risk of fetal loss.
CVS (Chorionic Villus Sampling):
- Performed at 10-13 weeks gestation (earlier than amniocentesis)
- Obtains chorionic villi (placental tissue) for genetic analysis
- Two approaches: transcervical (catheter through cervix) or transabdominal (needle through abdominal wall)
- Ultrasound guidance
- Detects chromosomal abnormalities (Down syndrome, Trisomy 18, etc.) and many genetic disorders
- Cannot detect NTDs
PUBS (Percutaneous Umbilical Blood Sampling / Cordocentesis):
- Performed at 18+ weeks gestation
- Obtains fetal blood from umbilical cord
- Needle through maternal abdomen → umbilical vein under ultrasound guidance
- Highest fetal loss rate of any invasive procedure (~1-2%)
- Used when rapid diagnosis or specific fetal blood test needed
Indications
CVS:
- Maternal age 35+ years
- Abnormal first-trimester screen
- Family history of genetic disorder
- Parent is known carrier
- Prior pregnancy with chromosomal abnormality
- Earlier diagnosis preferred (vs amniocentesis)
PUBS:
- Rapid chromosomal analysis when needed (severe IUGR, late detection of abnormality)
- Fetal anemia evaluation (Rh sensitization, parvovirus)
- Fetal blood transfusions (e.g., for severe hemolytic disease)
- Fetal blood typing
- Fetal infection testing (viral PCR)
- Fetal platelet count (alloimmune thrombocytopenia)
Interpretation of Findings
CVS results:
- Preliminary chromosomal results: 7-14 days
- Detects: chromosomal abnormalities, many genetic disorders
- Cannot detect: NTDs (would require AFP)
PUBS results:
- Rapid chromosomal analysis (24-48 hours)
- Fetal hematocrit, platelet count
- Fetal blood type
- Specific infection testing
- Allows simultaneous treatment (transfusion)
Nursing Interventions (pre, intra, post)
Pre-procedure (both):
- Detailed informed consent
- Verify gestational age
- Genetic counseling prior
- Rh status: RhoGAM if Rh-negative mother after procedure
- Empty bladder
- Ultrasound to locate placenta, fetus
- Local anesthesia for abdominal approach
CVS intra-procedure:
- Lithotomy position (transcervical) or supine (transabdominal)
- Aseptic prep
- Speculum exam if transcervical
- Catheter or needle inserted under ultrasound guidance
- Aspirate small amount of chorionic villi
- Procedure 15-30 minutes
PUBS intra-procedure:
- Supine, slight tilt
- Aseptic prep
- Continuous ultrasound guidance
- Needle through abdominal wall → umbilical vein (typically near placental cord insertion)
- Fetal blood sample drawn (1-4 mL)
- Possible transfusion if indicated
- Procedure 30-60 minutes
Post-procedure:
- Monitor fetal heart rate Q15-30 min × 1 hour
- Maternal vital signs
- Watch for cramping, bleeding, ROM
- RhoGAM administered if Rh-negative
- Activity restrictions × 24-48 hours (rest, no intercourse, no heavy lifting)
- Educate on warning signs
- Discharge instructions
- Results follow-up
Client Education
- Both are invasive — small risk of fetal loss
- CVS: ~0.5-1% loss rate (similar to amniocentesis)
- PUBS: 1-2% loss rate (highest)
- Done by experienced specialist (maternal-fetal medicine)
- Procedure takes 15-60 minutes
- Some discomfort, cramping
- Rh-negative women need RhoGAM
- Rest 24-48 hours after
- Watch for: vaginal bleeding, fluid leakage, severe cramping, fever, decreased fetal movement → call provider
- Results take days to weeks
- Most procedures have normal results
- Decisions about pregnancy based on results are yours
- Genetic counseling support
Potential Complications
CVS complications:
- Fetal loss (~0.5-1%)
- Bleeding
- Infection (chorioamnionitis)
- Limb reduction defects (rare, when done < 10 weeks — no longer done that early)
- Rh sensitization
- Cramping
- ROM
- Anxiety
PUBS complications:
- Fetal loss (1-2%)
- Cord hematoma
- Fetal bradycardia (most resolves)
- Fetal hemorrhage from puncture site
- Infection
- Rh sensitization
- Premature labor
- Maternal hematoma
Nursing Interventions
- Detailed informed consent
- Verify accurate gestational age
- Pre-procedure ultrasound
- Empty bladder
- IV access
- Rh status — RhoGAM ready if Rh-negative
- Aseptic technique
- Continuous fetal monitoring during procedure
- Post-procedure FHR monitoring
- Maternal vital signs
- Watch for: bleeding, cramping, ROM, fever
- RhoGAM administration if indicated
- Discharge instructions: rest, warning signs, when to call
- Coordinate genetic counseling
- Communicate results
- Emotional support
- Decision-making support
Description of Procedure
Battery of laboratory tests performed during prenatal care to identify conditions that affect pregnancy outcomes. Tests scheduled at different gestational ages.
First prenatal visit:
- CBC (anemia, infection)
- Blood type, Rh, antibody screen
- Rubella immunity
- Varicella immunity (history or titer)
- HIV, syphilis (RPR/VDRL), hepatitis B
- Hepatitis C (universal recommendation now)
- Chlamydia, gonorrhea (NAAT)
- Pap smear (if due)
- Urinalysis, urine culture
- TSH (some)
- Glucose (screening if high-risk)
- Tuberculosis screening if at risk
10-13 weeks:
- First-trimester screening: PAPP-A + hCG + nuchal translucency (NT)
- Cell-free fetal DNA (NIPT) — optional
15-20 weeks:
- Quad screen or single AFP
24-28 weeks:
- GDM screening: 1-hour 50g glucose challenge → 3-hour 100g if abnormal
- Repeat CBC, antibody screen (if Rh-negative)
- RhoGAM at 28 weeks if Rh-negative
- Repeat HIV, syphilis (some)
35-37 weeks:
- GBS culture
- HIV, syphilis re-testing
Third trimester (high-risk):
- NSTs, BPP, ultrasound
- Repeat antibody screen if Rh-negative
Indications
Indications for all pregnant women:
- Universal screening for routine prenatal labs
- Identify treatable conditions early
- Allow for genetic screening
- Detect infections that affect mother/fetus
- Optimize maternal health
High-risk additional testing:
- Previous GDM → early glucose screening
- Anemia → iron studies
- Sickle cell trait → partner testing, genetic counseling
- Thyroid disease → close monitoring
- Substance use → urine toxicology
- Prior cervical insufficiency → cervical length monitoring
- Recurrent pregnancy loss → thrombophilia workup, anatomic evaluation
Interpretation of Findings
CBC:
- Anemia: Hgb < 11 g/dL (first/third trimester) or < 10.5 g/dL (second trimester)
- Treat with iron supplementation
Blood type and Rh:
- Rh-negative mothers receive RhoGAM at 28 weeks and within 72 hours postpartum if baby Rh+
- Indirect Coombs if antibody screen positive
Rubella immunity:
- Non-immune: rubella vaccine after delivery (live virus — not in pregnancy)
- Educate about avoiding exposure during pregnancy
Varicella immunity:
- Non-immune: vaccine after delivery; immune globulin if significant exposure
HIV:
- Positive: antiretroviral therapy to prevent perinatal transmission
Syphilis (RPR):
- Positive: confirm with FTA-ABS; treat with penicillin G IM
Hepatitis B:
- HBsAg positive: refer to specialist; newborn HBIG + vaccine at birth
Chlamydia/Gonorrhea:
- Positive: treat with appropriate antibiotic; treat partner
Glucose:
- 1-hour 50g challenge: positive if ≥ 130-140 mg/dL → 3-hour 100g
- 3-hour GTT abnormal: GDM
GBS:
- Positive: intrapartum penicillin G
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Order tests appropriate for gestational age
- Patient identification
- Pre-test counseling for genetic tests
- Informed consent for screening tests
- Fasting if needed (glucose)
- Specimen collection containers ready
Intra-procedure:
- Aseptic technique for blood draw
- Proper labeling
- Special considerations: glucose tolerance test (drink solution, draw at specified intervals; patient stays in clinic; no eating/drinking during test)
- GBS culture: swab vagina and rectum (single swab, vagina then rectum)
- Urine: clean catch midstream
Post-procedure:
- Document tests completed
- Follow-up on results
- Communicate results to patient
- Document results in chart
- Plan follow-up based on results
- Schedule next visit
- Address any abnormal findings
Client Education
- Prenatal labs are recommended part of care
- Routine tests help us catch conditions early
- Genetic screening is optional — discuss with provider
- Some tests require fasting (glucose) — follow instructions
- If you have an aversion to needles, let staff know
- Results discussed at next visit (or sooner if urgent)
- You may need additional testing based on results (don't panic)
- Bring insurance information
- Hydrate before blood draw
- Don't eat/drink during glucose tolerance test
- Specific symptoms to report: bleeding, severe pain, fever, severe headache, vision changes, decreased fetal movement
- Communicate with healthcare team throughout
Potential Complications
- Anxiety about results
- False positive screening tests
- Need for additional invasive testing
- Discovering serious conditions (HIV, syphilis)
- Decision-making about screening/diagnostic testing
- Cost concerns
- Logistical challenges with multiple appointments
- Discomfort with frequent blood draws
Nursing Interventions
- Schedule tests at appropriate gestational ages
- Order tests based on patient risk factors
- Confidential, sensitive approach to sexual health, HIV testing
- Provide pre-test counseling
- Obtain informed consent for screening tests
- Coordinate blood draws
- Educate patient on each test
- Communicate results promptly
- Refer for additional testing or consultation
- Document carefully
- Coordinate with maternal-fetal medicine
- Address patient anxieties
- Help with insurance, financial issues
- Connect to community resources
Physical Development
Growth at birth (term newborn):
- Weight: 2500–4000 g (5 lb 8 oz – 8 lb 13 oz)
- Length: 45–55 cm (18–22 in)
- Head circumference: 32–37 cm
- Posterior fontanel closes 2–3 mo; anterior open until ~18 mo
Apgar scoring at 1 and 5 min — HR, RR, muscle tone, reflex irritability, color (0–2 each):
- 0–3 severe distress · 4–6 moderate · 7–10 minimal
Ballard score (within 48 hr) — assesses gestational age via neuromuscular + physical maturity.
Classification: AGA (10–90%ile) · SGA (<10%ile) · LGA (>90%ile) · LBW (≤2500 g).
Cognitive Development
Piaget — Sensorimotor stage (birth): reflexive activity only.
Neuromotor maturity assessed via reflex symmetry:
- Sucking and rooting — turns head, sucks when cheek stroked (disappears 3–4 mo)
- Palmar grasp — grasps placed object (lessens by 3–4 mo)
- Plantar grasp — toes curl when sole touched (to 8 mo)
- Moro — arms/legs symmetrically extend then abduct, fingers form "C" (to 8 wk)
- Tonic neck (fencer) — extends arm/leg on side head is turned to (to 3–4 mo)
- Babinski — toes fan upward when outer sole stroked (to 1 yr)
- Stepping — steps when held upright on flat surface (to 4 wk)
Absent or asymmetric reflexes may indicate CNS injury, prematurity, or chromosomal abnormality.
Psychosocial Development
Erikson — Trust vs. Mistrust: begins building trust through consistent caregiver response.
Behavioral states (Brazelton):
- Deep sleep · light sleep · drowsy · quiet alert (best for bonding) · active alert · crying
Sensory:
- Vision 8–10 inches; tracks faces; prefers black-white contrast
- Hearing intact at birth (mature)
- Distinguishes parent's voice within days
Bonding/attachment — promote early skin-to-skin contact; rooming-in; eye contact during feeds.
Age-Appropriate Activities
No play in the traditional sense — newborns engage through sensory experience and caregiver interaction.
Developmentally appropriate experiences:
- Skin-to-skin contact (kangaroo care) — regulates temp, glucose, HR; promotes bonding
- Holding, rocking, swaddling
- Soft talking, singing
- Black/white high-contrast images at 8–10 in
- Mobile (in line of sight)
- Brief tummy time when awake and observed
- Breastfeeding/feeding cues honored
Health Promotion
- Newborn screening (blood spot 24–48 hr, hearing, pulse ox for CCHD) before discharge
- Establish feeding — breast (first hour skin-to-skin) or iron-fortified formula; vitamin K + erythromycin eye ointment + HepB at birth
- Safe sleep (SIDS prevention): "back to sleep," firm mattress, no soft bedding, room-share without bed-share
- Bonding promotion: skin-to-skin, eye contact during feeds, responsive caregiving
- Parent education on warning signs: jaundice, feeding intolerance, temp instability, lethargy
- First well-visit within 3–5 days of discharge
Immunizations
Birth (before discharge):
- Hepatitis B #1 — within 24 hr of birth
- Vitamin K IM (not technically an immunization but standard at birth — prevents hemorrhagic disease)
- Erythromycin ophthalmic ointment — prophylaxis for gonococcal/chlamydial conjunctivitis
HepB #2 at 1–2 mo; #3 at 6–18 mo.
If mother is HBsAg+: also give HBIG within 12 hr.
Health Screening
- Newborn screen (blood spot) 24–48 hr after birth — PKU, congenital hypothyroidism, sickle cell, CF, MCAD, others (state-specific panel)
- Hearing screening before discharge (OAE or AABR)
- Pulse oximetry at 24 hr — screen for critical congenital heart disease
- Bilirubin assessment (visual + transcutaneous; serum if needed)
- Glucose screening if at-risk (IDM, SGA, LGA, late preterm)
- Vital signs and weight documented
- First well-visit within 3–5 days of discharge
Nutrition
Feeding cues: rooting, hand-to-mouth, smacking lips; crying is a LATE sign.
Breastfeeding:
- Initiate within first hour
- 8–12 feeds/day; on demand
- Newborn loses ≤7% body weight in first week; should regain by 10–14 days
- Latch: wide-open mouth, lower lip flanged out, areola in mouth, audible swallowing
- Adequate intake: 6+ wet diapers/day by day 4; yellow seedy stools
Formula feeding: iron-fortified formula; 2–3 oz every 3–4 hr initially.
Vitamin D 400 IU/day for all breastfed infants from birth.
Injury Prevention
Safe sleep (SIDS prevention):
- "Back to sleep" — supine on firm mattress
- No soft bedding, pillows, blankets, stuffed animals, bumpers
- Room-share without bed-share
- Avoid overheating (light blanket, swaddling per safe-sleep guidelines)
- Pacifier at sleep may reduce SIDS
Other safety:
- Rear-facing car seat in back seat for every ride home from hospital
- Never leave on elevated surfaces unattended
- Always support head and neck
- Hand hygiene; limit exposure to ill visitors
- No smoking around newborn
- Bathwater temp ≤ 100°F; never leave unattended near water
- CPR training recommended for caregivers
Expected Pharmacological Action
Inhibits dihydrofolate reductase, blocking DNA synthesis and stopping cell division. In ectopic pregnancy, dissolves the trophoblast tissue.
Therapeutic Use
- Termination of unruptured ectopic pregnancy
- Preserves fertility (vs surgical tube removal)
- Also used: rheumatoid arthritis, psoriasis, certain cancers
Complications
- Bone marrow suppression (anemia, leukopenia, thrombocytopenia)
- GI ulcers, mouth sores
- Hepatotoxicity, nephrotoxicity
- Photosensitivity
- Tubal rupture (despite treatment)
Contraindications/Precautions
- Confirmed/desired pregnancy (Category X)
- Breastfeeding
- Hepatic or renal disease
- Peptic ulcer disease
- Immunodeficiency
Interactions
- Folic acid (decreases efficacy — avoid prenatals)
- NSAIDs — increase methotrexate toxicity
- Penicillins — increase toxicity
- Alcohol — hepatotoxicity
Evaluation of Medication Effectiveness
- Serial declining hCG (weekly until negative)
- No tubal rupture signs
- Fallopian tube preserved on follow-up
- Resumption of normal menses
Medication Administration
- IM injection (single-dose protocol most common)
- Verify pregnancy is unruptured before administration
- Baseline labs: CBC, hepatic, renal panels
- Pre-treatment hCG to establish baseline
Nursing Interventions
- Monitor hCG levels post-treatment (weekly)
- Assess for tubal rupture: severe pain, hypotension, shoulder pain
- Monitor CBC, hepatic, renal labs
- Assess for bleeding, infection signs
- Emotional support; pregnancy-loss resources
Client Education
- Avoid folic-acid–containing vitamins — toxic response prevention
- Use sun protection (photosensitivity)
- No alcohol during therapy
- Report severe abdominal/shoulder pain immediately (rupture)
- Avoid pregnancy × 3 months after treatment
- Possible side effects: nausea, fatigue, mouth sores
- Use reliable contraception during follow-up
Expected Pharmacological Action
Crosses placenta and stimulates surfactant production by fetal alveolar Type II cells. Reduces incidence of respiratory distress syndrome (RDS), intraventricular hemorrhage, and necrotizing enterocolitis in preterm neonates.
Therapeutic Use
- Promote fetal lung maturity in anticipated preterm delivery (24–34 wks)
- Used in placenta previa with active bleeding requiring early delivery
- Also: preterm labor, PPROM, abruption
Complications
- Maternal: hyperglycemia, hypertension, transient leukocytosis
- Pulmonary edema (with concurrent tocolytics)
- Infection masking
- Fetal: minimal short-term; potential adrenal suppression
Contraindications/Precautions
- Active maternal infection
- Gestational diabetes (glucose monitoring required)
- Poorly controlled hypertension
- Systemic fungal infection
Interactions
- Tocolytics — combined risk of pulmonary edema
- Antidiabetic agents — glucose elevation
- NSAIDs — GI bleeding risk
- Live vaccines — avoid
Evaluation of Medication Effectiveness
- Both doses completed (24h apart)
- Reduced neonatal RDS if preterm delivery occurs
- Optimal benefit 24h after first dose
- Continued benefit ~7 days post-completion
Medication Administration
- 12 mg IM × 2 doses, 24 hours apart
- Deep IM injection (gluteal)
- Document doses given and timing
- Optimal benefit within 24–48 hours of first dose
Nursing Interventions
- Monitor maternal blood glucose (especially diabetic)
- Assess maternal fundal height, FHR
- Watch for pulmonary edema if tocolytics co-administered
- Monitor temperature for infection signs
- Document fetal movements
Client Education
- Purpose: help baby's lungs mature in case of early delivery
- Monitor blood glucose if diabetic; insulin may need adjustment
- Both doses needed for full effect — return for second dose in 24h
- Continue prescribed bed rest / activity restrictions
- Report any fever, increased contractions, or fluid leakage
Expected Pharmacological Action
Provides passive anti-D IgG antibodies that destroy any fetal Rh-positive RBCs in maternal circulation BEFORE the maternal immune system produces its own anti-D antibodies. Prevents future Rh isoimmunization.
Therapeutic Use
- Routine at 28 weeks gestation for Rh-negative mothers
- Within 72 hours postpartum if baby is Rh-positive
- After spontaneous abortion, ectopic, abruption, GTD
- Amniocentesis, CVS, abdominal trauma
Complications
- Local reactions (injection site pain, swelling)
- Fever, chills
- Hypersensitivity (rare)
- Hemolysis if given to Rh+ patient — DO NOT give
Contraindications/Precautions
- Rh-positive mother — no benefit, risk of hemolysis
- Known hypersensitivity to immune globulin
- IgA deficiency — anaphylaxis risk
- Maternal already sensitized (positive Coombs)
Interactions
- Live vaccines — avoid 3 months post-administration (decreased response)
- Other immune globulins — no clinically significant interaction
Evaluation of Medication Effectiveness
- Indirect Coombs negative on follow-up
- No anti-D antibodies developed
- No Rh sensitization in future pregnancies
Medication Administration
- IM injection (gluteal muscle)
- Standard dose 300 mcg for full-term events
- Lower doses (50 mcg) for early pregnancy losses (< 13 wks)
- Within 72 hours of qualifying event
- Document type, lot number, dose
Nursing Interventions
- Verify Rh status: mother Rh-negative, baby/POC Rh-positive
- Confirm indirect Coombs negative pre-administration
- Monitor for hypersensitivity reaction × 30 min post-injection
- Document administration and rationale
Client Education
- Why given: prevent your body from making antibodies that could harm a future baby
- Always inform future providers of Rh status
- May feel mild soreness at injection site
- Carry RhoGAM card; show to all healthcare providers
- Future pregnancies will require Rh testing and possible repeat injections
- Avoid live vaccines × 3 months after dose
Expected Pharmacological Action
Estrogen + progestin combination suppresses ovulation by inhibiting the hypothalamic GnRH and pituitary LH/FSH release. Thickens cervical mucus to block sperm. Alters the uterine decidua to prevent implantation.
Therapeutic Use
- Contraception (primary)
- Decreases menstrual blood loss & iron-deficiency anemia
- Regulates irregular cycles, treats dysmenorrhea/menorrhagia
- Acne improvement
- Reduces functional ovarian cysts
- Protects against endometrial, ovarian, and colon cancer
Complications
- Venous thromboembolism (VTE) — DVT, PE; most serious risk, especially in smokers > 35, obese, family history of clotting disorders
- Stroke and MI — risk substantially elevated in smokers over 35
- Hypertension (monitor BP at follow-up)
- Migraine — especially migraine with aura (CONTRAINDICATION due to stroke risk)
- Cholestasis, gallbladder disease, benign hepatic adenomas
- Breakthrough bleeding (common in first 3 months)
- Nausea, breast tenderness, headaches (often resolve with continued use)
- Weight changes
- Mood changes, depression
- ↓ libido
- Melasma (skin pigmentation, worsened by sun)
- Hypertriglyceridemia
- Slight ↑ cervical cancer risk; ↑ breast cancer risk while taking (returns to baseline after stopping)
- Decreased risk of ovarian and endometrial cancer (protective effect)
Contraindications/Precautions
- Thromboembolic history, stroke, MI, CAD
- Gallbladder/liver disease, liver tumor
- Severe headache with focal neuro signs
- Uncontrolled HTN, DM with vascular involvement
- Estrogen-dependent cancer (current or past)
- Pregnancy, lactating < 6 weeks postpartum
- Smoker > 35 yo (increased thromboembolic risk)
- Bariatric surgery, severe cirrhosis, lupus
Interactions
- Anticonvulsants (decrease efficacy via liver enzyme induction)
- Antifungals (rifampin notably)
- Some antibiotics
- Smoking magnifies cardiovascular risks
Evaluation of Medication Effectiveness
- No pregnancy (regular menses returns during inactive pill week)
- Tolerability: minimal adverse effects
- Therapeutic benefit: cycle regulation, decreased dysmenorrhea
- BP & weight stable on follow-up visits
Medication Administration
- Oral, same time daily for consistency
- Take at bedtime if nausea is an issue
- Routine Pap and breast exam follow-up
Nursing Interventions
- Screen for contraindications (smoking history, BP, DVT/MI history, age)
- Baseline BP, weight
- Educate on missed-dose protocol
- Monitor for complications at each visit
- Reinforce dual barrier method needed for STI protection
Client Education
- Take at the same time each day
- Report ACHES symptoms immediately: Abdominal pain · Chest pain/SOB · Headache (severe) · Eye changes · Severe leg pain
- Missed dose: 1 pill → take ASAP. 2–3 pills → follow manufacturer instructions; use backup method until regular dosing resumes
- No STI protection — use condom for STI prevention
- Notify provider if surgery is planned (stop 4 weeks before to reduce thrombosis risk)
- Annual follow-up with Pap and breast exam
- Avoid smoking
Expected Pharmacological Action
Depresses CNS irritability; relaxes smooth muscles. Decreases the threshold for seizure activity, preventing eclamptic seizures. Mild peripheral vasodilation, modest BP reduction. Crosses the placenta — neonatal effects expected with peripartum use.
Therapeutic Use
- Severe preeclampsia (seizure prophylaxis)
- Eclampsia (active seizure treatment)
- Preterm labor < 32 weeks (neuroprotection of preterm infant)
Contraindications/Precautions
- Active vaginal bleeding
- Cervical dilation > 6 cm (when used as tocolytic)
- Chorioamnionitis
- Gestation > 34 weeks (for tocolytic indication)
- Acute fetal distress
- Myasthenia gravis
- Renal failure / oliguria (drug excreted renally)
- Do NOT use concurrently with nifedipine (may potentiate hypotension)
Interactions
- Potentiates CNS depressants (opioids, sedatives)
- Potentiates effects of neuromuscular blockers
- Concurrent calcium channel blockers (nifedipine) → severe hypotension
- Concurrent terbutaline / beta-agonists may increase pulmonary edema risk
Medication Administration
- Use an infusion control device (pump) — never gravity drip
- Loading dose IV bolus, then continuous IV infusion
- Indwelling urinary catheter for accurate output
- Do not exceed prescribed serum levels (therapeutic 4–8 mg/dL)
- Maintain access for emergency administration of antidote
Nursing Interventions
- Setting: labor & delivery or high-acuity OB unit with continuous monitoring
- Loading dose: 4-6 g IV over 15-30 minutes; maintenance: 1-2 g/hr continuous IV infusion via pump
- Continuous fetal monitoring throughout therapy
- Vital signs q15 min during loading, then q30-60 min
- Hourly assessments:
- Deep tendon reflexes (DTRs) — patellar; loss of DTRs is the FIRST sign of toxicity
- Respiratory rate (must be ≥ 12)
- Urine output (must be ≥ 30 mL/hr — magnesium renally excreted)
- Level of consciousness
- Serum magnesium levels q6h — therapeutic: 4-7 mEq/L; toxic > 8
- HAVE CALCIUM GLUCONATE AT BEDSIDE — antidote for magnesium toxicity (1 g IV over 3 minutes)
- Toxicity signs (in order): loss of DTRs → respiratory depression → cardiac arrest
- Seizure precautions: padded side rails up, quiet/dim environment, suction equipment ready, oxygen available
- Strict I&O, indwelling catheter often used
- Side effects: warmth, flushing, nausea (common with loading dose), drowsiness, blurred vision
- Continue infusion 24 hours postpartum (seizure risk persists)
- Notify provider immediately for: RR < 12, UO < 30 mL/hr, absent DTRs, altered LOC
- Document all findings
Client Education
- Notify nurse immediately of: blurred vision, headache, nausea, vomiting, difficulty breathing
- Initial flushing and warmth from the bolus are expected
- Frequent assessments will be performed throughout the infusion (vitals, reflexes, urine output)
- You will have a urinary catheter for accurate fluid measurement
- Family/visitors may be limited to maintain a quiet environment if also being treated for severe preeclampsia
Nursing Evaluation of Effectiveness
- Absence of seizure activity
- BP within target range
- Stable maternal vitals and FHR
- Reflexes 1+ to 2+ (not absent)
- RR ≥ 12/min, urine output ≥ 30 mL/hr
- For tocolysis: cessation/reduction of contractions
Expected Pharmacological Action
Blocks calcium channels in vascular and uterine smooth muscle. Vascular effect → vasodilation → ↓ BP. Uterine effect → ↓ contractility (suppresses preterm labor). Crosses placenta minimally.
Therapeutic Use
- Gestational hypertension (BP control)
- Preeclampsia (BP control alongside seizure prophylaxis)
- Preterm labor < 37 weeks (tocolysis)
Contraindications/Precautions
- Do NOT administer concurrently with magnesium sulfate — may potentiate severe hypotension and neuromuscular blockade
- Do NOT administer with or immediately following a beta-adrenergic agonist (terbutaline)
- Severe hypotension
- Cardiogenic shock
- Use cautiously in clients with hepatic impairment
Interactions
- Magnesium sulfate — risk of severe hypotension/neuromuscular weakness
- Beta-blockers — additive cardiac depression
- Beta-agonists (terbutaline) — additive hypotension
- Grapefruit juice — ↑ nifedipine levels
- CYP3A4 inhibitors/inducers
Medication Administration
- PO (immediate-release) or extended-release
- Monitor BP, pulse before each dose
- Hold if BP < 90/60 mm Hg
- Encourage hydration to counter hypotension
- Educate to slowly change positions to upright
Nursing Interventions
- Indications in pregnancy: tocolytic for preterm labor (≤ 48 hr to allow steroids/transfer); chronic HTN; severe gestational HTN
- Monitor BP and HR before each dose; hold and notify provider for:
- SBP < 90 mmHg
- HR < 60 bpm
- For tocolysis: continuous fetal monitoring and uterine activity monitoring
- Position client semi-recumbent or lateral to optimize uteroplacental perfusion
- Monitor for hypotension — common; teach to rise slowly
- Common side effects: headache, flushing, dizziness, peripheral edema, reflex tachycardia, nausea
- Do NOT give concurrently with IV magnesium sulfate — additive hypotension and neuromuscular blockade risk
- Assess for pulmonary edema (rare but serious): cough, dyspnea, crackles
- Avoid grapefruit and grapefruit juice (↑ levels via CYP3A4)
- Use sublingual administration only in emergency (rapid BP drop)
- For sustained-release: swallow whole; do not crush or chew
- Daily weights for fluid retention
- Educate about position changes (orthostatic hypotension)
- Coordinate with provider for tocolytic effectiveness — uterine activity should decrease within 4-6 hours
Client Education
- Slowly change positions from supine to upright; sit until dizziness disappears
- Maintain adequate hydration to counter hypotension
- Report severe headache, chest pain, palpitations, swelling, fainting
- Headache and flushing are common initially
- Avoid grapefruit juice while taking this medication
- Take exactly as prescribed — do not stop abruptly
Nursing Evaluation of Effectiveness
- Tocolytic: cessation or significant reduction in contractions
- Antihypertensive: BP within target range without symptomatic hypotension
- Stable maternal vitals and FHR
- No worsening of preeclampsia signs
Expected Pharmacological Action
Bactericidal — inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis. Effective against gram-positive cocci including Streptococcus agalactiae (GBS).
Therapeutic Use
Intrapartum antibiotic prophylaxis (IAP) in clients with confirmed GBS colonization to prevent vertical transmission and early-onset neonatal GBS disease. Reduces transmission by > 80% when given ≥ 4 hours before delivery.
Complications
- Anaphylaxis (rare but life-threatening — 1 in 100,000)
- Rash, urticaria
- Diarrhea, nausea
- Vaginal candidiasis
- Pseudomembranous colitis (rare, C. diff)
- Local IV site reactions (pain, phlebitis)
- Hypersensitivity reactions in newborn from placental transfer
Contraindications/Precautions
- Penicillin allergy (anaphylaxis history is absolute)
- Use cefazolin if low-risk PCN allergy
- Use clindamycin or vancomycin if severe PCN allergy with confirmed sensitivity
- Caution in renal impairment (adjust dose)
Interactions
- Probenecid increases penicillin serum levels (potentiates effect)
- Aminoglycosides — synergistic effect against susceptible organisms (but inactivated if mixed in same IV line)
- Tetracyclines may decrease bactericidal effect
- Methotrexate elimination decreased — toxicity risk
Evaluation of Medication Effectiveness
- Adequate prophylaxis: ≥ 4 hours between dose and delivery
- Newborn signs of infection (if any) appear < 24 hours after birth
- No anaphylaxis or hypersensitivity reaction
- Maternal afebrile
- Continue assessment of newborn for first 24+ hours
Medication Administration
- Dose: 5 million units IV initial, then 2.5–3 million units IV q4hr until birth
- Reconstitute per facility protocol
- Administer over 15–30 minutes (slow IV push to avoid neuro irritation)
- Use dedicated IV line — do not mix with aminoglycosides
- First dose ideally given ≥ 4 hours before delivery
Nursing Interventions
- Assess for PCN allergy at admission
- Document time of each dose carefully (for newborn evaluation)
- Monitor for anaphylaxis (have epinephrine and diphenhydramine ready)
- Verify IV patency before each dose
- Educate client on purpose and importance
- Communicate dose times to neonatal team
Client Education
- Explain purpose: protects baby from GBS infection at birth
- Side effects: rash, itching, GI upset — notify nurse if severe
- Importance of completing all doses before delivery
- Yeast infection prevention (probiotics if recurrent)
- Reassurance that minimal medication transfers to fetus
Expected Pharmacological Action
Synthetic posterior pituitary hormone that stimulates uterine smooth muscle contraction by increasing intracellular calcium. Also has antidiuretic effect at high doses.
Therapeutic Use
Antepartum: Induction or augmentation of labor. Postpartum: Prevention and treatment of uterine atony / postpartum hemorrhage. Also used to manage incomplete or inevitable abortion.
Complications
- Tachysystole (> 5 contractions in 10 min averaged over 30 min) — leading complication
- Uterine rupture (especially with prior uterine surgery)
- Fetal distress (late or prolonged decels from hyperstimulation)
- Water intoxication / hyponatremia (at high doses due to ADH effect)
- Maternal hypotension with rapid IV push
- Postpartum hemorrhage if rapid discontinuation after long use
- Subarachnoid hemorrhage (rare)
Contraindications/Precautions
- Cephalopelvic disproportion (CPD)
- Placenta previa or vasa previa
- Active genital herpes
- Prior classical cesarean or other uterine surgery
- Nonreassuring fetal status
- Severe preeclampsia (relative — use cautiously)
- Multifetal gestation (relative)
- Hyperextended fetal position
Interactions
- Vasopressors — additive hypertensive effect
- Inhaled anesthetics — may reduce oxytocin effect
- Prostaglandins (misoprostol, dinoprostone) — wait 6–12 hours after PGE before starting oxytocin (synergistic uterine effect)
- Magnesium sulfate decreases oxytocin effectiveness (relaxes uterus)
Evaluation of Medication Effectiveness
- Adequate contraction pattern: 3–5 contractions in 10 minutes
- Cervical change / progression of labor
- Reassuring fetal heart rate tracing maintained
- No tachysystole, no fetal distress
- Postpartum: firm fundus, controlled bleeding
Medication Administration
- Always given IV via infusion pump on secondary line
- Induction: Start at 0.5–2 milliunits/min; increase by 1–2 mU/min q15–30 min until adequate pattern
- Postpartum: 10–40 units in 1 L IV solution at 125–200 mL/hr; or 10 units IM after delivery of placenta
- Standard concentration: 30 units in 500 mL LR (1 mU/min = 1 mL/hr)
- Discontinue immediately for tachysystole or nonreassuring FHR
Nursing Interventions
- Continuous EFM — assess for tachysystole and FHR changes
- VS q15min during induction, q30min once stable, q2hr postpartum
- Assess uterine activity (frequency, duration, intensity, resting tone) q15min
- Strict I&O — monitor for water intoxication
- Have terbutaline available for tocolysis if tachysystole
- Document contraction pattern, FHR, and infusion rate
Client Education
- Explain purpose and what to expect with induction
- Discomfort may increase with stronger contractions
- Report any sudden severe pain (rupture concern)
- Continuous monitoring requires limited mobility
- Pain management options available
Expected Pharmacological Action
Cofactor required for hepatic synthesis of coagulation factors II, VII, IX, X (vitamin K-dependent). Newborns have physiologic vitamin K deficiency at birth (sterile gut, low placental transfer, low breast milk content).
Therapeutic Use
Universal newborn administration within 1 hour after birth to prevent vitamin K deficiency bleeding (VKDB) of the newborn (formerly hemorrhagic disease of the newborn). Prevents intracranial, GI, and umbilical stump bleeding.
Complications
- Local reaction at injection site (rare)
- Hyperbilirubinemia (very rare, especially in preterm infants)
- Severe allergic reaction (extremely rare — anaphylactoid response from IV use)
- Hematoma at injection site
- Pain during administration
Contraindications/Precautions
- Hypersensitivity to phytonadione
- IV route generally avoided in newborns due to risk of severe reaction (use IM)
- Parental refusal (document, educate, escalate to provider)
Interactions
- Antagonizes warfarin (not relevant in newborns)
- May reduce effectiveness of certain anticoagulants
- Maternal use of warfarin, anticonvulsants, or rifampin during pregnancy increases newborn VKDB risk
Evaluation of Medication Effectiveness
- No bleeding from umbilical stump, circumcision site, or mucous membranes
- Normal coagulation parameters if checked
- No signs of internal bleeding (irritability, vomiting, seizures suggestive of intracranial)
- No injection site complications
Medication Administration
- Dose: 0.5–1 mg IM single dose (0.5 mg if < 1.5 kg)
- Site: vastus lateralis (middle one-third of anterolateral thigh)
- Needle: 5/8-inch, 25-gauge
- Within 1 hour of birth ideally (definitely within 6 hr)
- Use 23–25-gauge needle 5/8 inch
- Stabilize the thigh; use a 90° angle
Nursing Interventions
- Verify parental consent (some refuse)
- Confirm newborn ID before administration
- Use proper injection technique to avoid neurovascular injury
- Apply pressure post-injection
- Document time, site, dose, and parent education
- If parents refuse, educate on bleeding risk; escalate per facility policy
Client Education
- Explain purpose to parents: prevents serious bleeding (intracranial hemorrhage)
- Newborns have no vitamin K reserves and cannot make their own
- Single dose protects for several months until diet establishes vitamin K
- Without it, 0.25–1.7% risk of VKDB (some studies higher)
- Side effects rare and mild; benefits far outweigh risks
Expected Pharmacological Action
Bacteriostatic — inhibits bacterial protein synthesis by binding to 50S ribosomal subunit. Active against gram-positive cocci, some gram-negative organisms, including Neisseria gonorrhoeae and Chlamydia trachomatis.
Therapeutic Use
Universal newborn ophthalmic prophylaxis to prevent ophthalmia neonatorum (gonococcal and chlamydial conjunctivitis) acquired during passage through birth canal. Federally and state-mandated in U.S.
Complications
- Chemical conjunctivitis (mild, self-limiting redness and edema)
- Eye irritation
- Local hypersensitivity reaction (rare)
- Possible interference with bonding due to blurred vision (some delay administration 1 hour for bonding)
Contraindications/Precautions
- Macrolide hypersensitivity (very rare in newborns)
- Eye infection present at birth (treat infection, not prophylax)
Interactions
- None significant for topical ocular use
- Systemic erythromycin (oral/IV) has many interactions but not relevant for ophthalmic
Evaluation of Medication Effectiveness
- No signs of gonococcal or chlamydial infection within first week
- Eyes clear, no purulent discharge
- No persistent chemical conjunctivitis (resolves in 24–48 hr)
- No allergic reaction
Medication Administration
- Within 1 hour of birth (may delay up to 1 hour for bonding/breastfeeding)
- Wear clean gloves
- Open lower eye with thumb pulling down
- Apply 1 cm ribbon to lower conjunctival sac (inner to outer canthus)
- Repeat on other eye
- Allow newborn to close eyes — do NOT wipe excess
- Single dose to each eye
Nursing Interventions
- Verify newborn identification
- Position newborn with head stabilized
- Use new tube for each newborn (single-use)
- Avoid touching tube tip to eye
- Apply in inner-to-outer canthus direction
- Document time and any reactions
- Inform parents of brief blurred vision after administration
Client Education
- Explain mandate and purpose: prevents potentially blinding eye infection
- Even if mother tests negative, prophylaxis required by law in most states
- Mild redness or discharge for 24–48 hours is normal
- Do not wipe ointment out
- Bonding can occur after ointment is applied
- Report any persistent or worsening eye signs
Expected Pharmacological Action
Selectively stimulates beta-2 adrenergic receptors causing relaxation of uterine smooth muscle and bronchodilation. Also has some beta-1 effects causing tachycardia. Used acutely to delay preterm labor or for emergent uterine relaxation.
Therapeutic Use
Acute tocolysis in preterm labor to delay delivery 24–48 hours (allow for steroid administration and maternal transport). Emergency uterine relaxation for: uterine tachysystole, fetal distress before cesarean, cord prolapse, version, manual placental removal. NOT for prolonged tocolysis beyond 48–72 hr (FDA black box).
Complications
- Maternal tachycardia (most common — HR > 120)
- Tremors, nervousness, restlessness
- Palpitations, chest pain
- Pulmonary edema (most dangerous — especially with fluid overload)
- Hypotension
- Hyperglycemia
- Hypokalemia
- Headache, dizziness
- Nausea, vomiting
- Fetal: tachycardia, hyperinsulinemia
- Maternal death reported (FDA black box)
Contraindications/Precautions
- Cardiac disease (arrhythmias, ischemia)
- Uncontrolled diabetes
- Uncontrolled hyperthyroidism
- Severe preeclampsia or eclampsia
- Significant placental abruption or hemorrhage
- Intrauterine infection (chorioamnionitis)
- Fetal demise or anomalies incompatible with life
- Severe pulmonary hypertension
- FDA black box: avoid prolonged use (> 48–72 hr) or oral/SC outpatient
Interactions
- Beta-blockers antagonize effect
- Other beta-agonists potentiate effects (additive cardiac strain)
- Corticosteroids increase risk of pulmonary edema
- MAO inhibitors potentiate hypertensive effects
- Magnesium sulfate (concurrent use questionable — generally avoid)
- Digoxin may have additive cardiac effects
- Diuretics may worsen hypokalemia
Evaluation of Medication Effectiveness
- Cessation or slowing of contractions
- Maternal HR remains < 120 bpm
- No chest pain, dyspnea, pulmonary edema signs
- FHR remains reassuring
- Successful achievement of 48-hr delay for steroids
- Stable blood glucose and potassium
Medication Administration
- Acute tocolysis: 0.25 mg SC q20–30min x 3 doses (max)
- Emergency relaxation: 0.25 mg SC single dose
- Some protocols: IV 2.5–10 mcg/min titrated
- Hold if maternal HR > 120 or chest pain
- Do NOT use orally or pump for outpatient (FDA black box)
- Limit duration to 48–72 hr
- Continuous EFM during administration
Nursing Interventions
- Continuous maternal cardiac monitoring
- Maternal pulse before each dose — hold if > 120
- Continuous EFM
- Assess lung sounds q1hr for crackles (pulmonary edema)
- Strict I&O — limit IV fluids to 2,500 mL/24 hr
- Monitor glucose q4hr (especially if diabetic)
- Monitor potassium
- Position left lateral
- Document maternal and fetal HR, contractions, side effects
- Have propranolol (beta-blocker antidote) at bedside
Client Education
- Explain purpose: delay labor 48–72 hr for steroid effect
- Side effects: tremors, anxiety, fast heart rate are common and will subside
- Report: chest pain, severe shortness of breath
- Importance of bedrest
- Lifelong avoidance not needed after pregnancy
- Antenatal steroid effect peaks 24–48 hr
Expected Pharmacological Action
Synthetic prostaglandin E1 analog that softens and dilates the cervix (cervical ripening) and stimulates uterine contractions. Originally developed for peptic ulcer prevention. Off-label use widely accepted for OB indications.
Therapeutic Use
Cervical ripening and labor induction (when Bishop score < 6). Treatment of postpartum hemorrhage (uterine atony). Management of incomplete or missed abortion. Used off-label in obstetrics (no FDA approval but ACOG-endorsed).
Complications
- Tachysystole (> 5 contractions in 10 min) — most common
- Uterine hyperstimulation with FHR changes
- Uterine rupture (especially with prior cesarean — CONTRAINDICATED)
- Nausea, vomiting, diarrhea (GI side effects)
- Shivering, fever, chills
- Headache
- Possible meconium-stained amniotic fluid
- Maternal hypotension (high doses)
Contraindications/Precautions
- Previous cesarean delivery or uterine surgery (uterine rupture risk — ABSOLUTE)
- Active vaginal bleeding
- Placenta previa
- Nonreassuring fetal status
- Active genital herpes
- Maternal cardiac/pulmonary/renal disease (caution)
- Cephalopelvic disproportion
- Malpresentation
- Active asthma, glaucoma (relative)
- Hypersensitivity to prostaglandins
Interactions
- Oxytocin: wait 4 hours after last misoprostol dose before starting oxytocin (synergistic effect → tachysystole)
- Dinoprostone (other PG agents) — do not use concurrently
- Antacids decrease absorption (oral route)
- NSAIDs may decrease PG effect
Evaluation of Medication Effectiveness
- Progressive cervical ripening (Bishop score improvement)
- Onset of regular contractions
- Reassuring fetal heart rate tracing
- No tachysystole
- Postpartum: firm fundus, controlled bleeding
- Successful completion of incomplete abortion management
Medication Administration
- Cervical ripening: 25 mcg vaginally q3–6hr (max 6 doses)
- PPH: 600–1,000 mcg PR or 800 mcg buccal/sublingual
- Incomplete abortion: 600 mcg PO or 400 mcg SL
- Routes: oral, vaginal, sublingual, buccal, rectal
- Place vaginally in posterior fornix
- Patient remains supine for 30–40 min after vaginal dose
- Wait 4 hours after last dose before starting oxytocin
Nursing Interventions
- Continuous EFM during induction
- Assess Bishop score before and after
- VS q30min, then q1hr
- Monitor for tachysystole and FHR changes
- Remove tablet if hyperstimulation or nonreassuring FHR (vaginal route)
- Have terbutaline available for tocolysis
- Position upright or side-lying for cervical effect
- Document time, dose, route of each administration
- Avoid simultaneous oxytocin
Client Education
- Explain purpose: prepare cervix for induction or stop bleeding
- May cause GI upset
- Report contractions, ROM, bleeding, severe pain
- Stay in bed 30–40 min after vaginal placement
- Inform of expected timeline (may take 12–24+ hr)
- Discuss alternative methods if not effective
Expected Pharmacological Action
Mixed agonist-antagonist opioid — agonist at kappa receptors (analgesia, sedation) and partial antagonist at mu receptors. Provides moderate to severe pain relief with less respiratory depression than pure agonists. Onset 5–10 min IV; duration 3–4 hr.
Therapeutic Use
Pain management during active labor when epidural is not available, declined, or contraindicated, OR in early labor before epidural is appropriate. May also be used postoperatively for cesarean delivery pain. Provides moderate analgesia without complete pain elimination.
Complications
- Neonatal respiratory depression (if given within 1 hr of birth)
- Maternal sedation, drowsiness
- Nausea, vomiting
- Dizziness, lightheadedness
- Mild euphoria or dysphoria (psychomimetic effects)
- Pruritus, sweating
- Bradycardia, hypotension
- Confusion, hallucinations (rare)
- Withdrawal in opioid-dependent client (antagonist effects)
- Decreased fetal heart rate variability (transient)
Contraindications/Precautions
- Imminent delivery (within 1 hour — neonatal respiratory depression)
- Maternal opioid dependence (precipitates withdrawal)
- Severe asthma or respiratory disease
- Increased intracranial pressure or head injury
- Severe hepatic or renal impairment
- Hypersensitivity to butorphanol
- Concurrent MAO inhibitors (within 14 days)
Interactions
- Other CNS depressants (benzodiazepines, alcohol, antihistamines) — potentiates sedation/respiratory depression
- Pure opioid agonists (morphine, fentanyl) — partially antagonizes their effect
- Magnesium sulfate — additive CNS depression
- MAO inhibitors — severe hypertension
- Phenothiazines — increased CNS effects
- Anesthesia agents — additive respiratory depression
Evaluation of Medication Effectiveness
- Pain reduction by 2+ points on 0–10 scale
- Maternal comfort improved
- Maternal RR remains > 12, SpO₂ > 95%
- FHR remains reassuring
- No excessive sedation (responds to voice)
- Newborn vigorous at birth, Apgar > 7
- No neonatal respiratory depression at birth
Medication Administration
- Standard dose: 1–2 mg IV q3–4hr OR 1–4 mg IM
- Slow IV push over 1–2 minutes
- Time administration in early to mid-labor
- Avoid within 1 hour of anticipated delivery
- Have naloxone (Narcan) available for newborn
- Document time, dose, route
- Reassess pain at 15–20 min
- Maximum dose: 6 mg in 24 hr
Nursing Interventions
- Continuous EFM during and after administration
- VS before, 15 min after, and q30min for duration
- Assess fetal status — decreased variability expected, transient
- Side rails up, call light within reach
- Assess sedation level q30min
- Bedrest after administration (fall risk)
- Naloxone at bedside (newborn dose 0.1 mg/kg)
- Reassess pain and offer non-pharmacologic measures
- If delivery occurs within 1 hour: alert pediatric team
- Maintain hydration
- Monitor for nausea — antiemetic PRN
Client Education
- Explain expected partial pain relief (not complete elimination)
- May feel drowsy, lightheaded — stay in bed
- Side effects: nausea, drowsiness — these usually decrease
- Will not slow labor
- Doesn't replace epidural option
- Effect lasts 3–4 hours
- Newborn will be assessed for breathing after delivery
- Call nurse before getting up
- Bring partner/support person aware of effects
Category Class
Contraceptive devices — inserted into the uterine cavity for long-acting reversible contraception (LARC).
Therapeutic Intent
Prevent pregnancy by creating spermicidal environment (copper) or by releasing progestin to thicken cervical mucus, thin endometrium, and suppress ovulation (hormonal).
Expected Pharmacologic Action
- Copper IUD (ParaGard):
- Non-hormonal; copper-wrapped T-shaped device
- Effective up to 10-12 years
- Copper creates spermicidal environment
- Prevents fertilization; possibly prevents implantation
- Can be used as emergency contraception within 5 days
- Hormonal IUDs (Mirena, Liletta, Kyleena, Skyla):
- T-shaped device releasing levonorgestrel locally
- Mirena: 5 years (off-label up to 7); Liletta: 6 years; Kyleena: 5 years; Skyla: 3 years
- Thickens cervical mucus (sperm cannot reach ovum)
- Thins endometrium (prevents implantation if fertilization occurs)
- Suppresses ovulation in some women (especially Mirena)
- Efficacy: > 99% for all IUDs
Therapeutic Use
- Long-acting reversible contraception (LARC)
- Copper IUD: also used as emergency contraception
- Hormonal IUDs: also used for heavy menstrual bleeding, dysmenorrhea, endometriosis, endometrial hyperplasia prevention
- Postpartum contraception (immediate post-placental, post-cesarean, or 6-week visit)
- Postabortion contraception
Nursing Care
- Pre-insertion:
- Verify negative pregnancy test
- Assess for STIs (test if at risk; treat any active infection BEFORE insertion)
- Bimanual exam to assess uterine size and position
- Educate on procedure, side effects, expected duration
- NSAIDs (ibuprofen 600-800 mg) 30-60 min before insertion for cramping
- Empty bladder
- During insertion:
- Provide support during procedure
- Brief but acute cramping is normal
- Vasovagal response possible (rare): bradycardia, hypotension, syncope
- Post-insertion:
- VS monitoring × 30 min
- Patient may rest, then dress slowly
- Provide post-procedure instructions
- Schedule follow-up at 4-6 weeks (string check, satisfaction)
- Insertion timing:
- During menstruation (cervix slightly dilated, rules out pregnancy)
- Immediately postpartum (within 10 min of placental delivery)
- At cesarean delivery
- Postabortion
Client Education
- String check monthly after each menstrual period — strings should be palpable but not visibly protruding
- If can't find strings, can't feel them, or they feel longer: see provider, use backup contraception
- Side effects (Copper): heavier menses, increased cramping (improves over months)
- Side effects (Hormonal): irregular spotting first 3-6 months; eventual lighter menses or amenorrhea (50% by 1 year with Mirena)
- Resume sexual activity when comfortable
- Use condoms for STI protection (IUD doesn't protect)
- Mild cramping × 24-48 hr after insertion is normal — NSAIDs
- PAINS warning signs to report:
- P — Period late, pregnancy
- A — Abdominal pain, pain with intercourse
- I — Infection (abnormal discharge)
- N — Not feeling well, fever, chills
- S — Strings missing, shorter, longer
- Removal: requires office visit; rapid return to fertility
- If pregnancy occurs with IUD: see provider immediately (higher proportion ectopic; remove IUD if visible)
Evaluation / Monitoring
- 4-6 week follow-up (string check)
- Annual exam thereafter
- Cervical cancer screening per usual
- STI screening as indicated
- Replace at end of effective period
- Document last menstrual period at each visit
Medication / Food Interactions
- No drug interactions (local effect only)
- Antibiotics: no effect on hormonal IUDs (unlike COCs)
- Anticoagulants: may increase bleeding with copper IUD
- MRI: most IUDs are MRI-conditional (verify type)
- Hysteroscopy, cervical biopsy: avoid if possible during use (rare complications)
Complications
- Expulsion: 2-10% in first year (highest with copper, postpartum insertion, nulliparas)
- Perforation: rare (1 per 1,000 insertions)
- Ectopic pregnancy: rare overall (IUD prevents pregnancy) but if pregnancy occurs, higher proportion ectopic
- PID: slightly increased risk first 3 weeks after insertion only
- Vasovagal reaction at insertion
- Heavier menses, dysmenorrhea (copper)
- Hormonal side effects: acne, mood changes, breast tenderness (low overall with local progestin)
- Ovarian cysts (hormonal IUDs — usually asymptomatic, self-resolve)
Expected Pharmacological Action
All hormonal contraceptives work via:
- Inhibition of ovulation (primary)
- Thickening cervical mucus (blocks sperm)
- Thinning endometrium (impedes implantation)
- Slowing tubal motility
Combined methods (estrogen + progestin): patch, ring, COCs
Progestin-only: mini-pill, DMPA injection, implant
Therapeutic Use
- Prevention of pregnancy
- Menstrual cycle regulation
- Reduce dysmenorrhea, heavy bleeding
- Improve acne (combined methods)
- Endometriosis management
- PCOS
- Reduce ovarian, endometrial cancer risk
- Reduce ectopic pregnancy
Specific products:
- Transdermal patch (Xulane) — applied weekly × 3, off 1; combined
- Vaginal ring (NuvaRing, EluRyng) — inserted for 3 weeks, removed 1; combined
- DMPA injection (Depo-Provera) — every 3 months IM/SQ; progestin-only
- Implant (Nexplanon) — subdermal, 3-5 years; progestin-only
- Mini-pill (progestin-only pill, POP) — daily; for breastfeeding women, contraindications to estrogen
Complications
Combined (estrogen-containing) methods:
- VTE/PE (most serious)
- Stroke (especially smokers > 35)
- MI
- HTN
- Hepatic adenoma
- Cervical cancer (slight ↑)
- Breast cancer (controversial, slight ↑)
- Migraine with aura — contraindication
- Nausea, breast tenderness
- Mood changes
- Decreased libido
- Spotting
Progestin-only:
- Irregular bleeding (most common)
- Amenorrhea (DMPA — often)
- Weight gain (DMPA)
- Bone mineral density loss (DMPA — usually reversible)
- Delayed return to fertility (DMPA — up to 12 months)
- Acne
- Mood changes
- Headache
- Implant: insertion site issues
All:
- No STI protection
- Drug interactions
- Decreased efficacy in obesity (some methods)
Contraindications/Precautions
Absolute contraindications to estrogen (combined methods):
- VTE history or thrombophilia
- Stroke history
- Cardiovascular disease, MI
- Hypertension uncontrolled
- Migraine with aura
- Smoking + age > 35
- Breast cancer (current or history)
- Active liver disease
- Estrogen-sensitive tumors
- Pregnancy
- Postpartum < 21 days (VTE risk); < 42 days if other risks
- Major surgery with immobilization
Progestin-only safer in:
- Smoking, age > 35
- VTE history
- Hypertension
- Migraine with aura
- Breastfeeding (no effect on milk supply)
- Postpartum (start immediately or any time)
DMPA precautions:
- Bone density issues (osteoporosis)
- Long-term use considerations
Interactions
- CYP3A4 inducers (decrease efficacy): rifampin, certain antiepileptics (carbamazepine, phenytoin, phenobarbital), St. John's wort, some HIV drugs
- Antibiotics: rifampin definitely decreases; other antibiotics not clinically significant
- Antacids may decrease absorption (mini-pill)
- Some HIV medications
Evaluation of Medication Effectiveness
- No pregnancy
- Cycle regulation (some)
- Symptom relief (acne, dysmenorrhea)
- No major side effects
- Patient satisfaction
- Continuation of method
Medication Administration
Patch:
- Apply weekly × 3 weeks (upper arm, buttock, abdomen, back; not breasts)
- Off 1 week (menses)
- Same day of week
- Less effective if weight > 198 lbs
Vaginal ring:
- Insert; leave 3 weeks; remove 1 week (menses)
- Or continuous use (skip menses)
- Stored in fridge if longer than 4 months
DMPA injection:
- IM (Depo) or SQ (Depo-SubQ)
- Every 12 weeks (allow up to 15 weeks if missed)
- Don't massage injection site
Implant:
- Inserted subdermally in non-dominant upper arm
- Replace every 3 years (5 years per recent guidance)
Mini-pill:
- Daily, SAME TIME each day (3-hour window)
- No pill-free week
Nursing Interventions
- Assess for contraindications
- BP screening
- Smoking history
- Medical and family history
- Education on specific method
- Side effect education
- Set realistic expectations (irregular bleeding common initially)
- Schedule follow-ups
- DMPA: schedule next injection
- Implant insertion: aseptic technique, monitor site
- Watch for: severe abdominal pain, chest pain, leg pain/swelling, severe headache, visual changes (ACHES)
- STI counseling — separate from contraception
- Backup method first 7 days (with most methods)
- Address concerns about weight, mood, libido
Client Education
Patch:
- Apply once a week, change same day each week
- Various sites except breasts
- Don't use creams/lotions where applied
- Watch for skin reactions, fall-off
- Replace within 24 hours if falls off
Ring:
- Insert and remove yourself (can wait until period or after)
- If out > 3 hours, less effective
- Can use during sex
DMPA:
- Visit every 3 months
- Periods may become irregular or stop
- Weight gain possible
- Calcium/vitamin D supplementation
- Weight-bearing exercise
- Limited duration (concern for BMD)
- Fertility may take 9-12 months to return
Implant:
- 3-5 year duration
- Insertion and removal needed
- Effective within 24 hours of insertion (with backup × 7 days unless within 5 days of menses)
- Irregular bleeding common
Mini-pill:
- Take SAME TIME daily (within 3-hour window)
- No pill-free week
- If miss by > 3 hours: take immediately and use backup × 48 hours
- Less effective than COCs if not taken consistently
All:
- Doesn't protect against STIs — use condoms
- Warning signs: severe headache, severe leg pain, chest pain, abdominal pain, visual changes
- Watch for new symptoms
- Inform other providers
- Stop if planning pregnancy (varies by method)
Description of Skill
External manual stimulation of the postpartum uterine fundus through the abdominal wall to promote uterine contraction. The dominant hand cups the fundus while the non-dominant hand supports the lower uterine segment just above the symphysis pubis. Massage is performed in a circular motion until the fundus firms.
Indications
- Routine assessment during the 4th stage of labor and postpartum period
- Boggy or soft uterus on palpation
- Excessive lochia or postpartum hemorrhage from uterine atony
- Fundus higher than expected or deviated from midline
Outcomes/Evaluation
- Fundus is firm, midline, and at or below umbilicus
- Lochia decreases to expected amount
- Stable vital signs (no signs of hypovolemic shock)
- Client reports no excessive cramping discomfort
Nursing Interventions (pre, intra, post)
Pre: Have client void (a full bladder displaces the uterus and inhibits contraction). Position supine with knees flexed. Don clean gloves; assess lochia amount, color, and clots.
Intra: Place non-dominant hand just above the symphysis pubis to stabilize the lower uterine segment (prevents uterine inversion). Cup the fundus with the dominant hand and massage in a circular motion until firm. Continue palpation while assessing lochia for clots and amount.
Post: Reassess fundal tone, height, and position. Document findings. Reassess every 15 min × 1 hr in 4th stage; q4hr thereafter, or more frequently if boggy. Notify provider if fundus remains boggy after massage and bladder is empty.
Client Education
- Massage may cause cramping discomfort; this is expected and temporary
- Empty bladder regularly to prevent uterine displacement
- Teach self-massage if discharged with risk of atony
- Report saturating a pad in 15 min or large clots to the nurse
Potential Complications
- Uterine inversion — most serious; from excessive force without supporting the lower segment
- Severe cramping or pain
- Continued atony despite massage (escalate: empty bladder, second-line uterotonics, bimanual compression)
- Hemorrhagic shock if atony unresolved
Nursing Interventions
- Assess fundus q15min × 1hr postpartum, then q30min × 2hr, q1hr × 4hr, q4hr × 24hr
- Always support the lower uterine segment with the non-dominant hand
- If boggy: massage → reassess → empty bladder if full → notify provider if no improvement
- Have IV access established (large-bore preferred) for rapid uterotonic delivery
- Monitor VS for early signs of hypovolemic shock (rising pulse, falling BP)
Description of Skill
Capillary blood sampling from the outer lateral aspect of the heel for routine screening. The puncture must be no deeper than 2.4 mm to avoid bone penetration. Performed using a sterile lancet on a warmed heel after the newborn has been feeding adequately (for the newborn metabolic screen).
Indications
- Newborn metabolic screening (PKU, hypothyroidism, hemoglobinopathies, etc.) at 24–48 hr
- Capillary blood glucose monitoring (at-risk newborns: LGA, SGA, IDM, preterm)
- Total serum bilirubin (transcutaneous and serum)
- Capillary blood gases or hematocrit when ordered
Outcomes/Evaluation
- Adequate blood sample obtained on first attempt when possible
- Minimal tissue trauma and no bone contact
- Hemostasis achieved within 1–2 minutes
- Newborn comforted; pain response minimized
Nursing Interventions (pre, intra, post)
Pre: Verify order and identification using two identifiers. Warm the heel for 5–10 min with a commercial warmer (improves blood flow). Position newborn supine; offer non-nutritive sucking or breastfeeding for comfort. Don gloves.
Intra: Cleanse with alcohol; allow to fully dry. Hold heel firmly. Puncture the outer lateral aspect of the heel, no deeper than 2.4 mm. Wipe away first drop. Collect sample drops onto card without smearing or touching skin to card.
Post: Apply pressure with dry gauze (NOT alcohol — can prolong bleeding and worsen pain). Cover with sterile gauze. Document site, sample, and newborn tolerance. Discard lancet in sharps container. Comfort newborn (skin-to-skin, swaddling, feeding).
Client Education
- Explain the purpose of the test to parents (screens for treatable conditions before symptoms appear)
- Test results will be returned by primary provider within 1–2 weeks
- Site may have a small bruise that resolves spontaneously
- Parents may comfort newborn during procedure (skin-to-skin reduces pain)
Potential Complications
- Necrotizing osteochondritis — from puncture too deep (> 2.4 mm) hitting calcaneus
- Cellulitis or abscess at puncture site
- Nerve injury (from medial puncture too close to plantar arch)
- Inadequate sample requiring repeat puncture
- Excessive pain response without comfort measures
Nursing Interventions
- Always use the outer lateral aspect — never the center or arch of the heel
- Warm the heel pre-procedure for adequate blood flow
- Use the lancet only once; dispose in sharps container immediately
- Offer non-nutritive sucking, swaddling, or breastfeeding for pain management
- Document site, sample collected, and newborn's response
Description of Skill
Systematic measurement of newborn temperature, heart rate, respiratory rate, and oxygen saturation. HR is auscultated apically for a full 60 seconds; RR is counted for a full minute (irregular respirations are common). Temperature is taken axillary, not oral or rectal.
Indications
- Initial assessment immediately after birth
- Q30 min × 2 hours during transition period (1st period of reactivity)
- Then q1hr × 2–4 hours, then routine every 8 hours per facility protocol
- Suspected distress (cold stress, hypoglycemia, sepsis, respiratory difficulty)
Outcomes/Evaluation
- Temp: 36.5–37.5°C (97.7–99.5°F) axillary
- HR: 110–160 bpm awake (90–110 sleeping)
- RR: 30–60/min, irregular pattern expected
- SpO₂: ≥ 95% after 10 min of life
- No signs of distress (grunting, flaring, retractions, cyanosis beyond acrocyanosis)
Nursing Interventions (pre, intra, post)
Pre: Gather equipment (stethoscope, thermometer, pulse oximeter). Pre-warm hands and stethoscope to prevent cold-stress conduction loss. Position newborn under radiant warmer or with parent skin-to-skin.
Intra: Take HR apically for 60 seconds (count irregular rhythms accurately). Count RR for 1 full minute (newborn breathing is irregular). Axillary temperature for at least 3 minutes. Pulse ox on right hand (preductal) and either foot (postductal) for screening cardiac anomalies.
Post: Cover newborn promptly to prevent heat loss. Document each value with route/site. Notify provider of any abnormal finding immediately. Repeat assessment as indicated.
Client Education
- Explain to parents what each value means and the normal ranges
- Show parents how to count respirations at home if requested
- Demonstrate signs to report (cyanosis, no breathing for >20 sec, persistent grunting)
- Teach axillary temperature technique for home use
Potential Complications
- Missed signs of distress if assessment is rushed or incomplete
- Cold stress from prolonged exposure during assessment
- False-low HR or RR if counted for less than full minute
- Delayed identification of critical congenital heart disease without bilateral pulse ox
Nursing Interventions
- Always count HR and RR for full minute (irregular patterns require full assessment)
- Compare preductal and postductal SpO₂ — >3% difference can indicate cardiac anomaly
- Maintain neutral thermal environment during assessment
- Reassess after any intervention to evaluate effectiveness
- Document trends, not just isolated values
Description of Skill
Routine care of the umbilical cord stump from birth until separation (typically 7–14 days postpartum). Goal: keep clean, dry, and protected from contamination to promote healing and prevent infection (omphalitis).
Indications
- Every newborn after birth until cord separation
- Routine daily care during nursery and postpartum stay
- Continued home care until cord falls off
- Increased attention if signs of contamination, malodor, or potential infection
Outcomes/Evaluation
- Cord remains clean and dry
- Cord progressively dries and darkens (black/brown) within 24–48 hr
- Cord separates between 7 and 14 days (range 5–21)
- No signs of infection (redness, swelling, purulent drainage, foul odor, periumbilical erythema)
- Umbilical site heals completely after separation
- Family demonstrates correct cord care technique
Nursing Interventions (pre, intra, post)
- Initial care (delivery room):
- Clamp cord 1–3 cm from abdomen with sterile cord clamp
- Wait 30–60 seconds before clamping (delayed cord clamping benefits)
- Cut cord with sterile scissors
- Assess number of cord vessels (normal: 2 arteries, 1 vein — AVA)
- Inspect for true knot, anomalies
- Daily care:
- Hand hygiene before touching cord
- Inspect cord and base each shift
- Keep dry — air exposure is best
- Fold diaper BELOW the cord to allow air exposure and prevent urine soiling
- If cord becomes soiled, clean with water and gauze; pat dry
- 'Dry cord care' is current standard (no alcohol, antiseptics in most settings)
- Antiseptic (chlorhexidine) only in high-infection-risk areas or institutions
- Cord clamp removal:
- Remove clamp when cord is dry (typically 24–48 hr)
- Use cord clamp cutter or scissors
- Sterile technique
- After separation:
- Mild bleeding at separation site is normal
- Continue keeping area clean and dry until fully healed
Client Education
- Keep cord clean and dry — this is the most important principle
- Fold diaper below cord to expose to air
- Avoid baths until cord falls off (sponge baths only)
- No alcohol or ointments on cord (delays healing)
- Clean only if soiled with stool or urine — use water and gauze
- Cord will turn black/brown and shrivel — normal
- Cord falls off in 1–3 weeks
- Small amount of bleeding when cord falls off is normal
- Call provider for: redness around base, swelling, pus, foul odor, fever, bleeding that doesn't stop, cord still attached after 3 weeks
- Sponge bath only until cord falls off and area heals
- Avoid submerging in water
- Comfortable to touch cord clamp, but no need
Potential Complications
- Omphalitis (umbilical infection) — periumbilical erythema, swelling, drainage, fever, lethargy
- Delayed cord separation (> 3 weeks — may suggest immune deficiency)
- Umbilical granuloma (small pink-red growth at navel after separation)
- Persistent bleeding at cord site
- Patent urachus or omphalomesenteric duct (drainage of urine or stool from umbilicus)
- Umbilical hernia (visible after cord falls off)
- Sepsis (from omphalitis spread)
- Necrotizing fasciitis (rare, life-threatening)
Nursing Interventions
- Hand hygiene before and after cord care
- Assess cord and umbilical area each shift
- Look for: redness, swelling, drainage, foul odor, bleeding
- Document cord appearance (color, dryness, attached/separated)
- Fold diaper BELOW cord
- Keep cord exposed to air (no diaper coverage)
- Clean only if soiled — use water and gauze, pat dry
- Avoid alcohol unless ordered (delays separation)
- Chlorhexidine if institutional protocol or high-risk newborn
- Remove cord clamp when dry (24–48 hr)
- Sponge bathing only until cord falls off
- Educate family at every opportunity
- Document family's understanding and return demonstration
- Report any concerning findings to provider
Description of Skill
Surgical removal of the foreskin (prepuce) of the penis in male newborns. Elective procedure typically performed in first 24–72 hr after birth. Three main techniques: Gomco clamp, Mogen clamp, and Plastibell. Requires informed parental consent and adequate analgesia.
Indications
- Parental choice (cultural, religious, or personal reasons) — most common
- Religious requirements (Judaism, Islam)
- Reduced risk of UTI in infancy
- Reduced risk of penile cancer (rare)
- Reduced risk of STIs in adulthood (modest)
- Personal hygiene preference
- NOT routinely medically indicated per AAP (informed parental choice)
Outcomes/Evaluation
- Successful removal of foreskin without complications
- Adequate hemostasis
- Normal urination within 6–8 hours
- Healing site progresses normally (yellow exudate is expected, NOT pus)
- No infection
- Plastibell falls off in 7–10 days (if used)
- Parents demonstrate appropriate care
- Newborn recovery comfortable with adequate pain control
Nursing Interventions (pre, intra, post)
- Pre-procedure:
- Verify informed parental consent
- Vitamin K administered first
- Newborn has voided at least once
- Adequate oral intake established
- Verify newborn is stable (no jaundice, illness, anomalies)
- Check for hypospadias — CONTRAINDICATION
- Pain management plan: sucrose pacifier, EMLA cream, dorsal penile nerve block (DPNB), or ring block
- During procedure:
- Swaddle for warmth
- Restrain on circumcision board (Olympic or similar)
- Provide sucrose pacifier for comfort
- Adequate analgesia is ESSENTIAL
- Cleanse perineum
- Apply chosen device (Gomco, Mogen, or Plastibell)
- Excise foreskin
- Verify hemostasis
- Apply petroleum-impregnated gauze (Gomco/Mogen) — NOT for Plastibell
- Post-procedure:
- Comfort newborn (swaddle, hold, feed)
- Inspect for bleeding q15min for 1 hr, then q1hr for 4 hr
- Apply petroleum jelly to site with each diaper change (except Plastibell)
- Document time of procedure, type of device, complications
- Plastibell: ring falls off in 7–10 days — DO NOT pull off
Client Education
- Apply petroleum jelly with each diaper change for 5–7 days (Gomco/Mogen)
- Plastibell: do NOT use ointment; ring will fall off naturally in 7–10 days
- Yellow crusting/exudate is NORMAL healing (NOT pus)
- Slight swelling and redness expected first 24 hr
- Site should not be 'cleaned' — gentle water rinse only
- Diaper change frequently to keep site clean
- Sponge baths only until healed (no tub baths)
- Newborn may be fussy or sleepy first 24 hr
- Report to provider: active bleeding (more than dime-sized spot), increasing redness/swelling beyond first 24 hr, no urination within 6–8 hr, foul-smelling drainage, fever, ring not falling off in 14 days
- Plastibell will fall off — DO NOT pull
- Acetaminophen for comfort (per provider)
- Healing complete in 7–10 days
Potential Complications
- Bleeding (most common — usually controlled with pressure)
- Infection (rare)
- Inadequate skin removal (need for revision)
- Excessive skin removal
- Meatal stenosis (long-term, narrowing of urethral opening)
- Phimosis (scarring with adhesions)
- Adhesions (skin sticking to glans)
- Urethral injury (rare)
- Glans injury (rare)
- Plastibell complications: ring stuck on, premature dislodgement
- Pain (if inadequate analgesia)
- Contraindications missed: hypospadias, bleeding disorders
Nursing Interventions
- Verify informed consent BEFORE procedure
- Confirm vitamin K administered, voided, stable
- Inspect for hypospadias — CRITICAL safety check
- Provide sucrose pacifier 1–2 min before and during procedure
- Position on circumcision board
- Assist provider with technique
- Pain management: verify DPNB or ring block performed by provider
- Post-procedure:
- Inspect for bleeding q15min x 4, then q1hr x 4, then q4hr
- Apply petroleum gauze (NOT Plastibell)
- Verify newborn voids within 6–8 hr
- Calm and feed newborn
- Document: procedure type, time, blood loss, pain measures, voiding, parental education
- Educate parents thoroughly with return demonstration
- Provide written discharge instructions
Description of Skill
Systematic evaluation of how effectively the newborn attaches to the breast during breastfeeding. Adequate latch is essential for milk transfer, nipple comfort, and successful breastfeeding establishment. Multiple tools exist: LATCH score (most common — 5 items, 0–10 scale).
Indications
- All breastfeeding newborns at every feeding initially
- When mother reports nipple pain
- Inadequate weight gain or excessive weight loss
- Sleepy or fussy newborn unable to feed
- Engorgement
- First-time breastfeeding mother
- Premature or late-preterm newborn
- Lactation consultant referral situations
- Insufficient milk supply concerns
Outcomes/Evaluation
- Audible swallowing with feeds
- Comfortable, pain-free latch for mother
- Visible suck-swallow-breathe pattern
- Newborn appears satisfied after feeding
- Adequate weight gain (after initial 5–7% loss)
- 6+ wet diapers and 3–4 stools per day by day 4
- Mother demonstrates correct positioning and latch technique
- LATCH score ≥ 7 generally indicates adequate breastfeeding
Nursing Interventions (pre, intra, post)
- Pre-feeding assessment:
- Quiet environment, comfortable positioning
- Mother's hand washed
- Awake, alert newborn (early hunger cues: rooting, hand-to-mouth, mouthing — NOT crying)
- Cradle, cross-cradle, football, or side-lying positions
- Pillows for support
- LATCH scoring (each 0–2, max 10):
- Latch: 0 = sleepy/no latch · 1 = repeated attempts, sucks/releases · 2 = grasps, rhythmic suck
- Audible swallowing: 0 = none · 1 = few with stimulation · 2 = spontaneous
- Type of nipple: 0 = inverted · 1 = flat · 2 = everted
- Comfort: 0 = engorged/cracked/severe pain · 1 = filling/red/mild pain · 2 = soft, non-tender
- Hold (positioning): 0 = full assist · 1 = some assist · 2 = no assist
- Signs of proper latch:
- Wide-open mouth covering more areola below than above
- Lips flanged outward ('fish lips')
- Chin and nose touching breast
- Cheeks rounded, not dimpled
- Audible/visible swallowing after every 1–3 sucks
- No clicking or smacking sounds
- Signs of poor latch:
- Painful for mother (after initial 30 seconds)
- Tongue clicking, smacking, hissing
- Compressed/lipstick-shaped nipple after feed
- Cheeks dimpled
- Lips inverted
- No audible swallowing
- Newborn slips off frequently
Client Education
- Position: tummy-to-tummy, baby's head aligned with body
- Support breast with C-hold (thumb on top, fingers below; away from areola)
- Wait for wide-open mouth before bringing baby to breast
- Aim nipple toward roof of mouth
- Both lips should flange out
- Should NOT hurt — pain after initial 30 sec means re-latch
- Break suction by inserting finger into corner of mouth before removing
- Feed on cue (8–12 times in 24 hours)
- Alternate which breast offered first
- 10–20 min per breast typical (some babies shorter or longer)
- Signs of adequate intake: 6+ wet diapers, 3–4 stools per day, weight gain after day 5
- Avoid bottle/pacifier first 2–4 weeks (nipple confusion)
- When to seek help: cracked nipples, ongoing pain, no audible swallowing, inadequate diapers
Potential Complications
- Cracked, sore, bleeding nipples (from poor latch)
- Engorgement (from inadequate milk removal)
- Plugged ducts
- Mastitis
- Newborn dehydration (poor milk transfer)
- Hyperbilirubinemia (suboptimal feeding)
- Failure to thrive
- Early cessation of breastfeeding
- Maternal pain and frustration
- Nipple confusion if bottle introduced too early
- Yeast infection (thrush) if breakdown of nipple skin
Nursing Interventions
- Assess every breastfeeding session initially
- Document LATCH score
- Observe complete feeding (start to finish)
- Assess positioning, latch, transfer (audible swallowing), mother's comfort, signs of milk transfer
- Encourage skin-to-skin contact
- Provide pillows, footstool for positioning
- Teach mother to recognize hunger cues
- Demonstrate proper latch and re-latch
- Teach mother to break suction before removing
- Assess nipple after feeding (compression, color)
- Address concerns about adequacy
- Encourage feeding 8–12 times/24 hr first week
- Daily weight (expected loss 5–7% first week, regain by day 14)
- Daily wet and dirty diaper counts
- Refer to lactation consultant for persistent issues
- Provide written materials and resources
- Postpartum follow-up call or visit
Description of Procedure
Safe preparation and administration of infant formula. Errors in preparation can cause water intoxication, dehydration, malnutrition, or bacterial infection. Education must include type selection, preparation, feeding technique, and safety.
Indications
- Maternal choice not to breastfeed
- Medical contraindication to breastfeeding (HIV in developed countries, active herpes lesion on breast, untreated TB, certain medications, mother on chemo)
- Newborn with inability to breastfeed (galactosemia, severe oral anomalies)
- Supplementation when breastfeeding alone is insufficient
- Mother needs return to work without pumping option
- Adoption or surrogacy without induced lactation
Client Preparation
- Educate on formula type selection (cow's milk-based standard, soy, hydrolyzed, amino acid, preterm)
- Review form: ready-to-feed (sterile, expensive), concentrated liquid (mix with equal water), powdered (cheapest, NOT sterile)
- Demonstrate proper hand hygiene
- Sterilize bottles, nipples, equipment before first use (boil 5 min)
- Wash bottles and equipment in hot soapy water after each use
- Provide written instructions
Nursing Actions
- Hand hygiene before preparation
- For powdered formula:
- Use bottled water or boiled tap water (cooled)
- For newborns < 2 months OR immunocompromised: use sterile water (boil 1 min, cool to body temp)
- Add exact amount of water specified to bottle FIRST
- Add specified scoops of powder (level scoops, not packed)
- Cap bottle and shake well to dissolve completely
- For concentrated liquid:
- Mix with equal amount of water (1:1 ratio)
- For ready-to-feed:
- Pour into clean bottle; no mixing needed
- Warming:
- Place bottle in warm water for a few minutes OR bottle warmer
- NEVER MICROWAVE — creates hot spots that burn mouth
- Test temperature on inner wrist before feeding (should feel warm, not hot)
- Feeding technique:
- Hold newborn semi-upright in cradle position
- Maintain eye contact, talk to newborn
- Tilt bottle so nipple is always filled with formula (prevents air swallowing)
- NEVER PROP THE BOTTLE — risks: choking, aspiration, ear infection, dental decay (when teeth come in), bonding deficit
- Burp at mid-feed and after
- Allow newborn to set pace; don't force feeding
- Feeding cues: hunger (rooting, sucking, mouth opening), satiety (turning head away, falling asleep, decreased sucking)
- Volume:
- Day 1-2: ~1/2-1 oz/feed
- Day 3-7: 1-2 oz/feed
- Week 2-4: 2-3 oz/feed
- Month 1+: 3-4 oz/feed
- Frequency: on demand, typically every 3-4 hours (8-10 feedings per 24 hr initially)
- Daily intake by 1 month: ~24 oz / 24 hr
Potential Complications
- Improper dilution:
- Over-diluted (too much water): water intoxication, malnutrition, failure to thrive, hyponatremia
- Under-diluted (too little water): dehydration, renal strain, electrolyte imbalance
- Contamination: bacterial infection (E. coli, Salmonella) from unwashed equipment or non-sterile water
- Burns from microwave heating (hot spots)
- Aspiration from propped bottle or excessive flow
- Choking
- Ear infections from feeding flat
- Bottle caries (when teeth erupt)
- Decreased bonding compared to breastfeeding
- Constipation (low-iron formula or low water)
- Allergic reaction (cow's milk protein allergy, soy allergy)
- Cost — significant family expense
Client Education
- Wash hands every time before preparing or feeding
- Use exact water amount on can — don't dilute or concentrate
- Iron-fortified formula recommended (don't use low-iron unless prescribed)
- Most formulas contain vitamin D — additional supplementation not needed
- Discard remaining formula after each feeding (saliva bacteria contaminate)
- Prepared formula storage:
- Room temperature: 1 hour MAX
- Refrigerated: 24 hours
- Don't freeze
- Opened ready-to-feed: refrigerate; use within 48 hours
- Powdered formula (mixed): use within 24 hours refrigerated
- Daily intake initially: 2-3 oz every 3-4 hours; increase as newborn grows
- Watch hunger cues, not the clock alone
- Don't put formula in microwave
- Test temperature on inner wrist
- Burp halfway through feeding and at end
- Hold newborn for all feedings
- NEVER prop the bottle
- Common normal observations: gentle spit-up, occasional gas, occasional firmer stools
- Report to pediatrician: projectile vomiting, refusing feeds, fewer than 6 wet diapers in 24 hr after day 5, lethargy, fever, rash, blood in stool, signs of dehydration
- Don't introduce solid foods until 4-6 months
- Switch to whole cow's milk at 12 months (NOT before)
- Cost considerations: WIC supports formula for eligible families; powder is most cost-effective
Interprofessional Care
- Pediatrician — formula recommendations, growth tracking
- Lactation consultant (if mixed feeding or weaning)
- Nutritionist/dietitian — feeding issues, allergies
- Pediatric GI — milk allergy, formula intolerance
- Social worker — WIC eligibility, formula access
- Pharmacist — formula availability, recalls
Alterations in Health (Diagnosis)
Abnormal implantation of the placenta in the lower uterine segment near or over the cervical os instead of the fundus. Four classifications:
- Complete (total): cervical os completely covered
- Incomplete (partial): cervical os partially covered
- Marginal: placenta in lower segment, does not reach os
- Low-lying: exact relationship to os not yet determined
Pathophysiology Related to Client Problem
As cervix dilates and effaces in the third trimester, the abnormally placed placenta is disrupted from its attachment, causing painless bleeding. Maternal vessels at the implantation site bleed without disturbing the underlying uterine muscle.
Health Promotion and Disease Prevention
- Smoking cessation reduces risk
- Avoid IUD use (uterine scarring)
- Limit elective cesarean births
- Repeat ultrasounds in late pregnancy to monitor placental position
Risk Factors
- Previous placenta previa
- Uterine scarring (prior C-section, curettage, endometritis)
- Maternal age > 35 years
- Multifetal gestation, multiparity
- Smoking
Expected Findings
- Painless bright red vaginal bleeding (2nd or 3rd trimester)
- Uterus soft, relaxed, nontender, normal tone
- Fundal height greater than expected
- Fetal malpresentation (breech, oblique, transverse)
- Reassuring FHR typically
- Decreasing urinary output (better blood-loss indicator)
Laboratory Tests
- Hgb/Hct — assess blood loss
- CBC, blood type and Rh
- Coagulation profile
- Kleihauer-Betke (fetal blood in maternal circulation)
Diagnostic Procedures
- Transabdominal or transvaginal ultrasound — placental placement
- Continuous fetal monitoring — fetal well-being
- Refrain from vaginal exams — can exacerbate bleeding
- Have oxygen equipment ready for fetal distress
- Strict bed rest during bleeding episodes
- Type and crossmatch blood available
Complications
- Hemorrhage (maternal)
- Preterm birth
- Fetal hypoxia
- Maternal hypovolemic shock
- DIC
Nursing Care
- Assess bleeding, leakage, contractions
- Monitor fundal height serially
- Continuous FHR monitoring
- Monitor maternal vitals; watch for shock
- IV access, fluids, blood products
Medications
- Betamethasone — fetal lung maturation if early delivery
- Rho(D) immune globulin — if Rh-negative
- IV fluids, blood products as needed
Client Education
- Adhere to bed rest
- Do not insert anything into vagina
- Report any bleeding immediately
- No tampons, intercourse, or douching
Therapeutic Procedures
- Cesarean birth if active bleeding or term gestation
- Avoid vaginal birth in complete or incomplete previa
Interprofessional Care
- OB/GYN — primary management
- Neonatology — preterm delivery preparation
- Anesthesiology — cesarean planning
- Blood bank — type and screen, transfusion readiness
Alterations in Health (Diagnosis)
Premature separation of the placenta from the uterine wall (partial or complete detachment) after 20 weeks of gestation. Leading cause of maternal death related to bleeding.
Pathophysiology Related to Client Problem
Placental separation disrupts maternal-fetal circulation. Bleeding may be revealed (vaginal) or concealed (between placenta and uterine wall). Thromboplastin release into maternal circulation triggers DIC in moderate-to-severe cases.
Health Promotion and Disease Prevention
- Manage chronic hypertension during pregnancy
- Smoking and cocaine cessation
- Seat belt use to reduce abdominal trauma
- Domestic violence screening and resources
Risk Factors
- Maternal hypertension (chronic or gestational)
- Blunt abdominal trauma (MVC, battering)
- Cocaine use (vasoconstriction)
- Previous abruption
- Smoking / nicotine
- Premature rupture of membranes
- Multifetal pregnancy
Expected Findings
- Sudden intense localized uterine pain
- Dark red vaginal bleeding (may be concealed)
- Boardlike, tender uterus with hypertonicity
- Contractions with poor relaxation
- Fetal distress on tracing
- Hypovolemic shock signs
Laboratory Tests
- Hgb/Hct decreased
- Coagulation factors decreased — DIC profile
- Cross and type match — possible transfusion
- Kleihauer-Betke — fetal blood in maternal circulation
- Fibrinogen (low in DIC)
Diagnostic Procedures
- Ultrasound — fetal well-being and placental assessment
- Biophysical profile (BPP)
- Continuous fetal monitoring
- Continuous fetal monitoring — non-reassuring tracing → immediate delivery
- Watch for DIC signs (oozing IV sites, decreasing fibrinogen)
- Aggressive shock management; large-bore IV access
- Have OR ready for emergent cesarean
Complications
- DIC (disseminated intravascular coagulopathy)
- Hypovolemic shock, maternal death
- Fetal hypoxia, fetal demise
- Couvelaire uterus (uterine apoplexy)
- Hysterectomy in severe cases
- Acute kidney injury
Nursing Care
- Palpate uterus for tenderness and tone
- Serial fundal height monitoring
- Continuous FHR pattern assessment
- Oxygen 8–10 L/min via face mask
- IV fluids, blood products, medications
- Monitor maternal vitals and urinary output
Medications
- IV fluids and blood products (RBCs, FFP, platelets)
- Betamethasone — if early delivery anticipated
- Rho(D) immune globulin — if Rh-negative
Client Education
- Report any abdominal pain, bleeding, or decreased fetal movement immediately
- Risk of recurrence in future pregnancies — early prenatal care
- Emotional support resources
Therapeutic Procedures
- Immediate birth is the management
- Cesarean for severe abruption or fetal distress
- Vaginal birth possible for mild abruption with stable mother and fetus
Interprofessional Care
- OB/GYN, neonatology, anesthesiology
- Blood bank — emergency transfusion
- ICU consult if significant shock
- Social services if domestic violence suspected
Alterations in Health (Diagnosis)
Pregnancy ending from natural causes before 20 weeks of gestation, or fetus < 500 g. Use the lay term "miscarriage" with clients. Types: threatened, inevitable, incomplete, complete, missed, septic, recurrent.
Pathophysiology Related to Client Problem
Most often due to chromosomal abnormalities (~25%). Other mechanisms: maternal endocrine/metabolic disease, infection, immunologic factors, uterine anatomic abnormalities, placental dysfunction.
Health Promotion and Disease Prevention
- Manage chronic conditions (diabetes, thyroid, antiphospholipid syndrome)
- Avoid teratogens, alcohol, drugs of abuse
- Adequate prenatal care and nutrition
- Treat infections promptly
Risk Factors
- Chromosomal abnormalities (~25%)
- Maternal illness (Type 1 DM)
- Advanced maternal age
- Premature cervical dilation
- Chronic infections, malnutrition
- Trauma, substance use, antiphospholipid syndrome
Expected Findings
- Abdominal cramping or pain
- Vaginal bleeding (varies by type)
- Rupture of membranes
- Cervical dilation (varies by type)
- Fever (septic abortion)
- Hemorrhage signs (hypotension, tachycardia)
Laboratory Tests
- Serum hCG — confirm pregnancy
- Hgb/Hct — significant blood loss
- Clotting factors — DIC monitoring
- WBC — suspected infection
- Type and Rh
Diagnostic Procedures
- Ultrasound — viable fetus vs retained products
- Cervical exam — opened or closed
- Avoid vaginal exams
- Bed rest with fall precautions if sedated
- Save passed tissue for examination
- Monitor for hemorrhage, infection, DIC
Complications
- Hemorrhage
- Infection (septic abortion → sepsis)
- DIC (with retained products of conception)
- Anemia
- Emotional/psychological — depression, anxiety, grief
Nursing Care
- Pregnancy test, observe color and amount of bleeding (count pads)
- Bed rest
- Provide emotional support
- Use lay term "miscarriage"
- Refer to pregnancy-loss support groups
Medications
- Analgesics, sedatives
- Prostaglandin (vaginal suppository)
- Oxytocin
- Broad-spectrum antibiotics — septic abortion
- Rho(D) immune globulin — if Rh-negative
Client Education
- Notify provider for heavy bright-red bleeding, fever, or foul-smelling discharge
- Small amount of discharge normal × 1–2 weeks
- Take prescribed antibiotics
- No tub baths, intercourse, or vaginal insertion × 2 weeks
- Discuss grief/loss before next pregnancy attempt
Therapeutic Procedures
- Dilation & curettage (D&C) — for inevitable / incomplete abortion
- Dilation & evacuation (D&E) — after 16 weeks
- Prostaglandins/oxytocin — induce expulsion
Interprofessional Care
- OB/GYN — surgical/medical management
- Mental health / pregnancy-loss support specialists
- Genetic counseling — recurrent loss
- Social work for emotional support
Alterations in Health (Diagnosis)
Abnormal implantation of a fertilized ovum outside the uterine cavity, usually in the fallopian tube. Tubal rupture causes life-threatening hemorrhage. Second most frequent cause of early-pregnancy bleeding and a leading cause of infertility.
Pathophysiology Related to Client Problem
Compromised tubal patency prevents normal ovum transport. Implantation occurs in fallopian tube (most commonly), ovary, abdomen, or cervix. As embryo grows, it stretches tubal walls until rupture, causing hemorrhage into peritoneal cavity.
Health Promotion and Disease Prevention
- STI screening and prompt treatment
- Avoid IUD use if high-risk for STIs
- Smoking cessation
- Use barrier protection
Risk Factors
- Sexually transmitted infections
- Assisted reproductive technologies
- Tubal surgery
- Contraceptive intrauterine device (IUD)
- Previous ectopic pregnancy
- Smoking
Expected Findings
- Unilateral stabbing pain in lower-abdominal quadrant
- Menses delayed (1–2 wks), lighter, or irregular
- Scant dark red/brown vaginal spotting 6–8 wks after last menses
- Referred shoulder pain (rupture)
- Hypotension, tachycardia, pallor (rupture)
Laboratory Tests
- Serum progesterone — lower than expected
- Serum hCG — does not double normally
- CBC, type and Rh
- Liver/renal function (before methotrexate)
Diagnostic Procedures
- Transvaginal ultrasound — empty uterus
- Caution with vaginal/bimanual examination
- Monitor for tubal rupture: severe pain, hypotension, shoulder pain
- IV access for fluid resuscitation
- Type and crossmatch for transfusion if rupture suspected
Complications
- Tubal rupture with hemorrhage
- Hypovolemic shock, maternal death
- Loss of fallopian tube → infertility
- Recurrence in future pregnancies
- Methotrexate toxicity (BM suppression, hepato/nephrotoxicity)
Nursing Care
- Replace fluids; maintain electrolyte balance
- Administer medications as prescribed
- Pre-op preparation if surgery indicated
- Postoperative monitoring
- Emotional support; pregnancy-loss referral
Medications
- Methotrexate — dissolves pregnancy (unruptured)
- Analgesics
- Rho(D) immune globulin — if Rh-negative
- IV fluids, blood products if needed
Client Education
- Avoid folic-acid–containing vitamins with methotrexate
- Sun protection (photosensitivity)
- Report severe abdominal pain or shoulder pain immediately
- No alcohol during methotrexate therapy
- Avoid pregnancy × 3 months after methotrexate
Therapeutic Procedures
- Salpingostomy — preserves tube (unruptured)
- Salpingectomy (laparoscopic) — tube removed (ruptured)
Interprofessional Care
- OB/GYN — surgical or medical management
- Pharmacy — methotrexate dosing/safety
- Mental health / pregnancy-loss support
- Reproductive endocrinology — fertility planning
Alterations in Health (Diagnosis)
Proliferation and degeneration of trophoblastic villi — placenta becomes swollen, fluid-filled, with grape-like cluster appearance. Embryo fails to develop. Complete mole (all paternal genetic material; ~20% progress to choriocarcinoma) and partial mole (both maternal and paternal; ~6% progress).
Pathophysiology Related to Client Problem
Abnormal fertilization → trophoblastic overgrowth. Hemorrhage into uterine cavity causes vaginal bleeding. Massive hCG production from trophoblast drives hyperemesis and early-onset preeclampsia signs.
Health Promotion and Disease Prevention
- Awareness in higher-risk groups (early teens, > age 40)
- Adequate prenatal care for early detection
- Nutrition (some studies suggest folate, carotene deficiency may contribute)
Risk Factors
- Prior molar pregnancy
- Early teenage years
- Maternal age > 40
Expected Findings
- Excessive vomiting (hyperemesis gravidarum)
- Rapid uterine growth — beyond expected for gestation
- Bleeding: dark brown ("prune juice") or bright red, may pass vesicles
- Anemia from blood loss
- Preeclampsia signs before 24 weeks
Laboratory Tests
- Serum hCG — persistently elevated (vs expected decline at 10–12 wks)
- CBC — anemia
- Type and Rh
- Hepatic, renal panel — pre-procedure
Diagnostic Procedures
- Ultrasound — dense growth with vesicles, no fetus
- Pelvic exam & abdominal ultrasound (post-evacuation baseline)
- Reliable contraception during follow-up — pregnancy obscures hCG monitoring
- Avoid IUD specifically
- Monitor for choriocarcinoma during follow-up
- Save clots/tissue for evaluation
Complications
- Choriocarcinoma (20% complete moles, 6% partial moles)
- Hemorrhage
- Preeclampsia (early onset)
- Anemia
- Future pregnancy complications (recurrent molar pregnancy)
Nursing Care
- Measure fundal height
- Assess vaginal bleeding/discharge; save tissue
- Monitor for preeclampsia signs
- Pre/post-op care for evacuation
- Emotional support; pregnancy-loss referral
Medications
- Rho(D) immune globulin — if Rh-negative
- Chemotherapy — if choriocarcinoma develops
- Antiemetics for hyperemesis
- IV fluids
Client Education
- Reliable contraception; avoid IUD
- Strict follow-up — hCG weekly × 3 wks, monthly × 6 months, up to 1 year
- Pregnancy-loss support resources
- Risk of choriocarcinoma if hCG rises
Therapeutic Procedures
- Suction curettage — aspirate & evacuate the mole
- Hysterectomy (rare; older patients, completed family)
Interprofessional Care
- OB/GYN — primary management
- Gynecologic oncology — if choriocarcinoma
- Mental health / pregnancy-loss support
- Pharmacy — chemotherapy if needed
Alterations in Health (Diagnosis)
Fetal umbilical vessels implant into the fetal membranes rather than the placenta. Vessels run between fetus and cervix unprotected by Wharton's jelly. Variations: velamentous, succenturiate, battledore insertion of the cord.
Pathophysiology Related to Client Problem
Unprotected fetal vessels are vulnerable to compression and rupture during labor or membrane rupture. Vessel rupture causes rapid fetal exsanguination since it is fetal blood loss, not maternal.
Health Promotion and Disease Prevention
- Routine prenatal ultrasound for placental and cord insertion
- Targeted screening in IVF, multifetal gestation, low-lying placenta
- Planned cesarean if diagnosed antenatally
Risk Factors
- Velamentous cord insertion
- Multifetal gestation
- IVF / assisted reproduction
- Low-lying placenta or placenta previa history
- Bilobed or succenturiate placenta
Expected Findings
- Often asymptomatic until membranes rupture
- Painless vaginal bleeding (fetal blood) at ROM
- Sudden fetal heart rate changes — bradycardia, sinusoidal pattern
- Possible fetal exsanguination
Laboratory Tests
- Apt test (rare) — distinguishes fetal vs maternal blood
- Maternal CBC, type and Rh
Diagnostic Procedures
- Antenatal ultrasound — visualize vessels over cervix
- Color Doppler — blood flow in fetal vessels
- Closely monitor for excessive bleeding during labor and delivery
- If diagnosed antenatally → planned cesarean (typically 34–36 wks with steroids)
- Continuous fetal monitoring during labor
Complications
- Fetal exsanguination if vessels rupture
- Fetal demise
- Preterm birth (planned)
- Neonatal anemia, hypoxia
Nursing Care
- Continuous FHR monitoring
- Anticipate emergent cesarean
- Have neonatal resuscitation team ready
- Monitor for fetal distress signs
Medications
- Betamethasone — fetal lung maturation prior to planned preterm delivery
- Rho(D) immune globulin — if Rh-negative
Client Education
- Importance of planned cesarean
- Inpatient hospitalization may be needed late pregnancy
- Report any bleeding immediately
Therapeutic Procedures
- Planned cesarean delivery (avoid spontaneous labor/ROM)
- Emergent cesarean if vessel rupture detected
Interprofessional Care
- Maternal-fetal medicine — antenatal management
- Neonatology — preterm delivery support, resuscitation
- Anesthesiology — cesarean readiness
Alterations in Health (Diagnosis)
Inability to conceive despite engaging in unprotected sexual intercourse for ≥ 12 months. For clients > 35 years or with a known risk factor, the recommended workup threshold is ≥ 6 months. Approximately 40% of cases involve male-factor infertility.
Pathophysiology Related to Client Problem
Multifactorial. Common causes include decreased sperm production/motility, ovulation disorders, endometriosis, tubal occlusion, hormonal imbalances (HPO axis), uterine anomalies, and age-related decline in oocyte quality.
Health Promotion and Disease Prevention
- Avoid teratogen exposure (occupational/environmental)
- Maintain healthy weight
- Smoking, alcohol, illicit drug cessation
- Avoid high scrotal temperatures (males)
- Prompt STI treatment to prevent tubal scarring
Risk Factors
- Age (especially > 35 yo)
- Weight (under or overweight)
- Duration of infertility
- Medical, surgical, obstetric, gynecologic history
- Sexual history (partners, STI Hx)
- Substance use (alcohol, tobacco, heroin, methadone)
- Occupational/environmental exposure
- Mumps after adolescence (males)
Expected Findings
- Couple has not conceived after 12 months of unprotected intercourse
- Female: irregular menses, anovulation, atypical secondary sex characteristics
- Male: abnormal sperm count/motility/morphology on semen analysis
- Emotional distress: denial, anger, grief, guilt, self-blame
Laboratory Tests
- Semen analysis — first test in workup
- Hormone panel: prolactin, FSH, LH, estradiol, progesterone, thyroid
- STI screening
- Genetic testing if indicated
Diagnostic Procedures
- Pelvic examination
- Postcoital test
- Ultrasonography (transvaginal/abdominal/transrectal)
- Hysterosalpingography (HSG) — fallopian tube patency
- Hysteroscopy
- Laparoscopy (most invasive)
- HSG: screen for iodine/seafood allergy before contrast dye administration
- Monitor for adverse effects of fertility medications
- Counsel that fertility meds increase multiple-gestation risk > 25%
- Refer for genetic counseling when indicated (sickle cell, von Willebrand, age > 35, family Hx)
Complications
- Ectopic pregnancy — increased risk; recurrence after first ectopic
- Multiple gestation from ART — preterm labor, IUGR, twin-twin transfusion
- Treatment cost burden, relationship strain, depression/anxiety
- Ovarian hyperstimulation syndrome (with fertility medications)
Nursing Care
- Encourage couple to express and discuss feelings
- Recognize infertility as a major life stressor
- Assist with options consideration; provide education for decision-making
- Construct multi-generational family medical history
- Refer to grief and infertility support groups
Medications
- Clomiphene citrate — ovarian stimulation
- Letrozole — alternative ovulation induction
- Metformin — supports ovulation in PCOS
- Antimicrobials for preexisting infections
Client Education
- Both partners must be evaluated — infertility is a couple's diagnosis
- Semen analysis comes first (cheaper, less invasive)
- Lifestyle: nutrition, exercise, stress management, avoid scrotal heat
- Discuss ART options and reproductive alternatives (adoption, surrogacy)
- Provide written info about each diagnostic procedure
Therapeutic Procedures (ART)
- Intrauterine insemination (IUI)
- In vitro fertilization-embryo transfer (IVF-ET)
- Gamete intrafallopian transfer (GIFT)
- Donor oocyte / donor embryo (embryo adoption)
- Gestational carrier / surrogate mother
- Therapeutic donor insemination
Interprofessional Care
- Reproductive endocrinologist — diagnostic and treatment lead
- Genetic counselor — heritable risk evaluation
- Geneticist — confirmatory testing
- Pharmacist — fertility medication education and monitoring
- Mental health / counseling — stress, grief, partner relationship
- Social work — adoption and surrogacy resources
Alterations in Health (Diagnosis)
Uterine contractions and cervical changes that occur between 20 and 37 weeks of gestation. Categorized as very preterm (< 32 wk), moderately preterm (32–34 wk), and late preterm (34–36 wk). Shorter gestation = higher neonatal risks.
Pathophysiology Related to Client Problem
Multifactorial. Common pathways: infection-driven inflammation (chorioamnionitis, UTI), uterine overdistention (multifetal, hydramnios), decidual hemorrhage, maternal/fetal stress, cervical insufficiency. End common pathway: prostaglandin release, uterine contractility, cervical change.
Health Promotion and Disease Prevention
- Treat UTIs, vaginal infections, STIs promptly
- Smoking and substance use cessation
- Optimize prenatal care and weight
- Address abuse / psychosocial stressors
- Cervical length screening for high-risk clients
- Cerclage for cervical insufficiency
Risk Factors
- Infections — UTI, vaginal infection, HIV, active herpes, chorioamnionitis
- Previous preterm birth
- Multifetal pregnancy
- Smoking, substance use
- Violence or abuse
- Lack of prenatal care
- Uterine abnormalities
- Low prepregnancy weight
- Hydramnios, diabetes mellitus
Expected Findings
- Persistent low backache
- Pressure in the pelvis and cramping
- GI cramping, sometimes with diarrhea
- Urinary frequency
- Vaginal discharge — increase, change, or blood
- Change in cervical dilation
- Regular contractions every 10 min or greater, lasting ≥ 1 hr
- Premature rupture of membranes
Laboratory Tests
- Fetal fibronectin (vaginal swab)
- Cervical cultures
- CBC
- Urinalysis
Diagnostic Procedures
- Test for fetal fibronectin — protein presence at 24–34⁶/⁷ wks indicates ↑ PTL risk within 2 weeks
- Ultrasound to measure endocervical length — > 30 mm = low risk
- Cervical culture for infectious organisms
- Biophysical profile
- Nonstress test
- Home uterine activity monitoring
- Suspect chorioamnionitis with elevated maternal temperature + tachycardia
- Fetal tachycardia (FHR > 160/min) often indicates infection; frequently associated with PTL
- Avoid strict bed rest (adverse effects); use modified bed rest
- Tocolytics: see specific contraindications for each agent
Complications
- Preterm birth → neonatal RDS, IVH, NEC, sepsis
- Chorioamnionitis (with PROM)
- Placental abruption
- Cord prolapse / compression (with PROM)
- Fetal pulmonary hypoplasia (prolonged PPROM)
- Fetal/neonatal death
- Maternal: postpartum hemorrhage, postpartum endometritis
Nursing Care
- Activity restriction with bathroom privileges
- Encourage left lateral position (↑ uterine blood flow)
- Monitor vaginal discharge (color, amount, odor)
- Monitor vital signs and temperature
- Continuous FHR and contraction monitoring
- Ensure hydration (dehydration → ADH → oxytocin → contractions)
- Avoid sexual intercourse
Medications
Tocolytics:
- Nifedipine (CCB) — first-line
- Magnesium sulfate (CNS depressant)
- Terbutaline (β-agonist)
- Indomethacin (NSAID, < 32 wks only, ≤ 48 hr)
Fetal lung maturity: betamethasone 12 mg IM × 2 doses 24 hr apart (24–34 wks)
Infection treatment: ampicillin (chorioamnionitis), broad-spectrum antibiotics for PROM
Client Education
- Adhere to bed rest with bathroom privileges
- Maintain hydration
- Avoid sexual intercourse
- Daily kick counts
- Report: contractions, vaginal discharge changes, fever, decreased fetal movement
- If PROM: nothing in vagina, showers only, wipe front to back
Therapeutic Procedures
- Cervical cerclage (if cervical insufficiency contributory)
- Amniocentesis for fetal lung maturity (L/S ratio, PG)
- Antenatal corticosteroid administration
Interprofessional Care
- OB / maternal-fetal medicine specialist
- Neonatology — anticipate preterm delivery
- Respiratory therapy — neonatal RDS planning
- Lactation consultant — breastfeeding the preterm infant
- Social work / case management — home care, financial, abuse screening
- Pharmacist — tocolytic dosing/monitoring
Alterations in Health (Diagnosis)
Meconium passage in the amniotic fluid. Antepartum passage typically not associated with unfavorable outcome; intrapartum passage with abnormal FHR pattern is ominous. Fetus has had loss of sphincter control, allowing meconium into amniotic fluid.
Pathophysiology Related to Client Problem
Umbilical cord compression → fetal hypoxia → vagal nerve stimulation → peristalsis of fetal GI tract + relaxation of anal sphincter → meconium release.
Increased incidence after 38 weeks gestation due to fetal maturity of normal physiological functions. Risk: meconium aspiration syndrome (MAS) at birth → respiratory distress, pneumonitis, persistent pulmonary hypertension of the newborn.
Health Promotion and Disease Prevention
- Identify and treat fetal distress early
- Continuous EFM in high-risk pregnancies
- Avoid postterm pregnancy (induce by 41–42 weeks)
- Monitor fetal well-being in clients with HTN, DM, oligohydramnios
- Daily kick counts
Risk Factors
- Gestation > 38 weeks — fetal maturity
- Umbilical cord compression → fetal hypoxia → vagal stimulation
- Postmaturity (post-dates pregnancy)
- Uteroplacental insufficiency
- Oligohydramnios
- Maternal HTN, preeclampsia, DM
Expected Findings
- Amniotic fluid color: black to greenish, or yellow — meconium-stained often green
- Consistency: thin or thick
- Often present in breech presentation (might NOT indicate hypoxia in this context)
- If present WITHOUT FHR changes — generally not concerning
- If present WITH variable or late decelerations — OMINOUS finding
Laboratory Tests
Cord blood gases obtained at delivery to assess fetal acid-base status.
Diagnostic Procedures
- Electronic fetal monitoring (EFM)
- Visual assessment of amniotic fluid color and consistency upon ROM
- Continuous FHR monitoring throughout labor
- Possible biophysical profile if antepartum concern
- Notify neonatal resuscitation team to be present at birth
- Have suction equipment, bag-mask, ETT, and laryngoscope ready
- Prepare for potential meconium aspiration syndrome (MAS) management
- Continuous FHR monitoring — variable or late decels with meconium = ominous
Complications
- Meconium aspiration syndrome (MAS) — respiratory distress, pneumonitis
- Persistent pulmonary hypertension of the newborn (PPHN)
- Air leak syndromes (pneumothorax, pneumomediastinum)
- Hypoxic-ischemic encephalopathy
- Long-term neurodevelopmental sequelae if severe
- Maternal: amniotic fluid embolism risk ↑ with meconium-stained fluid
Nursing Care
- Document color and consistency of stained amniotic fluid
- Notify neonatal resuscitation team to be present at birth
- Gather equipment for neonatal resuscitation
- Continuous FHR monitoring
- Position client in left lateral position
- Prepare for possible cesarean if fetal distress develops
Medications
No specific medications for the meconium itself. Neonate may require:
- Surfactant administration (if MAS develops)
- Antibiotics (if pneumonitis suspected)
- Inhaled nitric oxide (for persistent pulmonary HTN)
Client Education
- Meconium is the baby's first stool (dark green, sticky). When passed before birth, it stains the amniotic fluid green or yellow-brown
- Most often related to fetal stress, post-term pregnancy, or normal physiologic maturity
- If you notice green, yellow, or brown-stained fluid when your water breaks, come to the hospital right away
- Risks:
- Baby can inhale meconium during birth → meconium aspiration syndrome (MAS) with breathing difficulty
- Most babies with meconium-stained fluid do well
- What to expect at delivery:
- A specialized newborn team may be at the delivery prepared to help with breathing if needed
- If baby is vigorous (good muscle tone, crying, good HR): routine care, skin-to-skin contact
- If not vigorous: airway clearance and resuscitation may be needed
- Baby may need observation in the nursery or NICU
- After birth, watch for: rapid or labored breathing, grunting, blue color, poor feeding, fever — report immediately
- Most babies recover fully; severe MAS is uncommon with current management
- Follow-up pediatric appointment as scheduled
- Ask questions; understanding the plan helps reduce anxiety
Therapeutic Procedures
- Intrapartum amnioinfusion (controversial; not routinely recommended)
- Cesarean if fetal distress develops
- Neonatal resuscitation per NRP guidelines
- Mechanical ventilation if MAS develops
Interprofessional Care
- Obstetrician / midwife — labor management
- Neonatology / NICU team — present at delivery for resuscitation
- Respiratory therapy — neonatal airway management
- Pediatrician — ongoing neonatal care if MAS develops
Alterations in Health (Diagnosis)
DVT is a thrombus that is associated with inflammation. It can occur in a superficial or deep vein, most often the femoral, saphenous, or popliteal vein. The postpartum client is at greatest risk for a DVT, which can lead to a pulmonary embolism.
Pathophysiology Related to Client Problem
Pregnancy and the postpartum period induce a physiologic state of hypercoagulability — coagulation factors and fibrinogen levels remain elevated for weeks after birth. Combined with venous stasis (pelvic vein compression, decreased mobility, supine positioning) and potential vessel injury (cesarean, operative birth), this completes Virchow's triad → thrombus formation.
Health Promotion and Disease Prevention
- Initiate early and frequent postpartum ambulation
- Sequential compression devices until ambulation established
- Active and passive ROM if bed rest > 8 hr
- Antiembolic stockings for high-risk clients
- Smoking cessation education
- Adequate hydration to prevent sluggish circulation
Risk Factors
- Pregnancy
- Cesarean birth (doubles the risk)
- Operative vaginal birth
- Pulmonary embolism or varicosities
- Immobility
- Obesity
- Smoking
- Multiparity
- Age > 35 years
- History of previous thromboembolism
Expected Findings
- Leg pain and tenderness
- Unilateral area of swelling, warmth, redness
- Hardened vein over the thrombosis
- Calf tenderness on palpation
- Possible elevated temperature
Laboratory Tests
- D-dimer (elevated in active thrombus formation)
- CBC, coagulation profile
- aPTT (heparin monitoring): 1.5–2.5 × control of 30–40 sec
- PT (warfarin monitoring): 1.5–2.5 × control of 11–12.5 sec
- INR (warfarin monitoring): 2–3
Diagnostic Procedures
- Doppler ultrasound scanning (noninvasive — first-line)
- Computed tomography
- Magnetic resonance imaging
- DO NOT massage the affected extremity — risk of dislodging thrombus → pulmonary embolus
- Avoid using a knee gatch or pillow under knees (impedes venous return)
- Bed rest with extremity elevated above level of heart
- Monitor for signs of pulmonary embolus: sudden chest pain, dyspnea, hemoptysis, tachycardia
Complications
- Pulmonary embolism (life-threatening; presenting symptoms: chest pain, dyspnea, hemoptysis, tachycardia, hypoxia)
- Post-thrombotic syndrome (chronic venous insufficiency)
- Recurrent DVT
- Bleeding from anticoagulation
- Heparin-induced thrombocytopenia
Nursing Care
- Bed rest with affected extremity elevated above heart
- Frequent position changes
- Intermittent or continuous warm moist compresses
- Measure leg circumferences for trending
- Thigh-high antiembolism stockings
- Monitor for pulmonary embolus signs
Medications
Heparin (anticoagulant):
- IV continuous infusion 3–5 days; doses adjusted by aPTT
- Antidote: protamine sulfate
- Monitor aPTT (1.5–2.5 × control)
Warfarin (anticoagulant):
- Oral, ~3 months
- Antidote: phytonadione (vitamin K)
- Monitor PT and INR
- Teratogenic — birth control required
NSAIDs for analgesia.
Client Education for Prevention
- Wear antiembolic stockings until ambulation established
- Perform active ROM when on bed rest > 8 hr
- Initiate early and frequent postpartum ambulation
- Avoid prolonged periods of standing, sitting, or immobility
- Elevate the legs when sitting
- Avoid crossing legs
- Maintain 2–3 L of daily fluid intake from food and beverage sources
- Discontinue smoking
Therapeutic Procedures
- Anticoagulant therapy (most cases)
- Thrombolytic therapy if PE develops (alteplase, streptokinase)
- Embolectomy if surgical intervention needed for PE
Interprofessional Care
- Hematologist for anticoagulation management
- Vascular medicine specialist if recurrent
- Pharmacist — anticoagulation dosing/monitoring
- Physical therapy — early mobility
- Lactation consultant — anticoagulant compatibility (heparin and warfarin both safe with breastfeeding)
Alterations in Health (Diagnosis)
Endometritis is an infection of the uterine lining or endometrium. It usually begins on the second to fifth postpartum day as a localized infection at the placental attachment site and spreads to include the entire endometrium. It is the most frequently occurring puerperal infection.
Pathophysiology Related to Client Problem
Polymicrobial infection — typically ascending pathogens from the lower genital tract (group B streptococcus, anaerobes, E. coli, Bacteroides) colonize the uterine cavity following ROM, manual placenta extraction, or surgical entry. The placental site provides necrotic tissue ideal for bacterial proliferation. Without treatment, infection can spread to parametrium, peritoneum, and bloodstream → sepsis.
Health Promotion and Disease Prevention
- Limit number of vaginal exams after ROM
- Aseptic technique during labor, birth, and postpartum care
- Thorough hand hygiene; gloves for all care
- Prophylactic antibiotics for high-risk procedures (cesarean, manual placental extraction)
- Identify and treat chorioamnionitis promptly
Risk Factors
- Cesarean birth
- Prolonged rupture of membranes
- Retained placental fragments / manual extraction of placenta
- Bladder catheterization
- Chorioamnionitis
- Internal fetal/uterine pressure monitoring
- Multiple vaginal examinations after ROM
- Prolonged labor
- Postpartum hemorrhage
- Operative vaginal birth
- Lacerations or hematomas
- DM, immunosuppression, anemia, malnutrition
Expected Findings
- Uterine tenderness and enlargement
- Dark, profuse lochia
- Malodorous or purulent lochia
- Temperature > 38°C (100.4°F) on 3rd or 4th postpartum day
- Tachycardia
- Pelvic pain
- Chills
- Fatigue, loss of appetite
- Flu-like manifestations (body aches, malaise)
Laboratory Tests
- Vaginal and blood cultures to identify offending organism
- Intracervical and intrauterine bacterial cultures
- WBC count: leukocytosis
- RBC sedimentation rate: distinctly increased
- RBC count: anemia
Diagnostic Procedures
- Physical examination — fundal tenderness, lochia assessment
- Cultures (blood, vaginal, intracervical, intrauterine)
- Pelvic ultrasound to evaluate for retained products of conception
- Monitor for progression to sepsis: hypotension, tachycardia, altered mental status, oliguria
- Strict aseptic technique for all procedures
- Isolate purulent drainage; appropriate PPE
- Verify no allergy to prescribed antibiotics before administration
Complications
- Septicemia / sepsis (major complication of any puerperal infection)
- Pelvic abscess
- Septic pelvic thrombophlebitis
- Peritonitis
- Infertility from tubal scarring
- Chronic pelvic pain
Nursing Care
- Collect vaginal and blood cultures
- Administer IV antibiotics (broad-spectrum until culture sensitivities return)
- Administer analgesics
- Frequent vital signs monitoring
- Assess fundal height, position, consistency; lochia color/quantity/odor
- Encourage rest, hydration, and adequate nutrition
- Maintain or initiate IV access
Medications
- Clindamycin — primary antibiotic for endometritis
- Cephalosporins, penicillins, gentamicin (combination broad-spectrum)
- Continue until afebrile for 24–48 hr
Client teaching for antibiotics:
- Take all medication as prescribed
- Notify provider of watery, bloody diarrhea (C. difficile)
- Notify provider if breastfeeding
Client Education
- Effective hand hygiene techniques
- Maintain interaction with the infant to facilitate bonding (don't isolate from infant)
- Complete the entire course of antibiotics
- Report worsening symptoms (increased pain, fever, foul lochia)
- Diet high in protein for tissue healing
- Adequate fluid intake
- Front-to-back perineal hygiene
Therapeutic Procedures
- D&C if retained placental fragments are identified
- Surgical drainage if abscess develops
- Hysterectomy in severe, refractory cases (rare)
Interprofessional Care
- OB/GYN — primary management
- Infectious disease consultation if refractory
- Pharmacist — antibiotic dosing, monitoring
- Lactation consultant — antibiotic compatibility with breastfeeding
- Dietitian — protein-rich diet for healing
Alterations in Health (Diagnosis)
Postpartum depression occurs within 12 months of delivery. It is characterized by persistent feelings of sadness and intense mood swings. It occurs in 10–15% of new parents and usually does not resolve without intervention. It is similar to nonpostpartum mood disorders.
Distinguished from postpartum blues (up to 85%, self-limiting in 10 days, no intervention required) and postpartum psychosis (within 2–3 weeks, severe; hallucinations, delusions, paranoia; bipolar history is a risk factor).
Pathophysiology Related to Client Problem
Multifactorial. Hormonal — rapid postpartum decline in estrogen and progesterone alters neurotransmitter regulation (serotonin, norepinephrine, dopamine). Psychosocial factors include sleep deprivation, life-role transition, and the stress of caregiving. Genetic predisposition (history of depressive disorder) increases vulnerability.
Health Promotion and Disease Prevention
- Routine prenatal mental health screening
- Postpartum depression screening at follow-up visits (per provider)
- Build social support system before delivery
- Plan for adequate rest and partner support after birth
- Address treatable medical contributors (thyroid imbalance, anemia)
Risk Factors
- Hormonal changes — rapid decline in estrogen and progesterone
- Individual socioeconomic factors
- Decreased social support system
- Anxiety about assuming new role as a parent
- Unintended pregnancy
- History of previous depressive disorder
- Low self-esteem
- History of partner violence
- Medical conditions (thyroid imbalance, diabetes, infertility)
- Complications with breastfeeding
- Parent of multiples
Expected Findings
- Feelings of guilt and inadequacies
- Irritability
- Anxiety
- Fatigue persisting beyond a reasonable amount of time
- Feeling of loss
- Lack of appetite
- Persistent feelings of sadness
- Intense mood swings
- Sleep pattern disturbances (insomnia)
- Crying, weight loss, flat affect
- Rejection of the infant
- Severe anxiety and panic attack
Laboratory / Diagnostic Tests
- Edinburgh Postnatal Depression Scale (or similar validated screening tool)
- Thyroid function studies (rule out hypothyroidism mimicking depression)
- CBC (rule out anemia)
- Mental status examination
Diagnostic Procedures
- Clinical interview by mental health provider
- Use of validated depression screening tools at postpartum visits
- Assessment for postpartum psychosis (more severe presentation)
- Directly ask the client whether they have thoughts of self-harm, suicide, or harming the infant — priority safety action
- Monitor the client for indications of postpartum psychosis
- Monitor infant for failure to thrive
- Prioritize care to ensure safety of client and infant
- If psychosis or significant suicidal ideation present: ensure not left alone with infant; activate crisis support
Complications
- Progression to postpartum psychosis in some cases
- Impaired parent-infant bonding
- Infant failure to thrive
- Long-term effects on child development
- Family relationship strain
- Risk of harm to self or infant if untreated
Nursing Care
- Monitor client-infant interactions; encourage bonding activities
- Monitor the client's mood and affect
- Encourage verbalization of feelings; validate and address personal conflicts; reinforce personal power and autonomy
- Reinforce compliance with medication regimen
- Provide referral and schedule appointment with appropriate community resource
- Monitor for indications of postpartum psychosis
- Prioritize care to ensure the safety of client and infant
Medications
Antidepressants can be prescribed by the provider if indicated.
Antipsychotics and mood stabilizers can be prescribed for clients who have postpartum psychosis (a different condition with different risks).
Considerations:
- SSRIs are commonly first-line; some are considered compatible with breastfeeding (per provider)
- Allow 2–4 weeks for therapeutic effect
- Monitor for adverse effects and adherence
Client Education
- Get plenty of rest; nap when the infant sleeps
- Make time for self
- Seek counseling and use resources provided by referred community agencies
- Schedule a follow-up visit prior to the traditional postpartum visit if at risk
- Consider community resources (La Leche League, community mental health centers)
- Notify provider of recurring or worsening symptoms
Therapeutic Procedures
- Pharmacotherapy (antidepressants)
- Psychotherapy (individual or group)
- Cognitive-behavioral therapy
- Support groups for new parents
Interprofessional Care
- Mental health provider (psychiatrist, psychiatric NP, or therapist)
- Primary care or OB/GYN follow-up
- Social services for community resources
- Lactation consultant if breastfeeding (medication compatibility)
- Pediatrician for infant well-being monitoring
Alterations in Health (Diagnosis)
Neonatal Hyperbilirubinemia (Jaundice) — elevated serum bilirubin causing visible yellow discoloration of skin and sclera in newborns.
- Physiologic jaundice: appears after 24 hr of life; peaks day 3-5 (term) or day 5-7 (preterm); resolves by 1-2 weeks
- Pathologic jaundice: appears within 24 hr of birth, rises > 5 mg/dL/day, peak > 17 mg/dL, persists > 2 weeks; always requires investigation
- Breastfeeding jaundice (early, 1st week): inadequate intake → poor stool output → ↑ enterohepatic recirculation
- Breast milk jaundice (late, after 1st week): factors in breast milk inhibit conjugation; persists weeks-months; baby is otherwise well
Pathophysiology Related to Client Problem
- Bilirubin is a byproduct of red blood cell breakdown (hemoglobin → heme → biliverdin → bilirubin)
- Two forms:
- Unconjugated (indirect) bilirubin: fat-soluble; can cross blood-brain barrier → kernicterus
- Conjugated (direct) bilirubin: water-soluble; excreted in bile and stool
- Conversion requires hepatic enzyme UDP-glucuronyl transferase — immature in newborns
- Newborn factors that increase bilirubin:
- ↑ RBC mass and shorter RBC lifespan (90 days vs 120 days)
- Immature liver enzyme activity
- ↓ albumin binding capacity
- ↓ gut motility → ↑ enterohepatic recirculation
- Sterile gut (no bacteria to convert bilirubin)
- Severe unconjugated bilirubin crosses BBB → deposits in basal ganglia → kernicterus (irreversible neurologic damage)
Health Promotion and Disease Prevention
- Early and frequent feeding (8-12 feedings/day for breastfed; on-demand) — promotes stooling and bilirubin elimination
- Lactation support to ensure adequate intake
- Universal screening: assess all newborns for jaundice in first 24-48 hr with transcutaneous bilirubin or serum bilirubin
- Plot bilirubin levels on the Bhutani nomogram to assess risk by hour of life
- Discharge planning includes bilirubin recheck at 24-48 hr if risk factors
- Educate parents to recognize worsening jaundice and importance of follow-up
- Maternal: blood type and Rh screening prenatally; RhoGAM if Rh-negative
- Avoid certain medications during pregnancy/breastfeeding that may exacerbate jaundice (e.g., sulfonamides)
- Encourage placement in well-lit room (allows skin assessment, not as treatment)
Risk Factors
- Prematurity (less mature liver, ↓ feeding, ↑ bruising)
- Hemolytic disease:
- ABO incompatibility (mother O, baby A or B)
- Rh incompatibility
- G6PD deficiency
- Hereditary spherocytosis
- Birth trauma: bruising, cephalohematoma, vacuum/forceps delivery
- Maternal diabetes (↑ polycythemia in infant)
- East Asian, Mediterranean, Native American ancestry
- Inadequate feeding / dehydration / weight loss > 10% birth weight
- Sibling with jaundice requiring phototherapy
- Exclusive breastfeeding (without supplementation)
- Male sex
- Macrosomia of diabetic mother
- Sepsis, intrauterine infection (TORCH)
- Delayed cord clamping (slight ↑)
- Hypothyroidism
- Biliary atresia (rare; presents later)
Expected Findings
- Skin and sclera yellowing — progresses cephalocaudally (face → trunk → extremities)
- Visible at TSB ~5 mg/dL on face, ~12 mg/dL on trunk, ~15 mg/dL on lower extremities
- Blanch skin over bony prominence (sternum, forehead, nose) to reveal yellow tinge
- Best assessed in natural light; difficult in dark-skinned infants — examine sclera and oral mucosa
- Yellow discoloration of sclera, oral mucosa, and palms/soles (later sign)
- Dark urine (older infants), pale stools (in conjugated hyperbilirubinemia from biliary obstruction)
- Mild lethargy, decreased feeding (with progression)
- Severe (acute bilirubin encephalopathy / kernicterus):
- Early: lethargy, poor feeding, hypotonia, decreased reflexes
- Intermediate: irritability, high-pitched cry, fever, opisthotonos (arching), retrocollis
- Late: seizures, apnea, coma, death
- Tachycardia or bradycardia (severe)
- Weight loss > 10% may signal feeding inadequacy contributing
Laboratory Tests
- Total serum bilirubin (TSB) with direct (conjugated) and indirect (unconjugated) fractions
- Used to plot on Bhutani nomogram by hour of life to determine risk zone and treatment threshold
- Direct antiglobulin test (Coombs) — positive in immune-mediated hemolysis (Rh, ABO incompatibility)
- Hemoglobin and hematocrit — anemia with hemolysis; polycythemia (Hct > 65%) as a cause
- Reticulocyte count — elevated in hemolysis
- Peripheral blood smear — RBC morphology (spherocytes, fragmented cells)
- Blood type and Rh of mother and infant — identify incompatibilities
- G6PD screen in at-risk populations
- Albumin — bilirubin binding capacity
- Thyroid function — hypothyroidism prolongs jaundice
- If conjugated hyperbilirubinemia: liver enzymes, infection workup, abdominal ultrasound (consider biliary atresia)
Diagnostic Procedures
- Transcutaneous bilirubinometer (TcB) — non-invasive screening on forehead or sternum; useful for monitoring but less accurate at high levels — confirm with serum if approaching treatment threshold
- Serial serum bilirubin levels — plotted on Bhutani nomogram
- Bhutani nomogram zones:
- Low risk: minimal monitoring
- Low-intermediate: routine follow-up
- High-intermediate: closer monitoring
- High risk: phototherapy threshold may be reached
- Ultrasound if biliary obstruction suspected (e.g., persistent conjugated hyperbilirubinemia > 2-3 weeks)
- HIDA scan for biliary atresia evaluation
- Newborn hearing screen — kernicterus causes sensorineural hearing loss
- Cranial MRI in suspected acute bilirubin encephalopathy
Complications
- Acute bilirubin encephalopathy (ABE) — reversible in early stages with prompt treatment; characterized by lethargy, hypotonia, poor feeding
- Kernicterus — chronic, IRREVERSIBLE neurologic damage from bilirubin deposition in basal ganglia and brainstem nuclei
- Athetoid cerebral palsy (involuntary movements)
- Sensorineural hearing loss (audiology follow-up essential)
- Gaze abnormalities (upward gaze paralysis)
- Dental enamel hypoplasia
- Intellectual disability (variable)
- Dehydration from poor feeding (compounds hyperbilirubinemia)
- Hypoglycemia from poor intake
- Anemia in hemolytic causes
- Hyperthermia or hypothermia during phototherapy
- Skin rash, dehydration, and "bronze baby syndrome" (from phototherapy in conjugated hyperbilirubinemia)
- Disruption of bonding and breastfeeding (separation for phototherapy)
- Exchange transfusion complications: thromboembolism, infection, electrolyte imbalance, NEC
- Parental anxiety, guilt
Nursing Care
- Assess jaundice every 8-12 hours in natural light; press skin over bony prominence to blanch and observe
- Monitor TcB or TSB per protocol; plot on nomogram
- Feeding support:
- Encourage 8-12 feedings/day for breastfed infants
- Assess latch, milk transfer, output (≥ 6 wet diapers, ≥ 3-4 stools/day by day 4)
- Lactation consultation
- Supplementation with expressed breast milk or formula if intake inadequate (avoid water/dextrose water)
- Phototherapy care:
- Eye protection (opaque patches/mask) — remove during feedings
- Minimal clothing (diaper only) to maximize skin exposure
- Frequent position changes (q2h)
- Monitor temperature q2-4h (risk of hyper- and hypothermia)
- Monitor hydration: I&O, weight, fontanel, skin turgor
- Feedings continue (out of light box for direct breastfeeding or held positions)
- Skin assessment for irritation, rash, or burns
- Remove all lotions/creams (may cause burns)
- Daily weights — limit weight loss to < 10% birth weight
- Promote bonding: encourage parent presence, skin-to-skin during feeds
- Coordinate with lactation, pediatrics, and follow-up
- Document jaundice level, feeding, output, bilirubin trends, parent response
Medications
- IVIG (intravenous immune globulin) — for severe hemolytic disease (Rh or ABO incompatibility)
- Dose: 0.5-1 g/kg IV over 2-4 hr
- Reduces hemolysis by blocking Fc receptors
- Can reduce need for exchange transfusion
- Albumin infusion — occasionally used before exchange transfusion to ↑ bilirubin binding
- Phenobarbital — rarely used; can induce hepatic enzymes (UDP-glucuronyl transferase) for chronic conditions like Crigler-Najjar type II
- NO specific medication for routine physiologic jaundice — supportive care only
- Tin-mesoporphyrin (heme oxygenase inhibitor) — investigational
- RhoGAM is given to Rh-negative mother (not infant) — prevents future hemolytic disease
- Avoid medications that displace bilirubin from albumin: sulfonamides, ceftriaxone (in newborns with hyperbilirubinemia)
Client Education
- Explain in plain language: yellow color comes from extra bilirubin (waste product from broken-down red blood cells)
- Most newborn jaundice is temporary and resolves without lasting effects
- Frequent feeding is the most important thing you can do — every 2-3 hours, 8-12 times/day; this helps the baby pass the bilirubin in stools
- Watch for signs of worsening jaundice:
- Increasing yellowness, especially down the body
- Sleepiness, hard to wake for feeds
- Poor feeding, decreased wet diapers (< 6/day) and stools
- High-pitched cry or unusual irritability
- Stiffness or arching
- Fever or low temperature
- If any of these → call provider or seek care immediately
- Follow-up bilirubin check at 2-3 days after discharge (especially if discharged before 72 hours)
- About phototherapy: not painful; helps convert bilirubin to a form baby can excrete; baby needs eye protection
- You can still feed and hold your baby during therapy breaks
- Continue breastfeeding unless specifically told otherwise (rarely temporarily stopped for diagnostic purposes)
- Do NOT use sunlight as treatment at home — uncontrolled and can cause burns/hyperthermia
- Trust your instincts — call provider if anything seems "off"
- Take photos in good light to track jaundice if uncertain
Therapeutic Procedures
- Phototherapy (most common treatment):
- Special blue-spectrum lights (~460-490 nm) convert unconjugated bilirubin to water-soluble photoisomers excretable in urine and bile without conjugation
- Conventional (overhead bank), fiberoptic blanket, or intensive phototherapy
- Continuous (except feedings) for moderate-to-high TSB
- Effectiveness assessed by TSB after 4-6 hours
- Discontinue when TSB falls below threshold for age
- Exchange transfusion (severe cases):
- Indications: TSB unresponsive to intensive phototherapy, rapidly rising despite treatment, signs of acute bilirubin encephalopathy
- Replaces ~85% of infant's blood with type-compatible blood
- Removes bilirubin, antibody-coated RBCs (in hemolytic disease), and replaces with normal RBCs
- Performed via umbilical vein/artery; double-volume exchange typical
- Higher-risk procedure — reserved for severe cases
- IVIG infusion — for immune hemolytic disease
- Hydration support (IV or supplementation) if dehydrated
- Bili blanket for home phototherapy (mild cases, well-feeding infants)
Interprofessional Care
- Pediatrician/neonatologist — diagnosis, treatment plan, follow-up
- Lactation consultant — essential for breastfeeding support; addresses inadequate intake (a major cause)
- NICU staff — if exchange transfusion or intensive care needed
- Audiology — newborn hearing screen and follow-up (kernicterus causes sensorineural hearing loss)
- Ophthalmology — if eye injury suspected from phototherapy (rare with proper protection)
- Hematology — if hemolytic cause (Rh/ABO, G6PD, hereditary spherocytosis)
- Pediatric gastroenterology — for persistent conjugated hyperbilirubinemia (rule out biliary atresia)
- Pediatric surgery — if biliary atresia (Kasai procedure must be done by ~8 weeks of life)
- Genetic counseling — if hereditary cause (G6PD, Crigler-Najjar, Gilbert syndrome)
- Social work — extended hospitalization, parental support, transportation/financial barriers to follow-up
- Home health — home phototherapy, bilirubin checks if outpatient management
- Primary care follow-up — recheck 24-72 hr after discharge; developmental follow-up
Alterations in Health (Diagnosis)
Maternal colonization with Streptococcus agalactiae (Group B Strep) in vagina or rectum at 35–37 weeks of gestation. Vertical transmission during birth can cause neonatal sepsis, pneumonia, or meningitis.
Pathophysiology Related to Client Problem
GBS is part of normal vaginal/rectal flora in 10–30% of pregnant clients. Bacteria can be transmitted to the newborn during birth (ascending after ROM or contact during delivery). Newborns can develop early-onset sepsis (first 7 days), pneumonia, or meningitis with high mortality.
Health Promotion and Disease Prevention
Universal screening at 36 0/7 to 37 6/7 weeks via vaginal-rectal swab. Intrapartum antibiotic prophylaxis (IAP) for all positive cultures reduces early-onset neonatal GBS disease by > 80%. Re-screen if delivery has not occurred by 5 weeks after initial screen.
Risk Factors
- Previous infant with invasive GBS disease
- GBS bacteriuria during current pregnancy
- Unknown GBS status at delivery if < 37 weeks gestation
- Membrane rupture ≥ 18 hours
- Intrapartum maternal temperature ≥ 38°C (100.4°F)
Expected Findings
- Most colonized clients are asymptomatic
- Possible UTI symptoms (dysuria, frequency, urgency)
- In newborn: fever, lethargy, poor feeding, respiratory distress, tachypnea, hypotonia
- Newborn sepsis presents within first 24 hours typically
Laboratory Tests
- Vaginal-rectal swab culture at 36 0/7 – 37 6/7 weeks
- Urine culture (if bacteriuria suspected)
- Newborn: CBC, blood culture, lumbar puncture if sepsis suspected
Diagnostic Procedures
- Rapid intrapartum GBS PCR test if status unknown (some facilities)
- Newborn chest X-ray if respiratory distress
- Newborn lumbar puncture if sepsis suspected
- IV penicillin G is first-line for intrapartum prophylaxis
- Cefazolin is alternative for low-risk penicillin allergy
- Clindamycin or vancomycin for severe penicillin allergy (only after sensitivity testing)
- Begin antibiotics as soon as labor starts or membranes rupture
- Antibiotic must be administered ≥ 4 hours before delivery for optimal effect
Complications
- Early-onset neonatal GBS sepsis (first 7 days)
- Late-onset GBS disease (1 week–3 months)
- Maternal endometritis or wound infection
- Anaphylactic reaction to antibiotic
- Chorioamnionitis with prolonged ROM
Nursing Care
- Document GBS status on prenatal record and labor chart
- Notify pharmacy and provider on admission if positive
- Establish IV access for prophylaxis administration
- Monitor for anaphylaxis with each antibiotic dose
Medications
- Penicillin G 5 million units IV initial, then 2.5–3 million units q4hr until birth
- Cefazolin 2 g IV initial, then 1 g q8hr (low-risk PCN allergy)
- Clindamycin 900 mg IV q8hr (sensitivity-confirmed)
- Vancomycin 20 mg/kg IV q8hr (severe allergy with resistance)
Client Education
- Explain purpose of antibiotic prophylaxis at admission for known positive clients
- Report any allergy history
- Antibiotic is given to protect the newborn, not the mother
- Newborn will be observed for signs of infection 24+ hours after birth
Therapeutic Procedures
- Continuous fetal heart monitoring during labor
- Adequate fluid hydration
- Avoid unnecessary vaginal exams to reduce ascending infection
Interprofessional Care
- Lab — culture processing and sensitivity testing
- Pharmacy — antibiotic preparation and timing
- Neonatology — newborn evaluation if risk factors present
- Pediatrics — discharge follow-up
Alterations in Health (Diagnosis)
Glucose intolerance with onset or first recognition during pregnancy, typically diagnosed in the 2nd or 3rd trimester. Distinct from pregestational diabetes.
Pathophysiology Related to Client Problem
Placental hormones (hPL, cortisol, progesterone) cause maternal insulin resistance. When pancreatic β-cells cannot compensate with adequate insulin output, hyperglycemia develops. Glucose readily crosses placenta; insulin does not. Fetal pancreas responds by producing excess insulin, causing macrosomia and after birth, neonatal hypoglycemia.
Health Promotion and Disease Prevention
Universal screening at 24–28 weeks with 1-hour 50-g glucose challenge test (GCT). If GCT > 140 mg/dL, proceed to 3-hour 100-g oral glucose tolerance test (OGTT). Diet modification and exercise are first-line.
Risk Factors
- Previous GDM or macrosomic infant (> 9 lb / 4,000 g)
- Obesity (BMI > 30) or excessive weight gain
- Maternal age > 25
- Family history of diabetes
- History of PCOS, hypertension, or unexplained stillbirth
- Ethnicity: Hispanic, Black, Native American, Asian, Pacific Islander
Expected Findings
- Often asymptomatic — diagnosed on routine screening
- Glucosuria
- Fundal height larger than expected
- Recurrent UTIs or yeast infections
- Polyhydramnios
- Polyuria, polydipsia, fatigue (less common in GDM than overt DM)
Laboratory Tests
- 1-hour GCT at 24–28 weeks (positive if > 140 mg/dL)
- 3-hour 100-g OGTT (diagnostic): fasting > 95, 1-hr > 180, 2-hr > 155, 3-hr > 140 — 2+ values = GDM
- Fasting glucose target: 60–95 mg/dL
- 1-hour postprandial: < 140 mg/dL
- 2-hour postprandial: < 120 mg/dL
- HgbA1c (baseline)
Diagnostic Procedures
- Ultrasound for fetal growth (monitor for macrosomia, polyhydramnios)
- Nonstress test (NST) starting at 32 weeks (weekly or biweekly)
- Biophysical profile (BPP) if NST nonreactive
- Monitor for hypoglycemia in newborn first 4 hours
- Risk of shoulder dystocia and birth trauma due to macrosomia
- Strict glycemic control during labor — fluctuations cause fetal acidosis
- Insulin requirements DROP sharply after delivery (placenta gone)
Complications
- Maternal: preeclampsia, polyhydramnios, infection, cesarean birth
- Fetal: macrosomia, shoulder dystocia, birth trauma, stillbirth
- Newborn: hypoglycemia (first 4 hr), respiratory distress syndrome, hyperbilirubinemia, hypocalcemia
- Long-term: 50–60% lifetime risk of type 2 DM in mother; childhood obesity risk in infant
Nursing Care
- Teach blood glucose self-monitoring (4×/day: fasting + 1 or 2 hr postprandial)
- Monitor weight gain weekly
- Assess fundal height at every visit
- Continuous fetal monitoring in labor
- Newborn glucose checks per protocol
Medications
- Insulin (first-line if diet fails) — does not cross placenta
- Glyburide or metformin (oral, second-line in some protocols)
- NO oral hypoglycemics like sulfonylureas (older agents cross placenta)
Client Education
- Diet: 175 g carbs/day in 3 meals + 2–3 snacks (complex carbs, low simple sugars)
- Daily exercise (walking 30 min after meals)
- Sick day rules (continue insulin, hydrate, monitor closely)
- Recognition of hypo- and hyperglycemia
- Postpartum: 75-g OGTT at 6–12 weeks to screen for persistent DM
Therapeutic Procedures
- Medical nutrition therapy with registered dietitian
- Blood glucose self-monitoring schedule
- Insulin therapy if diet alone inadequate
Interprofessional Care
- Endocrinology — complex glycemic management
- Dietitian — meal planning
- Diabetes educator — initial teaching and follow-up
- Neonatology — newborn glucose management
Alterations in Health (Diagnosis)
Spontaneous rupture of membranes before 37 weeks of gestation and before onset of labor. Distinguished from PROM (occurs ≥ 37 weeks) and prolonged ROM (> 18 hours before delivery).
Pathophysiology Related to Client Problem
Causes include infection (most common), inflammation, decidual hemorrhage, uterine overdistention, and tissue weakness. Loss of amniotic fluid risks ascending infection (chorioamnionitis), cord compression, cord prolapse, placental abruption, and pulmonary hypoplasia in newborn.
Health Promotion and Disease Prevention
Treat lower genital tract infections during pregnancy. Avoid coitus if prior PPROM history. Smoking cessation counseling. Adequate nutrition.
Risk Factors
- Previous PPROM or preterm delivery
- Genital tract infection (BV, GBS, chlamydia)
- Cervical insufficiency or short cervix
- Multiple gestation, polyhydramnios
- Smoking
- Low socioeconomic status
- Prior cervical surgery (LEEP, cone biopsy)
Expected Findings
- Sudden gush or steady leak of fluid from vagina
- Continuous wetness on perineal pad
- Pooling of fluid in vagina on sterile speculum exam
- Possible fetal heart rate changes (variable decels from cord compression)
- Maternal fever, tachycardia if chorioamnionitis develops
Laboratory Tests
- Nitrazine test: amniotic fluid (pH 7.0–7.5) turns paper BLUE; urine/vaginal secretions (pH 4.5–5.5) stay yellow
- Ferning test: microscopic 'ferning' pattern in dried amniotic fluid
- Commercial amniotic fluid markers (AmniSure, ROM Plus) for ambiguous cases
- CBC (monitor for leukocytosis)
- Cervical/vaginal cultures (GBS, chlamydia, gonorrhea)
Diagnostic Procedures
- Sterile speculum exam (NO digital vaginal exam — increases infection risk)
- Ultrasound to assess amniotic fluid index (AFI)
- Continuous fetal monitoring
- Minimize vaginal exams to reduce ascending infection
- Strict bed rest with bathroom privileges
- Continuous fetal heart monitoring
- Monitor for chorioamnionitis (fever, uterine tenderness, fetal tachycardia)
- Watch for cord prolapse (immediate emergency)
Complications
- Maternal: chorioamnionitis, endometritis, sepsis, placental abruption
- Fetal: cord prolapse, cord compression, oligohydramnios sequence
- Newborn: prematurity complications (RDS, IVH, NEC, sepsis), pulmonary hypoplasia
Nursing Care
- Assess fluid color, odor, amount with each pad change
- VS q4hr including temperature
- Daily FHR monitoring (or continuous if > 32 wk)
- Fetal kick counts
- Pad count and weight to estimate fluid loss
- Strict aseptic technique for any necessary exams
Medications
- Corticosteroids (betamethasone or dexamethasone) — for fetal lung maturity if 24–34 weeks
- Prophylactic antibiotics (ampicillin + erythromycin) for 7 days — prolong latency, prevent neonatal infection
- Magnesium sulfate — for fetal neuroprotection if < 32 weeks
- Tocolytics (selective use, generally NOT recommended < 34 weeks PPROM)
Client Education
- Explain risks and benefits of expectant management vs delivery
- Signs and symptoms of infection to report immediately
- Importance of bed rest and pelvic rest
- Pad-tracking system for fluid loss
- Steroid effect (24–48 hr for maximum effect)
Therapeutic Procedures
- Inpatient management with expectant observation until 34 weeks (if no infection or distress)
- Delivery indicated for: chorioamnionitis, abruption, nonreassuring FHR, or 34+ weeks completed
- Cesarean delivery may be needed for nonreassuring FHR or malpresentation
Interprofessional Care
- Maternal-fetal medicine — high-risk management
- Neonatology — delivery planning for preterm newborn
- NICU — postnatal care
- Social work — psychological support during prolonged hospitalization
Alterations in Health (Diagnosis)
Early (primary): blood loss > 500 mL vaginal birth or > 1,000 mL cesarean within 24 hr of delivery, OR > 10% drop in Hct. Late (secondary): excessive bleeding after first 24 hr to 12 weeks postpartum.
Pathophysiology Related to Client Problem
Four T's of PPH: Tone (uterine atony — 70–80%), Trauma (lacerations, hematoma — 20%), Tissue (retained placental fragments), Thrombin (coagulopathy). Uterine atony is the leading cause; the relaxed uterus fails to compress placental site vessels.
Health Promotion and Disease Prevention
Active management of 3rd stage labor with prophylactic oxytocin after delivery of anterior shoulder. Avoid prolonged labor and routine episiotomy. Aggressive treatment of intrapartum infection.
Risk Factors
- Uterine overdistention (multiples, polyhydramnios, macrosomia)
- Prolonged or rapid labor; precipitous delivery
- Use of oxytocin or magnesium sulfate (uterine relaxant)
- Grand multiparity (≥ 5 births)
- Lacerations or operative delivery (forceps, vacuum)
- Retained placental fragments
- Chorioamnionitis or maternal infection
- Coagulation disorder (DIC, anticoagulation, HELLP syndrome)
Expected Findings
- Boggy uterus (above umbilicus or deviated, soft on palpation)
- Excessive lochia (saturating pad in < 15 minutes)
- Blood clots passed
- Tachycardia early; hypotension late (shock indicators)
- Pallor, cool clammy skin, restlessness
- Decreased urine output (< 30 mL/hr)
- Perineal/vaginal pain disproportionate to findings (suggests hematoma)
Laboratory Tests
- CBC: H&H drop, leukocytosis if infection
- Type and crossmatch for 2+ units PRBC
- PT/PTT/INR, fibrinogen (for coagulopathy)
- Platelet count
- BUN, creatinine, electrolytes if shock present
Diagnostic Procedures
- Bimanual exam to identify atony vs trauma vs retained tissue
- Inspection of placenta for completeness
- Speculum exam for laceration
- Ultrasound for retained products
- Continuous VS monitoring
- Massage fundus FIRST for atony — single most effective initial intervention
- Empty bladder (full bladder displaces uterus)
- Establish 2 large-bore IVs
- Avoid methylergonovine in hypertension
- Avoid carboprost in asthma
- Have blood products ready and crossmatched
Complications
- Hypovolemic shock
- DIC (disseminated intravascular coagulation)
- Acute kidney injury
- Pituitary necrosis (Sheehan syndrome)
- Postpartum anemia
- Need for hysterectomy → loss of future fertility
- Maternal death (leading cause of obstetric mortality globally)
Nursing Care
- Fundal massage while supporting lower uterine segment
- VS q5–15min until stable
- Strict I&O (urine output indicator of perfusion)
- Weigh pads to quantify blood loss
- Continuous SpO₂ and cardiac monitoring
- Trendelenburg position contraindicated; flat or modified
- Position client supine with knees flexed for procedures
Medications
- Oxytocin (Pitocin) 20–40 units in 1 L IV — first-line
- Methylergonovine (Methergine) 0.2 mg IM q2–4hr — AVOID if HTN
- Carboprost (Hemabate) 250 mcg IM q15–90min — AVOID if asthma
- Misoprostol (Cytotec) 800–1,000 mcg PR
- Tranexamic acid (TXA) 1 g IV — anti-fibrinolytic
- Blood products (PRBC, FFP, platelets, cryoprecipitate)
Client Education
- Explain assessments and interventions as performed (client may be anxious)
- Encourage hydration and rest after bleeding controlled
- Iron supplementation post-discharge
- Signs of late PPH to report (saturating pad in 1 hr, large clots, fever)
- Discuss future pregnancy risk (recurrence ~10%)
Therapeutic Procedures
- Fundal massage (always first)
- Bimanual uterine compression
- Uterine balloon tamponade (Bakri balloon)
- Uterine artery embolization (IR)
- Surgical: B-Lynch suture, hysterectomy as last resort
Interprofessional Care
- Anesthesia — emergent intervention support
- Blood bank — rapid blood product availability
- Surgical team — if surgical intervention needed
- Intensive care — if significant hemodynamic instability
Alterations in Health (Diagnosis)
Pulmonary disorder caused by insufficient surfactant production in immature lungs, leading to alveolar collapse and impaired gas exchange. Most common in preterm newborns < 35 weeks.
Pathophysiology Related to Client Problem
Type II pneumocytes produce surfactant beginning at 22–24 weeks, with adequate quantities by 35 weeks. Surfactant lowers surface tension and prevents alveolar collapse on expiration. Without it, alveoli collapse → atelectasis → hypoxemia → respiratory acidosis → increased work of breathing.
Health Promotion and Disease Prevention
Antenatal corticosteroids (betamethasone or dexamethasone) at 24–34 weeks for any preterm delivery risk. Avoid elective delivery before 39 weeks unless medically indicated. Prevention of preterm birth.
Risk Factors
- Prematurity (most significant — < 35 weeks)
- Maternal diabetes (delays surfactant production)
- Cesarean birth without labor (no stress hormones to mature lungs)
- Perinatal asphyxia or hypothermia
- Multiple gestation
- Male sex (slightly higher risk)
- Family history of RDS
Expected Findings
- Onset within minutes to hours of birth
- Tachypnea (> 60/min)
- Grunting (auto-PEEP to prevent alveolar collapse)
- Nasal flaring
- Retractions (intercostal, subcostal, suprasternal, xiphoid)
- Cyanosis on room air
- Hypotonia, lethargy
- Acrocyanosis progressing to central cyanosis
- Decreased breath sounds bilaterally
Laboratory Tests
- ABG: respiratory acidosis (pH < 7.25), hypoxemia (PaO₂ < 50), hypercapnia (PaCO₂ > 55)
- Pulse oximetry continuous
- CBC with differential (rule out sepsis)
- Blood culture
- Blood glucose
Diagnostic Procedures
- Chest X-ray: diffuse ground-glass appearance, air bronchograms, decreased lung volume
- Pre/post ductal SpO₂ (rule out cardiac anomaly)
- Echocardiogram (if persistent pulmonary hypertension suspected)
- Maintain neutral thermal environment — cold stress worsens RDS
- Minimize handling and stimulation
- Avoid hyperoxia (target SpO₂ 90–95%) — high O₂ causes retinopathy
- Cluster nursing care to allow rest periods
- Strict infection control (sepsis worsens RDS)
Complications
- Pneumothorax (from positive-pressure ventilation)
- Bronchopulmonary dysplasia (BPD) / chronic lung disease
- Patent ductus arteriosus (PDA)
- Intraventricular hemorrhage (IVH)
- Necrotizing enterocolitis (NEC)
- Retinopathy of prematurity (ROP)
- Death (mortality higher with severe RDS < 28 weeks)
Nursing Care
- Continuous cardiopulmonary monitoring
- Assess respiratory status q1hr or more frequently
- Position prone or side-lying to improve oxygenation
- Suction PRN with bulb syringe or low-pressure suction
- Cluster nursing interventions
- Strict I&O; daily weight
- Family education and support
Medications
- Surfactant (poractant alfa, beractant) — intratracheal via ETT, given prophylactically or as rescue
- Caffeine citrate — for apnea of prematurity
- Antibiotics empirically if sepsis suspected
- Dopamine or dobutamine for hypotension
Client Education
- Explain pathophysiology and treatment to parents
- Encourage parent visitation and skin-to-skin (kangaroo care) when stable
- Discuss expected NICU course and milestones
- Long-term follow-up (developmental and pulmonary)
- Discharge planning (oxygen at home if needed)
Therapeutic Procedures
- Surfactant replacement therapy via ETT
- CPAP or nasal cannula for mild distress
- Mechanical ventilation for severe RDS
- Warmed humidified oxygen as needed
- Maintain hydration with IV fluids (TPN if NPO)
Interprofessional Care
- Neonatology — primary management
- Respiratory therapy — ventilator management
- NICU nursing — intensive care
- Pediatric ophthalmology — ROP screening
- Developmental specialists — follow-up care
Alterations in Health (Diagnosis)
Hypertensive disorder of pregnancy with new-onset BP ≥ 140/90 mm Hg after 20 weeks gestation PLUS proteinuria (≥ 300 mg/24 hr or P/C ratio ≥ 0.3) OR end-organ dysfunction. Eclampsia = preeclampsia with new-onset tonic-clonic seizures.
Pathophysiology Related to Client Problem
Abnormal placentation in early pregnancy causes shallow trophoblast invasion of spiral arteries. Resulting placental ischemia releases anti-angiogenic factors (sFlt-1, sEng) causing endothelial dysfunction, vasoconstriction, increased vascular permeability, and decreased organ perfusion. Affects all organ systems.
Health Promotion and Disease Prevention
Aspirin 81 mg daily from 12–28 weeks for high-risk clients. Adequate calcium intake (1,500 mg/day). Early and consistent prenatal care for BP monitoring. Risk assessment at first visit.
Risk Factors
- Nulliparity, age < 18 or > 35
- Multifetal gestation
- Previous preeclampsia or family history
- Pregestational diabetes, chronic HTN, kidney disease
- Obesity (BMI > 30)
- Autoimmune disease (SLE, antiphospholipid syndrome)
- IVF pregnancy
Expected Findings
- BP ≥ 140/90 on two readings 4 hr apart
- Severe features: BP ≥ 160/110, proteinuria, plt < 100,000, LFTs 2x normal, creatinine > 1.1, pulmonary edema, persistent headache, visual changes (scotomata, blurred vision)
- Edema — face, hands, generalized; sudden weight gain
- Epigastric or RUQ pain (hepatic capsule stretch — ominous)
- Hyperreflexia with possible clonus
- Decreased urine output (< 30 mL/hr)
- Seizure activity (eclampsia)
Laboratory Tests
- Proteinuria: ≥ 300 mg/24-hr collection, OR P/C ratio ≥ 0.3, OR dipstick 1+
- CBC — hemoconcentration; platelets < 100,000 in severe
- LFTs: AST/ALT 2x normal in severe
- BUN, creatinine elevated
- Uric acid elevated
- Coagulation panel (PT, PTT, INR, fibrinogen)
- Magnesium serum level (therapeutic 4–7 mEq/L)
Diagnostic Procedures
- NST and BPP for fetal well-being
- Doppler flow studies of umbilical artery
- Ultrasound — fetal growth, oligohydramnios
- Continuous EFM if hospitalized
- Seizure precautions: private quiet room, padded side rails up, suction at bedside, O₂ ready
- Magnesium sulfate for seizure prophylaxis (4–6 g loading, 1–2 g/hr maintenance)
- Monitor for mag toxicity: loss of DTRs, RR < 12, urine output < 30 mL/hr
- Calcium gluconate at bedside as mag antidote (1 g IV slow push)
- BP monitoring q15min during acute phase; q1–2hr stable
- If eclamptic seizure: turn to side, protect airway, do NOT restrain
Complications
- Eclampsia (tonic-clonic seizures)
- HELLP syndrome
- Placental abruption
- Pulmonary edema
- Cerebral hemorrhage / stroke
- Acute renal failure
- DIC
- Fetal: IUGR, oligohydramnios, preterm birth, stillbirth
Nursing Care
- VS including BP q1–4hr (more frequent if severe)
- Daily weight
- Strict I&O — Foley catheter often placed
- Continuous EFM
- Assess DTRs q4hr, monitor for clonus
- Limit visitors, decrease stimulation (light, sound)
- Quiet, dimly lit room
- Bedrest in left lateral position
- Headache, visual changes, epigastric pain — report immediately
Medications
- Magnesium sulfate — seizure prophylaxis (NOT for BP)
- Labetalol 10–20 mg IV q10min (max 300 mg) — first-line antihypertensive
- Hydralazine 5–10 mg IV q20min — alternative
- Nifedipine 10 mg PO — for oral management
- Betamethasone 12 mg IM x 2 doses (fetal lungs if < 34 wk)
- AVOID: ACE inhibitors, ARBs (teratogenic)
Client Education
- Explain disease process and treatment plan
- Importance of bedrest in left lateral position
- Report headache, visual changes, epigastric pain, decreased fetal movement immediately
- Need for frequent prenatal visits, BP checks at home if discharged
- Definitive treatment is delivery — induction often required at 37 wk
- Risk of recurrence 25% in future pregnancies
Therapeutic Procedures
- Bed rest with bathroom privileges
- Continuous fetal and maternal monitoring
- Delivery is the only cure — timing based on severity and gestational age
- Induction often at 37 weeks for preeclampsia without severe features
- Delivery within 24 hr if severe features develop
Interprofessional Care
- Maternal-fetal medicine consultation
- Anesthesia — early epidural placement, careful fluid management
- Neonatology — preterm delivery planning
- Critical care — if severe complications develop
Alterations in Health (Diagnosis)
Severe variant of preeclampsia characterized by Hemolysis, Elevated Liver enzymes, and Low Platelets. Life-threatening multisystem disorder.
Pathophysiology Related to Client Problem
Endothelial damage from preeclamptic vasospasm causes hemolysis of RBCs through narrowed vessels, hepatic ischemia and necrosis with elevation of liver enzymes, and platelet activation/consumption. May progress to DIC.
Health Promotion and Disease Prevention
Aggressive treatment of preeclampsia. Early recognition of warning signs. Maternal monitoring of liver function in known preeclamptic clients. Aspirin prophylaxis in high-risk clients.
Risk Factors
- Pre-existing preeclampsia (especially with severe features)
- Multiparity (paradoxically, opposite of preeclampsia)
- Maternal age > 25
- Caucasian ethnicity (higher in this population)
- Previous HELLP syndrome
- Family history
Expected Findings
- RUQ or epigastric pain (hepatic capsule distention — hallmark)
- Nausea, vomiting
- Malaise / flu-like symptoms
- Headache, visual changes
- Jaundice, scleral icterus
- Petechiae, bruising, bleeding gums
- May have BP elevation but can present normotensive
- Hyperreflexia
Laboratory Tests
- Hemolysis: hemoglobin < 10, LDH > 600, total bilirubin > 1.2, schistocytes on peripheral smear
- Elevated liver enzymes: AST > 70, ALT > 70 (often 2x ULN)
- Low platelets: < 100,000
- Coagulation panel — may develop DIC
- Haptoglobin decreased
- Uric acid elevated
Diagnostic Procedures
- CT or MRI of liver — rule out subcapsular hematoma if pain severe
- Continuous EFM
- BPP, NST for fetal status
- Hepatic rupture is rare but catastrophic — avoid abdominal palpation if severe RUQ pain
- Seizure precautions per preeclampsia protocol
- Mag sulfate for seizure prophylaxis
- Strict bleeding precautions if platelets low
- Avoid IM injections; minimize venipuncture
- Cross-match blood products
- Hold pressure 5+ min after any venipuncture
Complications
- DIC (10–20%)
- Placental abruption
- Acute renal failure
- Hepatic hematoma / rupture (rare, often fatal)
- ARDS, pulmonary edema
- Cerebral hemorrhage
- Fetal: IUGR, preterm birth, stillbirth
- Maternal mortality 1%
Nursing Care
- VS q15min during acute phase
- Strict I&O — Foley catheter
- Continuous EFM
- Assess for bleeding (gums, IV sites, urine, stool)
- Monitor neurologic status closely
- Calm, low-stimulation environment
- Position left lateral
- Daily weights
Medications
- Magnesium sulfate — seizure prophylaxis
- Antihypertensives: labetalol or hydralazine
- Corticosteroids — betamethasone for fetal lungs (some evidence helps platelet recovery in mother)
- Blood products as needed (platelets if < 50,000 with bleeding or pre-cesarean)
- Avoid NSAIDs (worsen platelet dysfunction)
Client Education
- Explain serious nature of condition and need for prompt delivery
- Report any bleeding immediately
- Discuss risk of recurrence (~20% in future pregnancies)
- Importance of bedrest and quiet environment
- Postpartum: condition may worsen for 24–48 hr before resolving
Therapeutic Procedures
- Delivery is the definitive treatment
- Cesarean if < 34 weeks and unfavorable cervix, or platelets very low
- If > 34 weeks: deliver promptly (vaginal or cesarean as indicated)
- Continuous monitoring postpartum for 48+ hours
Interprofessional Care
- Maternal-fetal medicine
- Anesthesia — careful planning if epidural (avoid if plt < 50,000)
- Hematology if DIC develops
- Neonatology
- ICU if severe complications
Alterations in Health (Diagnosis)
Severe, persistent nausea and vomiting in pregnancy causing weight loss ≥ 5% of prepregnancy weight, dehydration, electrolyte imbalance, ketosis, and metabolic alkalosis. Distinguished from typical 'morning sickness' by severity and persistence.
Pathophysiology Related to Client Problem
Etiology incompletely understood. Hypotheses include elevated hCG and estrogen levels, serotonin sensitivity, vitamin deficiencies, and psychosocial factors. Often persists beyond first trimester. Excessive vomiting depletes fluid, electrolytes (esp. K+, Na+), and acid (HCl) causing metabolic alkalosis.
Health Promotion and Disease Prevention
Early recognition and treatment of nausea/vomiting in pregnancy. Vitamin B6 (pyridoxine) and dietary management before symptoms worsen. Adequate prenatal hydration.
Risk Factors
- First pregnancy
- Multifetal gestation, molar pregnancy (high hCG)
- Previous hyperemesis
- Family history
- Maternal age < 20
- History of motion sickness or migraine
- Female fetus (slight increase)
Expected Findings
- Persistent vomiting (> 3 times/day)
- Weight loss > 5% of prepregnancy weight
- Signs of dehydration: dry mucous membranes, decreased skin turgor, tachycardia, hypotension, oliguria
- Ptyalism (excessive saliva)
- Fatigue, weakness, malaise
- Possible jaundice (hepatic dysfunction in severe)
Laboratory Tests
- Urine: ketonuria (> 2+), specific gravity > 1.025, decreased volume
- Serum electrolytes: hypokalemia, hyponatremia, hypochloremia
- ABG: metabolic alkalosis
- BUN elevated (prerenal)
- LFTs may be mildly elevated
- TSH (rule out hyperthyroidism)
- Hgb elevated (hemoconcentration)
Diagnostic Procedures
- Ultrasound (rule out molar pregnancy, multiples)
- Weight at each visit
- Daily urine ketones
- Liver and thyroid function panels
- Risk of Wernicke encephalopathy from B1 deficiency — give thiamine BEFORE glucose-containing fluids
- Aspiration risk during emesis (positioning)
- Esophageal tear (Mallory-Weiss) from forceful vomiting
- Strict I&O monitoring
- Daily weight
Complications
- Severe dehydration and electrolyte imbalance
- Wernicke encephalopathy (B1 deficiency)
- Esophageal tear, retinal hemorrhage
- Acute renal failure
- Hepatic dysfunction
- Fetal: IUGR (in severe, prolonged cases), preterm delivery
- Maternal psychological complications (depression)
Nursing Care
- Maintain IV hydration
- NPO initially, advance diet slowly as tolerated
- Small, frequent, bland meals when eating resumes
- Quiet environment, minimize odors
- Position upright after meals
- Encourage rest periods
- Monitor for psychological distress (depression, anxiety)
- Frequent oral care
Medications
- Pyridoxine (B6) + doxylamine (Diclegis) — first-line
- Ondansetron (Zofran) 4–8 mg PO/IV q8hr — second-line
- Promethazine (Phenergan) 12.5–25 mg PO/IV/PR q4–6hr
- Metoclopramide (Reglan) 5–10 mg q8hr
- Methylprednisolone — if severe, refractory
- Thiamine 100 mg IV before dextrose
- Glucose-containing IVF with electrolyte replacement
Client Education
- Eat dry crackers/toast before getting out of bed
- Small, frequent meals (every 2–3 hr)
- Bland, dry foods — avoid greasy, spicy, strong odors
- Stay hydrated between meals, not with meals
- Ginger, lemon, peppermint may help
- Avoid lying flat after eating
- Vitamin B6 supplements safe in pregnancy
- When to call: weight loss, decreased urine, can't keep fluids down
Therapeutic Procedures
- IV hydration with D5LR or D5NS + KCl replacement
- Nutritional support — enteral feeding or TPN if severe
- Antiemetic therapy escalation as needed
- Acupuncture, acupressure (P6 wrist point — Sea-Band)
- Hospitalization if outpatient management fails
Interprofessional Care
- Maternal-fetal medicine consultation
- Nutritionist — meal planning, supplements
- Psychiatry/counseling if psychological factors contributing
- GI consultation if persistent
Alterations in Health (Diagnosis)
Obstetric emergency in which the anterior fetal shoulder becomes impacted behind the maternal symphysis pubis after delivery of the head, preventing completion of birth. Defined by need for additional maneuvers beyond gentle downward traction.
Pathophysiology Related to Client Problem
After fetal head delivers, normal restitution does not occur and head retracts tightly against the perineum ('turtle sign'). The anterior shoulder is wedged against the symphysis pubis. Cord may be compressed between fetal body and pelvis, and chest compression prevents respiration.
Health Promotion and Disease Prevention
Identification of risk factors. Estimated fetal weight via ultrasound. Counseling regarding cesarean delivery for suspected macrosomia (> 5,000 g in non-diabetics, > 4,500 g in diabetics). Optimal positioning during delivery.
Risk Factors
- Macrosomia (> 4,000 g — strongest predictor)
- Maternal diabetes (gestational or pregestational)
- Maternal obesity
- Previous shoulder dystocia
- Prolonged second stage of labor
- Operative vaginal delivery (forceps, vacuum)
- Postdates pregnancy
- Excessive maternal weight gain
Expected Findings
- 'Turtle sign' — head retracts tightly against perineum after delivery
- Inability to deliver shoulders with gentle downward traction
- Fetal head appears to be 'stuck'
- May be sudden after presumed normal labor
Laboratory Tests
- Cord blood gas after delivery (assess fetal acidosis)
- CBC, type and screen — bleeding risk
- Newborn: blood glucose, brachial nerve function assessment
Diagnostic Procedures
- Clinical recognition based on inability to deliver shoulders
- Post-delivery newborn assessment for brachial plexus injury
- X-ray if clavicle fracture suspected
- Call for help immediately — additional staff, NICU, anesthesia
- Document time — head-to-body delivery interval critical
- Do NOT apply fundal pressure (worsens impaction)
- HELPERR mnemonic: Help, Evaluate for episiotomy, Legs (McRoberts), Pressure (suprapubic), Enter for internal rotation, Remove posterior arm, Roll patient (Gaskin)
- Avoid excessive lateral traction — risk of brachial plexus injury
Complications
- Brachial plexus injury (Erb's palsy, Klumpke's palsy) — 10–20%
- Clavicle or humerus fracture
- Birth asphyxia, hypoxic-ischemic encephalopathy
- Cord compression with fetal acidosis
- Fetal death (rare with prompt management)
- Maternal: postpartum hemorrhage, 3rd/4th degree lacerations, symphyseal separation, uterine rupture
Nursing Care
- McRoberts maneuver first — hyperflex maternal hips to chest (each nurse holds one leg)
- Suprapubic pressure — apply pressure just above pubis, NOT fundal
- Time delivery interval and announce loudly
- Document maneuvers used and order
- Position patient as directed for various maneuvers
- Continuous fetal monitoring
- Emotional support to mother and partner — quick clear communication
- Anticipate hemorrhage postpartum
Medications
- IV access established prior to delivery for emergencies
- Oxytocin postpartum for hemorrhage prevention
- Methergine, carboprost, misoprostol available for PPH
- No specific medications for the dystocia itself
Client Education
- Explain situation calmly during emergency
- Discuss maneuvers being performed
- Post-delivery: explain newborn assessment for injury
- Risk of recurrence (10% in future pregnancies)
- Future delivery planning (may discuss elective cesarean)
Therapeutic Procedures
- Maneuvers performed in sequence: McRoberts → suprapubic pressure → internal rotation (Wood's screw, Rubin's) → delivery of posterior arm → Gaskin (all-fours)
- Symphysiotomy or Zavanelli (replace fetal head) — rare last resort
- Episiotomy if needed for access
- Immediate newborn resuscitation often required
Interprofessional Care
- OB provider — primary management
- Anesthesia — emergency intervention
- Neonatology — newborn resuscitation
- Additional OB nurses for maneuvers
- Operating room team on standby
Alterations in Health (Diagnosis)
Obstetric emergency in which the umbilical cord descends through the cervix and into the vagina BEFORE the fetal presenting part. Can be overt (cord visible/palpable) or occult (cord beside presenting part, not protruding).
Pathophysiology Related to Client Problem
Cord compression between presenting part and bony pelvis interrupts fetal blood flow and oxygenation. Can cause profound bradycardia, hypoxia, and fetal death within minutes. Often occurs at time of membrane rupture when fluid carries cord through partially dilated cervix.
Health Promotion and Disease Prevention
Identify risk factors antepartum and avoid AROM in unfavorable positions. Document fetal position before AROM. Strict bedrest if known unstable lie at term. Careful fetal monitoring.
Risk Factors
- Malpresentation: breech (especially footling), transverse, oblique lie
- Polyhydramnios
- Multiple gestation (especially 2nd twin)
- Premature or unengaged presenting part
- Long umbilical cord
- Low birth weight or preterm fetus
- Multiparity
- AROM with unengaged presenting part (iatrogenic)
- External cephalic version
Expected Findings
- Sudden severe variable or prolonged decelerations, often with bradycardia
- Visible cord at perineum (overt)
- Palpable pulsating cord on vaginal exam
- Maternal report of feeling something in vagina
- Recent rupture of membranes with sudden FHR changes
- Loss of fetal heart variability
Laboratory Tests
- Cord blood gas after delivery (assess acidosis)
- Type and crossmatch — emergency surgery
- CBC, coagulation panel
Diagnostic Procedures
- Vaginal exam confirms diagnosis
- Continuous EFM
- Ultrasound (not required for diagnosis, may show occult prolapse)
- Immediately CALL FOR HELP and notify provider
- Do NOT push cord back in
- Hold presenting part OFF cord — insert gloved hand into vagina and elevate presenting part
- Maintain hand position until delivery
- Position knee-chest or steep Trendelenburg to use gravity to relieve pressure
- If cord protrudes outside vagina, cover with warm saline-soaked gauze (NOT push back)
- Anticipate emergent cesarean delivery
Complications
- Fetal asphyxia / hypoxic-ischemic encephalopathy
- Fetal death (high mortality if delay)
- Cerebral palsy, neurologic deficits
- Stillbirth
- Maternal complications of emergent cesarean (bleeding, infection)
- Time-to-delivery is critical — outcomes worsen rapidly after 10 min
Nursing Care
- One nurse maintains manual elevation of presenting part entire time
- Position client knee-chest or Trendelenburg with hips elevated
- Administer O₂ 10 L/min by face mask
- Stop oxytocin if running
- Begin IV fluid bolus
- Continuous fetal monitoring
- Prepare for emergency cesarean — call OR team
- Emotional support — explain urgency calmly
- Document time of diagnosis, FHR, interventions
Medications
- Terbutaline 0.25 mg SC — tocolytic if delay in cesarean
- Oxygen 10 L/min nonrebreather
- IV crystalloid fluid bolus
- Pre-op antibiotics if time permits
- Emergency cesarean meds (anesthesia)
Client Education
- Explain emergency situation calmly
- Importance of position maintenance
- What to expect during emergency cesarean
- Postpartum: discuss what happened
- Future pregnancy implications
Therapeutic Procedures
- Emergency cesarean delivery — primary treatment
- If vaginal delivery imminent (multiparous, full dilation, station +2 or below): assist rapid vaginal delivery
- Maintain pressure relief on cord until delivery
- Neonatal resuscitation prepared
Interprofessional Care
- OB provider — emergency cesarean
- Anesthesia — emergency anesthesia (general often required)
- OR team — rapid setup
- Neonatology — immediate resuscitation
- Additional nursing staff for positioning and transport
Alterations in Health (Diagnosis)
Life-threatening obstetric emergency involving complete or partial separation of the uterine wall, with or without extrusion of the fetus into the maternal abdomen. May involve a previous uterine scar (most common) or unscarred uterus.
Pathophysiology Related to Client Problem
Increased intrauterine pressure or weakened uterine wall (typically previous cesarean scar) causes muscular layer separation. Bleeding into peritoneum causes maternal hypovolemia; fetal blood supply via placenta is disrupted causing rapid fetal compromise. Maternal mortality 1–4%; fetal mortality 15–30%.
Health Promotion and Disease Prevention
Careful candidate selection for TOLAC (trial of labor after cesarean). Cesarean for multiple previous cesareans. Avoid oxytocin or prostaglandins (especially misoprostol) in TOLAC. Recognition of early warning signs.
Risk Factors
- Previous uterine surgery (cesarean, especially classical/T-incision)
- TOLAC / VBAC attempt
- Excessive uterine stimulation (oxytocin, prostaglandins)
- Misoprostol in TOLAC is contraindicated
- Grand multiparity
- Uterine overdistention (multifetal, polyhydramnios, macrosomia)
- Obstructed labor / CPD
- Trauma (MVA, fall)
- Previous uterine perforation
Expected Findings
- Sudden severe abdominal pain (may feel 'tearing')
- Loss of fetal station (presenting part recedes)
- Cessation of contractions after intense pain
- Nonreassuring FHR (bradycardia, late decels, loss of variability)
- Vaginal bleeding (may be minimal — most bleeding intraperitoneal)
- Signs of hypovolemic shock (tachycardia, hypotension, pallor)
- Palpable fetal parts through abdominal wall
- Change in uterine shape
Laboratory Tests
- STAT type and crossmatch for 4+ units PRBC
- CBC — H&H drop
- Coagulation panel (PT, PTT, INR, fibrinogen)
- Cord blood gas after delivery
- Comprehensive metabolic panel
Diagnostic Procedures
- Clinical diagnosis — confirmed at emergency laparotomy
- Continuous EFM showing nonreassuring tracing
- Bedside ultrasound (may show fetus in abdomen)
- FAST exam if available
- Immediate emergency cesarean delivery
- Two large-bore IVs and aggressive fluid resuscitation
- Mass transfusion protocol
- Hold pressure to wound; prepare for OR
- Monitor for shock and DIC
- Strict NPO once diagnosis suspected
Complications
- Maternal hypovolemic shock and death
- DIC
- Hysterectomy (loss of fertility)
- Bladder, bowel injury
- Sheehan syndrome
- Fetal: hypoxic injury, cerebral palsy, fetal death (15–30%)
- Postoperative infection, thromboembolism
Nursing Care
- STAT notification of provider
- Continuous EFM and maternal VS q5–15 min
- Stop oxytocin immediately
- Establish 2 large-bore IVs (16 or 18 gauge)
- O₂ 10 L/min nonrebreather mask
- Prepare for emergency cesarean — call OR team
- Foley catheter
- Type and crossmatch — call blood bank
- Strict I&O monitoring
- Family support and explanation
Medications
- IV crystalloid bolus (LR or NS 1–2 L)
- Blood products: PRBC, FFP, platelets, cryoprecipitate (mass transfusion)
- Oxytocin postoperatively for uterine tone
- Pre-op antibiotics if time permits
- Vasopressors if shock (phenylephrine, norepinephrine)
- Pain management postoperatively
Client Education
- Explain emergency briefly and calmly
- Discuss expected outcomes during recovery
- Postpartum: review what happened, expected healing
- Future pregnancy: cesarean delivery required; TOLAC contraindicated
- Risk of recurrence in future pregnancies
- Importance of follow-up imaging if conservative repair
Therapeutic Procedures
- Emergency laparotomy with cesarean delivery
- Repair vs hysterectomy depending on damage extent
- Bladder repair if involved
- Aggressive resuscitation
- ICU postoperative monitoring
Interprofessional Care
- OB provider — emergency surgery
- Anesthesia — general anesthesia, mass transfusion management
- OR team — rapid setup
- Neonatology — immediate resuscitation
- Hematology — DIC management
- Urology — if bladder involved
- Critical care — postoperative ICU
Alterations in Health (Diagnosis)
Inflammatory infection of breast tissue in a lactating client, most commonly caused by Staphylococcus aureus entering through cracked or fissured nipples. Typically unilateral.
Pathophysiology Related to Client Problem
Bacterial entry through nipple skin disruption + milk stasis creates ideal growth environment. Infection in the lactiferous ducts and surrounding connective tissue causes local inflammation, edema, and erythema. May progress to abscess if untreated.
Health Promotion and Disease Prevention
Proper latch technique from first feeding. Avoid prolonged engorgement. Empty breasts frequently and completely. Treat nipple cracks promptly. Avoid tight bras. Hand hygiene before feeding.
Risk Factors
- Cracked, fissured, or sore nipples (entry portal)
- Engorgement, blocked milk duct
- Incomplete breast emptying
- Missed feedings, prolonged intervals
- Poor latch technique
- Tight bras, sleeping on stomach
- Maternal stress, fatigue
- Maternal immunosuppression
- Previous mastitis
Expected Findings
- Unilateral breast pain (usually one quadrant)
- Warm, erythematous, tender, swollen area (typically wedge-shaped)
- Fever ≥ 38.5°C (101.3°F)
- Flu-like symptoms: chills, malaise, body aches, fatigue
- Possible palpable hard area
- Tachycardia
- May or may not have purulent discharge
- Axillary lymphadenopathy
Laboratory Tests
- CBC — leukocytosis with left shift
- Milk culture (if recurrent or treatment-resistant)
- Wound culture if drainage present
- Blood culture if sepsis suspected
Diagnostic Procedures
- Clinical diagnosis based on signs and symptoms
- Breast ultrasound if abscess suspected
- Mammography if not resolving with treatment (rule out inflammatory breast cancer)
- Continue breastfeeding on affected side — milk is NOT contaminated
- Empty breast completely with feedings or pumping
- Monitor for abscess formation (firm, fluctuant mass)
- Watch for systemic infection / sepsis signs
- Verify medication safety for breastfeeding
Complications
- Breast abscess (5–10%)
- Recurrent mastitis
- Sepsis (rare)
- Cessation of breastfeeding (avoidable with proper management)
- Decreased milk supply on affected side
- Chronic breast pain
Nursing Care
- Assess and improve breastfeeding latch
- Encourage frequent feeding from affected side first
- Apply warm compresses before feeding (promotes letdown)
- Cold packs between feedings for inflammation
- Massage affected area toward nipple during feeding
- Vary feeding positions
- Increase maternal fluid intake to 2.5–3 L/day
- Rest periods
- Pain relief before feeding
Medications
- Dicloxacillin 500 mg PO QID x 10–14 days (first-line, anti-staph)
- Cephalexin 500 mg PO QID x 10–14 days (alternative)
- Clindamycin 300 mg PO QID — if PCN allergy or MRSA suspected
- Acetaminophen or ibuprofen for pain and fever
- Continue antibiotics for full course even after symptoms resolve
- Avoid: tetracyclines, sulfonamides in early breastfeeding
Client Education
- Complete full antibiotic course (10–14 days)
- Continue breastfeeding on affected side
- Symptoms should improve in 24–48 hr — if not, return for evaluation
- Proper latch and positioning
- Adequate rest, fluids, nutrition
- Empty breasts at every feeding
- Report worsening pain, fever, hard lump (abscess)
- Hand hygiene and breast hygiene
Therapeutic Procedures
- Oral antibiotic therapy
- Frequent breast emptying (feeding or pumping)
- Warm/cold compresses
- Adequate rest and hydration
- Pain management
- Abscess: incision and drainage if formed
Interprofessional Care
- Primary care or OB provider — diagnosis and prescription
- Lactation consultant — latch assessment and education
- Surgery — if abscess drainage required
- Pharmacist — medication compatibility with breastfeeding
Alterations in Health (Diagnosis)
Blood glucose < 40–45 mg/dL in term newborns or < 25 mg/dL in first 4 hours of life. Can be transient (most common) or persistent. Symptomatic OR asymptomatic hypoglycemia requires intervention.
Pathophysiology Related to Client Problem
Newborns transition from continuous glucose supply via placenta to intermittent feedings. Hepatic glycogen stores are limited. Infants of diabetic mothers develop fetal hyperinsulinemia from maternal hyperglycemia; after birth glucose supply stops but insulin remains high, causing rapid drop in glucose. SGA infants have inadequate glycogen reserves.
Health Promotion and Disease Prevention
Early feeding initiation (within 1 hr of birth). Frequent feedings (q2–3hr). Skin-to-skin contact (thermoregulation prevents glucose use for warmth). Glucose screening per protocol in at-risk newborns. Maternal glucose control during pregnancy.
Risk Factors
- Infant of diabetic mother (IDM)
- Large for gestational age (LGA) — macrosomia
- Small for gestational age (SGA), IUGR
- Preterm newborn (< 37 weeks)
- Late preterm (34 0/7 to 36 6/7)
- Perinatal stress (asphyxia, cold stress, sepsis, RDS)
- Cold stress, hypothermia
- Maternal use of beta-blockers or terbutaline
- Polycythemia (RBCs use glucose)
- Beckwith-Wiedemann syndrome
Expected Findings
- Often asymptomatic — screening is critical
- Jitteriness, tremors
- Lethargy, poor tone (hypotonia), poor feeding
- Temperature instability / hypothermia
- Apnea, respiratory distress, cyanosis
- Irritability, high-pitched cry
- Seizures (late, severe sign)
- Diaphoresis, pallor
- Tachycardia
Laboratory Tests
- Heel-stick blood glucose per protocol
- Most facilities: first glucose at 30 min, then per protocol q3hr x 3, then q6hr
- Confirm low values with serum/plasma glucose
- CBC (rule out polycythemia, sepsis)
- If persistent hypoglycemia: insulin, cortisol, GH, ketones, ammonia
Diagnostic Procedures
- Heel-stick glucose monitoring
- Serum confirmation for borderline values
- Continuous monitoring in high-risk newborns
- Endocrine workup if persistent > 72 hr
- Asymptomatic glucose < 25 first 4 hr or < 35 hr 4–24 → feed and recheck
- Symptomatic or glucose < 25 → IV glucose immediately
- Never bolus highly concentrated glucose (rebound hypoglycemia)
- Verify glucometer accuracy (newborn-specific)
- Monitor for rebound hypoglycemia after IV start
- Maintain neutral thermal environment (cold stress depletes glucose)
Complications
- Seizures
- Neurologic injury — cognitive impairment, cerebral palsy (severe, prolonged)
- Developmental delays
- Apnea, respiratory compromise
- Cardiac arrhythmias
- Death (rare, severe untreated cases)
- Increased risk of future metabolic syndrome
Nursing Care
- Initiate early feeding (within 1 hr of birth)
- Skin-to-skin contact immediately after birth
- Maintain neutral thermal environment
- Frequent feedings q2–3hr
- Heel-stick glucose per protocol
- Monitor for symptoms continuously in at-risk newborns
- Assess for adequate intake (urine, stool output)
- Daily weight (expected loss 5–7% first week)
- Family education and support
Medications
- IV dextrose 10% (D10W) — 2 mL/kg bolus, then 4–6 mL/kg/hr
- Never use D50% in newborns (causes rebound hypoglycemia, vessel damage)
- Glucagon 0.025–0.3 mg/kg IM if no IV access
- Diazoxide for persistent hyperinsulinism
- Octreotide for severe hyperinsulinism
- Hydrocortisone for adrenal insufficiency
Client Education
- Importance of early and frequent feedings
- Recognize signs of hypoglycemia
- Encourage breastfeeding (colostrum has high concentrations)
- Skin-to-skin benefits
- Avoid wrapping too tightly (overheating); maintain warmth
- Discharge teaching: feed q2–3hr at home
- Follow-up pediatric appointment scheduled
Therapeutic Procedures
- Oral feeding (breast or formula) if asymptomatic
- 10% oral dextrose gel (Glucose Gel) — 200 mg/kg buccal — emerging first-line
- IV dextrose if symptomatic or feeding fails
- Skin-to-skin contact
- Thermoregulation
Interprofessional Care
- Neonatology — high-risk management
- Pediatrics — discharge follow-up
- Endocrinology — persistent hypoglycemia
- Lactation consultant
- Dietary — formula/feeding consultation
Alterations in Health (Diagnosis)
Withdrawal syndrome in a newborn exposed to substances (most commonly opioids, but also benzodiazepines, alcohol, SSRIs) during pregnancy. Symptoms appear within hours to days of birth depending on substance half-life.
Pathophysiology Related to Client Problem
Substances cross placenta during pregnancy → fetus develops physical dependence. After birth, abrupt cessation of supply causes withdrawal of CNS depressant effects. Hyperactivity of CNS, autonomic nervous system, GI tract, and respiratory system. Symptom timing depends on substance half-life: heroin (24 hr), methadone (24–72 hr), buprenorphine (36–60 hr), SSRIs (24–48 hr).
Health Promotion and Disease Prevention
Substance use screening at every prenatal visit. Treatment of maternal substance use disorder (methadone or buprenorphine maintenance preferred over abstinence). Non-stigmatizing care. Trauma-informed approach. Prenatal substance use treatment.
Risk Factors
- Maternal opioid use (heroin, prescription opioids, methadone, buprenorphine)
- Maternal use of: benzodiazepines, barbiturates, alcohol, SSRIs
- Polysubstance use
- Maternal smoking (potentiates symptoms)
- Late preterm or term infants (more severe than preterm)
- Insufficient prenatal care
- Concurrent maternal psychiatric illness
Expected Findings
- CNS: high-pitched cry, irritability, tremors, jitteriness, increased muscle tone, hyperactive reflexes, seizures (severe)
- Autonomic: sneezing, yawning, mottling, fever, sweating, tachycardia
- GI: poor feeding, vomiting, diarrhea, dehydration, weight loss, excoriation of buttocks
- Respiratory: tachypnea, nasal stuffiness
- Other: excessive frantic sucking, sleep disturbance, hypertonia
- Onset: heroin within 24 hr; methadone/buprenorphine 24–72 hr; can present up to 7 days
Laboratory Tests
- Meconium toxicology screen — most sensitive, detects 20 weeks gestation exposure
- Umbilical cord toxicology — quick alternative
- Urine toxicology (newborn) — detects recent exposure only
- Hair sample (less common)
- Maternal urine drug screen (consent required)
- Glucose, electrolytes, CBC
Diagnostic Procedures
- Finnegan Neonatal Abstinence Scoring System — q3–4hr, score > 8 (3 consecutive) indicates need for treatment
- Newer: Eat, Sleep, Console (ESC) approach — functional assessment, less medication use
- Maternal history and toxicology
- Echocardiogram, head US if congenital anomalies suspected
- Quiet, low-stimulation environment (dim lights, low noise)
- Soft swaddling for comfort
- Skin-to-skin contact when possible
- Non-judgmental support to mother
- Monitor for seizures
- Maintain hydration and nutrition
- Strict I&O monitoring
- Skin protection (frequent diaper changes for diarrhea)
Complications
- Seizures
- Failure to thrive
- Skin breakdown from excoriation
- Aspiration from vomiting
- Developmental delays, behavioral problems
- Sudden infant death syndrome (SIDS) risk
- Long-term: ADHD, learning disabilities, anxiety
- Maternal relapse and home environment issues
- Prolonged hospitalization (mean 17–22 days for pharmacologic treatment)
Nursing Care
- Reduce stimulation — quiet room, swaddling, dim lights
- Cluster nursing care to allow rest periods
- Frequent small feedings (high-calorie formula if poor weight gain)
- Skin-to-skin contact with parent
- Position pacifier for non-nutritive sucking
- Gentle rocking, swaddling, swaying
- Score symptoms using Finnegan or ESC
- Daily weight
- Protect skin (excoriation prevention)
- Support and educate parents
- Encourage breastfeeding (unless contraindicated — HIV, cocaine, marijuana)
Medications
- Morphine 0.05 mg/kg PO q3–4hr (first-line for opioid withdrawal)
- Methadone alternative oral medication
- Buprenorphine emerging alternative
- Phenobarbital for sedative withdrawal or adjunct
- Clonidine adjunct for autonomic symptoms
- Weaning protocol: gradual dose decrease over 1–4 weeks
Client Education
- Non-judgmental support to mother
- Encourage maternal involvement in care
- Teach swaddling, soothing techniques
- Breastfeeding generally encouraged (review contraindications)
- Importance of maternal substance use treatment continuation
- Long-term follow-up: developmental, behavioral
- Recognize signs of withdrawal at home
- Safety: avoid co-sleeping, smoke-free environment
Therapeutic Procedures
- Non-pharmacologic first: swaddling, skin-to-skin, frequent feedings, quiet environment
- ESC approach (Eat, Sleep, Console) — newer functional assessment
- Pharmacotherapy if scores remain elevated despite non-pharm
- Gradual weaning of medications
- Discharge with established outpatient follow-up
Interprofessional Care
- Neonatology — primary management
- Pediatrics — discharge and long-term follow-up
- Social services — home environment assessment, Child Protective Services if needed
- Maternal substance use treatment provider
- Lactation consultant — breastfeeding compatibility
- Developmental specialists — long-term follow-up
- Early intervention program enrollment
Alterations in Health (Diagnosis)
New-onset BP ≥ 140/90 mm Hg after 20 weeks gestation on two readings 4 hr apart, in a previously normotensive client, WITHOUT proteinuria or end-organ dysfunction. Distinguished from chronic HTN (before 20 wk) and preeclampsia (with proteinuria/end-organ).
Pathophysiology Related to Client Problem
Pregnancy-induced vasoconstriction and decreased plasma volume expansion. The underlying mechanism is similar to early preeclampsia but without the proteinuria/end-organ involvement. 15–25% progress to preeclampsia. Resolves by 12 weeks postpartum (if not, reclassify as chronic HTN).
Health Promotion and Disease Prevention
Aspirin 81 mg/day starting 12–28 weeks for high-risk clients. Calcium supplementation (1,500 mg/day). Early prenatal care with BP monitoring. Risk assessment at first visit. Lifestyle modifications (diet, moderate exercise, weight management).
Risk Factors
- Nulliparity (first pregnancy)
- Maternal age < 20 or > 35
- Family history of preeclampsia or HTN
- Multifetal gestation
- Obesity (BMI > 30)
- Diabetes (pregestational or gestational)
- Chronic kidney disease
- Autoimmune disease (SLE, antiphospholipid syndrome)
- Previous pregnancy with gestational HTN
Expected Findings
- BP ≥ 140/90 on two occasions 4 hr apart
- NO proteinuria
- NO end-organ dysfunction (normal LFTs, platelets, creatinine)
- May have mild edema (pedal, dependent)
- Generally asymptomatic — diagnosed on routine BP screening
- No headache, visual changes, epigastric pain (if present, evaluate for preeclampsia)
Laboratory Tests
- Urinalysis — protein NEGATIVE or trace
- 24-hour urine protein < 300 mg or P/C ratio < 0.3
- CBC — normal
- LFTs (AST, ALT) — normal
- Creatinine — normal
- Uric acid — may be slightly elevated
- Coagulation panel — normal
Diagnostic Procedures
- Baseline assessment for end-organ involvement (rule out preeclampsia)
- NST starting at 32 weeks (weekly)
- Ultrasound for fetal growth q3–4 weeks
- Home BP monitoring (twice daily, log readings)
- Monitor closely for progression to preeclampsia
- Educate on warning signs requiring immediate evaluation
- Outpatient management often appropriate if BP < 160/110
- Lifestyle modifications, NOT bedrest (no evidence of benefit)
- Antihypertensives only if BP ≥ 160/110 (severe range)
Complications
- Progression to preeclampsia (15–25%)
- Severe gestational hypertension (BP ≥ 160/110)
- Placental abruption
- IUGR
- Preterm birth
- Postpartum: persistent HTN, cardiovascular risk later in life
- Future pregnancy: recurrence and preeclampsia risk
Nursing Care
- BP measurement at every visit using proper technique (sitting, 5 min rest)
- Weekly weight checks
- Educate on signs/symptoms of preeclampsia progression
- Daily fetal kick counts after 28 weeks
- Avoid salt restriction (no benefit)
- Encourage adequate hydration
- Stress reduction techniques
Medications
- Antihypertensives only if BP ≥ 160/110:
- Labetalol 200–400 mg PO BID (first-line oral)
- Nifedipine XL 30–60 mg PO daily
- Methyldopa 250–500 mg PO BID/QID (safe alternative)
- AVOID: ACE inhibitors, ARBs (teratogenic)
- Aspirin 81 mg/day (continued from earlier prophylaxis)
Client Education
- Report immediately: severe headache, visual changes (scotomata, blurred vision)
- Report: epigastric/RUQ pain, sudden swelling, decreased fetal movement
- BP self-monitoring twice daily; record and bring to visits
- Weekly to twice-weekly prenatal visits required
- Importance of NSTs and growth scans
- Expected resolution by 12 weeks postpartum
- Risk of preeclampsia in future pregnancies elevated
- Long-term: elevated risk of cardiovascular disease later in life
Therapeutic Procedures
- Outpatient management if BP < 160/110
- Increased prenatal visits (twice weekly after 36 wk)
- Antepartum testing (NST, BPP)
- Delivery at 37 weeks if uncomplicated
- Hospitalization if severe range BP or progression to preeclampsia
Interprofessional Care
- Maternal-fetal medicine if complicated
- Anesthesia consultation late pregnancy
- Pharmacist — medication compatibility, dosing
- Cardiology if persistent postpartum (chronic HTN)
Alterations in Health (Diagnosis)
Collection of blood in soft tissues of the genital tract following injury to a blood vessel during delivery. Most commonly vulvar (superficial), vaginal (paravaginal), or retroperitoneal (deepest, most dangerous).
Pathophysiology Related to Client Problem
Trauma during delivery (laceration, episiotomy, operative delivery, prolonged or precipitous labor) damages a blood vessel that bleeds into surrounding tissue without external loss. Bleeding continues until pressure within the tissue equals pressure in the vessel. Can result in significant occult blood loss.
Health Promotion and Disease Prevention
Careful episiotomy technique. Adequate repair of lacerations with hemostasis. Avoid operative delivery when possible. Postpartum assessment of perineum at frequent intervals. Recognition of early warning signs.
Risk Factors
- Operative vaginal delivery (forceps, vacuum)
- Episiotomy or perineal lacerations
- Precipitous delivery
- Prolonged second stage of labor
- Macrosomic infant
- Nulliparity
- Coagulation disorders
- Genital tract varicosities
- Inadequate hemostasis during repair
Expected Findings
- Severe perineal, vaginal, or rectal pain disproportionate to apparent injury
- Pressure sensation in vagina/rectum
- Visible bulging discolored mass on perineum/vulva (vulvar)
- Difficulty voiding (vaginal hematoma compressing urethra)
- Hypovolemic shock signs WITHOUT obvious bleeding (retroperitoneal — concerning!)
- Tachycardia, hypotension out of proportion to visible loss
- Restlessness, anxiety
- Pallor, diaphoresis
Laboratory Tests
- CBC — H&H drop without obvious blood loss is suggestive
- Type and crossmatch for 2+ units PRBC
- Coagulation panel (PT, PTT, INR, fibrinogen)
- Comprehensive metabolic panel
- Lactate (perfusion marker)
Diagnostic Procedures
- Direct visualization (vulvar)
- Vaginal/rectal exam (paravaginal)
- CT or MRI for suspected retroperitoneal hematoma
- Ultrasound (less reliable for retroperitoneal)
- Continuous VS monitoring
- Always assess for hematoma when severe pain reported postpartum
- Monitor for hypovolemic shock — particularly in occult bleeding
- Strict bed rest until stable
- Frequent VS monitoring
- Ice pack to vulvar hematoma in first 12 hr
- Adequate analgesia (severe pain typical)
Complications
- Hypovolemic shock from occult bleeding
- Infection / abscess formation
- Necrosis of overlying skin
- Necrosis from prolonged pressure
- DVT from prolonged immobility
- Urinary retention
- Persistent pain (long-term)
- Future delivery concerns (varicosities, episiotomy site)
Nursing Care
- VS q15min initially, then q30–60min
- Assess perineum and vagina q1–2hr for first 24 hr
- Apply ice pack to vulvar hematoma first 12 hr
- Warm sitz baths after 12 hr (or per provider)
- Strict I&O — Foley if voiding difficulty
- Pain assessment and adequate analgesia
- Stool softeners to prevent straining
- Monitor for re-expansion of hematoma
- Emotional support — explain situation
- Daily H&H
Medications
- Analgesics: opioids (oxycodone, hydromorphone) for severe pain
- Ibuprofen 600 mg q6hr scheduled
- Acetaminophen 1,000 mg q6hr
- Stool softeners (docusate) and laxatives (Miralax)
- Antibiotics if surgical drainage performed
- Iron supplementation for anemia
- Blood products if significant hemorrhage
Client Education
- Explain hematoma cause and management plan
- Importance of bed rest if instructed
- Pain control plan and medication schedule
- Sitz baths and perineal care technique
- Stool softener importance (avoid straining)
- Activity restrictions
- Report: increasing pain, fever, urinary retention
- Expected timeline of resolution (2–6 weeks for absorption)
- Follow-up appointment importance
Therapeutic Procedures
- Small stable hematomas (< 4–5 cm): conservative management with ice, pressure, observation
- Larger or expanding hematomas: surgical incision, drainage, ligation of bleeding vessel
- Retroperitoneal hematomas: often require interventional radiology embolization or exploratory laparotomy
- Blood transfusion if significant hemorrhage
- Pressure dressing post-evacuation
Interprofessional Care
- OB provider — assessment and management decisions
- Anesthesia — pain management, surgical anesthesia
- Interventional radiology — embolization if needed
- Surgery — large hematoma evacuation
- Blood bank — products preparation
Alterations in Health (Diagnosis)
Rare but severe psychiatric emergency typically occurring within first 2 weeks postpartum (peak 3–10 days). Characterized by delusions, hallucinations, severe mood lability, disorganized thinking, and impaired reality testing. Higher risk of infanticide and suicide than other postpartum mood disorders.
Pathophysiology Related to Client Problem
Likely related to dramatic hormonal shifts after delivery (estrogen, progesterone) in genetically predisposed individuals. Often unmasks underlying bipolar disorder. May represent first manifestation of bipolar disorder in some women. Sleep deprivation contributes to symptom expression.
Health Promotion and Disease Prevention
Mental health screening at every prenatal visit. Detailed psychiatric history including family history. Postpartum mental health follow-up at 2 and 6 weeks. Adequate sleep prioritization in postpartum period. Support systems in place.
Risk Factors
- Personal history of bipolar disorder (highest risk — 25–50%)
- Previous postpartum psychosis (recurrence 31–57%)
- Family history of bipolar or postpartum psychosis
- Primiparity
- Sleep deprivation
- Pregnancy or postpartum complications
- Discontinuation of psychiatric medications during pregnancy
- Severe psychosocial stressors
- Maternal age extremes
Expected Findings
- Onset within 2 weeks of birth (rapid)
- Delusions — often baby-focused (special powers, demonic possession, child in danger)
- Hallucinations — auditory most common (commands to harm baby)
- Disorganized thinking and speech
- Severe mood lability — depression, mania, mixed episodes
- Confusion, disorientation
- Insomnia or refusal to sleep
- Paranoia
- Bizarre or impulsive behavior
- Suicidal or infanticidal ideation
- Inability to care for self or infant
Laboratory Tests
- Comprehensive metabolic panel (rule out medical causes)
- CBC
- Thyroid function (rule out thyroiditis)
- Urinalysis (rule out infection, drug screen)
- B12, folate levels
- Calcium, magnesium
- Toxicology screen
Diagnostic Procedures
- Comprehensive psychiatric evaluation
- Mental status examination
- Edinburgh Postnatal Depression Scale (PD-specific screen)
- Rule out medical causes (Sheehan syndrome, thyroid storm, infection)
- CT/MRI if neurologic signs
- Mood disorder questionnaire
- PSYCHIATRIC EMERGENCY — immediate hospitalization typically required
- NEVER LEAVE INFANT UNATTENDED WITH MOTHER
- Suicide precautions: 1:1 observation, remove harmful objects
- Infanticide risk assessment — ALL psychotic mothers need supervision
- Family members aware of warning signs
- Discontinue breastfeeding if antipsychotics started (some compatible)
- Safety contracts ineffective in psychotic patients
Complications
- Maternal suicide (4% lifetime risk)
- Infanticide (4% lifetime risk)
- Recurrence in future pregnancies (31–57%)
- Disruption of mother-infant bonding
- Long-term psychiatric illness (often bipolar)
- Marital and family disruption
- Postpartum psychosis episodes outside pregnancy
- Child outcomes: increased risk of psychiatric and developmental issues
Nursing Care
- Provide safe quiet environment
- 1:1 supervision
- Frequent mental status assessments
- Ensure infant safety — separation if needed
- Encourage adequate rest and sleep
- Reorient to time, place, person frequently
- Limit visitors initially (may worsen agitation)
- Establish therapeutic relationship
- Family support and education
- Coordinate with mental health team
Medications
- Antipsychotics: haloperidol, olanzapine, risperidone, quetiapine
- Mood stabilizers: lithium (highly effective), valproate, lamotrigine
- Benzodiazepines for agitation (lorazepam, clonazepam) — short-term
- ECT (electroconvulsive therapy) for refractory or breastfeeding-compatible cases — rapid response
- Antidepressants if depressive component — caution in bipolar
- Breastfeeding considerations: many drugs compatible; lithium passes; valproate caution
Client Education
- Educate family on signs and need for emergency mental health care
- Importance of taking medications as prescribed
- Future pregnancy risk discussion
- Plan for prophylactic medication in future pregnancies
- Long-term mental health follow-up essential
- Bonding can recover with treatment
- Reassurance that condition is treatable
- Sleep prioritization importance
Therapeutic Procedures
- Inpatient psychiatric hospitalization
- Mother-baby psychiatric unit when available (preserves bonding)
- ECT for severe or breastfeeding clients (rapid effect, safe)
- Antipsychotic and mood stabilizer therapy
- Family therapy
- Outpatient psychiatric follow-up
- Postpartum support groups (Postpartum Support International)
- Long-term psychiatric care
Interprofessional Care
- Psychiatry — primary management
- Social work — discharge planning, family support
- Mental health nursing
- OB/GYN — ongoing women's health care
- Pediatrics — infant welfare assessment
- Lactation consultant — breastfeeding compatibility
- Child Protective Services if safety concerns
- Family support / counseling
Alterations in Health (Diagnosis)
Self-limited respiratory disorder of the newborn caused by delayed clearance of fetal lung fluid. Most common cause of respiratory distress in term and late preterm newborns. Presents in first hours of life and resolves within 24–72 hr.
Pathophysiology Related to Client Problem
In utero, fetal lungs are filled with fluid. During vaginal birth, the chest is compressed, expelling much of this fluid. Catecholamine surge at birth also stimulates absorption via ion channels. After cesarean (especially without labor) or rapid birth, fluid remains in alveoli and interstitium, impairing gas exchange. Excess fluid is absorbed over 24–72 hr.
Health Promotion and Disease Prevention
Avoid elective cesarean before 39 weeks. Labor exposure (vaginal or cesarean after labor onset) helps fluid clearance. Treatment of maternal conditions. Antenatal corticosteroids if preterm delivery anticipated.
Risk Factors
- Cesarean birth without labor (highest risk)
- Late preterm (34 0/7 to 36 6/7 weeks)
- Precipitous delivery
- Macrosomia
- Male sex
- Maternal asthma
- Maternal diabetes
- Maternal sedation in labor
- Multiple gestation
Expected Findings
- Tachypnea (RR > 60/min) — hallmark
- Onset in first 2 hours of life
- Mild to moderate retractions
- Nasal flaring
- Mild grunting (less than RDS)
- Mild cyanosis on room air (responds to low FiO₂)
- Clear lung fields on auscultation
- Generally well-appearing infant
- Resolves within 24–72 hr
Laboratory Tests
- ABG: mild respiratory alkalosis (from tachypnea) or mild hypoxemia
- SpO₂: 90–95% on low FiO₂ (improves quickly)
- CBC with differential (rule out sepsis)
- Blood culture (rule out sepsis)
- CRP/procalcitonin
- Blood glucose
Diagnostic Procedures
- Chest X-ray: fluid in interlobar fissures, hyperinflation, perihilar streaking, increased pulmonary vascularity — 'wet lung' appearance
- Pre/post-ductal SpO₂ (rule out cardiac)
- Echocardiogram if persistent or worsening
- Continuous cardiopulmonary monitoring
- Differentiate from RDS, MAS, pneumonia, sepsis (TTN diagnosis of exclusion)
- Monitor for worsening — TTN should improve, not worsen
- Cluster nursing care
- Maintain neutral thermal environment
- Adequate hydration
- Avoid hypothermia (worsens respiratory distress)
Complications
- Generally none — self-limited disease
- Rarely requires mechanical ventilation
- Delayed feeding establishment
- Hypoglycemia from NPO status
- Hospital prolongation
- Misdiagnosis (missing RDS, MAS, sepsis, pneumonia, congenital heart disease)
- Parental anxiety
Nursing Care
- Continuous cardiopulmonary monitoring
- Respiratory assessment q1hr initially
- Position prone or side-lying (improves oxygenation)
- Maintain neutral thermal environment
- Cluster nursing care
- Minimize handling and stimulation
- NPO if RR > 60–80 (aspiration risk)
- IV fluids if NPO
- Daily weight
- Family education and support
Medications
- Supplemental O₂ as needed (target SpO₂ 90–95%)
- CPAP if moderate distress
- IV fluids (D10W or D5W at maintenance) if NPO
- Empiric antibiotics (ampicillin + gentamicin) often given until sepsis ruled out
- Caffeine citrate if preterm
- No specific treatment — supportive care
- Avoid diuretics (no benefit)
Client Education
- Explain self-limited nature to parents
- Expected resolution in 24–72 hours
- Reassurance — most newborns recover completely
- Importance of monitoring and tests
- Bonding can occur once newborn stabilizes
- When feeding can resume
- Discharge timeline (typically 48–72 hr)
- No long-term respiratory consequences expected
Therapeutic Procedures
- Supportive care primarily
- Oxygen via nasal cannula (target SpO₂ 90–95%)
- CPAP if moderate respiratory distress
- IV hydration until feeding tolerated
- Resume feedings when RR < 60
- Continued observation until resolution
Interprofessional Care
- Neonatology — primary management
- Pediatrics — discharge planning
- Respiratory therapy — O₂/CPAP management
- Lactation consultant — feeding plan
- NICU/special care nursery as needed
Alterations in Health (Diagnosis)
Respiratory distress in a newborn with meconium-stained amniotic fluid and radiographic findings of aspiration that cannot be otherwise explained. Caused by inhalation of meconium into the airways before, during, or immediately after birth.
Pathophysiology Related to Client Problem
Fetal hypoxia or stress causes relaxation of anal sphincter and gasping respirations. Meconium is aspirated into airways. After birth: (1) airway obstruction (ball-valve mechanism causes air trapping, pneumothorax), (2) chemical pneumonitis (inflammation), (3) surfactant inactivation (atelectasis), (4) persistent pulmonary hypertension (PPHN — right-to-left shunting).
Health Promotion and Disease Prevention
Adequate fetal monitoring to detect distress early. Prompt cesarean for nonreassuring fetal status. Avoid postdates pregnancy. Tracheal suctioning per current NRP guidelines (only if non-vigorous).
Risk Factors
- Postdates pregnancy (≥ 42 weeks)
- Fetal distress / hypoxia
- Intrauterine growth restriction (IUGR)
- Cord prolapse, cord compression
- Placental insufficiency
- Maternal diabetes, HTN, preeclampsia
- Smoking, drug use
- Chorioamnionitis
- Oligohydramnios
- Operative delivery, instrumented birth
Expected Findings
- Meconium-stained amniotic fluid at delivery (green/brown)
- Meconium staining of skin, nails, umbilical cord
- Respiratory distress at birth
- Tachypnea (RR > 60)
- Retractions, nasal flaring, grunting
- Cyanosis
- Barrel chest (hyperinflation)
- Coarse crackles, decreased breath sounds
- Low Apgar scores
- Hypotonia, lethargy
Laboratory Tests
- ABG: hypoxemia, hypercapnia, metabolic and respiratory acidosis
- Pulse oximetry — pre/post-ductal (PPHN screening)
- CBC with differential
- Blood culture
- Lactate
- Coagulation panel if severe
- Comprehensive metabolic panel
Diagnostic Procedures
- Chest X-ray: patchy infiltrates, hyperinflation, areas of consolidation alternating with atelectasis, possible pneumothorax
- Echocardiogram — evaluate for persistent pulmonary hypertension
- Pre/post-ductal SpO₂ — > 10% difference suggests PPHN
- Cranial ultrasound (if asphyxia)
- EEG if seizures
- Resuscitate per NRP guidelines
- Minimize handling — cluster care
- Maintain neutral thermal environment
- Avoid bag-mask ventilation if possible (worsens air trapping)
- Intubation and tracheal suction only if non-vigorous at birth (newer NRP guidelines)
- Monitor for pneumothorax constantly
- Strict infection control
- Pain management
Complications
- Persistent pulmonary hypertension (PPHN)
- Pneumothorax / pneumomediastinum
- Air leak syndromes (PIE)
- Chemical pneumonitis
- Bacterial pneumonia (secondary)
- Acute respiratory failure
- Hypoxic-ischemic encephalopathy (HIE)
- Multiorgan dysfunction
- Chronic lung disease (rare)
- Death (mortality 5–10% with current treatment, higher without)
- Long-term: asthma, recurrent wheezing
Nursing Care
- Suction nasopharynx if obstructed (before delivery of body in vaginal birth)
- After birth: assess vigor — vigorous = routine; non-vigorous = consider intubation
- Continuous cardiopulmonary monitoring
- Frequent respiratory assessments
- Position prone for optimal oxygenation
- Cluster nursing care
- Maintain neutral thermal environment
- Minimize stimulation (avoid handling, noise)
- Strict I&O, daily weights
- Emotional support to family
Medications
- Surfactant replacement (lavage or bolus)
- Inhaled nitric oxide (iNO) — for PPHN
- Sildenafil — pulmonary vasodilator
- Antibiotics (ampicillin + gentamicin) — empiric for pneumonia/sepsis
- Sedation (fentanyl, midazolam) — reduces O₂ demand
- Vasopressors (dopamine, dobutamine) for hypotension
- Sodium bicarbonate for severe acidosis (controversial)
Client Education
- Explain pathophysiology to parents
- Severity ranges from mild to life-threatening
- Treatment course (NICU stay)
- Possible long-term respiratory follow-up
- Encourage skin-to-skin when stable
- Discharge teaching: signs of respiratory distress to monitor
- Long-term: pulmonary follow-up, asthma risk
- Developmental follow-up if HIE present
Therapeutic Procedures
- Mechanical ventilation — often high-frequency oscillatory (HFOV)
- Surfactant administration
- Inhaled nitric oxide for PPHN
- ECMO (extracorporeal membrane oxygenation) — severe cases
- Therapeutic hypothermia if HIE present
- Chest tube placement if pneumothorax
- IV fluids, nutritional support
Interprofessional Care
- Neonatology — primary management
- Respiratory therapy — advanced ventilation
- Pediatric cardiology — PPHN assessment
- Pediatric pulmonology — long-term follow-up
- NICU nursing — intensive care
- Developmental specialists
- Pediatric infectious disease if pneumonia
- ECMO team if needed
Alterations in Health (Diagnosis)
Most common medical disorder of pregnancy. Defined as Hgb < 11 g/dL (Hct < 33%) in 1st & 3rd trimesters OR Hgb < 10.5 g/dL (Hct < 32%) in 2nd trimester. Caused by inadequate iron stores to meet increased pregnancy demands.
Pathophysiology Related to Client Problem
Pregnancy increases iron requirements 2-3 fold (RBC mass increases 20-30%, fetal/placental iron storage, blood loss at delivery). Without supplementation, demand exceeds intake → depleted iron stores → impaired hemoglobin synthesis → microcytic, hypochromic anemia.
Health Promotion and Disease Prevention
Routine iron supplementation 27 mg/day starting at first prenatal visit; iron-rich diet; vitamin C with iron for absorption; treatment of pre-existing anemia before conception; adequate spacing between pregnancies.
Risk Factors
- Adolescent pregnancy (growing maternal needs)
- Vegan/vegetarian diet
- Multiple gestations
- Closely-spaced pregnancies (< 2 years)
- Heavy menstrual bleeding pre-pregnancy
- Chronic disease (renal, GI malabsorption)
- Hyperemesis gravidarum
- Low socioeconomic status / food insecurity
- Postpartum hemorrhage history
Expected Findings
- Fatigue, weakness, lethargy
- Pallor (skin, mucous membranes, conjunctiva, nail beds)
- Tachycardia, dyspnea on exertion
- Dizziness, lightheadedness
- Headache
- Pica (especially craving ice — pagophagia)
- Brittle hair and nails
- Cold intolerance
- Restless legs syndrome
- Glossitis, angular cheilitis (severe)
Laboratory Tests
- Hgb < 11 g/dL (1st/3rd tri); < 10.5 (2nd tri)
- Hct < 33% (1st/3rd tri); < 32% (2nd tri)
- Serum ferritin < 15 ng/mL (most sensitive)
- Serum iron < 30 mcg/dL
- Total iron-binding capacity (TIBC) elevated
- Transferrin saturation < 16%
- MCV < 80 fL (microcytic)
- MCHC < 32 g/dL (hypochromic)
- Reticulocyte count low
Diagnostic Procedures
- CBC with peripheral smear (microcytic, hypochromic RBCs)
- Iron studies (ferritin, iron, TIBC, transferrin saturation)
- Stool occult blood (rule out GI bleeding)
- Reticulocyte count
- Hemoglobin electrophoresis (rule out thalassemia, sickle cell)
- Iron supplementation safety: keep out of reach of children (iron overdose = leading cause of pediatric poisoning death)
- Avoid taking with calcium, antacids, milk, caffeine (decrease absorption)
- Monitor for fall risk from dizziness/lightheadedness
- Blood transfusion only if symptomatic at Hgb < 7 g/dL or near term
- Postpartum: assess for excessive blood loss
Complications
- Maternal: increased risk preeclampsia, peripartum hemorrhage complications, infection susceptibility, poor wound healing, fatigue, depression
- Fetal/neonatal: IUGR, low birth weight, preterm birth, increased perinatal mortality, infant iron deficiency anemia (depleted stores last only 4-6 months), impaired neurocognitive development
Nursing Care
- Educate on diet rich in iron sources
- Administer iron between meals with vitamin C source
- Monitor for therapeutic response (reticulocyte count rises in 7-10 days)
- Monitor stools (will be dark green/black — normal)
- Stool softener for iron-induced constipation
- Encourage rest periods
- Position changes slowly (orthostatic hypotension)
- Recheck Hgb in 4 weeks
- Postpartum: continue iron supplementation 6+ weeks
Medications
- Ferrous sulfate 325 mg PO 1-3 times daily (65 mg elemental iron)
- Ferrous gluconate 240 mg PO (alternative)
- Ferrous fumarate 200 mg PO (highest elemental iron)
- Take with vitamin C (orange juice) on empty stomach
- IV iron sucrose if oral intolerance/severe anemia
- Avoid: milk, calcium, antacids, caffeine within 2 hours
- PRBC transfusion if symptomatic at Hgb < 7 g/dL
Client Education
- Iron-rich foods: red meat, liver, fish, poultry, beans, lentils, fortified cereals, dark leafy greens
- Enhance absorption with vitamin C (citrus, tomatoes, peppers, strawberries)
- Take iron between meals with water or juice
- Dark stools are normal with iron — not concerning
- Increase fluids and fiber for constipation
- Continue iron for 6 weeks postpartum
- Report worsening fatigue, palpitations, severe dizziness
- Follow-up labs at 4 weeks
Therapeutic Procedures
- Oral iron supplementation (first-line)
- IV iron (iron sucrose 200 mg) if intolerance/severe
- PRBC transfusion if Hgb < 7 + symptomatic
- Dietary counseling with nutritionist
- Postpartum continued supplementation
Interprofessional Care
- Obstetrician — prenatal management
- Nutritionist/dietitian — dietary planning
- Hematologist if severe or refractory
- Pharmacist — drug interactions
- Social work — WIC, food security resources
Alterations in Health (Diagnosis)
Pregnancy with underlying cardiac disease (congenital, valvular, cardiomyopathy, ischemic, arrhythmias). Pregnancy increases cardiac workload 30-50% — may decompensate previously stable disease. Leading cause of indirect maternal mortality.
Pathophysiology Related to Client Problem
Pregnancy causes: ↑ blood volume 40-50%, ↑ cardiac output 30-50%, ↓ SVR, ↑ HR 10-15 bpm. Peak hemodynamic stress at 28-32 weeks and immediately postpartum (autotransfusion). Diseased hearts cannot accommodate these changes.
Health Promotion and Disease Prevention
Pre-conception counseling and risk assessment; optimize cardiac function before pregnancy; genetic counseling for congenital heart disease; modify medications before conception (avoid ACE-I, ARBs, warfarin in 1st tri); contraception until cardiac function optimized.
Risk Factors
- Pre-existing congenital heart disease (most common)
- Rheumatic heart disease
- Cardiomyopathy (peripartum, dilated, hypertrophic)
- Valvular disorders (mitral stenosis most dangerous)
- Ischemic heart disease
- Pulmonary hypertension (extreme risk)
- Marfan syndrome (aortic dissection risk)
- Prior cardiac surgery, prosthetic valves
- Maternal age > 35
Expected Findings
- Dyspnea (especially with exertion or supine)
- Orthopnea, PND
- Fatigue out of proportion to pregnancy
- Palpitations, irregular pulse
- Chest pain or pressure
- Peripheral edema (worse than expected for GA)
- Cough, hemoptysis
- Cyanosis
- Jugular venous distention
- Murmurs (some normal in pregnancy; pathologic if loud, harsh, diastolic)
- Crackles in lungs (pulmonary edema)
- Syncope
Laboratory Tests
- CBC (anemia worsens cardiac symptoms)
- BMP (renal function)
- BNP / NT-proBNP — elevated in heart failure
- Troponin — rule out MI
- TSH
- ABGs if respiratory distress
Diagnostic Procedures
- ECG (baseline, then as indicated)
- Echocardiogram (preferred — no radiation; assess EF, valves, chamber size)
- Chest X-ray (with abdominal shielding)
- Holter monitor if arrhythmia
- Cardiac MRI if needed
- Right heart catheterization if pulmonary HTN suspected
- Continuous fetal monitoring during labor
- NYHA Functional Classification I-IV
- Pulmonary hypertension is associated with extremely high maternal mortality (30-50%) — counsel against pregnancy
- Marfan syndrome with aortic root > 4 cm — risk of dissection during labor
- Avoid Valsalva (closed glottis pushing) — increases cardiac strain
- Position left lateral (avoids vena cava compression)
- Strict I&O; daily weights
- Anticoagulation if mechanical valve or atrial fibrillation
- Endocarditis prophylaxis with delivery if high-risk valve disease
- Highest decompensation risk: 28-32 wk and immediate postpartum
Complications
- Maternal: heart failure, arrhythmias, MI, stroke, thromboembolism, pulmonary edema, cardiogenic shock, death
- Peripartum cardiomyopathy (specific to last month of pregnancy through 5 mo postpartum)
- Endocarditis
- Aortic dissection (Marfan)
- Fetal: IUGR, prematurity, fetal demise, congenital heart disease (if maternal CHD — recurrence 3-50%)
Nursing Care
- Frequent VS during labor (q5-15 min)
- Continuous cardiac monitoring during labor
- Continuous EFM
- Pulse oximetry continuous
- Strict I&O; restrict IV fluids (pulmonary edema risk)
- Position left lateral or semi-Fowler
- Oxygen as needed; target SpO₂ > 95%
- Adequate pain control (decreases cardiac strain)
- Limit pushing in 2nd stage — instrumented delivery often preferred
- Postpartum: monitor for decompensation × 48 hr
- DVT prophylaxis (SCDs, anticoagulation)
Medications
- Continue cardiac meds compatible with pregnancy
- SAFE: beta-blockers (labetalol, metoprolol — but cause IUGR), digoxin, hydralazine, methyldopa, low-dose aspirin
- AVOID: ACE inhibitors, ARBs (teratogenic), warfarin in 1st trimester (replace with heparin)
- Anticoagulation for mechanical valves: LMWH or unfractionated heparin (NOT warfarin in 1st tri)
- Diuretics (furosemide) for heart failure
- Antiarrhythmics as needed
- Endocarditis prophylaxis for high-risk valves at delivery
Client Education
- Activity modification per NYHA class
- Avoid heat, dehydration, fatigue
- Adequate rest, side-lying position
- Recognize early signs of decompensation (worsening dyspnea, edema, fatigue)
- Report immediately: chest pain, palpitations, severe SOB, syncope
- Daily weight check
- Low-sodium diet if heart failure
- Postpartum recurrence risk discussion
- Future pregnancy counseling
Therapeutic Procedures
- Multidisciplinary team approach
- Cardiac valve replacement (rare during pregnancy)
- Mechanical ventilation if severe HF
- ICU admission for decompensation
- Operative vaginal delivery preferred (limits Valsalva)
- Cesarean only for obstetric indications (more stressful than vaginal)
- ECMO in severe cases
Interprofessional Care
- Maternal-fetal medicine co-management
- Cardiology (preferably with high-risk pregnancy experience)
- Cardiac anesthesia at delivery
- Neonatology if preterm anticipated
- Cardiothoracic surgery (consultation)
- Genetics if congenital heart disease
- Social work, mental health support
Alterations in Health (Diagnosis)
Rare (1 in 8,000–80,000) but catastrophic obstetric emergency: amniotic fluid, fetal cells, or debris enters maternal circulation through uterine veins → anaphylactoid reaction → cardiovascular collapse, coagulopathy. Maternal mortality 20–60%.
Pathophysiology Related to Client Problem
Anaphylactoid syndrome — not a true embolism. Trigger of fetal antigens enters maternal circulation → immune-mediated cytokine release → pulmonary vasospasm → right heart failure → left heart failure → hypoxia → coagulopathy (DIC). Pulmonary hypertension is initial phase; LV dysfunction follows.
Health Promotion and Disease Prevention
Prevention not currently possible — etiology poorly understood. Recognition of high-risk situations and immediate response is critical.
Risk Factors
- Advanced maternal age (> 35)
- Multiparity / grand multiparity
- Induced labor (especially with oxytocin)
- Cesarean delivery
- Polyhydramnios
- Multifetal gestation
- Placental abruption
- Placenta previa
- Uterine rupture
- Trauma during pregnancy
- Cervical lacerations
- Fetal distress / meconium-stained fluid
Expected Findings
- SUDDEN onset during or immediately after labor
- Acute hypoxia: sudden dyspnea, cyanosis, respiratory arrest
- Hemodynamic collapse: profound hypotension, cardiogenic shock, cardiac arrest
- Coagulopathy/DIC: oozing from IV sites, severe vaginal bleeding, GI bleeding, hematuria, petechiae
- Seizures
- Altered mental status, loss of consciousness
- Fetal bradycardia/distress (if antepartum)
- Tachycardia, anxiety, sense of impending doom (early)
- Pulmonary edema (frothy sputum)
Laboratory Tests
- CBC: decreasing Hgb/Hct
- Coagulation panel: prolonged PT/aPTT/INR, decreased fibrinogen, decreased platelets, elevated D-dimer
- ABGs: severe hypoxia, metabolic acidosis
- Type and crossmatch (multiple units)
- Comprehensive metabolic panel
- Lactate (perfusion marker)
- Cardiac enzymes
- Fibrinogen serial measurements
Diagnostic Procedures
- CLINICAL DIAGNOSIS based on triad of hypoxia, hypotension, coagulopathy
- ECG (right heart strain, dysrhythmias)
- Chest X-ray (pulmonary edema)
- Echocardiogram (acute RV dysfunction, then LV)
- Continuous fetal monitoring
- Histopathology of fetal squamous cells in maternal pulmonary circulation (post-mortem or central line aspirate)
- OBSTETRIC EMERGENCY — activate response team immediately
- Multiple large-bore IV access
- Aggressive resuscitation
- Perimortem cesarean delivery within 4 minutes of maternal arrest if no ROSC
- Notify anesthesia, OR, blood bank, NICU, ICU
- Massive transfusion protocol
- Continuous cardiopulmonary monitoring
Complications
- Maternal death (20-60%) — half within first hour
- Acute respiratory failure, ARDS
- Cardiac arrest, cardiogenic shock
- Severe coagulopathy/DIC
- Hypoxic-ischemic encephalopathy
- Renal failure, hepatic failure (multi-organ failure)
- Stroke
- PTSD in survivors
- Newborn: 70% survive if delivered promptly; HIE common; long-term neurologic sequelae
Nursing Care
- Call rapid response / Code Blue
- CPR if cardiac arrest (use left uterine displacement to improve cardiac return)
- Maintain airway, intubation, 100% O₂
- Large-bore IV access × 2-3
- Aggressive fluid resuscitation (initially); restrict fluids if pulmonary edema develops
- Type and crossmatch; initiate massive transfusion protocol
- Monitor for and treat coagulopathy
- Foley catheter, strict I&O
- Document timeline meticulously
- Emotional support to family
Medications
- 100% oxygen via face mask or ventilator
- Vasopressors: epinephrine, norepinephrine, dopamine, phenylephrine
- Inotropes: dobutamine for cardiogenic shock
- Blood products: PRBCs, FFP, platelets, cryoprecipitate (1:1:1 ratio)
- TXA (tranexamic acid) for bleeding
- Calcium for massive transfusion
- Hydrocortisone (controversial)
- Sodium bicarbonate for severe acidosis
Client Education
- Family education during crisis — keep informed
- Post-event debriefing
- Long-term follow-up: PTSD risk, future pregnancy counseling
- AFE recurrence risk unknown but case reports exist
- Genetic factors not established
Therapeutic Procedures
- Aggressive resuscitation
- Mechanical ventilation
- Massive transfusion protocol
- ECMO if refractory
- Pulmonary artery catheterization for hemodynamic monitoring
- Perimortem cesarean delivery if arrest
- ICU admission
- Hysterectomy if uncontrolled hemorrhage
Interprofessional Care
- OB anesthesia, intensivist, hematologist
- Cardiology, pulmonology
- Cardiothoracic surgery (ECMO)
- Blood bank pathologist (massive transfusion)
- Neonatology (newborn resuscitation)
- Critical care nursing
- Mental health support post-event
Alterations in Health (Diagnosis)
Failure of the uterus to return to its non-pregnant state within the expected timeframe. Usually identified at the 4–6 week postpartum visit when the uterus remains enlarged. Major cause of late postpartum hemorrhage.
Pathophysiology Related to Client Problem
Normal involution involves contractions of uterine smooth muscle to expel retained tissue and reduce uterine size from ~1,000 g to 60–80 g over 6 weeks. Subinvolution occurs when this process is impaired by retained placental fragments, endometrial infection, or uterine atony.
Health Promotion and Disease Prevention
Complete examination of placenta and membranes after delivery; fundal massage in 4th stage; complete and timely emptying of bladder postpartum; breastfeeding (oxytocin release promotes involution); early ambulation; recognition of warning signs.
Risk Factors
- Retained placental fragments (most common cause)
- Endometritis (postpartum infection)
- Uterine fibroids (myomas)
- Multiparity / grand multiparity
- Multifetal gestation (overdistended uterus)
- Hydramnios
- Prolonged labor with uterine exhaustion
- Cesarean delivery
- Lack of breastfeeding
- Postpartum hemorrhage history
Expected Findings
- Uterus larger than expected for postpartum day (palpable above symphysis pubis beyond 14 days)
- Lochia abnormalities: prolonged rubra beyond 3–4 days OR return of rubra after serosa/alba
- Heavy bleeding (late PPH)
- Foul-smelling lochia (if infection)
- Pelvic heaviness or backache
- Boggy uterus on bimanual exam
- Fever > 38°C (if endometritis)
- Pelvic tenderness
- Fatigue out of proportion to expected postpartum
Laboratory Tests
- CBC (decreased Hgb/Hct from blood loss; elevated WBC if infection)
- Beta-hCG (rule out gestational trophoblastic disease)
- Endometrial cultures if infection suspected
- Coagulation panel
- Type and crossmatch if active bleeding
Diagnostic Procedures
- Bimanual pelvic exam (enlarged, boggy uterus)
- Pelvic ultrasound — visualize retained tissue, abnormal uterine size
- MRI for uncertain cases
- Endometrial biopsy if persistent
- Pad count for bleeding quantification
- Monitor for late postpartum hemorrhage
- Assess for signs of infection
- VS trends
- Educate on warning signs to report
- Iron supplementation if anemic
Complications
- Late postpartum hemorrhage
- Severe anemia requiring transfusion
- Endometritis (if infection)
- Sepsis
- Need for D&C or hysterectomy
- Asherman's syndrome (intrauterine adhesions from D&C)
- Future fertility concerns
Nursing Care
- Bimanual fundal assessment at follow-up visits
- Pad count, lochia assessment
- VS monitoring
- Patient education on lochia progression
- Encourage breastfeeding (if applicable)
- Ensure bladder empty during fundal assessments
- Document fundal height, consistency, lochia
- Coordinate D&C if indicated
Medications
- Methylergonovine (Methergine) 0.2 mg PO q3-4hr × 24-48 hr (uterotonic — promotes contraction)
- Avoid Methergine if HTN
- Antibiotics if endometritis suspected (clindamycin + gentamicin)
- Iron supplementation
- NSAIDs for pain
- Misoprostol (Cytotec) as alternative uterotonic
Client Education
- Normal lochia progression (rubra→serosa→alba)
- Warning signs: heavy bleeding, large clots, foul odor, persistent rubra, fever, pelvic pain
- Importance of completing antibiotics if prescribed
- Take iron supplements if anemic
- Return for follow-up appointments
- When to call: saturating pad < 1 hr, fever, increasing pain
Therapeutic Procedures
- Methylergonovine for uterine contraction
- Dilation and Curettage (D&C) if retained tissue confirmed
- Antibiotics if infection
- Hysterectomy as last resort (rare)
- Iron supplementation for anemia
- Blood transfusion if severe anemia
Interprofessional Care
- Obstetrician
- Radiologist (ultrasound interpretation)
- Hematology if severe anemia
- Pharmacist
- Lactation consultant
Alterations in Health (Diagnosis)
Acquired GI emergency primarily affecting preterm newborns. Inflammation and necrosis of the intestine (most commonly distal ileum and proximal colon). Severity ranges from mild illness to fulminant disease with perforation, peritonitis, and death.
Pathophysiology Related to Client Problem
Multifactorial: (1) immature intestinal mucosa with weakened barrier function, (2) immature immune system, (3) abnormal bacterial colonization, (4) intestinal ischemia (decreased perfusion), (5) feeding-related factors. Process: mucosal injury → bacterial invasion → pneumatosis intestinalis → transmural necrosis → perforation.
Health Promotion and Disease Prevention
Breast milk feeding (reduces NEC risk 6-10x vs formula); slow advancement of feeds in preterm; probiotics (some evidence); avoiding unnecessary antibiotics; antenatal corticosteroids; minimizing hypoxic/ischemic events.
Risk Factors
- Prematurity (single greatest risk factor — > 90% of cases < 32 wk)
- Very low birth weight (< 1,500 g)
- Formula feeding (vs breast milk)
- Rapid advancement of enteral feeds
- Asphyxia / perinatal hypoxia
- Persistent ductus arteriosus (PDA)
- Indomethacin exposure
- Polycythemia
- Maternal cocaine use
- Prolonged antibiotic exposure (alters gut flora)
- Sepsis
- Anemia / transfusions (TANEC — transfusion-associated NEC)
Expected Findings
- Onset typically 2nd-3rd week of life (later in extremely preterm)
- Abdominal distention (early sign)
- Feeding intolerance: increased gastric residuals, emesis (may be bilious)
- Bloody stools (occult or frank)
- Decreased bowel sounds
- Visible bowel loops
- Abdominal tenderness, erythema, induration
- Temperature instability (hypothermia common in newborns)
- Bradycardia, apnea
- Lethargy, hypotonia
- Respiratory distress
- Shock signs (poor perfusion, hypotension, metabolic acidosis)
- Bell staging system: Stage I (suspected), II (definite), III (advanced with perforation)
Laboratory Tests
- CBC: thrombocytopenia (early sign), leukopenia or leukocytosis, anemia
- Blood gases: metabolic acidosis (lactate accumulation)
- Blood culture
- Stool culture and occult blood
- CRP (elevated)
- Electrolytes (hyponatremia common)
- Coagulation panel (DIC possible)
- Glucose (instability)
Diagnostic Procedures
- Abdominal X-ray (every 6 hr in active disease):
- Pneumatosis intestinalis — air in bowel wall (PATHOGNOMONIC)
- Portal venous gas (severe)
- Pneumoperitoneum — free air (perforation; surgical emergency)
- Distended bowel loops, ileus pattern
- Sentinel (persistent) fixed loop
- Abdominal ultrasound (more sensitive for bowel wall thickening)
- Hold all enteral feedings at first suspicion
- NPO for 7-10+ days in confirmed NEC
- Strict isolation precautions (some NEC clusters reported)
- Continuous monitoring in NICU
- Watch for clinical deterioration → perforation
- Pain assessment and management
- Maintain neutral thermal environment
- Cluster care to minimize stress
Complications
- Mortality 15-30% overall; higher with perforation
- Bowel perforation, peritonitis
- Sepsis, DIC
- Short bowel syndrome (extensive resection)
- Intestinal strictures (requires later surgery)
- Cholestasis (from prolonged TPN)
- Failure to thrive
- Long-term: neurodevelopmental impairment, feeding difficulties, malabsorption
- Recurrence (rare)
Nursing Care
- Stop all enteral feedings (NPO)
- Orogastric tube to low intermittent suction (decompression)
- Continuous cardiopulmonary monitoring
- Strict I&O, daily weights
- Abdominal girth measurements q4-6hr
- Assess for blood in stool
- Position prone or side-lying (improves comfort, gas distribution)
- Maintain neutral thermal environment
- Cluster care
- Serial abdominal X-rays
- IV access (often central line)
- Family support and updates
Medications
- Broad-spectrum IV antibiotics × 7-14 days:
- Ampicillin + gentamicin + clindamycin or metronidazole (anaerobic coverage)
- Or vancomycin + piperacillin-tazobactam
- Total parenteral nutrition (TPN) — provides nutrition during NPO
- IV fluids and electrolyte management
- Vasopressors if hypotension (dopamine, dobutamine)
- Analgesics (fentanyl, morphine)
- Blood products if needed
Client Education
- Explain pathophysiology to parents
- Prognosis varies — mild cases recover well; severe cases have 20-30% mortality
- Long-term outcomes: feeding difficulties, short bowel syndrome, strictures
- Encourage continued pumping if breastfeeding (provides milk for when feeds resume)
- Anticipate prolonged NICU stay
- Long-term GI follow-up
- Developmental follow-up
Therapeutic Procedures
- Bowel rest (NPO 7-14 days)
- NG decompression
- Broad-spectrum antibiotics
- TPN until feeds resume
- Slow reintroduction of feeds (breast milk preferred)
- Surgery if perforation or refractory disease: bowel resection, primary anastomosis OR ostomy creation
- Bedside peritoneal drainage (alternative for extremely fragile infants)
- Reanastomosis at later date if ostomy created
Interprofessional Care
- Neonatology — primary management
- Pediatric surgery — surgical consultation/intervention
- Pediatric GI — long-term follow-up
- Nutrition/dietitian — TPN management
- Pharmacist
- Infectious disease (if sepsis)
- Lactation consultant
- Social work, chaplaincy (parental support)
Alterations in Health (Diagnosis)
Acute infection of the chorion, amnion, amniotic fluid, and/or placenta. Most commonly polymicrobial. Major cause of preterm labor, maternal sepsis, and neonatal morbidity. Most common complication of PPROM.
Pathophysiology Related to Client Problem
Ascending bacterial infection from vagina/cervix through ruptured (or even intact) membranes. Inflammatory cascade activates → cytokines/prostaglandins → uterine contractions → preterm labor. Bacteria invade fetal compartment → neonatal sepsis.
Health Promotion and Disease Prevention
Adequate prenatal screening (GBS, STIs); treatment of BV/UTI; avoid unnecessary vaginal exams (especially after ROM); appropriate management of PROM/PPROM; GBS prophylaxis when indicated.
Risk Factors
- Prolonged ROM (> 18 hours)
- Preterm ROM (PPROM)
- Multiple vaginal exams after ROM
- Internal fetal monitoring (FSE, IUPC)
- Prolonged labor
- GBS colonization
- BV, STIs, UTI during pregnancy
- Cervical insufficiency / short cervix
- Nulliparity
- Meconium-stained amniotic fluid
- Smoking, substance use
- Immunocompromise
Expected Findings
- Gibbs criteria: Maternal temp ≥ 38°C (100.4°F) PLUS at least one of:
- Maternal tachycardia > 100 bpm
- Fetal tachycardia > 160 bpm (earliest sign!)
- Uterine tenderness
- Foul-smelling or purulent amniotic fluid
- Maternal leukocytosis (WBC > 15,000)
- Maternal chills, malaise
- Increased uterine contractions
- Decreased fetal movement
Laboratory Tests
- CBC: WBC > 15,000 with left shift
- CRP elevated
- Procalcitonin elevated
- Blood culture
- Urinalysis and urine culture
- Vaginal/cervical cultures (GBS, GC/CT)
- Amniotic fluid analysis (if amnio performed): WBC, glucose < 14 mg/dL, Gram stain positive
- Fetal fibronectin (preterm labor)
Diagnostic Procedures
- Clinical diagnosis (Gibbs criteria)
- Continuous EFM (fetal tachycardia, decreased variability)
- Speculum exam for fluid characteristics
- Amniocentesis in selected cases
- Placental pathology (post-delivery confirmation): chorioamnionitis on histology
- Prompt delivery REQUIRED regardless of gestational age
- Aggressive antipyretic therapy (acetaminophen)
- IV antibiotics initiated immediately
- Continuous EFM
- Notify NICU — newborn at high risk for sepsis
- Monitor maternal sepsis signs
- Adequate hydration
- Cesarean delivery only for obstetric indications (not because of chorioamnionitis alone)
Complications
- Maternal: endometritis (postpartum), bacteremia/sepsis, septic shock, DIC, pulmonary edema, ARDS, postpartum hemorrhage, increased cesarean rate, hysterectomy (rare)
- Fetal/Neonatal: early-onset sepsis, pneumonia, meningitis, IVH, periventricular leukomalacia (PVL), cerebral palsy, neurodevelopmental impairment, death
- Preterm birth and its sequelae
- Increased risk of postpartum depression
- Recurrence in future pregnancies
Nursing Care
- Continuous EFM
- VS q1hr (temp q15 min if fever)
- Aggressive antipyretic therapy (acetaminophen 650 mg PO/PR q4-6hr)
- IV antibiotics immediately
- Adequate IV fluids
- Limit vaginal exams
- Strict I&O
- Document onset of fever, antibiotic time
- Prepare for delivery
- Notify NICU/neonatology of chorioamnionitis status
- Educate client on importance of treatment and delivery
- Continue antibiotics postpartum (24-48 hr after fever resolution typically)
Medications
- IV antibiotics (broad-spectrum):
- Ampicillin 2 g IV q6hr + Gentamicin 1.5 mg/kg IV q8hr (or 5 mg/kg q24hr)
- Add clindamycin or metronidazole if cesarean (anaerobic coverage)
- If penicillin-allergic: vancomycin + gentamicin
- Continue antibiotics until afebrile 24-48 hr postpartum
- Acetaminophen for fever
- GBS prophylaxis if not yet given and applicable
Client Education
- Explain diagnosis and need for prompt delivery
- Antibiotic regimen and importance of completion
- Postpartum: monitor for endometritis (worsening pain, fever, foul discharge)
- Newborn will be monitored for sepsis (blood cultures, antibiotics)
- Possible NICU stay for newborn
- Future pregnancy considerations
Therapeutic Procedures
- Delivery (vaginal preferred if possible)
- IV antibiotics
- Antipyretics
- IV fluids
- NICU coordination for newborn
- Postpartum monitoring for endometritis
Interprofessional Care
- Obstetrician — delivery management
- Neonatology — newborn evaluation and management
- Anesthesia (epidural/cesarean)
- Infectious disease (consultation if severe)
- Pharmacist
- Lactation consultant
Alterations in Health (Diagnosis)
Disseminated Intravascular Coagulation — pathologic activation of clotting cascade throughout the vasculature → simultaneous widespread microthrombosis AND consumption of clotting factors/platelets → bleeding. Always secondary to another condition.
Pathophysiology Related to Client Problem
Trigger (e.g., abruption, AFE, HELLP) → release of tissue factor → massive thrombin generation → microthrombi consume platelets and clotting factors → fibrinolysis activated → fibrin degradation products inhibit further clotting → bleeding predominates. End result: hemorrhage AND organ ischemia simultaneously.
Health Promotion and Disease Prevention
Recognize and treat triggering conditions promptly (preeclampsia, abruption, sepsis, retained dead fetus); monitor at-risk patients vigilantly; have massive transfusion protocols ready.
Risk Factors
- Severe preeclampsia / HELLP syndrome
- Placental abruption
- Amniotic fluid embolism
- Intrauterine fetal demise (especially retained > 4 weeks)
- Sepsis (chorioamnionitis, endometritis)
- Postpartum hemorrhage of any cause
- Acute fatty liver of pregnancy
- Anaphylaxis
- Massive transfusion
- Trauma
- Saline abortion
Expected Findings
- Bleeding manifestations:
- Oozing from IV sites, surgical wounds, gums
- Petechiae, ecchymoses, purpura
- Hematuria, GI bleeding (hematemesis, melena)
- Postpartum hemorrhage refractory to uterotonics
- Bleeding from venipuncture sites
- Thrombotic manifestations:
- Acute kidney injury (renal ischemia)
- Mental status changes (cerebral ischemia)
- Respiratory failure (pulmonary ischemia)
- Hepatic dysfunction
- Multi-organ failure
- Tachycardia, hypotension, shock
Laboratory Tests
- Decreased platelets (< 100,000)
- Prolonged PT, aPTT, INR
- Decreased fibrinogen < 150 mg/dL (dangerous < 100)
- Elevated D-dimer (markedly)
- Elevated fibrin degradation products (FDPs)
- Schistocytes on peripheral smear (microangiopathic hemolysis)
- Decreasing Hgb/Hct (bleeding)
- Elevated LDH, indirect bilirubin (hemolysis)
- Elevated lactate (poor perfusion)
Diagnostic Procedures
- Clinical findings + lab criteria
- ISTH (International Society on Thrombosis and Haemostasis) DIC score > 5
- Continuous monitoring of all labs (q2-4hr in acute phase)
- Imaging as indicated for end-organ assessment
- Treat the underlying cause (delivery if obstetric; antibiotics for sepsis)
- Activate massive transfusion protocol early
- Multiple large-bore IV access
- ICU-level monitoring
- Avoid IM injections (bleeding into muscle)
- Apply prolonged pressure to all puncture sites
- Avoid antiplatelet agents
- Heparin generally NOT used in obstetric DIC (bleeding predominant)
Complications
- Maternal mortality 30-50%
- Hypovolemic shock
- Multi-organ failure
- ARDS
- Acute kidney injury (often requiring dialysis)
- Stroke, cerebral hemorrhage
- Hepatic failure
- Need for hysterectomy
- Long-term: PTSD, post-ICU syndrome, chronic organ dysfunction
- Fetal/neonatal: dependent on cause and gestational age
Nursing Care
- Multiple large-bore IV access (peripheral and/or central)
- Continuous cardiopulmonary monitoring
- Arterial line for BP monitoring
- Frequent lab draws (q2-4hr)
- Strict I&O; Foley catheter
- Bleeding precautions: soft toothbrush, electric razor, no rectal temps
- Apply prolonged pressure to puncture sites
- Pad rails (bleeding risk from trauma)
- Position for maximum oxygenation
- Monitor for organ dysfunction
- Emotional support to family
- Document timeline meticulously
Medications
- Blood products (1:1:1 ratio):
- PRBCs for anemia (transfuse if Hgb < 7)
- FFP for clotting factors (10-15 mL/kg)
- Platelets (1 unit/10 kg; goal > 50,000)
- Cryoprecipitate for fibrinogen < 100 mg/dL (goal > 150-200)
- Tranexamic acid (TXA) 1 g IV (antifibrinolytic)
- Calcium gluconate (massive transfusion)
- Vasopressors for shock (norepinephrine, dopamine)
- Heparin RARELY used in OB DIC — only in select thrombotic predominant cases
Client Education
- Explain pathophysiology in simple terms during crisis
- Keep family informed
- Post-event debriefing
- Long-term follow-up for organ function
- Possible PTSD
- Future pregnancy planning
- Iron supplementation for anemia recovery
Therapeutic Procedures
- Treat underlying cause (most important)
- Massive transfusion protocol
- Mechanical ventilation if respiratory failure
- Vasopressor support
- Continuous renal replacement therapy if AKI
- ICU admission
- Plasma exchange (selected cases)
Interprofessional Care
- OB/MFM — primary obstetric management
- Hematology — coagulation expertise
- Intensivist/Critical Care
- Blood bank pathologist
- Anesthesia
- Nephrology if AKI
- Pulmonology if ARDS
Alterations in Health (Diagnosis)
HIV infection in a pregnant client. Universal screening recommended at first prenatal visit. With proper management (antiretroviral therapy throughout pregnancy + appropriate delivery + newborn prophylaxis + formula feeding), perinatal transmission risk reduces from ~25% (untreated) to < 1-2%.
Pathophysiology Related to Client Problem
HIV is a retrovirus that infects CD4+ T-cells, leading to immune dysfunction. Vertical transmission occurs: in utero (transplacental — 5-10%), intrapartum (most common — 60-75% of cases), or postpartum (breastfeeding — 14% additional risk without ART).
Health Promotion and Disease Prevention
Universal HIV screening at first prenatal visit (opt-out testing); repeat screening in 3rd trimester for high-risk clients; pre-conception counseling for HIV+ women; partner testing and treatment; safe sex education; pre-exposure prophylaxis (PrEP) for high-risk negative clients.
Risk Factors
- IV drug use (current or past)
- Multiple sexual partners
- Unprotected sex with HIV+ partner
- History of other STIs
- Blood transfusion before 1985
- Sex worker
- Incarceration history
- Born in high-prevalence country
- MSM partner
- Healthcare worker with needlestick exposure
Expected Findings
- Often asymptomatic (most pregnant clients diagnosed by screening)
- Acute HIV (seroconversion): fever, lymphadenopathy, sore throat, rash, fatigue, weight loss (often missed)
- Chronic HIV: recurrent infections, fatigue, oral thrush, weight loss
- AIDS-defining illnesses: opportunistic infections (PCP, toxoplasmosis, CMV), Kaposi sarcoma, severe weight loss
Laboratory Tests
- HIV antibody test (4th generation: detects antigen + antibody) — initial screen
- Western blot or HIV-1/HIV-2 differentiation immunoassay — confirmation
- HIV viral load (PCR) — measures viral replication
- CD4 count — measures immune status
- Drug resistance testing before initiating ART
- Hepatitis B and C co-infection screening
- STI screening (syphilis, gonorrhea, chlamydia)
- TB screening (PPD or IGRA)
- CBC, comprehensive metabolic panel
- Pap test
Diagnostic Procedures
- Standard prenatal labs
- Routine viral load monitoring (q4-6 weeks initially, then q3 months)
- CD4 count quarterly
- Ultrasound for fetal growth
- Continuous EFM in labor
- Standard precautions (universal)
- AVOID: internal fetal monitoring (FSE, IUPC), fetal scalp sampling, operative delivery (forceps, vacuum), AROM (if possible), invasive procedures
- Minimize duration of ROM
- Avoid breastfeeding (developed countries)
- Confidentiality of HIV status
- Educate about reducing transmission to others
- Bathe newborn before any injections
Complications
- Perinatal transmission (reduced to < 1-2% with proper management)
- Opportunistic infections during pregnancy
- Preterm birth, low birth weight
- IUGR
- Increased risk of preeclampsia
- Stillbirth (rare with treatment)
- Maternal: ART side effects, depression, social stigma, opportunistic infections, AIDS progression if non-adherent
- Newborn: HIV infection (if transmission), ART side effects, congenital anomalies (rare)
- Decreased fertility in future pregnancies
- Social and partner relationship complications
Nursing Care
- Standard precautions
- Emotional support; address stigma concerns
- Coordinate with infectious disease specialist
- Medication compliance support and reminders
- Monitor for ART side effects
- Routine prenatal care PLUS HIV-specific monitoring
- IV zidovudine in labor (3 hr before scheduled cesarean OR at labor onset)
- Monitor fetal status continuously in labor
- Document HIV status and treatments clearly
- Anticipate cesarean if viral load > 1,000 copies/mL
- Suppress lactation (tight bra, cold packs)
- Bathe newborn before injections
Medications
- Antiretroviral therapy (ART) throughout pregnancy:
- Typical regimen: 2 NRTIs + 1 third agent (integrase inhibitor or protease inhibitor)
- Common: Tenofovir + Emtricitabine + Dolutegravir or Raltegravir
- Avoid: efavirenz in 1st trimester (neural tube defects — historical concern, now thought safer); avoid dolutegravir at conception (newer data largely reassuring)
- IV zidovudine 2 mg/kg load over 1 hr, then 1 mg/kg/hr during labor until cord clamping
- Newborn zidovudine within 6-12 hours of birth × 6 weeks
- Higher-risk newborns: triple ART × 6 weeks
- Suppress lactation (cabergoline 0.5 mg PO × 2 doses if needed)
- Routine prenatal vitamins
Client Education
- Importance of ART adherence (cannot miss doses)
- Side effects of ART: nausea, diarrhea, hepatotoxicity, rash, anemia, neuropathy
- Mode of delivery decision based on viral load
- NO breastfeeding in developed countries
- Bottle/formula feeding instructions
- Newborn will require HIV testing × multiple times (PCR — not antibody since maternal antibodies transfer)
- Newborn antiretroviral prophylaxis
- Safer sex practices (condoms always)
- Reduce transmission to others
- Partner notification and testing
- Mental health support resources
- Future pregnancy planning
Therapeutic Procedures
- Antiretroviral therapy
- Scheduled cesarean at 38 weeks if viral load > 1,000 copies/mL at 36 weeks
- Vaginal birth acceptable if viral load < 1,000 copies/mL
- IV zidovudine intrapartum
- Newborn antiretroviral prophylaxis
- Formula feeding (developed countries)
- Continued ART postpartum (lifelong for maternal health)
Interprofessional Care
- Infectious disease specialist
- Maternal-fetal medicine
- Pediatric infectious disease (newborn care)
- Pharmacist (drug interactions)
- Social worker (stigma, support, financial)
- Mental health support
- Substance abuse counseling (if applicable)
- Partner services / contact tracing
- Lactation suppression counseling
Alterations in Health (Diagnosis)
Most common bacterial STI in U.S. Caused by Chlamydia trachomatis. Often asymptomatic in women (~70%) — silent infection. Untreated → PID, infertility, ectopic pregnancy, neonatal conjunctivitis and pneumonia. Routine screening in pregnancy at first visit (and third trimester if high-risk).
Pathophysiology Related to Client Problem
Intracellular bacterial pathogen infects columnar epithelium of cervix, urethra, rectum. During delivery, can transmit to newborn via infected birth canal → neonatal conjunctivitis (5-12 days post-birth) or chlamydial pneumonia (1-3 months).
Health Promotion and Disease Prevention
- Routine prenatal screening at first prenatal visit
- Repeat screening in third trimester for high-risk clients
- Annual screening for sexually active women < 25 yr (CDC)
- Safer sex education
- Condom use
- Partner notification and treatment
- Treat all partners before resuming sex
- Test of cure 3-4 weeks after treatment in pregnancy
- Universal erythromycin eye prophylaxis for newborns
Risk Factors
- Age < 25 years
- Multiple sexual partners
- New sexual partner
- Inconsistent condom use
- History of STI
- Concurrent gonorrhea (~30-50% coinfection)
- Sex work
- Substance use
- Living in high-prevalence area
Expected Findings
Mother (often asymptomatic — 70%):
- Mucopurulent cervical discharge
- Cervical friability, bleeding on exam or after intercourse
- Dysuria, urinary frequency
- Pelvic pain
- Postcoital bleeding
- Sometimes spotting
Newborn (untreated maternal infection):
- Chlamydial conjunctivitis 5-12 days after birth: mucopurulent eye drainage, swelling, redness
- Chlamydial pneumonia 1-3 months: staccato cough, tachypnea, afebrile
Laboratory Tests
- NAAT (Nucleic Acid Amplification Test) — gold standard, sensitive: cervical, urine, or vaginal swab
- Test of cure 3-4 weeks after treatment in pregnancy
- Concurrent gonorrhea testing
- HIV, syphilis, hepatitis B screening
- LFTs (azithromycin)
Diagnostic Procedures
- Routine prenatal screening per CDC at first visit
- Repeat in third trimester if high-risk
- Speculum exam (often unrevealing)
- Partner testing and treatment
Safety Considerations
- Azithromycin is safe in pregnancy — first-line
- Doxycycline contraindicated in pregnancy (tooth discoloration, bone effects in fetus)
- Partner treatment essential — without it, reinfection
- Test of cure in pregnancy (3-4 weeks post-treatment)
- Abstinence × 7 days after treatment, until partners treated
- Universal newborn eye prophylaxis with erythromycin 0.5% ointment
- Notify pediatrician of maternal status
Complications
Maternal:
- Pelvic inflammatory disease (PID)
- Tubal scarring → infertility, ectopic pregnancy
- Chronic pelvic pain
- Preterm labor
- PPROM
- Postpartum endometritis
Pregnancy:
- Preterm birth
- Low birth weight
- PROM
- Stillbirth (rare)
Neonatal (40-50% if maternal untreated):
- Conjunctivitis
- Pneumonia
- Long-term: bronchiolitis, possible chronic respiratory issues
Nursing Care
- Screening at first prenatal visit, repeat third trimester if high-risk
- Privacy, confidential discussion
- Sexual health history (HEEADSSS for adolescents)
- Educate about infection, transmission, treatment
- Administer azithromycin as ordered (single dose 1g PO or 7-day course)
- Encourage partner testing/treatment
- Test of cure 3-4 weeks post-treatment
- Abstinence × 7 days post-treatment, until partners treated
- STI panel (concurrent infections)
- Newborn: erythromycin eye prophylaxis
- Watch for neonatal conjunctivitis or pneumonia
- Maternal mental health support
- Reportable to public health
Medications
Pregnancy treatment:
- Azithromycin 1 g PO single dose (first-line, safe in pregnancy)
- Alternative: amoxicillin 500 mg PO TID × 7 days
- DOXYCYCLINE CONTRAINDICATED IN PREGNANCY
- Erythromycin estolate also contraindicated (hepatotoxicity)
- Erythromycin base or stearate acceptable alternatives
Newborn:
- Universal eye prophylaxis: erythromycin 0.5% ophthalmic ointment within 1 hour of birth
- If chlamydial conjunctivitis/pneumonia: oral erythromycin 14 days (note: ↑ pyloric stenosis risk)
- Alternative: azithromycin
Therapeutic Procedures
- Antibiotic treatment
- Partner notification (Expedited Partner Therapy in many states)
- Test of cure in pregnancy
- Counseling on safer sex
- STI panel for all
- Newborn eye prophylaxis
- Treat neonatal infection if occurs
Client Education
Mother:
- Chlamydia is very common and curable
- Often no symptoms — that's why screening matters
- Take all medication as prescribed
- Azithromycin: single dose — easy to take
- NO sex for 7 days after treatment AND until partners treated
- Inform ALL recent partners (within 60 days) so they can be tested and treated
- Test of cure required 3-4 weeks after treatment in pregnancy
- Untreated infection can harm baby (eye infection, pneumonia)
- Notify pediatrician of your treatment
- Universal eye drops for newborns prevent infection
Prevention:
- Use condoms with all partners
- Limit number of sexual partners
- Mutual monogamy with tested, treated partner
- Regular STI screening for sexually active women
- Notify partners of any future positive results
Watch newborn for:
- Eye redness, drainage in first 2 weeks → call provider
- Persistent cough at 1-3 months → call provider
- Difficulty breathing
Interprofessional Care
- Obstetric provider
- Pediatric primary care (newborn follow-up)
- Public health (reportable disease)
- Partner services / contact tracing
- Pharmacy
- Mental health (psychosocial)
- Social work
- STI clinic
Alterations in Health (Diagnosis)
STI caused by Neisseria gonorrhoeae (gram-negative diplococcus). Often coinfected with chlamydia (~30-50%). Can cause maternal complications and severe neonatal infection. Universal newborn eye prophylaxis prevents ophthalmia neonatorum. Routine screening in pregnancy.
Pathophysiology Related to Client Problem
Infects mucous membranes (cervix, urethra, pharynx, rectum, conjunctiva). Hematogenous spread possible → disseminated gonococcal infection (arthritis, dermatitis, endocarditis). During delivery, transmits to newborn → severe conjunctivitis → corneal damage and blindness if untreated.
Health Promotion and Disease Prevention
- Routine prenatal screening at first prenatal visit
- Repeat screening in third trimester for high-risk
- Annual screening for sexually active women < 25 yr
- Safer sex education
- Condom use
- Partner notification and treatment
- Treat all partners before resuming sex
- Universal erythromycin eye prophylaxis for newborns
Risk Factors
- Age < 25 years
- Multiple sexual partners
- New sexual partner
- Inconsistent condom use
- History of STI
- Concurrent chlamydia (~30-50% coinfection)
- Sex work
- Substance use
- Living in high-prevalence area
- MSM partners
Expected Findings
Mother (often asymptomatic — 50%):
- Purulent yellow-green cervical/vaginal discharge
- Dysuria, urinary frequency
- Postcoital bleeding
- Pelvic pain
- Cervical friability, bleeding
- Pharyngitis (oral)
- Rectal discharge, pain (anal)
- Disseminated: fever, arthritis (knees, wrists), rash (pustular on extremities, palms, soles)
Newborn (ophthalmia neonatorum):
- Severe purulent conjunctivitis 2-5 days after birth
- Eyelid edema
- Copious eye drainage
- Without treatment: corneal ulceration, perforation, blindness
- Can also have sepsis, arthritis, meningitis (rare)
Laboratory Tests
- NAAT — gold standard; can be done on cervical, urine, vaginal swab
- Culture (also obtained, especially for antibiotic susceptibility — increasing resistance)
- Test of cure 3-4 weeks after treatment in pregnancy
- Concurrent chlamydia testing (high coinfection)
- HIV, syphilis, hepatitis B screening
Diagnostic Procedures
- Routine prenatal screening at first visit per CDC
- Repeat in third trimester if high-risk
- Speculum exam
- Partner testing/treatment
- Pharyngeal/rectal testing if exposure
Safety Considerations
- Increasing antibiotic resistance — adherence to current CDC treatment crucial
- Ceftriaxone IM is first-line in pregnancy
- Always treat empirically for chlamydia (azithromycin) — high coinfection
- Partner treatment essential
- Test of cure in pregnancy (3-4 weeks post-treatment)
- Abstinence × 7 days post-treatment, until partners treated
- Universal newborn eye prophylaxis
- Notify pediatrician of maternal status
- Disseminated infection requires hospitalization
Complications
Maternal:
- PID, tubal scarring
- Infertility
- Ectopic pregnancy
- Disseminated gonococcal infection (arthritis, dermatitis, endocarditis)
- Chorioamnionitis
- Postpartum endometritis
Pregnancy:
- Preterm labor, preterm birth
- PROM
- Low birth weight
- Chorioamnionitis
- Stillbirth
Neonatal (severe if untreated):
- Ophthalmia neonatorum → BLINDNESS
- Sepsis
- Arthritis
- Meningitis
- Scalp abscess
Nursing Care
- Screening at first prenatal visit, repeat third trimester if high-risk
- Privacy, confidentiality
- Sexual health history
- Educate about infection
- Administer ceftriaxone IM as ordered (500 mg single dose, plus azithromycin for chlamydia)
- Encourage partner testing/treatment
- Test of cure 3-4 weeks post-treatment
- Abstinence × 7 days post-treatment, until partners treated
- STI panel (concurrent infections)
- Newborn: erythromycin eye prophylaxis within 1 hour of birth
- Watch newborn for conjunctivitis
- Reportable to public health
- Mental health support
Medications
Pregnancy treatment (per CDC 2021 update):
- Ceftriaxone 500 mg IM single dose (1g if > 150 kg) — first-line, safe in pregnancy
- PLUS treatment for chlamydia (azithromycin) due to high coinfection
- Alternative if penicillin/cephalosporin allergic: gentamicin + azithromycin (specialized)
Newborn:
- Universal eye prophylaxis: erythromycin 0.5% ointment within 1 hour
- If gonococcal conjunctivitis: ceftriaxone IV/IM single dose 25-50 mg/kg, plus saline eye irrigation
- Disseminated infection: ceftriaxone 7 days IV/IM
Disseminated maternal:
- Ceftriaxone 1 g IV q24h × 7 days
Therapeutic Procedures
- Antibiotic treatment
- Partner notification (Expedited Partner Therapy)
- Test of cure in pregnancy
- STI panel
- Newborn eye prophylaxis
- Treat neonatal infection promptly
- Saline eye irrigation for ophthalmia neonatorum
Client Education
Mother:
- Gonorrhea is curable but increasingly resistant — current treatment is one IM injection
- Often no symptoms — that's why screening matters
- Receive ceftriaxone injection plus oral azithromycin (treat both chlamydia and gonorrhea)
- NO sex for 7 days after treatment AND until partners treated
- Inform ALL recent partners (within 60 days)
- Test of cure required 3-4 weeks after treatment
- Untreated gonorrhea can blind your baby
- Notify pediatrician of treatment
- Universal eye prophylaxis for all newborns
Prevention:
- Condom use with all partners
- Limit number of partners
- Mutual monogamy with tested, treated partner
- Regular STI screening
- Notify future partners of positive history
Watch newborn for:
- Eye drainage, swelling 2-5 days after birth → ER immediately
- Severe purulent discharge
- Fever, irritability (sepsis)
Interprofessional Care
- Obstetric provider
- Pediatric primary care
- Public health (reportable)
- Partner services / contact tracing
- Pharmacy
- Mental health, social work
- STI clinic
- Pediatric ophthalmology (if conjunctivitis)
Alterations in Health (Diagnosis)
STI caused by Treponema pallidum (spirochete). Stages: primary (chancre), secondary (rash, systemic), latent (asymptomatic), tertiary (years later — cardiovascular, neurosyphilis, gummas). Congenital syphilis is preventable with treatment. Rising rates in U.S. — including congenital cases.
Pathophysiology Related to Client Problem
Spirochete penetrates intact mucosa or skin breaks → bloodstream and tissue invasion → multi-system disease. Transplacental transmission throughout pregnancy → fetal infection → high fetal mortality and severe congenital syphilis (stillbirth, hydrops, multi-organ involvement).
Health Promotion and Disease Prevention
- Universal prenatal screening at first visit
- Rescreening at 28 weeks and at delivery for high-risk areas (CDC)
- Routine partner notification and treatment
- Safer sex education
- Condom use
- Routine adolescent screening
- Avoid IV drug use and needle sharing
- Treat all sexual partners within 90 days
- Penicillin desensitization in pregnancy if allergic (no acceptable alternative)
Risk Factors
- Multiple sexual partners
- New sexual partner
- Inconsistent condom use
- History of STI
- MSM (males)
- IV drug use
- Sex work
- HIV-positive
- Incarceration
- Living in high-prevalence community
- Inadequate prenatal care
Expected Findings
Primary syphilis (3-90 days after exposure):
- Painless chancre (firm, indurated ulcer) at site of inoculation
- Regional lymphadenopathy
- Heals in 3-6 weeks even without treatment
- Often missed (especially cervical, internal)
Secondary syphilis (weeks-months later):
- Diffuse maculopapular rash (often includes palms and soles)
- Mucous patches (mouth, genitals)
- Condyloma lata (smooth, moist, warty lesions)
- Generalized lymphadenopathy
- Fever, malaise, weight loss
- Patchy alopecia ("moth-eaten" hair loss)
- Hepatitis, glomerulonephritis (rare)
Latent syphilis:
- Asymptomatic; serology positive
- Early latent (< 1 year): treat as primary/secondary
- Late latent (> 1 year): treat as tertiary
Tertiary syphilis (years later):
- Gummas (skin, bone)
- Cardiovascular: aortitis, aortic aneurysm
- Neurosyphilis: meningitis, tabes dorsalis, dementia
Congenital syphilis:
- Early (< 2 years): hepatosplenomegaly, jaundice, rhinitis "snuffles," rash (palms/soles), bony abnormalities, hydrops, prematurity, stillbirth
- Late (> 2 years): Hutchinson teeth, mulberry molars, saddle nose, saber shins, interstitial keratitis, deafness, neurologic
Laboratory Tests
Non-treponemal screening:
- VDRL or RPR — quantitative titer, used to monitor treatment response
- False positives: lupus, pregnancy, viral infections
Treponemal confirmatory:
- FTA-ABS, TP-PA, or treponemal EIA — confirms diagnosis
- Stays positive for life
Other:
- Dark field microscopy of chancre (rarely available)
- HIV testing
- CSF analysis (neurosyphilis suspected, congenital syphilis)
- Hepatitis serology
- Newborn: RPR/VDRL, FTA-ABS, LFTs, CBC, long bone X-rays, CSF
Diagnostic Procedures
- Universal screening at first prenatal visit
- Rescreen at 28 weeks and delivery for high-risk areas
- Reverse sequence screening (treponemal first, then non-treponemal) increasingly common
- Confirm titers, document stage
- Newborn evaluation if maternal positive
- Lumbar puncture (neurosyphilis, congenital)
- Ophthalmologic exam (interstitial keratitis)
- Long bone X-rays in newborn
Safety Considerations
- Penicillin G is the ONLY treatment for syphilis in pregnancy
- Penicillin-allergic patients MUST be desensitized — no acceptable alternative
- Watch for Jarisch-Herxheimer reaction (within 24 hours of treatment) — fever, chills, headache, myalgia, possibly preterm labor; treat with antipyretics, monitoring
- Hospitalization for treatment in second/third trimester (Jarisch-Herxheimer risk)
- Partner treatment essential
- Notify pediatrician of maternal status — all newborns require evaluation
- Reportable disease
Complications
Maternal:
- Tertiary syphilis (untreated)
- Neurosyphilis
- Cardiovascular syphilis
- Jarisch-Herxheimer reaction
Pregnancy (transplacental transmission):
- Spontaneous abortion (10-40%)
- Stillbirth (10%)
- Preterm birth
- IUGR
- Hydrops fetalis
- Neonatal death
Congenital syphilis:
- Multi-system involvement
- Death
- Long-term disabilities (deafness, intellectual disability, dental, bone, neuro)
- Hutchinson triad: teeth, deafness, interstitial keratitis
Nursing Care
- Universal screening
- Rescreen at 28 weeks and delivery for high-risk
- Confidential discussion
- Educate about infection, treatment
- Administer benzathine penicillin G IM (often hospitalized in 2nd/3rd trimester for Jarisch-Herxheimer monitoring)
- Monitor for Jarisch-Herxheimer reaction (fever, chills, headache, ↑ contractions) within 24 hours
- Fetal monitoring during/after treatment
- Penicillin desensitization if allergic (in monitored setting)
- Partner notification and treatment
- Test of cure: monthly RPR/VDRL titers in pregnancy
- Repeat treatment if 4-fold rise or no decline
- Newborn evaluation at birth
- STI panel
- Public health reporting
- Mental health support
Medications
Pregnancy — penicillin G is ONLY acceptable treatment:
- Primary/secondary/early latent: benzathine penicillin G 2.4 million units IM single dose
- Late latent/unknown duration/tertiary (non-neuro): benzathine penicillin G 2.4 million units IM weekly × 3 doses
- Neurosyphilis: aqueous crystalline penicillin G 18-24 million units/day IV × 10-14 days (hospitalized)
- Penicillin-allergic: must desensitize in hospital — NO alternative in pregnancy
- Symptomatic treatment for Jarisch-Herxheimer: acetaminophen, monitoring
Newborn (with maternal syphilis):
- Aqueous crystalline penicillin G IV × 10 days, or procaine penicillin G IM × 10 days
- Single-dose benzathine penicillin G if low-risk congenital infection
Therapeutic Procedures
- Penicillin G IM (single dose to weekly × 3 depending on stage)
- Hospitalization for treatment in 2nd/3rd trimester
- Jarisch-Herxheimer monitoring
- Partner notification
- Monthly titers in pregnancy
- Repeat treatment if needed
- Newborn evaluation and treatment if applicable
- Penicillin desensitization (allergic)
- Public health follow-up
Client Education
Mother:
- Syphilis is serious but treatable
- Penicillin is the only treatment in pregnancy — if allergic, you need desensitization
- Treatment in second/third trimester requires hospitalization to monitor for reaction
- Jarisch-Herxheimer reaction may occur — fever, chills, contractions — within 24 hours of treatment; monitored carefully
- Without treatment, syphilis can cause stillbirth, severe birth defects, or newborn death
- Partners must be tested and treated
- Notify all sexual partners within last 3 months (or 1 year for late latent)
- Monthly blood tests during pregnancy to monitor treatment
- Use condoms going forward
- Newborn will need evaluation and possibly treatment
- Notify pediatrician
Prevention:
- Condom use with all partners
- Limit partners
- Regular STI screening
- Don't share needles
- Notify future partners
Newborn watch for:
- Snuffles (persistent rhinitis)
- Rash (especially palms, soles)
- Jaundice
- Hepatosplenomegaly
- Poor feeding, irritability
- Hearing or vision concerns later
Interprofessional Care
- Obstetric provider (specialized for syphilis in pregnancy)
- Maternal-fetal medicine
- Pediatric infectious disease
- Pediatric primary care
- Public health (reportable)
- Partner services / contact tracing
- Pharmacy
- Allergy (penicillin desensitization)
- Mental health, social work
Alterations in Health (Diagnosis)
Sexually transmitted virus — most common STI. Many strains. Low-risk strains (6, 11) cause genital warts (condyloma acuminata). High-risk strains (16, 18 especially) cause cervical, anal, oropharyngeal cancers. HPV vaccine prevents most strains. In pregnancy, genital warts may grow rapidly; cervical screening may be deferred. Rare neonatal complications.
Pathophysiology Related to Client Problem
Virus infects epithelial cells via micro-abrasions during sexual contact → integration into host DNA → cellular proliferation → warts (low-risk) or dysplasia/cancer (high-risk). Pregnancy hormones and immune changes may cause rapid wart growth.
Health Promotion and Disease Prevention
- HPV vaccine — recommended starting age 9-12 (routine), through age 26 (catch-up); not given in pregnancy but safe in lactation
- Cervical cancer screening per ASCCP guidelines
- Condom use (reduces but doesn't eliminate transmission)
- Limit sexual partners
- Don't smoke (increases risk of HPV persistence/cancer)
- Adolescent/young adult vaccination most effective
Risk Factors
- Sexual activity (almost all sexually active people exposed)
- Multiple partners
- New sexual partner
- Early sexual debut
- Smoking
- Immunosuppression
- Other STIs
- Lack of HPV vaccination
Expected Findings
Genital warts (low-risk HPV):
- Soft, flesh-colored or pink growths
- Cauliflower-like, raised or flat
- Vulva, perineum, vagina, cervix, anal area
- Usually painless; sometimes itchy
- May enlarge significantly during pregnancy
- Rarely obstruct birth canal (large lesions)
High-risk HPV (often asymptomatic):
- Detected on cervical screening
- Abnormal Pap (LSIL, HSIL)
- Cervical, vaginal, vulvar, anal dysplasia or cancer
Newborn (rare complication):
- Recurrent respiratory papillomatosis (RRP) — laryngeal papillomas; hoarseness, stridor, respiratory distress in infancy/childhood
- Rare even with maternal genital warts
Laboratory Tests
- Pap smear (cytology) — usually deferred in pregnancy unless severe abnormality
- HPV DNA testing (high-risk strains)
- Colposcopy if abnormal Pap (can be done in pregnancy)
- Biopsy (selective in pregnancy)
Diagnostic Procedures
- Visual inspection of external genitalia
- Speculum exam
- Cervical cancer screening per guidelines (may defer in pregnancy)
- Colposcopy if indicated
- Acetic acid application (turns warts white)
- Biopsy (selective)
- Postpartum follow-up for cervical screening
Safety Considerations
- Most genital wart treatments contraindicated in pregnancy:
- - Podophyllin (teratogenic)
- - Podofilox (teratogenic)
- - Imiquimod (limited data, generally avoided)
- - 5-fluorouracil (teratogenic)
- Acceptable in pregnancy: trichloroacetic acid (TCA), cryotherapy, surgical excision, laser
- Large warts may bleed during vaginal birth — usually still vaginal delivery
- Cesarean ONLY if warts obstruct birth canal (rare)
- HPV vaccination postponed until after pregnancy (not contraindicated in lactation)
- Defer Pap follow-up until postpartum if abnormal but not high-grade
Complications
Maternal:
- Rapid wart growth in pregnancy
- Bleeding from warts during labor/birth
- Cervical dysplasia, cancer (rare during pregnancy)
- Recurrence after treatment
Pregnancy:
- Usually minimal pregnancy complications
- Rarely obstructs vaginal delivery
Neonatal:
- Recurrent respiratory papillomatosis (rare — 1 in 1000)
- Usually presents in early childhood with hoarseness, stridor
Nursing Care
- Pap screening per guidelines (often deferred in pregnancy)
- Confidential discussion
- Educate about HPV (very common, often clears on its own)
- Assess for genital warts
- Administer or assist with treatment (TCA, cryotherapy)
- Monitor for bleeding during/after treatment
- Wart growth monitoring in pregnancy
- Plan delivery route (usually vaginal unless large warts obstruct)
- Postpartum follow-up for cervical screening, vaccination
- Newborn observation
- HPV vaccine for postpartum/breastfeeding patient if eligible
- Encourage family planning vaccinations (children, partner)
Medications
Genital warts in pregnancy (acceptable):
- Trichloroacetic acid (TCA) 80-90% — applied weekly by provider
- Cryotherapy (liquid nitrogen)
- Surgical excision
- Laser ablation
Contraindicated in pregnancy:
- Podophyllin, podofilox
- Imiquimod (generally)
- 5-fluorouracil
- Interferon
HPV vaccine (postpartum if eligible, OK in lactation):
- Gardasil 9 (9-valent)
Therapeutic Procedures
- Genital wart removal (TCA, cryotherapy, surgical) — multiple sessions often needed
- Cervical screening per guidelines
- Colposcopy if indicated
- Cervical excision/ablation for high-grade lesions (usually postpartum unless cancer)
- HPV vaccination for prevention
- Vaginal birth typically; cesarean only if obstruction
- Postpartum follow-up
Client Education
Mother:
- HPV is extremely common — most sexually active people get it
- Most HPV infections clear on their own
- Genital warts may grow rapidly during pregnancy due to hormones
- Treatable but may recur
- Treatment in pregnancy is limited but effective options available
- Most can deliver vaginally — cesarean rarely needed
- Newborn rarely has issues
- Get HPV vaccine after pregnancy (safe in lactation)
- Pap follow-up after delivery
- Notify partners (vaccination if eligible)
Prevention:
- HPV vaccine for all kids age 9-12 (and through 26 catch-up)
- Condoms (reduce but don't eliminate transmission)
- Limit sexual partners
- Mutual monogamy with screened partner
- Don't smoke
- Regular cervical cancer screening
Newborn watch for (rare):
- Hoarseness, weak cry
- Stridor
- Respiratory difficulty
- → See pediatrician
Long-term:
- Lifetime cervical cancer screening
- Vaccinate children when age-appropriate
Interprofessional Care
- Obstetric provider
- Adolescent gynecology / gynecologic oncology (if cancer)
- Pediatric primary care (vaccinations, newborn)
- Pediatric otolaryngology (if RRP)
- Public health (vaccine programs)
- Mental health
Alterations in Health (Diagnosis)
Three common vaginal infections in pregnancy with distinct causes and treatments:
- Trichomoniasis: STI caused by Trichomonas vaginalis (protozoan); ↑ preterm birth risk
- Bacterial vaginosis (BV): overgrowth of anaerobic bacteria (Gardnerella vaginalis, others) with loss of lactobacilli; ↑ preterm birth, PROM
- Candidiasis (yeast): overgrowth of Candida albicans; not an STI; very common in pregnancy
Pathophysiology Related to Client Problem
Trichomoniasis: sexually transmitted protozoan infects vagina, urethra → inflammation. BV: shift in vaginal flora from lactobacilli-dominant (acidic) to anaerobe-dominant (alkaline) → discharge with characteristic smell. Candidiasis: hormonal changes, immune changes in pregnancy, antibiotics → yeast overgrowth.
Health Promotion and Disease Prevention
- Routine pelvic exam
- Symptomatic patients evaluated
- BV screening not routinely recommended; treat if symptomatic
- Trichomoniasis screening for high-risk; partner treatment
- Don't douche (disrupts flora)
- Cotton underwear
- Avoid scented hygiene products
- Probiotics may help recurrent BV/candidiasis
- Adequate glucose control (GDM ↑ candidiasis)
- Wipe front to back
Risk Factors
Trichomoniasis: sexual activity (STI), multiple partners, history of STI.
BV: douching, multiple sexual partners, new partner, lack of condom use, smoking. (Not strictly an STI but sexual activity is a risk factor.)
Candidiasis: pregnancy (hormonal), diabetes/GDM, antibiotics, immunosuppression, OCPs, tight/synthetic clothing, douching.
Expected Findings
Trichomoniasis:
- Frothy yellow-green discharge
- Foul/fishy odor
- Vulvar/vaginal irritation, itching, burning
- Dyspareunia
- Dysuria
- "Strawberry cervix" (punctate hemorrhages — pathognomonic but uncommon)
- Vaginal pH > 4.5
- Often asymptomatic in men
BV:
- Thin, gray-white discharge
- "Fishy" odor, worse after sex (KOH "whiff test" positive)
- Usually NO itching/irritation
- Vaginal pH > 4.5
- "Clue cells" on wet mount (epithelial cells covered with bacteria)
Candidiasis:
- Thick, white "cottage cheese" discharge
- Intense itching, burning
- Vulvar erythema, swelling
- Dyspareunia, dysuria
- Usually no odor
- Vaginal pH normal (3.8-4.5)
- Pseudohyphae and budding yeast on KOH wet mount
Laboratory Tests
Wet mount (saline):
- Trichomoniasis: motile trichomonads, WBCs
- BV: clue cells, scant WBCs
KOH prep:
- Candidiasis: pseudohyphae, budding yeast
- BV: positive whiff test (fishy odor on KOH addition)
Vaginal pH:
- Normal: 3.8-4.5
- Trich, BV: > 4.5
- Candida: usually normal
Other:
- NAAT for trichomoniasis (most sensitive)
- Culture for resistant Candida
- STI panel if trich positive
Diagnostic Procedures
- Clinical history (discharge characteristics, itching, odor)
- Speculum exam
- Vaginal pH
- Wet mount, KOH
- NAAT for trichomoniasis
- Amsel criteria for BV (3 of 4: thin discharge, pH > 4.5, clue cells, positive whiff test)
Safety Considerations
- Metronidazole and tinidazole are safe in pregnancy (previous concerns disproven)
- Tinidazole has less safety data — usually metronidazole preferred
- Topical azoles preferred for candidiasis in pregnancy (oral fluconazole — limited use, AVOID in first trimester)
- Partner treatment for trichomoniasis
- Trichomoniasis is reportable in some states
- Avoid alcohol with metronidazole (disulfiram-like reaction)
- Watch for recurrent infections (treat underlying conditions: diabetes, immunocompromise)
- BV treatment in symptomatic pregnant women only (not asymptomatic — controversial)
Complications
Trichomoniasis:
- Preterm birth, PROM
- Low birth weight
- ↑ HIV transmission risk
BV:
- Preterm birth, PROM
- Postpartum endometritis
- ↑ HIV/STI transmission
- Post-procedure infection
Candidiasis:
- Recurrent infections
- Maternal discomfort
- Neonatal thrush (oral candidiasis at delivery)
- Rarely systemic infection
Nursing Care
- Assessment of discharge characteristics
- Pelvic exam preparation
- Wet mount, KOH, pH testing assistance
- Administer/teach medications
- Educate on transmission and treatment
- Partner notification for trichomoniasis
- Comfort measures (sitz baths, cool compresses for itching)
- STI panel for trichomoniasis
- Recurrence prevention education
- Newborn assessment (thrush)
- Watch for preterm labor signs
Medications
Trichomoniasis:
- Metronidazole 500 mg PO BID × 7 days (preferred in pregnancy) OR 2 g single dose
- Tinidazole — alternative; less data in pregnancy
- Treat ALL sexual partners
- Avoid alcohol × 24 hours after metronidazole, 72 hours after tinidazole
BV:
- Metronidazole 500 mg PO BID × 7 days
- Or clindamycin 300 mg PO BID × 7 days
- Topical: metronidazole gel or clindamycin cream
- No partner treatment needed
Candidiasis:
- Topical azoles × 7 days in pregnancy:
- - Miconazole 2% cream
- - Clotrimazole 1% cream
- - Terconazole
- Avoid oral fluconazole in first trimester (birth defect concerns); single dose may be OK in second/third trimester per provider
Therapeutic Procedures
- Appropriate antimicrobial therapy
- Partner treatment (trichomoniasis)
- STI panel for trichomoniasis
- Address modifiable risk factors
- Postpartum follow-up
- Recurrence prevention
Client Education
Trichomoniasis:
- STI — partners must be treated
- Don't have sex until you and partners complete treatment
- NO alcohol while taking metronidazole and 24 hours after (severe reaction)
- Use condoms going forward
- STI testing for other infections
BV:
- Not strictly an STI — partners don't need treatment
- Don't douche
- Cotton underwear
- Avoid scented products
- Recurrence common — may need repeat treatment
- NO alcohol with metronidazole
Candidiasis:
- Not an STI — your partner doesn't need treatment unless they have symptoms
- Very common in pregnancy due to hormones
- Use vaginal cream as directed × 7 days (longer course in pregnancy)
- Don't use oral fluconazole in first trimester
- Loose, cotton underwear
- Avoid douching, scented products
- Probiotics may help
- Good glucose control if GDM (yeast loves sugar)
- Watch for recurrence
Newborn:
- If maternal yeast: watch newborn for thrush (white patches in mouth)
- Pediatrician treats with oral nystatin
Interprofessional Care
- Obstetric provider
- Pediatric primary care (newborn thrush)
- Public health (trich reporting)
- STI clinic
- Partner services (trichomoniasis)
Alterations in Health (Diagnosis)
Painless, premature cervical dilation in second trimester (often 16-24 weeks) → potential for pregnancy loss, preterm birth. Diagnosed in pregnancy with cervical changes or history of prior second-trimester loss with similar pattern. Treatable with cervical cerclage.
Pathophysiology Related to Client Problem
Cervix unable to support the pregnancy → progressive painless dilation and effacement → membranes prolapse → PROM → preterm delivery or pregnancy loss. May be congenital (defects of cervix), acquired (cervical trauma — prior LEEP, cone biopsy, mechanical dilation, obstetric trauma), or related to connective tissue disorders.
Health Promotion and Disease Prevention
- Avoid excessive cervical procedures when possible (LEEP, cone biopsy)
- Early identification with history
- Transvaginal ultrasound cervical length screening in high-risk women (16-24 weeks)
- Cerclage placement for at-risk women
- Vaginal progesterone for short cervix
- Activity modification
- Routine prenatal care
- Genetic counseling (connective tissue disorders)
Risk Factors
- Prior second-trimester pregnancy loss (most predictive)
- Prior preterm birth from cervical insufficiency
- History of cervical trauma:
- - LEEP, cone biopsy
- - D&C, D&E
- - Cervical lacerations from previous delivery
- - Forceful mechanical dilation
- Congenital uterine anomalies (bicornuate, septate)
- DES exposure in utero
- Connective tissue disorders (Ehlers-Danlos)
- Multiple gestation (some)
- Short cervix on ultrasound (< 25 mm before 24 weeks)
Expected Findings
Often subtle/asymptomatic until late:
- Pelvic pressure, "heaviness"
- Backache, low pelvic discomfort
- Changes in vaginal discharge (increased, watery, blood-tinged)
- Spotting
- Painless dilation noted on exam
- NO regular contractions (vs. preterm labor)
- Bulging membranes visible at cervix (advanced)
- Cervical length shortening on ultrasound
Late/advanced:
- PROM
- Prolapsed membranes
- Cord prolapse
- Painful contractions when delivery imminent
Laboratory Tests
- Standard prenatal labs
- If infection suspected: CBC, urinalysis
- Wet mount if discharge
- Fetal fibronectin (some)
- Cultures for chorioamnionitis if PROM
Diagnostic Procedures
- Transvaginal ultrasound cervical length — screening at 16-24 weeks in high-risk; short cervix < 25 mm
- Speculum exam: visualize cervical changes
- Digital cervical exam: assess dilation, effacement, station
- History: prior second-trimester losses, cervical procedures
- Funneling on ultrasound (Y, V, or U-shaped)
- Rule out preterm labor (no regular painful contractions)
- Rule out infection
Safety Considerations
- Activity restrictions (modified bedrest controversial)
- Avoid intercourse
- Avoid vaginal exams (may worsen)
- Watch for infection signs
- Watch for ROM (membrane rupture)
- Post-cerclage: watch for contractions, infection, ROM
- Cerclage REMOVED at ~37 weeks (or earlier if labor, PROM, infection, fetal distress)
- Fetal viability considerations if very early presentation
- Pessary alternative (Arabin pessary)
- Emergent ("rescue") cerclage with significant risk
Complications
- Second-trimester pregnancy loss
- Preterm birth
- PPROM
- Chorioamnionitis
- Cord prolapse
- Maternal sepsis
- Cerclage complications: infection, bleeding, suture displacement, cervical laceration, PROM
- Future fertility issues
- Psychological impact of pregnancy loss
Nursing Care
- Identify at-risk women based on history
- Cervical length monitoring in high-risk
- Activity modification education
- Watch for symptoms: pressure, discharge changes, spotting, contractions
- Pre/post-cerclage care
- Bed rest assistance if ordered (controversial but sometimes recommended)
- Watch for infection signs (fever, foul discharge)
- Watch for ROM, preterm labor
- Vaginal progesterone administration
- Pessary care if used
- Emotional support — high anxiety, prior loss history
- Education on symptoms requiring immediate evaluation
- Plan for cerclage removal at ~37 weeks
- Postpartum follow-up, future pregnancy planning
Medications
- Vaginal progesterone (200 mg suppository or 90 mg gel daily) — short cervix on ultrasound
- 17-hydroxyprogesterone caproate (17P) IM — for prior preterm birth (use limited per FDA review)
- Antibiotics if infection
- Magnesium sulfate (neuroprotection if very preterm delivery imminent)
- Betamethasone (fetal lung maturity 24-34 weeks)
- Tocolytics (off-label, brief use)
Therapeutic Procedures
Cervical cerclage:
- History-indicated: elective placement at 12-14 weeks for women with prior recurrent second-trimester loss
- Ultrasound-indicated: short cervix in high-risk women
- Physical exam-indicated (rescue): for advanced dilation with bulging membranes; higher risk
- McDonald (simpler, transvaginal) or Shirodkar technique
- Transabdominal cerclage for failed cervical procedures
- Removal at ~37 weeks (planned vaginal delivery) or as needed
- Spinal anesthesia typically
Vaginal progesterone for short cervix.
Pessary (Arabin) — alternative.
Activity modification (controversial).
Client Education
Diagnosis:
- Cervical insufficiency is a recognized cause of second-trimester losses
- Treatable in current and future pregnancies
- Cerclage (stitch holding cervix closed) is highly effective
Care during pregnancy:
- Activity modification — discuss with provider
- Avoid sex, tampons, douching
- Avoid heavy lifting, prolonged standing
- Pelvic rest
- Frequent monitoring (cervical length, fetal status)
- Take progesterone as prescribed
- Cerclage planning
Watch for and report:
- Increasing pelvic pressure
- Backache
- Increased or watery discharge
- Spotting or bleeding
- Cramping or contractions
- Gush of fluid (PROM)
- Fever
- → Go to L&D immediately
After cerclage:
- May feel mild discomfort few days
- Activity restrictions as instructed
- Watch for infection, contractions, leakage
- Cerclage removed at ~37 weeks (outpatient)
- Planned vaginal delivery typical
Future pregnancies:
- High risk of recurrence — early cerclage usually planned (12-14 weeks)
- Close monitoring
- High success rate with cerclage
- Mental health support important after loss
Interprofessional Care
- Obstetric provider / maternal-fetal medicine
- OB anesthesia
- Genetic counseling (some)
- Mental health (loss support)
- Pregnancy loss support groups
- NICU (if preterm delivery)
- Social work
- Family planning for future pregnancies
Alterations in Health (Diagnosis)
Bacterial infection of urinary tract occurring in postpartum period. Common postpartum infection. Ranges from asymptomatic bacteriuria, cystitis (bladder), pyelonephritis (kidney). E. coli most common organism. Catheterization during labor/delivery is major risk factor.
Pathophysiology Related to Client Problem
Bacteria (most commonly from perineal/perianal flora) ascend through urethra into bladder, can ascend to kidneys. Postpartum bladder atony, urinary retention, frequent catheterization, and birth canal manipulation increase risk.
Health Promotion and Disease Prevention
- Limit unnecessary catheterization
- Aseptic technique with catheterization
- Encourage voiding within 6-8 hours postpartum
- Adequate fluid intake
- Perineal hygiene — front to back wiping
- Empty bladder regularly
- Early treatment of UTI in pregnancy
- Routine screening urine culture at first prenatal visit
- Treat asymptomatic bacteriuria in pregnancy
Risk Factors
- Cesarean birth
- Catheterization during labor
- Indwelling foley
- Prolonged labor
- Multiple vaginal exams
- Bladder atony postpartum
- Urinary retention
- Perineal trauma, episiotomy
- Epidural anesthesia (delayed sensation)
- History of UTI
- Diabetes, GDM
- Anatomic abnormalities
- Pyelonephritis history
Expected Findings
Cystitis:
- Dysuria (burning with urination)
- Frequency, urgency
- Suprapubic pain
- Hematuria (sometimes)
- Low-grade fever (sometimes)
- Cloudy, foul-smelling urine
Pyelonephritis:
- HIGH fever, chills
- CVA tenderness (flank pain)
- Nausea, vomiting
- Malaise
- Tachycardia
- Can progress to sepsis
Asymptomatic bacteriuria:
- No symptoms
- Positive urine culture
Laboratory Tests
- Urinalysis: leukocyte esterase+, nitrites+, WBCs, possibly RBCs
- Urine culture (gold standard) — > 100,000 CFU/mL
- Sensitivity testing
- CBC (leukocytosis with pyelo)
- BMP (renal function)
- Blood cultures if pyelo with sepsis
Diagnostic Procedures
- Clean-catch midstream urine specimen
- Catheterized specimen if needed
- UA dipstick
- Urine culture and sensitivities
- Imaging (renal US, CT) if pyelo, recurrent, or complicated
- Bladder scan if retention
Safety Considerations
- Adequate hydration
- Watch for progression to pyelonephritis
- Antibiotic compatibility with breastfeeding
- Watch for sepsis signs in pyelo
- Don't mask fever — investigate
- Monitor for breastfeeding issues
- Recurrence — assess underlying causes
Complications
- Ascending infection → pyelonephritis
- Sepsis, urosepsis
- Recurrent UTI
- Renal abscess
- Renal scarring
- Breastfeeding interruption (if hospitalization)
- Maternal fatigue affecting bonding
Nursing Care
- Postpartum urinary assessment: voiding within 6-8 hours, amount, retention
- Bladder scan if no voiding
- Encourage voiding
- Adequate fluid intake (cranberry juice OK but not therapeutic)
- Perineal hygiene teaching
- Wipe front to back
- Sitz baths if perineal discomfort
- Obtain clean catch sample
- Administer antibiotics on time
- Watch for response to treatment (improvement in 24-48 hours)
- Watch for pyelo signs
- Pain management
- Encourage rest
- Continue breastfeeding (with compatible antibiotic)
- Discharge teaching: complete antibiotics, fluids, follow-up
Medications
Cystitis (most antibiotics are compatible with breastfeeding):
- Nitrofurantoin 100 mg PO BID × 5-7 days (avoid in last weeks of pregnancy and infants < 1 month due to hemolytic anemia risk; OK in breastfeeding of older infants)
- TMP-SMX (Bactrim) — watch for kernicterus risk in jaundiced newborn, premature, or G6PD; otherwise compatible
- Cephalexin 500 mg PO QID × 5-7 days
- Fosfomycin 3 g PO single dose
- Phenazopyridine (Pyridium) for symptomatic relief × 2 days (orange urine, breastfeeding OK)
Pyelonephritis (often hospitalized):
- IV antibiotics: ceftriaxone, ampicillin + gentamicin, or piperacillin-tazobactam
- Transition to oral when improved
- 10-14 day total course
- Acetaminophen for fever
- Antiemetics
- IV fluids
Therapeutic Procedures
- Antibiotic therapy
- Hydration
- Symptomatic relief
- Pyelonephritis: hospitalization, IV antibiotics
- Bladder catheterization if retention
- Follow-up urine culture (some)
- Imaging if complicated
- Address underlying causes for recurrent
Client Education
- Common postpartum infection — easily treated with antibiotics
- Complete ALL prescribed antibiotics even if feeling better
- Drink plenty of water (8-10 glasses daily)
- Urinate frequently — don't hold
- Wipe front to back
- Urinate after intercourse
- Avoid bubble baths, scented products
- Cotton underwear
- Continue breastfeeding — most antibiotics safe
- Cranberry products may help but don't replace antibiotics
Watch for and report immediately:
- Fever > 100.4°F (38°C)
- Severe back/flank pain
- Chills, shaking
- Nausea, vomiting
- Symptoms worsening despite treatment
- Blood in urine
- → Indicates pyelonephritis — needs immediate evaluation
Postpartum recovery:
- Rest as much as possible
- Pain management
- Stay hydrated
- Continue postpartum care
- Follow-up appointment
Interprofessional Care
- Obstetric provider
- Pharmacy (breastfeeding compatibility)
- Lactation consultant
- Postpartum nurse
- Primary care follow-up
- Urology (recurrent UTIs)
Alterations in Health (Diagnosis)
Infection of postpartum surgical/birth wounds: cesarean incision, episiotomy, perineal/cervical lacerations. Usually develops 4-7 days postpartum. Most caused by skin flora (Staph, Strep) or polymicrobial. Risk factors include obesity, diabetes, prolonged ROM, chorioamnionitis.
Pathophysiology Related to Client Problem
Bacterial contamination of wound during birth or postpartum → colonization → infection. Skin flora (Staph aureus including MRSA, group A and B Strep) or polymicrobial (also anaerobes especially in episiotomy/perineal wounds). Necrotizing fasciitis is rare but devastating complication.
Health Promotion and Disease Prevention
- Aseptic technique during birth
- Pre-op skin prep and abdominal cleansing (cesarean)
- Prophylactic antibiotics for cesarean (within 60 min of incision)
- Chlorhexidine skin prep
- Hair removal with clippers (not razor)
- Maintain normothermia, normoglycemia perioperatively
- Wound cleansing, perineal hygiene
- Smoking cessation
- Avoid unnecessary episiotomy
- Treat infections before delivery
- Address obesity if planning pregnancy
- Glucose control in GDM/DM
Risk Factors
- Cesarean delivery (overall higher risk)
- Emergency cesarean
- Obesity (especially BMI > 35)
- Diabetes, GDM (poor glucose control)
- Prolonged labor
- Prolonged ROM
- Chorioamnionitis
- Multiple vaginal exams
- Episiotomy (third/fourth degree)
- Operative vaginal delivery
- Hematoma
- Smoking
- Immunosuppression
- Anemia
- Poor hygiene
- Pre-existing skin infection
Expected Findings
Cesarean wound infection:
- Redness, warmth, swelling around incision
- Pain or tenderness
- Purulent drainage
- Wound dehiscence (separation)
- Fever > 38°C
- Tachycardia
- Tender on palpation
- Subcutaneous induration
Episiotomy/perineal infection:
- Pain disproportionate to expected healing
- Redness, swelling at site
- Wound separation
- Purulent drainage
- Foul odor
- Sutures may be visible
- Difficulty sitting
- Urinary retention (severe)
- Fever
Necrotizing fasciitis (rare emergency):
- Severe pain out of proportion to exam
- Rapid spread of erythema, gray-purple discoloration
- Crepitus
- Bullae, necrosis
- Sepsis, shock
- Often poor prognosis
Laboratory Tests
- CBC: ↑ WBC, left shift
- ↑ CRP, ESR
- Wound culture (specifically asking for aerobic, anaerobic; MRSA)
- Blood cultures if febrile/systemic
- BMP
- Lactate if sepsis suspected
- Coagulation if surgical intervention
Diagnostic Procedures
- Wound assessment (REEDA scale: redness, edema, ecchymosis, discharge, approximation)
- Vital signs
- Palpation for tenderness, fluctuance, crepitus
- Wound culture
- Imaging (ultrasound, CT) for abscess, deep infection, necrotizing fasciitis
- Probe of wound (drainage)
Safety Considerations
- Recognize early signs of infection
- Wound assessment every shift
- Watch for necrotizing fasciitis (severe pain, rapid progression — surgical emergency)
- Aseptic technique with wound care
- Hand hygiene
- Isolation precautions for MRSA
- Antibiotic compatibility with breastfeeding
- Glucose control if diabetic
- Watch for sepsis
- Maternal bonding affected by hospitalization
Complications
- Wound dehiscence
- Abscess formation
- Cellulitis
- Necrotizing fasciitis (rare, life-threatening)
- Sepsis
- Need for surgical debridement
- Prolonged hospitalization
- Delayed wound healing
- Chronic wound
- Scarring
- Future pregnancy considerations
- Postpartum depression (worsened by complications)
- Disruption of bonding, breastfeeding
- Death (severe, necrotizing fasciitis, sepsis)
Nursing Care
- Routine wound assessment every shift (REEDA)
- Vital signs every 4-8 hours; more frequent if febrile
- Aseptic wound care, dressing changes
- Pain assessment and management
- Glucose monitoring if diabetic
- Encourage adequate nutrition, protein, hydration
- Position changes
- Encourage ambulation
- Sitz baths for episiotomy
- Ice for first 24 hours, warm sitz baths after
- Perineal hygiene
- Peri bottle for cleansing
- Watch for systemic symptoms
- Administer antibiotics on schedule
- Monitor labs (WBC, CRP)
- Wound culture before antibiotics if possible
- Continue breastfeeding (compatible antibiotics)
- Skin-to-skin when stable
- Mental health support
- Discharge teaching
Medications
Cellulitis (mild):
- Cephalexin 500 mg PO QID
- Dicloxacillin
- If MRSA risk: TMP-SMX, doxycycline (avoid in early breastfeeding), or clindamycin
Moderate-severe wound infection:
- IV antibiotics: cefazolin, ampicillin-sulbactam
- If MRSA: vancomycin
- If polymicrobial/episiotomy: piperacillin-tazobactam or clindamycin + gentamicin
- Anaerobic coverage for deep perineal
Pain:
- Acetaminophen, ibuprofen
- Opioids (short course)
- Topical anesthetic for perineum
Necrotizing fasciitis:
- Broad-spectrum: piperacillin-tazobactam + vancomycin + clindamycin (toxin suppression)
- Plus surgical debridement
Therapeutic Procedures
- Antibiotic therapy
- Wound care: dressing changes, irrigation
- Incision and drainage if abscess
- Wet-to-dry dressings or wound vac for open wounds
- Surgical debridement if necrotic tissue
- Necrotizing fasciitis: emergent extensive debridement, ICU care
- Hyperbaric oxygen (selected cases)
- Reconstructive surgery if extensive tissue loss
- Nutritional support
- Glucose optimization
Client Education
- Watch incision/perineum for: increased redness, swelling, drainage, foul odor, separation, pain, fever
- Take antibiotics as prescribed — complete the course
- Most antibiotics safe with breastfeeding
- Wound care:
- - Cesarean: keep clean and dry; gentle washing with soap and water; pat dry
- - Perineal: peri bottle after voiding, sitz baths, change pad frequently
- - Allow air drying
- Avoid: tight clothing, scented products, soaking tubs (initially)
- Adequate protein and nutrition for healing
- Stay hydrated
- Glucose control if diabetic
- Don't smoke (delays healing)
- Rest, but ambulate to prevent DVT
- Recognize warning signs: fever, increased pain, drainage, severe swelling → contact provider
- Take all medications as prescribed
- Pain management strategies
- Mental health support — wound complications are stressful
- Continue bonding with baby
- Follow-up appointment important
- Watch for postpartum depression
Interprofessional Care
- Obstetric provider
- Wound care specialist / wound nurse
- Pediatric primary care (newborn)
- Infectious disease (severe, MRSA, recurrent)
- Surgery (debridement)
- Lactation consultant
- Pharmacy (breastfeeding compatibility)
- Dietitian
- Mental health
- Social work
- Home health (wound care)
- Primary care follow-up
Alterations in Health (Diagnosis)
Systemic bacterial, viral, or fungal infection in newborn. Early-onset (< 72 hours): vertically acquired from mother — GBS, E. coli most common. Late-onset (3-28 days): nosocomial or community — coag-negative Staph, Staph aureus. Major cause of neonatal mortality. Non-specific presentation requires high suspicion.
Pathophysiology Related to Client Problem
Pathogen enters bloodstream → systemic inflammatory response → endothelial dysfunction → multi-organ dysfunction. Immature neonatal immune system → high vulnerability. Risk of meningitis is high in neonatal sepsis (~25%).
Health Promotion and Disease Prevention
- Maternal GBS screening at 35-37 weeks + intrapartum penicillin if positive
- Prenatal care, treat maternal infections (UTI, chorioamnionitis)
- Hand hygiene
- Aseptic technique with all procedures
- Limit invasive devices
- Breastfeeding (immune support)
- Immunizations as scheduled
- NICU infection control protocols
Risk Factors
Early-onset: Maternal GBS+ without prophylaxis; PROM > 18 hours; maternal chorioamnionitis (fever, fetal tachycardia); maternal UTI; prolonged labor; prematurity; LBW; male sex (slight).
Late-onset: Prematurity; LBW; central lines, indwelling catheters; mechanical ventilation; surgery; TPN; long NICU stay; skin breakdown.
Expected Findings
Subtle, non-specific (most common):
- Temperature instability (hypothermia more common than fever in neonates)
- Poor feeding
- Lethargy or irritability
- "Just doesn't look right"
- Tachycardia, bradycardia
- Tachypnea, apnea, grunting
- Hypotension (late)
- Cyanosis, pallor, mottling
- Hypoglycemia or hyperglycemia
- Hypotonia
- Seizures
- Bulging fontanel (meningitis)
- Vomiting, abdominal distension
- Jaundice
- Petechiae, purpura (DIC)
- Decreased urine output
- Hepatosplenomegaly
Laboratory Tests
- CBC with diff: ↑ or ↓ WBC, immature-to-total neutrophil ratio > 0.2, thrombocytopenia
- Blood cultures × 2 (before antibiotics if possible)
- CSF (lumbar puncture): cell count, protein, glucose, culture
- Urine culture (late-onset)
- CRP, procalcitonin (serial)
- ABG: metabolic acidosis
- Glucose (often abnormal)
- Electrolytes, BUN/Cr
- Coagulation (DIC)
- LFTs
- Lactate
Diagnostic Procedures
- Sepsis evaluation: cultures (blood, CSF, urine if late)
- Lumbar puncture (especially if neuro symptoms or stable)
- CXR (pneumonia)
- Abdominal X-ray (NEC concern)
- Head ultrasound (IVH, hydrocephalus)
- HSV testing if maternal HSV or skin/mouth lesions, seizures
Safety Considerations
- Don't wait for cultures — start empiric antibiotics ASAP (within 1 hour)
- Universal precautions, contact precautions per organism
- Strict hand hygiene
- Aseptic technique
- Limit invasive procedures
- Glucose monitoring
- Watch for: hypoglycemia, hypothermia, electrolyte issues
- Cluster care (minimize stress)
- Watch for DIC
- Monitor for shock
- Track development
- Watch for sequelae (hearing, vision, developmental)
Complications
- Meningitis (very common in neonates with sepsis — ~25%)
- Shock, multi-organ failure
- DIC
- Seizures
- Brain injury (hypoxic-ischemic, infectious)
- Hydrocephalus
- Hearing loss
- Vision impairment
- Cerebral palsy
- Developmental delay
- Pneumonia, respiratory failure
- NEC
- AKI
- Death
- Long-term morbidity
Nursing Care
- Frequent vital signs (Q1-2 hours initially)
- Temperature monitoring (axillary; rectal NOT done in neonates)
- Maintain neutral thermal environment (isolette/warmer)
- Continuous SpO₂, HR monitoring
- BP frequently
- Glucose monitoring
- Strict I&O (weigh diapers)
- Daily weights
- Cluster care
- Aseptic technique for all procedures
- Administer antibiotics on schedule
- Watch for adverse effects (aminoglycosides — peak/trough levels)
- Support respiratory needs
- Maintain hydration, glucose
- Skin care (fragile)
- Developmental care
- Family support (devastating)
- Encourage parental involvement (kangaroo care when stable)
- Follow-up: hearing, vision, developmental screening
- Discharge teaching
Medications
Empiric antibiotics (start immediately):
- Early-onset: Ampicillin + gentamicin (covers GBS, E. coli, Listeria)
- Late-onset: Vancomycin + gentamicin or cefotaxime (covers Staph, gram-negatives)
- Add acyclovir if HSV suspected
- Antifungal (fluconazole, amphotericin) if fungal sepsis
- Narrow once cultures back
- Duration: 7-21 days depending on organism and site
Supportive:
- IV fluids (NS or D10NS depending on glucose)
- Vasopressors if shock: dopamine, epinephrine
- Anticonvulsants (phenobarbital) if seizures
- Blood products if DIC, anemia
- Surfactant if respiratory failure
- Caffeine for apnea of prematurity
Therapeutic Procedures
- IV antibiotics
- Oxygen, mechanical ventilation
- Fluid resuscitation
- Vasopressors
- Phototherapy (jaundice)
- Treat seizures
- NEC management if present
- Source control if abscess
- Early intervention services post-discharge
- PT, OT, speech follow-up
Client Education
Family during treatment:
- Why hospitalized, expected course
- Cultures take 24-72 hours
- Antibiotics started before results — better safe than sorry
- Hand hygiene critical
- Limit visitors
- Encourage kangaroo care when stable
- Breastfeeding support (or pump)
- Skin-to-skin
- Photos, voice recordings while in NICU
Discharge teaching:
- Continue any home antibiotics as prescribed (rare)
- Watch for: fever (≥ 38°C in < 3 months = ER), poor feeding, lethargy, breathing problems, color changes
- Take temperature axillary
- Hand hygiene
- Limit exposure to sick people
- Vaccinations on schedule
- Follow-up: pediatrician within 1-2 days, hearing screen, vision, developmental
- Address family stress, PTSD
- Bonding important
- WIC, lactation, social work as needed
Interprofessional Care
- Neonatology / NICU (primary)
- Pediatric infectious disease
- Pediatric pharmacy (antibiotic dosing)
- Pediatric audiology
- Pediatric ophthalmology
- Developmental pediatrics
- PT, OT, speech
- Lactation
- Social work, chaplain
- Family support
- Early intervention services
- Pediatric primary care (follow-up)
- Maternal medicine (postpartum)
Alterations in Health (Diagnosis)
Newborn born before 37 weeks gestation. Categories: late preterm (34-36+6/7), moderate preterm (32-34), very preterm (28-32), extremely preterm (< 28). Approximately 10% of births. Multi-system immaturity → complications across all organ systems. Care complexity increases with decreasing gestational age.
Pathophysiology Related to Client Problem
Immature organ systems unable to support extrauterine life adequately. Pulmonary: surfactant deficiency. CNS: germinal matrix vulnerable to bleed; immature thermoregulation, feeding. GI: NEC risk, immature gut. Immune: high infection risk. Skin: fragile, ↑ insensible losses. Eyes: ROP risk.
Health Promotion and Disease Prevention
- Adequate prenatal care
- Treat infections (UTI, chorioamnionitis)
- Cervical insufficiency management
- Smoking cessation
- Address multiple gestation
- Optimal weight gain
- Treat hypertensive disorders
- Address mental health
- Antenatal corticosteroids 24-34 weeks if preterm labor
- Magnesium sulfate (neuroprotection < 32 weeks)
- Penicillin if GBS+
- Delayed cord clamping at delivery
Risk Factors
- Prior preterm birth
- Multiple gestation
- Maternal age < 18 or > 35
- Inadequate prenatal care
- Low socioeconomic status
- Substance use (smoking, alcohol, illicit drugs)
- Maternal infections
- Cervical insufficiency
- Uterine anomalies
- Hypertensive disorders
- Diabetes
- Stress, abuse
- Short interpregnancy interval
- Race (Black women higher risk)
- Genetic factors
Expected Findings
Physical:
- Small size, low birth weight
- Translucent, fragile skin
- Visible blood vessels
- Lanugo present (more in earlier preterm)
- Vernix abundant (or absent if very preterm)
- Few skin creases on soles
- Cartilage soft in ears
- Genitalia: undescended testes (boys), prominent clitoris (girls)
- Breast tissue minimal
- Posture: extended (vs. flexion of term)
- Loose joints, muscle hypotonia
Functional/physiologic:
- Respiratory: RDS, apnea
- Cardiovascular: PDA, low BP
- Thermoregulation: cold stress prone
- GI: feeding difficulties, NEC risk
- Metabolic: hypoglycemia, hyperbilirubinemia
- Renal: ↑ insensible water loss
- Immune: infection risk
- CNS: IVH risk
- Eyes: ROP risk
- Hematologic: anemia of prematurity
Laboratory Tests
- CBC, type and screen
- BMP, glucose
- ABG
- LFTs, bilirubin
- Cultures (sepsis workup)
- Newborn screen (timing varies)
- Specific tests per complications
Diagnostic Procedures
- Gestational age assessment: Ballard score, ultrasound dates
- Comprehensive physical exam
- Growth measurements: weight, length, head circumference
- Vital signs frequent
- Head ultrasound (IVH screening)
- Echocardiogram (PDA, structural)
- ROP screening (4-6 weeks chronologic age, < 32 weeks/< 1500g)
- Hearing screen
- Developmental assessment
Safety Considerations
- NICU admission
- Maintain neutral thermal environment (isolette, radiant warmer)
- Minimize handling, cluster care
- Strict hand hygiene, aseptic technique
- Watch for IVH (handle gently, avoid rapid position changes)
- Watch for sepsis
- Watch for NEC: distention, vomiting, bloody stools
- Watch for hypoglycemia (frequent monitoring)
- Adequate nutrition for growth
- RSV prophylaxis (palivizumab) per criteria
- Watch for ROP
- Watch for apnea (caffeine for prevention)
- Adjust medications for weight/gestational age
- Limit invasive procedures
- Skin protection
- Late preterm: deceptively well-appearing but at risk
Complications
- Respiratory distress syndrome (RDS)
- Bronchopulmonary dysplasia
- Apnea of prematurity
- Patent ductus arteriosus (PDA)
- Intraventricular hemorrhage (IVH)
- Periventricular leukomalacia
- Cerebral palsy
- Developmental delay
- Cognitive impairment
- Hearing loss
- Visual impairment
- Retinopathy of prematurity (ROP)
- Necrotizing enterocolitis (NEC)
- Feeding difficulties, FTT
- Hyperbilirubinemia
- Hypoglycemia
- Hypothermia
- Sepsis
- Anemia of prematurity
- SIDS (↑ risk)
- Death
- Long-term: chronic lung disease, neurodevelopmental issues
Nursing Care
- NICU care (level based on gestational age)
- Maintain thermal environment (isolette, prewarmed)
- Position: prone or side-lying for sleep is OK in NICU (continuous monitoring); back to sleep when discharged
- Cluster care (minimize stress, IVH risk)
- Gentle handling
- Strict I&O, daily weights (same scale/time)
- Continuous monitoring (SpO2, HR, RR)
- Respiratory support as needed (CPAP, ventilation)
- Nutrition: trophic feeds → advance as tolerated; fortified breast milk preferred; donor milk; preterm formula
- NG/OG feeds → bottle/breast when 32-34 weeks
- Suck-swallow-breath coordination develops 32-34 weeks
- Encourage kangaroo care
- Encourage maternal pumping
- Lactation support
- Developmental care (clustered, quiet, low light)
- Family-centered care
- Pain management (sucrose, swaddling, breastfeeding)
- Discharge planning: car seat test, hearing, eye exam, immunizations
- Early intervention referral
- Use corrected age for milestones
Medications
- Caffeine — apnea of prematurity, may reduce BPD
- Surfactant — RDS
- Vitamin K — at birth
- Eye prophylaxis — erythromycin
- Hepatitis B vaccine — birth dose
- Empiric antibiotics if sepsis suspected (ampicillin + gentamicin)
- Vasopressors (dopamine) — hypotension
- Inhaled nitric oxide — pulmonary HTN
- Diuretics — fluid overload
- Iron supplementation — anemia
- Vitamins (multivitamin)
- Indomethacin or ibuprofen — PDA closure
- RSV: Palivizumab (Synagis) — monthly during RSV season for high-risk
- Routine vaccinations on chronologic age (NOT corrected age)
Therapeutic Procedures
- NICU level of care
- Respiratory support: oxygen, CPAP, mechanical ventilation, surfactant
- Thermoregulation: isolette, radiant warmer
- Nutritional support: TPN, gavage feeds, oral feeds, fortified milk
- IV access (PICC, umbilical lines)
- Phototherapy for hyperbilirubinemia
- Transfusions for anemia
- Surgical interventions (NEC, PDA ligation, IVH)
- Eye exams, ROP treatment (laser, anti-VEGF)
- Hearing tests
- Developmental therapy (PT, OT, speech)
- Discharge: car seat test, follow-up appointments
- Early intervention services
Client Education
Family in NICU:
- NICU stay length varies — generally until 35-37 weeks corrected gestational age and meeting developmental criteria
- Encourage involvement in care (touch, kangaroo care)
- Pumping breast milk every 2-3 hours to establish supply
- Family-centered rounds
- Photo and voice recordings when separated
- Mental health support (NICU is stressful)
Discharge teaching:
- "Back to sleep" (now that home, baby sleeps on back)
- Safe sleep: firm crib, no soft bedding, room-sharing (not bed-sharing)
- Watch for: fever ≥ 38°C → ER, poor feeding, lethargy, color change, respiratory distress
- Hand hygiene critical
- Limit visitors and exposure to sick people
- No public outings initially (especially during RSV season)
- Use corrected age for developmental milestones
- Vaccinations on chronologic age
- RSV protection (palivizumab if eligible)
- Feeding: fortified breast milk or preterm formula
- Frequent small feeds
- Growth monitoring
- Multiple follow-up appointments
- Early intervention referrals
- Watch for vision, hearing concerns
- NICU follow-up clinic
- Address family bonding, mental health
- Sibling involvement
Long-term:
- Most do well with appropriate intervention
- Continued monitoring for: developmental milestones, growth, hearing/vision, cognitive function
- School services if needed
- Address health issues as they arise
Interprofessional Care
- Neonatology / NICU
- Pediatric pulmonology (BPD)
- Pediatric cardiology (PDA)
- Pediatric GI (feeding, NEC)
- Pediatric neurology (IVH)
- Pediatric ophthalmology (ROP)
- Pediatric audiology
- Developmental pediatrics
- PT, OT, speech therapy
- Dietitian, lactation
- Social work, chaplain
- Early intervention
- NICU follow-up clinic
- Pediatric primary care
- Genetics (if syndromic)
Alterations in Health (Diagnosis)
Mechanical injury to the newborn during labor or delivery. Common types: caput succedaneum (scalp edema, crosses suture lines, resolves days), cephalohematoma (subperiosteal bleed, doesn't cross suture lines, weeks-months), subgaleal hemorrhage (life-threatening), fractured clavicle, brachial plexus injury (Erb, Klumpke palsy), facial nerve palsy.
Pathophysiology Related to Client Problem
Pressure or traction forces during birth → injury to soft tissues, bones, or nerves. Risk factors: macrosomia, shoulder dystocia, instrumented delivery, breech, precipitous labor, CPD.
Health Promotion and Disease Prevention
- Adequate prenatal care
- Identify risk factors (macrosomia, malpresentation)
- GDM management
- Skilled delivery
- Appropriate use of operative vaginal delivery
- Cesarean for malpresentation, CPD
- Avoid unnecessary instrumented delivery
- Recognize and treat shoulder dystocia promptly
- Adequate training
Risk Factors
- Macrosomia (> 4000 g)
- Maternal diabetes (GDM, T1/T2)
- Shoulder dystocia
- Instrumented delivery (forceps, vacuum)
- Breech presentation
- Precipitous labor
- Prolonged labor
- CPD (cephalopelvic disproportion)
- Maternal obesity
- Postmaturity
- Multiple gestation
- Prematurity (some injuries)
- Large fetal head
Expected Findings
Caput succedaneum:
- Diffuse, pitting scalp swelling
- Crosses suture lines
- Present at birth
- Resolves spontaneously in days
Cephalohematoma:
- Localized swelling under periosteum
- Does NOT cross suture lines
- Develops over hours-days
- Resolves over weeks-months
- Can contribute to hyperbilirubinemia (RBC breakdown)
Subgaleal hemorrhage (LIFE-THREATENING):
- Fluctuant boggy mass on scalp
- Crosses suture lines
- Can hold large volume of blood (entire blood volume!)
- Pallor, tachycardia, hypotension
- Hypovolemic shock
Fractured clavicle:
- Crepitus, deformity over clavicle
- Decreased arm movement on affected side
- Pain with movement
- Asymmetric Moro reflex
- Crying when moving affected arm
Brachial plexus injury:
- Erb palsy (upper plexus C5-C6): arm adducted, internally rotated, "waiter's tip" posture; intact grasp
- Klumpke palsy (lower plexus C8-T1): hand paralysis, claw hand, possibly Horner syndrome
- Asymmetric Moro reflex
- Decreased grasp reflex
- Flaccid arm
Facial nerve palsy:
- Asymmetric crying face
- Affected side doesn't move
- Eye on affected side doesn't close completely
- Mouth drooping
- Often from forceps pressure
Laboratory Tests
- Bilirubin (rise with cephalohematoma)
- CBC, type and screen (subgaleal, hemorrhage)
- Coagulation studies
- Imaging-related
Diagnostic Procedures
- Detailed physical exam at birth and over time
- Documentation of any abnormalities
- X-rays for fractures
- Head ultrasound (subgaleal, IVH)
- CT/MRI head (severe head trauma, suspected ICH)
- EMG/nerve conduction (brachial plexus, if persistent)
- Vital signs frequently for subgaleal/significant injuries
Safety Considerations
- Subgaleal hemorrhage is life-threatening — recognize early (boggy scalp, crosses sutures, hypovolemia)
- Watch for hypovolemic shock signs
- Frequent head circumference, vital signs
- Watch for hyperbilirubinemia (especially with cephalohematoma)
- Pain management for fractures
- Avoid stress to affected limb
- Avoid pressure on affected eye (facial palsy)
- Lubricating drops for eye (facial palsy)
- Mandatory reporting if abuse suspected
- Position care: avoid affected side for fractures
Complications
- Hyperbilirubinemia (cephalohematoma, ecchymoses)
- Anemia, hypovolemic shock (subgaleal)
- Death (subgaleal hemorrhage, severe injuries)
- Permanent neurologic deficit (severe brachial plexus, head injury)
- Persistent weakness (brachial plexus — most resolve, some don't)
- Contractures
- Cosmetic concerns
- Corneal injury (facial palsy)
- Developmental delay (severe head injury)
- Family distress, anxiety
- Future delivery considerations (recurrence risk)
Nursing Care
- Thorough birth assessment
- Document all findings
- Frequent vital signs (subgaleal, fractures)
- Head circumference monitoring
- Watch for hypovolemic shock (subgaleal)
- Pain management
- Bilirubin monitoring
- Position care: avoid affected limb pressure (clavicle fracture)
- Soft swaddling, but allow affected arm out (brachial plexus)
- Range of motion (gentle, as recommended)
- Eye care: lubricating drops, patching (facial palsy)
- Feeding adjustments if needed
- Family education and support
- Reassurance about most injuries resolving
- Document carefully
- Coordinate specialist referrals
- Provide written instructions
Medications
- Acetaminophen for pain
- Phototherapy if hyperbilirubinemia
- Vitamin K (routine at birth)
- Eye lubrication for facial palsy
- Blood transfusion for severe hemorrhage
- Generally minimal medications needed
Therapeutic Procedures
- Observation for most
- Pain management
- Phototherapy if needed
- Subgaleal: aggressive resuscitation, transfusions, ICU
- Brachial plexus: PT/OT, range of motion, splinting; surgery if no recovery by 3-6 months
- Clavicle fracture: pin sleeve to side or gentle handling — heals in 1-2 weeks with callus
- Facial palsy: eye lubrication; usually resolves spontaneously
- Follow-up assessments
Client Education
Caput succedaneum:
- Soft swelling on baby's head from delivery pressure
- Will resolve in a few days
- No treatment needed
- Normal feeding, sleeping
Cephalohematoma:
- Collection of blood under the membrane covering the skull
- Doesn't cross sutures (limited to one bone)
- Takes weeks to months to resolve
- May cause jaundice — bilirubin monitoring
- Don't massage or apply pressure
- Do NOT puncture or drain
Subgaleal hemorrhage:
- Serious bleeding — requires hospitalization, transfusion
- Recognize and treat early
- Long recovery, careful monitoring
Clavicle fracture:
- Heals quickly (1-2 weeks) with callus formation
- You may feel a "lump" — this is normal healing
- Pin sleeve of affected arm to clothing
- Avoid lifting under arms — support body
- Gentle handling
- Will resolve completely
Brachial plexus injury (Erb/Klumpke):
- Nerve injury from stretching during birth
- Most resolve completely in weeks to months
- PT/OT important
- Range of motion exercises (taught by therapist)
- Surgery rarely needed (no recovery by 3-6 months)
- Don't pull on affected arm
Facial palsy:
- Asymmetric face/cry from nerve pressure
- Most resolve in days to weeks
- Lubricating eye drops if eye doesn't close
- Watch for: persistent weakness → see neurologist
Long-term:
- Most injuries resolve fully
- Follow-up with pediatrician
- Specialist referrals as needed
- Future delivery: discuss with provider
Interprofessional Care
- Neonatology
- Pediatric primary care
- Pediatric orthopedics (fractures)
- Pediatric neurology (brachial plexus, severe)
- Pediatric ophthalmology (facial palsy)
- PT, OT
- Pediatric neurosurgery (severe head injury)
- Maternal-fetal medicine (future pregnancy planning)
Alterations in Health (Diagnosis)
Excessive heat loss in newborn → ↑ metabolic demands to maintain body temperature → potential complications. Newborns have limited ability to thermoregulate (large surface area, thin skin, minimal subcutaneous fat, can't shiver effectively). Brown adipose tissue is primary source of heat (nonshivering thermogenesis). Preventable with proper newborn care.
Pathophysiology Related to Client Problem
Heat loss occurs via 4 mechanisms: conduction (cold surface), convection (cold air drafts), evaporation (wet skin), radiation (cold nearby objects). Cold stress → ↑ metabolic rate → ↑ O2 consumption → respiratory distress, hypoglycemia (uses glucose stores), metabolic acidosis (anaerobic metabolism), peripheral vasoconstriction.
Health Promotion and Disease Prevention
- Dry newborn immediately at birth, remove wet linens
- Skin-to-skin contact with mother (best thermoregulation)
- Warm radiant warmer at birth
- Pre-warmed blankets, isolette
- Hat on newborn (significant heat loss from head)
- Maintain ambient temperature
- Delay first bath until thermally stable (per WHO 24 hours, AAP recommends after first feeding)
- Don't place newborn on cold surfaces
- Avoid drafts
- Warm hands and instruments
- Maintain temperature 36.5-37.5°C axillary
Risk Factors
- Prematurity
- Small for gestational age (SGA)
- Hypoglycemia
- Wet skin (just after birth, after bath)
- Sepsis
- CNS injury
- Hypoxia
- Drafts, cold environment
- Cold blankets or surfaces
- Delayed drying
- Inadequate clothing
- Bathing too early
- Birth outside hospital (home, car)
Expected Findings
- Axillary temperature < 36.5°C (97.7°F)
- Cool, mottled skin (especially extremities)
- Acrocyanosis persisting beyond 24-48 hours
- Pallor
- Tachypnea
- Grunting, retractions, nasal flaring
- Apnea
- Lethargy, poor feeding
- Hypoglycemia (uses glucose stores)
- Weak cry
- Decreased activity
- Bradycardia (late)
- Metabolic acidosis
Laboratory Tests
- Glucose (hypoglycemia common)
- ABG (metabolic acidosis)
- CBC (rule out sepsis)
- Cultures if sepsis suspected
Diagnostic Procedures
- Vital signs including axillary temperature
- Continuous monitoring of temperature
- Rule out underlying causes (sepsis, hypoxia)
- Assess for hypoglycemia
Safety Considerations
- Maintain neutral thermal environment
- Routine assessment of temperature (axillary)
- Rewarm gradually (~0.5°C/hour) to avoid rapid changes
- Watch for hypoglycemia
- Watch for respiratory distress
- Identify underlying causes (sepsis?)
- Avoid hot water bottles, heating pads (burn risk)
- Skin-to-skin with mother is excellent rewarming
Complications
- Hypoglycemia
- Respiratory distress, increased O2 needs
- Metabolic acidosis
- Increased bilirubin (impaired conjugation)
- Pulmonary hypertension (vasoconstriction)
- Apnea
- Decreased surfactant production
- Cardiovascular collapse
- Death (severe, untreated)
Nursing Care
Prevention:
- Dry immediately at birth, remove wet linens
- Skin-to-skin with mother (provides warmth, bonding, breastfeeding initiation)
- Hat on newborn
- Pre-warmed blankets, isolette
- Radiant warmer at delivery
- Warm room temperature
- Avoid drafts
- Delay bath until thermally stable
- Warm hands, instruments
- Cluster nursing care
- Routine temperature checks
If hypothermia:
- Place under radiant warmer or in isolette
- Rewarm gradually (0.5°C/hour)
- Skin-to-skin with mother
- Check glucose
- Feed if able (calories for warmth)
- Monitor vital signs closely
- Assess for underlying cause (sepsis workup)
- Document temperature trend
Medications
- IV glucose if hypoglycemia
- IV fluids if needed
- Antibiotics if sepsis suspected
- Generally no specific medications for cold stress itself — treat underlying causes and warm
Therapeutic Procedures
- Rewarming: skin-to-skin, radiant warmer, isolette
- Adequate calories (feed)
- Treat hypoglycemia (D10W if severe)
- Respiratory support if needed
- Treat underlying causes
Client Education
Family — Prevention is key:
- Newborns can't regulate temperature well
- Keep baby warm and dry
- Dress baby in one more layer than you're comfortable in
- Hat on baby outside
- Skin-to-skin contact great for newborns
- Avoid drafts
- Delay first bath at home until baby is stable
- Warm bath water, warm towels, warm room for bath
- Don't leave baby in wet clothes
Watch for signs of cold stress:
- Cool skin (especially extremities)
- Mottled or pale skin
- Poor feeding
- Lethargy, decreased activity
- Fast breathing
- Bluish color around mouth (vs. normal acrocyanosis of hands/feet which is OK)
- → Warm baby with skin-to-skin and call provider
Take temperature axillary:
- Normal: 97.7-99.5°F (36.5-37.5°C)
- Below 97.7°F = cold
- Above 100.4°F = fever, call provider
Adequate feeding:
- Frequent feeds provide calories for warmth
- Breastfeeding encouraged
- Don't skip feedings
Interprofessional Care
- Labor and delivery nursing
- Newborn nursery / NICU
- Pediatric primary care
- Lactation consultant
- Pediatric infectious disease (if sepsis)
Alterations in Health (Diagnosis)
Classifications by birth weight relative to gestational age:
- SGA (Small for Gestational Age): birth weight < 10th percentile for gestational age; may be symmetric or asymmetric IUGR
- LGA (Large for Gestational Age): birth weight > 90th percentile for gestational age; macrosomia = > 4000g
- Postmature/post-term: ≥ 42 weeks gestation; placenta function declines
Pathophysiology Related to Client Problem
SGA: insufficient placental nutrient/oxygen delivery → restricted growth. Symmetric (early, proportionate) vs asymmetric (late, head-sparing). LGA: often maternal hyperglycemia → fetal hyperinsulinemia → ↑ fat deposition, ↑ growth. Postmature: placental aging → decreased oxygen/nutrient delivery → growth restriction, meconium passage, oligohydramnios.
Health Promotion and Disease Prevention
SGA prevention: Adequate prenatal care; smoking/alcohol/drug cessation; treat maternal HTN; treat infections; nutritional counseling; manage chronic conditions.
LGA prevention: Glucose control in GDM/DM; healthy weight gain.
Postmature prevention: Accurate dating; induction by 41-42 weeks if no labor; close monitoring after 40 weeks (NST, BPP).
Risk Factors
SGA: Maternal smoking, alcohol, drug use; HTN, preeclampsia; chronic disease; infections (TORCH); placental insufficiency; multiple gestation; advanced maternal age; chromosomal abnormalities; chronic poor nutrition.
LGA: Maternal diabetes (GDM, T1, T2); maternal obesity; excessive weight gain; postmaturity; genetics; multiparity; male sex (slight).
Postmature: Primigravida; prior post-term pregnancy; male fetus; genetic factors; inaccurate dating.
Expected Findings
SGA:
- Small body, normal-sized or relatively large head (asymmetric)
- Thin, loose skin
- Decreased subcutaneous fat
- Sunken abdomen (scaphoid)
- Wide-eyed, alert appearance
- Prominent skull sutures
- Sparse hair
- Hypoglycemia (limited stores)
- Hypothermia (limited fat)
- Polycythemia (chronic hypoxia in utero)
LGA:
- Large body, often with macrosomia (> 4000g)
- Plump, full-cheeked appearance
- Increased subcutaneous fat
- Birth trauma risk (shoulder dystocia, fractures)
- Hypoglycemia (especially infant of diabetic mother)
- Hyperbilirubinemia
- Polycythemia
- Possibly cardiomegaly (IDM)
Postmature:
- Long, thin appearance (loss of subcutaneous fat)
- Wrinkled, peeling skin
- Dry skin
- Long fingernails
- Profuse hair
- No vernix or lanugo
- Meconium-stained skin, nails, cord (greenish-yellow)
- Alert appearance
- Hypoglycemia (depleted stores)
- Increased risk for MAS
Laboratory Tests
- Blood glucose (frequent — hypoglycemia common in all three)
- CBC (polycythemia common — Hct > 65%)
- Bilirubin (elevated risk)
- Calcium, magnesium (IDM/LGA)
- Thyroid function (post-term)
- Newborn screen
Diagnostic Procedures
- Gestational age assessment (Ballard score)
- Birth weight, length, head circumference plotted on growth chart
- Comprehensive physical exam
- Vital signs frequently
- Glucose checks per protocol
- Imaging if injury suspected (LGA)
Safety Considerations
- Frequent glucose monitoring (all three at risk)
- Thermoregulation (SGA prone to cold stress)
- Watch for birth trauma in LGA (clavicle fracture, brachial plexus, hypoxia)
- Watch for MAS in postmature
- Polycythemia monitoring
- Adequate feeding (frequent)
- Bilirubin monitoring
- Watch for sepsis
- Cardiac assessment in LGA/IDM
Complications
SGA: hypoglycemia; hypothermia; polycythemia → hyperviscosity (jaundice, stroke); meconium aspiration; sepsis; perinatal asphyxia; long-term: developmental delay, learning issues, adult cardiometabolic disease.
LGA: birth trauma (shoulder dystocia, clavicle fracture, brachial plexus injury); hypoglycemia; hyperbilirubinemia; polycythemia; respiratory distress; cardiac complications (IDM); long-term: obesity, type 2 diabetes.
Postmature: meconium aspiration syndrome; hypoglycemia; perinatal asphyxia; cold stress; polycythemia; seizures; stillbirth.
Nursing Care
- Thermoregulation (warmer, skin-to-skin)
- Frequent glucose monitoring per protocol
- Early, frequent feedings (breast or formula)
- Watch for hypoglycemia signs: jitteriness, lethargy, poor feeding
- Treat hypoglycemia per protocol
- Polycythemia monitoring (Hct)
- Bilirubin monitoring
- LGA: assess for birth trauma, monitor for hypoglycemia frequently
- SGA: nutritional support, calories for growth
- Postmature: watch for MAS, suction at birth as needed (per current guidelines)
- Skin assessment (dryness, peeling — postmature)
- Cluster care
- Family education on growth, feeding
- Long-term follow-up
Medications
- IV glucose if hypoglycemia not corrected by feeding (D10W bolus 2 mL/kg, then maintenance)
- Phototherapy for hyperbilirubinemia
- Surfactant if RDS
- Antibiotics if sepsis suspected
- Vitamin K (routine)
Therapeutic Procedures
- Maintain thermal environment
- Frequent feedings (every 2-3 hours)
- IV glucose if hypoglycemic
- Phototherapy if jaundiced
- Partial exchange transfusion if symptomatic polycythemia
- Respiratory support if MAS or RDS
- Treat birth injuries (LGA)
- Discharge planning with close follow-up
- Early intervention if developmental concerns (SGA)
Client Education
SGA:
- Baby is smaller than expected for gestational age
- Needs frequent feedings to build up energy stores
- Watch for cold stress, low blood sugar
- Catch-up growth often occurs in first 2 years
- Some long-term concerns: developmental, academic; close follow-up
- Breastfeed often, or supplement as advised
LGA:
- Baby is larger than typical
- Watch for low blood sugar especially in first 24 hours
- If gestational diabetes — important for future pregnancies
- Watch for: jitteriness, sweating, poor feeding (low blood sugar signs)
- Frequent feedings
- Birth injury possible — watch movement of arms
- Risk of future obesity/diabetes — healthy lifestyle
Postmature:
- Baby was born after 42 weeks
- May have dry, peeling skin (resolves)
- Watch for low blood sugar, cold stress
- Possible respiratory issues if meconium was inhaled
- Feed frequently
- Skin care: gentle, no rubbing
All three:
- Pediatrician follow-up soon after discharge
- Track growth at well visits
- Address any developmental concerns
- Family support
Interprofessional Care
- Neonatology / nursery
- Pediatric primary care
- Lactation consultant
- Pediatric endocrinology (diabetes follow-up for LGA from IDM)
- PT/OT (birth trauma in LGA)
- Developmental pediatrics (SGA, postmature with complications)
- Early intervention
- Maternal-fetal medicine (future pregnancy)
Alterations in Health (Diagnosis)
Insufficient oxygen and/or blood flow to fetus/newborn around birth → hypoxia, acidosis, multi-organ dysfunction. May lead to hypoxic-ischemic encephalopathy (HIE) — brain injury. Severity ranges from mild to severe. Therapeutic hypothermia within 6 hours reduces brain injury in moderate-severe HIE.
Pathophysiology Related to Client Problem
Disruption of placental blood flow OR neonatal cardiopulmonary failure → ↓ O2, ↑ CO2, acidosis → cell injury, especially in brain (basal ganglia, watershed areas). Cardiac output redirects to vital organs → other organs (kidney, liver, gut) suffer.
Health Promotion and Disease Prevention
- Adequate prenatal care
- Manage maternal conditions (diabetes, HTN)
- Treat maternal infections
- Recognize fetal distress on monitoring
- Appropriate delivery (cesarean if indicated)
- Neonatal resuscitation training (NRP)
- Resuscitation equipment ready at every birth
- Skilled birth attendants
- Avoid prolonged labor without intervention
- Magnesium sulfate for preterm (neuroprotection)
Risk Factors
Antepartum: Maternal HTN, preeclampsia, diabetes, infection, smoking, drug use, post-term, multiple gestation, IUGR, placental insufficiency, abruption.
Intrapartum: Cord prolapse, uterine rupture, shoulder dystocia, abruption, placenta previa, prolonged labor, fetal distress, meconium, chorioamnionitis, breech with difficulty.
Neonatal: Difficult resuscitation, severe RDS, severe anemia, congenital heart disease.
Expected Findings
At birth:
- Low Apgar scores (especially < 5 at 5 minutes)
- Need for resuscitation
- Cyanosis, pallor
- Bradycardia (HR < 100)
- Poor respiratory effort, gasping
- Hypotonia, no response to stimulation
- Meconium present
Hypoxic-ischemic encephalopathy stages:
- Mild (Stage 1): Hyperalert, jittery, normal tone, hyperreflexia, no seizures; usually resolves < 24 hours; good prognosis
- Moderate (Stage 2): Lethargy, hypotonia, possible seizures, weak reflexes; ~25-50% have long-term sequelae
- Severe (Stage 3): Coma, flaccid, no reflexes, seizures, absent brainstem reflexes; high mortality, severe disability if survives
Multi-organ:
- Brain: encephalopathy, seizures
- Cardiac: hypotension, arrhythmia, poor function
- Respiratory: PPHN, RDS, meconium aspiration
- Renal: AKI, oliguria
- Hepatic: ↑ LFTs
- Hematologic: thrombocytopenia, DIC
- GI: feeding intolerance, NEC risk
Laboratory Tests
- ABG: severe metabolic acidosis (pH < 7.0, base deficit ≥ 16)
- Lactate (elevated)
- Glucose
- CBC, platelets (low)
- Coagulation studies
- LFTs, BUN/Cr (multi-organ injury)
- Electrolytes
- Cord blood gas
- Cultures (sepsis workup)
Diagnostic Procedures
- Apgar scoring
- Cord blood gas analysis
- Comprehensive physical and neurologic exam
- EEG (continuous if seizures or comatose) — amplitude-integrated
- MRI brain (after 4-7 days for prognosis)
- Cranial ultrasound (some)
- Echocardiogram (cardiac function, PPHN)
- Renal ultrasound if AKI
Safety Considerations
- Therapeutic hypothermia must start within 6 hours of birth for moderate-severe HIE — significantly improves outcomes
- Maintain temperature at 33-34°C × 72 hours, then rewarm slowly
- Avoid hyperthermia (worsens injury)
- Strict glucose, electrolyte control
- Watch for seizures
- Avoid hyperoxia, hypocapnia (vasoconstriction)
- Cluster care
- Multidisciplinary team
- Family communication essential
- Long-term developmental follow-up
Complications
- Death
- Cerebral palsy
- Seizure disorder, epilepsy
- Intellectual disability
- Microcephaly
- Hearing impairment
- Vision impairment, cortical blindness
- Developmental delay
- Behavioral problems
- Learning disabilities
- Multi-organ injury: AKI, hepatic dysfunction
- Feeding difficulties (long-term)
- NEC
- Persistent pulmonary hypertension
- Long-term need for special services
Nursing Care
- Neonatal resuscitation per NRP
- Document Apgar scores
- Cord blood gas
- Immediate transfer to NICU
- Continuous monitoring: HR, RR, SpO2, BP
- Maintain airway, ventilation
- Identify candidates for therapeutic hypothermia (per criteria)
- Initiate cooling within 6 hours if eligible — passive then active cooling to 33-34°C
- Monitor temperature continuously, target 33-34°C
- Avoid hyperthermia
- Slow rewarming after 72 hours
- Continuous EEG monitoring
- Treat seizures
- Monitor and treat multi-organ dysfunction
- Hold feeds initially, support nutrition (TPN)
- Limit invasive procedures, cluster care
- Pain management (sedation)
- Family support — devastating diagnosis
- Communicate prognosis carefully
- Coordinate care: neurology, cardiology, etc.
- Discharge planning with multiple follow-ups
- Early intervention referral
Medications
- Anticonvulsants: phenobarbital (first-line), levetiracetam, fosphenytoin
- Sedation during cooling: morphine, fentanyl
- Vasopressors if hypotension: dopamine, dobutamine, epinephrine
- Surfactant if respiratory
- Inhaled nitric oxide if PPHN
- Blood products if DIC, anemia
- Avoid: hyperglycemia (worsens injury) — careful glucose management
- Allopurinol (some studies — neuroprotection, investigational)
- Erythropoietin (investigational neuroprotection)
Therapeutic Procedures
- Therapeutic hypothermia (whole body or selective head cooling) × 72 hours, then rewarm; significantly improves outcomes
- Neonatal resuscitation (NRP)
- Mechanical ventilation if needed
- Inhaled nitric oxide (PPHN)
- ECMO (severe cases)
- Anticonvulsant therapy
- Continuous EEG
- Renal replacement therapy if AKI
- Long-term: early intervention (PT, OT, speech), special education
Client Education
At time of crisis:
- Explain what asphyxia is
- Therapeutic hypothermia is treatment to protect brain
- Why baby is cold (intentional cooling)
- Tubes and lines explained
- Long road ahead
- Encourage parental involvement (talking, gentle touch)
- Photographs, recordings
Outcomes vary widely:
- Mild encephalopathy — often good outcomes
- Moderate — variable outcomes
- Severe — significant disability or death
- Long-term follow-up essential
- Use corrected age
Long-term care:
- Multiple specialists (neurology, PT, OT, speech)
- Anticonvulsants if seizure disorder
- Developmental assessments
- Hearing, vision testing
- Early intervention services
- School services (IEP) as appropriate
- Wheelchair, equipment if needed
- Mental health support for family
- Support groups
Address grief:
- Loss of "expected" baby
- Counseling, therapy
- Other parents who have been through this
Interprofessional Care
- Neonatology / NICU (level III)
- Pediatric neurology
- Pediatric cardiology
- Pediatric nephrology
- Pediatric pulmonology
- Developmental pediatrics
- PT, OT, speech therapy
- Pediatric ophthalmology, audiology
- Pediatric pharmacy
- Genetics
- Social work, chaplain
- Mental health, palliative care
- Early intervention
- School services, IEP team
- Family support groups
Alterations in Health (Diagnosis)
Bleeding in newborn due to vitamin K deficiency → coagulation factor deficiency. Hemorrhagic disease of the newborn / Vitamin K deficiency bleeding (VKDB). Categories: early (first 24 hours — maternal medications), classic (2-7 days — most common), late (2-12 weeks — exclusively breastfed without prophylaxis, intracranial bleeding). Routine vitamin K at birth prevents.
Pathophysiology Related to Client Problem
Vitamin K-dependent coagulation factors (II, VII, IX, X) deficient at birth due to: limited placental transfer, immature gut flora (vitamin K synthesis), low breast milk vitamin K, immature liver. Without prophylaxis, severe bleeding can occur, including catastrophic intracranial hemorrhage.
Health Promotion and Disease Prevention
- Vitamin K 0.5-1 mg IM within 1 hour of birth — UNIVERSAL
- Educate parents who refuse — significant risk
- Oral vitamin K is INFERIOR to IM but acceptable if family refuses IM (multiple doses needed)
- Maternal vitamin K supplementation in pregnancy (some recommendations) if on anticonvulsants
- Avoid maternal medications that ↓ vitamin K when possible (anticonvulsants, warfarin, certain antibiotics)
- Awareness in exclusively breastfed infants
Risk Factors
- No vitamin K prophylaxis at birth (parents refused)
- Maternal medications: anticonvulsants (phenytoin, phenobarbital), warfarin, rifampin, isoniazid, certain antibiotics
- Prematurity
- Exclusive breastfeeding (low vitamin K in milk)
- Liver disease in newborn
- Malabsorption (cystic fibrosis, biliary atresia)
- Chronic diarrhea
- Home birth without medical supervision (vitamin K may be missed)
Expected Findings
Bleeding sites:
- GI bleeding: melena, hematemesis
- Umbilical cord bleeding
- Circumcision bleeding (prolonged)
- Skin: petechiae, ecchymoses
- Nasal, oral bleeding
- Bleeding from venipuncture sites
- Hematuria
- Intracranial hemorrhage (late VKDB) — most serious: bulging fontanel, irritability, seizures, lethargy, vomiting, poor feeding
Severity:
- Mild oozing to severe hemorrhage
- Anemia (with significant blood loss)
- Pallor, tachycardia
- Shock (severe)
Laboratory Tests
- ↑ PT, ↑ aPTT (prolonged)
- Normal platelets, fibrinogen
- Low vitamin K-dependent factors (II, VII, IX, X)
- CBC: anemia with significant bleeding
- PIVKA-II (Protein induced by vitamin K absence) elevated
- Type and crossmatch if transfusion needed
- Bilirubin (rise with hematoma absorption)
Diagnostic Procedures
- Physical exam: bleeding sites
- Vital signs (assess for shock)
- Neurologic exam (intracranial concern)
- Coagulation studies
- Head ultrasound or CT if intracranial bleed suspected
- Hemoglobin/hematocrit serial
- Detailed medication history
- Birth history (vitamin K given?)
Safety Considerations
- Universal vitamin K prophylaxis at birth is critical
- Document administration
- Educate parents who decline — risk is real
- Watch for bleeding signs
- Avoid IM injections in infants without vitamin K
- Vitamin K is fat-soluble — store appropriately
- Watch for late VKDB in exclusively breastfed infants (especially if vitamin K refused)
- Recognize signs of intracranial hemorrhage early
- Mandatory reporting if abuse suspected (differential)
Complications
- Severe hemorrhage
- Hypovolemic shock
- Anemia
- Intracranial hemorrhage (late VKDB) — high mortality and morbidity
- Permanent neurologic damage
- Death
- Need for transfusion
- Hyperbilirubinemia (RBC breakdown)
- Prolonged hospitalization
Nursing Care
- Administer vitamin K 0.5-1 mg IM within 1 hour of birth (universal)
- Document administration carefully
- Educate parents on importance
- If parents refuse, document refusal, educate on signs of VKDB, alternative oral schedule
- Assess for bleeding (mucosa, umbilical site, puncture sites)
- Watch for signs of bleeding throughout newborn course
- Vital signs frequently if bleeding
- Bleeding precautions: minimize venipunctures, hold pressure
- Watch for hypovolemia
- Watch for late VKDB in breastfed infants without vitamin K
- Educate about safe sleep, watch for irritability/lethargy
- Coordinate with pediatrician for follow-up
Medications
- Vitamin K (phytonadione, AquaMEPHYTON) 0.5-1 mg IM at birth — prophylactic
- For active bleeding: IV vitamin K plus fresh frozen plasma (FFP) for immediate factor replacement
- Vitamin K oral alternative (3 doses: at birth, 1 week, 4 weeks) — LESS effective
- Blood transfusion (PRBCs) if anemia/significant blood loss
- FFP for active bleeding
- Platelet transfusion if also low
- Cryoprecipitate (severe bleeding)
- Treat underlying cause if applicable
Therapeutic Procedures
- Vitamin K administration
- Fresh frozen plasma for active bleeding
- Blood transfusion for anemia/hypovolemia
- Treat shock (IV fluids, transfusions)
- Surgery rare
- Intensive care for intracranial hemorrhage
- Anticonvulsants if seizures
- Long-term follow-up if intracranial bleed
Client Education
Vitamin K importance:
- Babies are born with low vitamin K
- Without supplementation, can have bleeding (rare but serious)
- Late form can cause bleeding in brain — devastating
- Single IM injection at birth is highly effective
- Oral alternative requires multiple doses, less reliable
- Vitamin K is NOT a vaccine — it's a vitamin
If family declines:
- Educate on signs of bleeding
- Watch for: bleeding from umbilical cord, circumcision, nose; bruising; blood in stool/urine
- Watch for late VKDB (2-12 weeks): irritability, vomiting, lethargy, bulging soft spot, seizures → ER immediately
- Especially important if exclusively breastfeeding
- Have provider give oral vitamin K schedule
- Document refusal
- Mother's diet doesn't protect baby adequately
If bleeding occurs:
- Apply pressure to bleeding sites
- Seek immediate medical care
- Treatment available (vitamin K, transfusions)
Long-term:
- After treatment, most infants do well
- Intracranial hemorrhage may have lasting effects — close monitoring, follow-up
- Future children should get vitamin K
Interprofessional Care
- Neonatology
- Pediatric primary care
- Pediatric hematology (recurrent bleeding)
- Pediatric neurology (intracranial hemorrhage)
- Pediatric neurosurgery (intracranial)
- Pediatric pharmacy
- Blood bank
- Genetics (if underlying coagulopathy)
- Developmental pediatrics, early intervention (long-term)
Alterations in Health (Diagnosis)
Difficult or abnormally slow labor. Categories: powers (inadequate contractions), passenger (malposition, malpresentation, macrosomia), passage (pelvic abnormality, CPD), position (maternal), psyche (anxiety, fear). Most common cause of primary cesarean. Includes failure to progress, arrest of dilation, arrest of descent, hypotonic or hypertonic contractions.
Pathophysiology Related to Client Problem
Disruption in one or more of the 5 P's prevents normal labor progress. Hypotonic contractions: weak, infrequent. Hypertonic contractions: high resting tone, ineffective. Malposition (occiput posterior) or malpresentation (breech, transverse) prevents normal descent. Macrosomia or pelvic anomaly creates mechanical obstruction. Maternal exhaustion, anxiety, restricted movement contribute.
Health Promotion and Disease Prevention
- Adequate prenatal care
- Risk factor identification
- GDM control (avoid macrosomia)
- Healthy maternal weight
- Labor support, doula, family
- Continuous support during labor
- Position changes, ambulation
- Adequate hydration, nutrition in labor
- Address anxiety, fear
- Pain management as needed
- Avoid unnecessary interventions in early labor
- Adequate spacing between pregnancies
Risk Factors
- Maternal age < 18 or > 35
- Primigravida
- Obesity
- GDM/macrosomia
- Multiple gestation
- Polyhydramnios
- Uterine anomalies, fibroids
- Previous cesarean
- Pelvic abnormality (CPD)
- Malpresentation (breech, transverse)
- Malposition (occiput posterior)
- Postmaturity
- Anxiety, fear of labor
- Inadequate hydration, nutrition
- Epidural anesthesia (some)
- Prolonged immobility
- Premature pushing
Expected Findings
Hypotonic labor (more common):
- Contractions become less frequent, weaker, shorter as labor progresses
- Often after early active labor
- Inadequate dilation progress
- Often comfortable between contractions
Hypertonic labor:
- Frequent, painful contractions but ineffective
- High resting tone
- Often in early labor (latent phase)
- Very painful
- No progress despite contractions
- Maternal exhaustion, frustration
Arrest disorders:
- Arrest of dilation: no cervical change × 2 hours in active labor with adequate contractions
- Arrest of descent: no fetal descent × 1 hour in second stage
- Failure to progress: general term
Malposition signs:
- Persistent occiput posterior: back labor, prolonged labor, ineffective pushing
- Brow, face, or shoulder presentation: cesarean often needed
CPD:
- Failure of fetal head to engage
- Caput, molding excessive
- Bandl's ring (uterine constriction)
- Failure to dilate despite adequate contractions
Laboratory Tests
- Standard labor labs (CBC, T&S, electrolytes)
- Glucose (maternal exhaustion)
- ABG if prolonged
- Urinalysis (ketones suggest exhaustion)
- Fetal scalp pH (rare)
Diagnostic Procedures
- Continuous fetal monitoring
- Tocodynamometer/IUPC for contractions
- Cervical exams to assess progress
- Leopold maneuvers (presentation, position)
- Ultrasound if needed for presentation
- Pelvimetry (clinical)
- Maternal vital signs
- Friedman curve / Labor partogram
Safety Considerations
- Monitor mother and fetus continuously
- Watch for fetal distress
- Watch for uterine rupture (especially VBAC, hypertonic labor)
- Maternal exhaustion management
- Cesarean readiness
- Pain management — adequate but not over-sedating
- Avoid prolonged labor when intervention indicated
- Continuous reassessment
- Family support
- Document progress (or lack)
Complications
- Maternal exhaustion, dehydration
- Cesarean delivery
- Postpartum hemorrhage (uterine atony from exhaustion)
- Chorioamnionitis (prolonged labor with ROM)
- Fetal distress, hypoxia
- Birth trauma (instrumented delivery)
- Shoulder dystocia (macrosomia)
- Uterine rupture
- Stillbirth (rare, severe)
- Cervical lacerations
- Bladder injury
- Postpartum bladder dysfunction
- Pelvic floor injury
- Maternal psychological trauma
- Infection
Nursing Care
- Continuous monitoring (mother and fetus)
- Document contraction pattern (frequency, duration, intensity, resting tone)
- Cervical exams as indicated (limit to avoid infection)
- Assess fetal position, presentation
- Position changes: hands and knees, side-lying, peanut ball, standing/walking
- Hydration (IV/oral)
- Empty bladder (full bladder slows labor)
- Encourage rest if exhausted (sometimes labor pauses)
- Emotional support
- Pain management
- Encourage support person involvement
- Continuous labor support (doula effect)
- Educate about progress and options
- Prepare for interventions: amniotomy, oxytocin augmentation
- Prepare for possible cesarean
- Watch for fetal distress signs
- Watch for chorioamnionitis (fever)
- Postpartum: watch for hemorrhage (atony common after dystocia)
- Debriefing if traumatic
Medications
- Oxytocin (Pitocin) — augmentation for hypotonic labor; titrate to adequate contraction pattern
- IV fluids
- Pain management: epidural (relaxes pelvic floor, can help malposition), opioids
- Antibiotics if chorioamnionitis develops
- Tocolytics rarely (terbutaline if hyperstimulation)
- Postpartum uterotonics: oxytocin, methylergonovine, carboprost, misoprostol for PPH prevention
Therapeutic Procedures
- Position changes: hands and knees (OP rotation), side-lying, peanut ball, walking, squatting
- Amniotomy (rupture of membranes — if appropriate, helps with hypotonic)
- Oxytocin augmentation (after amniotomy often)
- Internal fetal monitoring if external inadequate
- IUPC for accurate contraction strength
- Operative vaginal delivery: vacuum, forceps if appropriate
- Cesarean birth if non-progressive or fetal distress
- Episiotomy (selective, not routine)
- Postpartum care, hemorrhage management
Client Education
During labor:
- Explain what's happening, options
- Reassurance — labor can be slow but still progressing
- Position changes can help
- Empty bladder frequently
- Adequate hydration
- Try to rest between contractions
- Emotional support — your partner, family, doula
- Pain management options
- Update on progress regularly
Decisions about interventions:
- Amniotomy: breaks water, may speed labor
- Pitocin: strengthens contractions
- Cesarean: if indicated for safety
- Informed consent — risks and benefits
Postpartum:
- Recovery may take longer after long labor
- Watch for: heavy bleeding, fever, severe pain, foul lochia
- Rest, support at home
- Future pregnancy planning
- Address birth experience emotionally
- Counseling if traumatic
- Breastfeeding support
- Vaginal birth often possible in next pregnancy
Interprofessional Care
- Obstetric provider
- OB anesthesia
- Labor and delivery nurses
- Doulas, support persons
- Neonatal team (for resuscitation if needed)
- Maternal-fetal medicine (high-risk)
- Mental health, social work
- Lactation consultant
- Postpartum care
- Birth trauma support
Alterations in Health (Diagnosis)
Labor lasting less than 3 hours from onset of regular contractions to delivery. Can occur with very strong contractions, low maternal resistance, or rapid descent in multiparous women. Risks both mother and infant: maternal lacerations, hemorrhage, fetal hypoxia, birth in inappropriate setting.
Pathophysiology Related to Client Problem
Combination of strong, frequent contractions and low resistance of pelvic soft tissues → rapid cervical dilation, descent, and delivery. May be associated with maternal cocaine use, oxytocin hyperstimulation, multiparity with relaxed perineum.
Health Promotion and Disease Prevention
- Identify risk factors prenatally
- Recognize signs of rapid labor
- Have multiparous women come to facility early in labor
- Plan for rapid response
- Avoid oxytocin hyperstimulation
- Education for high-risk women
- Cocaine cessation
Risk Factors
- Multiparity
- Previous precipitous delivery
- History of rapid labors
- Large pelvic outlet
- Small fetus
- Cocaine use
- Oxytocin hyperstimulation
- Maternal hypertonic contractions
- Soft, compliant maternal tissues
Expected Findings
- Strong, frequent, intense contractions (every 1-2 minutes)
- Rapid cervical dilation
- Sudden, intense pelvic pressure
- Strong urge to push
- Bloody show
- Rapid descent of fetus
- Labor begins suddenly with strong contractions
- Total labor < 3 hours
- Maternal feeling of loss of control
- Fetal heart rate changes (often deceleration)
Laboratory Tests
- Standard labor labs if time allows
- Blood type and crossmatch (postpartum hemorrhage risk)
- CBC
Diagnostic Procedures
- History (especially prior precipitous labor)
- Contraction monitoring
- Cervical exam
- Continuous fetal monitoring (if available)
Safety Considerations
- Never leave patient alone if labor is progressing rapidly
- Stay with patient at all times in active labor
- Prepare for delivery in any setting (room, car, ambulance)
- Don't try to "hold the baby in" — risk of injury
- Stop oxytocin immediately if hyperstimulation
- Have resuscitation equipment ready
- Watch for fetal distress (uteroplacental insufficiency from intense contractions)
- Postpartum: high risk of PPH (uterine atony, lacerations)
- Examine perineum for lacerations after delivery
- Document carefully
Complications
Maternal:
- Lacerations: cervical, vaginal, perineal (often severe)
- Hematomas
- Postpartum hemorrhage (atony, lacerations)
- Uterine rupture
- Amniotic fluid embolism
- Inadequate pain management
- Trauma to support persons
- Psychological trauma
- Bladder injury
Fetal/neonatal:
- Fetal distress, hypoxia
- Birth in inappropriate setting (no medical care)
- Cord prolapse if early rupture
- Birth trauma: head trauma from rapid descent
- Intracranial hemorrhage
- Aspiration
- Hypothermia
- Delayed cord care
Nursing Care
- Recognize risk factors on admission (history)
- Rapid response if labor progressing fast
- Stay with patient continuously
- Call for help, prepare equipment
- Encourage breathing through urges (don't push)
- Position: side-lying to slow descent if needed
- If birth imminent and no provider:
- - Don't restrain or block delivery
- - Support perineum gently to control delivery
- - Allow gradual delivery
- - Suction nose and mouth
- - Dry baby, place on mother
- - Cover baby
- - Cord care (clamp when pulsations cease)
- - Watch for placenta delivery
- - Massage fundus
- Post-delivery: assess for lacerations, hemorrhage
- Fundal massage
- IV oxytocin if PPH
- Newborn care: dry, warm, assess (Apgar)
- Emotional support — overwhelming experience
- Debrief after
Medications
- Oxytocin (Pitocin) for PPH
- Methylergonovine (Methergine) for PPH if normotensive
- Carboprost (Hemabate) for PPH
- Misoprostol
- IV fluids
- Magnesium sulfate (rarely needed)
- Vitamin K for newborn
Therapeutic Procedures
- Continuous nursing presence
- Stay with patient
- Delivery in whatever setting
- Fundal massage
- Manage lacerations (repair)
- PPH management
- Newborn resuscitation if needed
- Postpartum hemorrhage protocols
Client Education
If history of precipitous labor:
- Future pregnancies: come to facility at first signs of labor
- Don't wait to time contractions if you suspect labor
- Have transportation plan
- Family/partner training in emergency delivery
- Know nearest facility
If birth in non-medical setting (educate to call 911):
- Don't try to hold baby in
- Get clean towels, blankets
- Support perineum gently as head emerges
- Don't pull on baby
- Dry baby, place skin-to-skin with mother
- Cover baby and mother
- Don't cut cord
- Massage uterus after placenta delivers
- Watch for heavy bleeding
- Go to hospital ASAP
After delivery:
- Lacerations may take longer to heal
- Watch for postpartum bleeding
- Process the experience emotionally
- Counseling if traumatic
- Future pregnancies: same risk likely
- Pelvic floor exercises (Kegels)
- Mental health follow-up
Interprofessional Care
- Obstetric provider
- EMS (if out of hospital)
- Neonatal team
- OB anesthesia
- Operating room (cesarean preparedness)
- Mental health (trauma)
- Social work
Alterations in Health (Diagnosis)
Failure of placenta to deliver within 30 minutes after birth, or retention of placental fragments after delivery. Major cause of postpartum hemorrhage. Types: retained whole placenta, placenta accreta spectrum (abnormal attachment), retained fragments.
Pathophysiology Related to Client Problem
Failure of normal third stage mechanism (placental separation by uterine contractions). Causes: uterine atony, placenta accreta (abnormal trophoblast invasion through decidua), constricted cervix trapping placenta, incomplete separation with retained fragments.
Health Promotion and Disease Prevention
- Active management of third stage (oxytocin, controlled cord traction, fundal massage)
- Avoid premature traction on cord
- Identify risk factors (prior accreta, prior cesarean, placenta previa)
- Antenatal imaging for suspected accreta
- Skilled birth attendance
- Adequate uterine contractility (uterotonics)
Risk Factors
- Prior retained placenta
- Placenta previa
- Prior cesarean (increases accreta risk)
- Multiple prior cesareans
- Uterine surgery (myomectomy, D&C)
- Asherman syndrome (uterine adhesions)
- Advanced maternal age
- Grand multiparity
- Preterm labor
- Manual extraction history
- Uterine anomalies
- Placenta accreta history
Expected Findings
- Placenta not delivered within 30 minutes after birth
- Continued bleeding postpartum
- Boggy fundus
- Fundal height above expected
- Inability to manually remove placenta easily
- Visible cord without placenta delivery
- Heavy bleeding (PPH)
- Maternal tachycardia, hypotension
- Pallor, dizziness
- For accreta: extremely adherent placenta requiring forced removal
- Retained fragments: ongoing bleeding postpartum, subinvolution, foul lochia (later)
Laboratory Tests
- CBC (anemia, blood loss)
- Type and crossmatch
- Coagulation studies (DIC risk)
- Fibrinogen
- Beta-hCG (rare follow-up for trophoblastic disease consideration)
Diagnostic Procedures
- Visual inspection — placenta not delivered
- Examination of placenta (intact? missing pieces?)
- Ultrasound: retained fragments visible
- Manual exploration (anesthesia)
- Hysteroscopy (delayed cases)
Safety Considerations
- Major bleeding risk — prepare for hemorrhage
- Active management of third stage
- Vital signs frequently
- Two large bore IV lines
- Type and crossmatch ready
- Massive transfusion protocol if needed
- Manual removal under anesthesia (epidural or general)
- Watch for: bleeding, infection, retained fragments later
- Hysterectomy may be needed for accreta — plan ahead if known
- Antibiotics (manual removal increases infection risk)
Complications
- Postpartum hemorrhage
- Hypovolemic shock
- DIC
- Anemia, need for transfusion
- Postpartum infection (endometritis)
- Subinvolution
- Manual exploration injury
- Hysterectomy (placenta accreta, severe)
- Maternal death
- Future fertility issues
- Asherman syndrome (uterine adhesions)
- Bonding disruption
- Long-term emotional trauma
Nursing Care
- Time placental delivery — concerning if > 30 minutes
- Watch for bleeding signs
- Vital signs frequently
- Two large bore IVs (16-18g)
- IV fluids, blood ready
- Bladder empty (full bladder displaces uterus)
- Encourage breastfeeding (oxytocin release)
- Skin-to-skin (oxytocin release)
- Fundal massage
- Administer uterotonics as ordered
- Examine placenta for completeness (size, lobes intact)
- If incomplete: notify provider, prepare for exploration
- Prepare for manual removal: anesthesia, IV access, blood
- Post-removal: continued monitoring
- Antibiotics
- Bonding facilitation
- Family support
- Discharge teaching
Medications
- Oxytocin (Pitocin): 20-40 units in 1 L NS, infused at controlled rate
- Methylergonovine (Methergine): 0.2 mg IM (contraindicated if hypertension)
- Carboprost (Hemabate): 250 mcg IM (caution in asthma)
- Misoprostol (Cytotec): 800-1000 mcg rectally
- Tranexamic acid (TXA) for PPH
- Nitroglycerin (relaxes uterus for manual removal)
- Anesthesia for manual removal (spinal, epidural, general)
- Antibiotics: cefazolin, ampicillin-sulbactam
- Blood products as needed
- Pain management
Therapeutic Procedures
- Active management of third stage
- Manual removal of placenta under anesthesia
- Curettage if retained fragments
- Ultrasound-guided removal
- Hysteroscopic removal (delayed cases)
- Hysterectomy for severe placenta accreta
- Blood transfusions, FFP, platelets
- Antibiotics
- Pain management
- Iron supplementation postpartum
Client Education
During event:
- Explain procedure
- Manual removal needs anesthesia
- Watch for bleeding
- Address fear, anxiety
Discharge teaching:
- Watch for: heavy bleeding (saturating pad < 1 hour), foul-smelling lochia, fever > 100.4°F, severe pain, dizziness, weakness
- Iron supplements as prescribed
- Rest, adequate nutrition
- Postpartum follow-up
- Continue uterotonics if prescribed
- Watch for delayed PPH (retained fragments)
Future pregnancies:
- Tell future providers
- Risk of recurrence
- If placenta accreta — major surgery may be needed in future
- Possible hysterectomy if severe
- Discuss family planning
- If had hysterectomy: counseling, future planning
Bonding and breastfeeding:
- Reunite with baby ASAP after stable
- Skin-to-skin helps
- Breastfeeding releases oxytocin, helps uterus contract
- Mental health support
Interprofessional Care
- Obstetric provider, OB-GYN
- OB anesthesia
- Operating room
- Blood bank, transfusion service
- Critical care if severe
- Maternal-fetal medicine
- Pediatric team (newborn care)
- Mental health
- Lactation
- Social work
- Family planning counseling
Alterations in Health (Diagnosis)
Tears of perineum, vagina, cervix, or urethra during vaginal delivery. Perineal lacerations classified by degree: First (skin and superficial mucosa), Second (perineal muscles), Third (anal sphincter), Fourth (rectal mucosa). Cervical lacerations cause significant bleeding. Common cause of postpartum hemorrhage.
Pathophysiology Related to Client Problem
Stretching of tissues during delivery exceeds tissue elasticity → tearing. Factors: rapid descent, large baby, instrumented delivery, episiotomy extending, primigravida (less elastic tissue), maternal positions.
Health Promotion and Disease Prevention
- Avoid routine episiotomy
- Restrictive episiotomy practices (only when indicated)
- Slow controlled crowning
- Perineal massage in late pregnancy (some evidence)
- Warm compresses to perineum during second stage
- Position changes (side-lying, hands and knees may reduce trauma)
- Avoid unnecessary operative vaginal delivery
- Pelvic floor preparation
- Skilled birth attendance
- Limit episiotomy
- Avoid pulling on baby
Risk Factors
- Primigravida
- Macrosomia (> 4000g)
- Operative vaginal delivery (forceps especially)
- Episiotomy (especially midline — extends easily)
- Asian ethnicity (some studies)
- Short perineum
- Prolonged second stage
- Precipitous delivery
- Shoulder dystocia
- Occiput posterior position
- Maternal position (lithotomy worse)
- Prior third/fourth degree laceration
Expected Findings
Perineal lacerations:
- First-degree: skin, vaginal mucosa only
- Second-degree: extends into perineal muscles
- Third-degree: extends through anal sphincter
- Fourth-degree: extends through rectal mucosa
Other lacerations:
- Cervical: bleeding despite firm fundus, identified on speculum exam
- Vaginal sidewall
- Periurethral, urethral
- Labial
Bleeding:
- Bright red bleeding (vs lochia)
- Continuous flow
- Tachycardia, hypotension if severe
Pain:
- Local pain
- Pain with movement
- Difficulty sitting
- Difficulty urinating, defecating
Laboratory Tests
- CBC (anemia, hemorrhage)
- Type and crossmatch
- Coagulation if bleeding
Diagnostic Procedures
- Visual inspection of perineum, vagina
- Speculum exam for cervix, upper vagina
- Rectal exam for 3rd/4th degree extension
- Imaging rare
Safety Considerations
- Identify lacerations before discharge
- Adequate repair (anesthesia, lighting, exposure)
- Third/fourth-degree: layered repair, attention to anal sphincter
- Watch for hemorrhage with cervical lacerations
- Vaginal pack if severe bleeding
- Infection prevention
- Bowel preparation considerations for fourth degree
- Don't use rectal medications/suppositories after 3rd/4th degree
- Stool softeners after repair
- No tampons, douching, intercourse until healed
Complications
- Postpartum hemorrhage
- Hematoma formation
- Wound dehiscence
- Infection
- Rectovaginal fistula (3rd/4th degree)
- Anal incontinence (3rd/4th degree — even with good repair)
- Dyspareunia
- Urinary retention
- Chronic pain
- Sexual dysfunction
- Bowel dysfunction (3rd/4th degree)
- Need for re-repair
- Future delivery considerations
Nursing Care
- Assess perineum after delivery (REEDA scale)
- Document laceration degree
- Pain management
- Ice pack for first 24 hours (reduces edema, hematoma)
- Sitz baths after first 24 hours
- Peri bottle for cleansing
- Perineal hygiene: front to back
- Change pad frequently
- Topical anesthetics
- Stool softeners (especially 3rd/4th degree)
- High-fiber diet, adequate fluids
- Avoid constipation (3rd/4th degree)
- Position for comfort (side-lying)
- Pelvic floor exercises (Kegels)
- Watch for hematoma (severe pain, fullness, discoloration)
- Watch for infection signs
- Bonding facilitation
- Postpartum follow-up
- Discharge teaching
Medications
- Acetaminophen, ibuprofen (mainstay)
- Opioids (short-course for severe)
- Topical anesthetics (lidocaine spray, witch hazel pads)
- Stool softeners: docusate (Colace)
- Fiber supplements
- Sitz bath (warm water, after 24 hours)
- Antibiotics: prophylactic for 3rd/4th degree (cefoxitin)
- Iron supplements if anemia
- Topical estrogens not for postpartum lactating
Therapeutic Procedures
- Surgical repair (multiple layered suturing)
- Local or regional anesthesia for repair
- Ice packs initially
- Sitz baths
- Pelvic floor PT (especially 3rd/4th degree)
- Wound care
- Counsel about future delivery
- Possible cesarean if subsequent pregnancy with significant pelvic floor issues
Client Education
Acute care:
- Ice for first 24 hours, then sitz baths
- Pain medication as needed
- Frequent pad changes (every 2-4 hours, more if heavy)
- Peri bottle after urinating/defecating
- Wipe front to back
- Air drying when possible
- Stool softeners if prescribed
- High-fiber diet, fluids
Activity:
- Rest, gradual increase
- Side-lying position for comfort
- Avoid prolonged sitting
- Donut pillow may help
- Pelvic floor exercises (Kegels)
- No tampons, douching
- No intercourse until cleared (usually 6 weeks)
3rd/4th degree specifics:
- NO rectal suppositories, enemas, thermometers
- Stool softeners essential
- Avoid constipation
- Sitz baths beneficial
- Pelvic floor PT recommended
- Future pregnancy: discuss with provider (cesarean may be considered)
- Anal incontinence (gas, stool) — common, may need PT
Watch for and report:
- Increasing pain
- Foul-smelling discharge
- Fever > 100.4°F
- Severe swelling or discoloration
- Wound separation
- Inability to urinate
- Inability to control gas or stool (3rd/4th degree)
- → Call provider
Long-term:
- Most heal completely
- Pelvic floor PT helps
- Sexual function returns gradually
- Lubrication, gentle reintroduction
- Discuss any persistent issues at follow-up
Interprofessional Care
- Obstetric provider
- Colorectal surgeon (3rd/4th degree)
- Pelvic floor PT
- Wound care
- Mental health
- Sex therapy
- Maternal-fetal medicine (future planning)
Alterations in Health (Diagnosis)
Rare but life-threatening complication — uterus turns inside out, partially or completely, after delivery of placenta. May be partial (fundus dimples but doesn't protrude) or complete (uterus protrudes through cervix and vagina). Obstetric emergency: severe hemorrhage and neurogenic shock.
Pathophysiology Related to Client Problem
Fundus inverts through cervix into vagina due to: excessive cord traction before placental separation, uterine atony, fundal pressure on relaxed uterus, abnormal placentation (accreta), short umbilical cord, congenital abnormality. Severe pain, hemorrhage from uterine vessels, vasovagal shock from traction on ligaments.
Health Promotion and Disease Prevention
- Avoid premature/excessive cord traction
- Wait for placental separation signs before traction
- Active management of third stage (oxytocin) — but not excessive force
- Avoid Crede maneuver (fundal pressure)
- Identify high-risk patients (accreta, prior inversion)
- Skilled birth attendance
- Have anesthesia/OR available
Risk Factors
- Excessive cord traction
- Fundal pressure on relaxed uterus
- Placenta accreta
- Uterine atony
- Primigravida
- Short umbilical cord
- Prior inversion (high recurrence)
- Fundal implantation of placenta
- Uterine anomalies
- Connective tissue disorders
- Manual extraction
Expected Findings
- Severe sudden pain postpartum
- Massive hemorrhage
- Visible mass protruding from vagina (complete)
- Fundus not palpable abdominally
- Dimpled or absent fundus on palpation
- Hypotension (often profound — neurogenic + hypovolemic shock)
- Bradycardia (vagal — initially) or tachycardia (later — hypovolemia)
- Pallor, dizziness, syncope
- Diaphoresis
- Severe pain
Laboratory Tests
- CBC (anemia)
- Type and crossmatch — multiple units
- Coagulation studies
- Lactate
- BMP
Diagnostic Procedures
- Clinical diagnosis based on exam
- Inability to palpate fundus abdominally
- Visible mass or vaginal exam findings
- Ultrasound can confirm (rarely needed — emergency)
Safety Considerations
- Emergency — call for help immediately
- Multiple large-bore IVs
- Massive transfusion protocol
- Anesthesia for repositioning (often general)
- Avoid attempts to remove placenta if still attached until uterus repositioned
- Stop oxytocin (until uterus repositioned)
- Use uterine relaxant for repositioning (nitroglycerin, terbutaline, magnesium sulfate)
- After repositioning, give uterotonics to maintain contraction
- Frequent vital signs
- Watch for shock
- Address pain
- Mental health support after
Complications
- Massive postpartum hemorrhage
- Hypovolemic shock
- Neurogenic shock (vagal response)
- DIC
- Multi-organ failure
- Death (5-15% mortality if delayed treatment)
- Need for transfusions
- Need for hysterectomy (severe, recurrent)
- Sheehan syndrome (pituitary necrosis from hypotension)
- Recurrence in future pregnancies
- PTSD
- Sepsis (delayed)
- Long hospitalization
Nursing Care
- Recognize signs immediately
- Call for help / activate massive hemorrhage protocol
- Multiple large bore IVs (16-18g)
- Type and crossmatch (4+ units)
- Aggressive fluid resuscitation
- Blood products as available
- Vasopressors as ordered
- Oxygen, monitor O2 sat
- Trendelenburg position
- Empty bladder (catheter)
- Stop oxytocin temporarily
- Assist with manual replacement attempt (Johnson maneuver)
- Prepare for OR transfer if manual fails
- Anesthesia (often general)
- Tocolytics for uterine relaxation
- After repositioning: uterotonics
- Continued monitoring
- Frequent vital signs
- Coagulation monitoring
- Watch for DIC, organ failure
- Pain management
- Emotional support
- Document carefully
- Postpartum follow-up
- Mental health referral
Medications
- Tocolytics for repositioning (relax uterus):
- - Nitroglycerin 50-100 mcg IV (fast acting)
- - Terbutaline 0.25 mg SC/IV
- - Magnesium sulfate 4 g IV slow
- - Halothane/sevoflurane (general anesthesia)
- After repositioning: uterotonics to prevent recurrence:
- - Oxytocin (Pitocin) IV
- - Methylergonovine (Methergine) IM
- - Carboprost (Hemabate) IM
- - Misoprostol PR
- Tranexamic acid (TXA) for PPH
- Blood products: PRBCs, FFP, platelets, cryoprecipitate
- Vasopressors
- Antibiotics: prophylactic
- Iron supplementation post-recovery
Therapeutic Procedures
- Manual replacement (Johnson maneuver):
- - Hand cupped around fundus
- - Push back through cervix
- - Maintain position until contracted
- - Often requires general anesthesia
- Tocolytics for uterine relaxation
- If manual fails: surgical replacement (laparotomy)
- Antibiotics
- Aggressive fluid/blood resuscitation
- ICU care if shock
- Hysterectomy if all else fails
Client Education
During event/immediately after:
- What happened (severe, rare complication)
- Why interventions are needed urgently
- Anesthesia, ICU care explained
- Updates to family
Recovery:
- Long hospitalization usually
- Blood transfusions common
- Iron supplements
- Adequate nutrition for recovery
- Gradual return to activity
- Watch for: heavy bleeding (PPH can be delayed), fever, severe pain, dizziness, weakness → return to ER
- Postpartum depression risk ↑ after traumatic delivery
Bonding:
- May be delayed due to acuity
- Reunite with baby ASAP
- Skin-to-skin when stable
- Breastfeeding may be delayed but encouraged
- Pumping if separated
Future pregnancies:
- Recurrence risk possible
- Notify ALL future obstetric providers
- Consider cesarean for future delivery
- Specialized prenatal care
- Family planning
- If hysterectomy: family complete; counseling
Mental health:
- Traumatic event — PTSD risk
- Counseling/therapy
- Birth trauma support groups
- Address fear of future pregnancy
- Postpartum depression screening
Interprofessional Care
- Obstetric provider
- Maternal-fetal medicine
- OB anesthesia
- Operating room team
- Blood bank, massive transfusion service
- ICU
- Critical care
- Pharmacy
- Mental health, trauma counseling
- Lactation
- Social work, chaplain
- Family planning
- Future obstetric care team
Description of Procedure
External palpations of the maternal uterus through the abdominal wall to determine fetal positioning before fetal monitoring is performed. Identifies presenting part, fetal lie, fetal attitude, and location of the fetal back.
Indications
- Determining presenting part, fetal lie, and fetal attitude
- Assessing degree of descent into the pelvis
- Locating fetal back to guide FHR auscultation
- Pre-monitoring positioning before EFM application
Outcomes/Evaluation
- Fetal lie identified (longitudinal vs transverse)
- Presenting part confirmed (cephalic vs breech)
- Fetal attitude identified (flexion vs extension)
- FHR auscultation site established
Nursing Interventions (pre, intra, post)
Pre: Have client empty bladder. Position supine with pillow under head and knees slightly flexed. Place rolled towel under right or left hip to displace uterus and prevent supine hypotensive syndrome.
Intra: Perform the four maneuvers in sequence — (1) Fundal palpation: identify the part occupying the fundus (head: round/firm/movable; breech: irregular/soft). (2) Lateral palpation: locate fetal back vs small parts. (3) Pelvic inlet (Pawlik's): grasp lower uterine segment to assess descent and head flexion. (4) Cephalic prominence: face client's feet, palpate prominence with palmar fingertips to identify fetal attitude.
Post: Auscultate FHR after maneuvers to assess fetal tolerance. Document findings from each maneuver.
Client Education
- Procedure is brief, painless, and performed externally over the abdomen
- Purpose: identify fetal positioning to guide further monitoring
- Empty bladder before assessment for accuracy and comfort
- Findings will determine where the FHR can best be heard
Potential Complications
- Supine hypotensive syndrome (mitigated by hip wedge)
- Inability to determine position — maternal obesity, polyhydramnios, fetal position
- Client discomfort with prolonged or firm palpation
- Misidentification of presenting part if maneuvers performed without full sequence
Nursing Interventions
- Empty bladder pre-procedure for accurate palpation
- Position supine with hip wedge to prevent hypotension
- Use both hands; palmar surface for cephalic prominence
- Perform all four maneuvers sequentially
- Auscultate FHR after to verify fetal tolerance
- Document presentation, lie, attitude, and descent findings
Description of Procedure
Surgical procedure to dilate the cervical os and scrape (curette) the uterine walls to remove uterine contents. Used for incomplete or inevitable spontaneous abortion to evacuate retained products of conception. After 16 weeks gestation, the related procedure is dilation and evacuation (D&E).
Indications
- Inevitable abortion
- Incomplete abortion (retained products of conception)
- Suspected molar pregnancy (after suction curettage)
- Abnormal uterine bleeding workup
- Endometrial sampling
Outcomes/Evaluation
- Complete evacuation of uterine contents
- No retained tissue on follow-up ultrasound
- Bleeding controlled and decreasing
- No signs of infection or perforation
- Hgb/Hct stable
Nursing Interventions (pre, intra, post)
Pre: Verify NPO status (general anesthesia common). Confirm informed consent. Obtain baseline labs (CBC, type/Rh, coagulation profile). Establish IV access. Administer pre-medications. Empty bladder.
Intra: Position lithotomy. Monitor vital signs and bleeding. Provide emotional support. Document estimated blood loss.
Post: Monitor vaginal bleeding (count pads — >1 saturated pad/hour is concerning). Vital signs q15min × 2 hours, then q1h. Assess fundus tone. Watch for fever (q4h × 24h). Manage pain. Encourage voiding before discharge. Administer Rho(D) immune globulin if Rh-negative.
Client Education
- Expect light bleeding/discharge × 1–2 weeks (decreases gradually)
- Notify provider: heavy bright-red bleeding, fever, foul-smelling discharge, severe abdominal pain
- No tampons, douching, intercourse, or anything in vagina × 2 weeks
- Take prescribed antibiotics if ordered
- Discuss grief/loss; pregnancy-loss support resources
- Wait until next menstrual cycle before next pregnancy attempt (provider-guided)
- Follow-up appointment per provider
Potential Complications
- Hemorrhage
- Uterine perforation
- Infection (endometritis → sepsis)
- Asherman's syndrome (intrauterine adhesions)
- Anesthesia complications
- Retained products of conception (incomplete D&C)
- Cervical incompetence (rare, repeated procedures)
Nursing Interventions
- Monitor for bleeding (pad count, fundal tone)
- VS q15min × 2 hours then q1h
- Watch for hemorrhage signs (tachycardia, hypotension)
- Manage pain; assess level regularly
- Fall precautions if sedated
- Emotional support; respect grief response
- Provide privacy and presence
- Verify Rh status; administer Rho(D) if negative
Description of Procedure
Surgical procedure consisting of ligation and severance of the vas deferens to prevent sperm from traveling. Considered a permanent form of male sterilization. Reversal is possible but complex, expensive, and not always successful.
Indications
Advantages:
- Permanent contraception
- Procedure is short, safe, and simple
- No general anesthesia required
- Sexual function not impaired
- Rapid return to ADLs
- 99.8% effective once cleared of sperm
Disadvantages:
- Surgical procedure required
- Considered irreversible
- Sterility delayed (~20 ejaculations)
- No STI protection
Outcomes/Evaluation
- Sperm count = 0 on two consecutive tests confirms sterility
- No bleeding, hematoma, or infection at site
- Sexual function preserved
- Client and partner have a satisfactory permanent contraception solution
Nursing Interventions (pre, intra, post)
Pre: Verify informed consent (irreversibility discussed); confirm understanding that fertility ends. Offer sperm banking for future use option. Discuss with sexual partner. Confirm no contraindications.
Intra: Local anesthesia. Position supine. Monitor comfort.
Post: Apply ice intermittently to scrotum for 24 hr to reduce swelling. Provide scrotal support (jockstrap or snug underwear). Assess for hematoma, infection. Pain management with mild analgesics.
Client Education
- Wear scrotal support and limit activity for several days to improve comfort
- Use alternate contraception until cleared — ~20 ejaculations needed to clear remaining sperm from the proximal vas
- Follow up with sperm count; sterility confirmed when zero on two consecutive tests
- Reversal possible but complex/expensive — consider sperm banking if uncertain about future fertility
- No STI protection — barrier method still needed if at risk
- Sexual function and libido unchanged
- Resume normal activities in a couple of days
- Report excessive swelling, severe pain, fever, or signs of infection
Potential Complications
- Bleeding · hematoma at site
- Infection
- Anesthesia reaction
- Granulomas (sperm accumulation)
- Chronic scrotal pain (rare; may need reversal)
- Kidney stones (rare association)
- Unwanted pregnancy if intercourse resumes before cleared
Nursing Interventions
- Reinforce that sterility is delayed
- Educate on need for backup contraception
- Schedule sperm count follow-ups
- Assess emotional readiness; address concerns about masculinity, identity, or partner agreement
- Provide written discharge instructions
- Document teaching and consent
Description of Procedure
Surgical reinforcement of the cervix with a heavy ligature (suture) placed submucosally around the cervix to strengthen it and prevent premature cervical dilation. Treats cervical insufficiency (premature cervical dilation). Best results when placed at 12–14 weeks gestation; removed at 36–38 weeks or with spontaneous labor.
Indications
- Cervical insufficiency / premature cervical dilation
- Hx of cervical trauma (tears from previous deliveries, excessive dilations, biopsy curettage, cervical surgery)
- Pregnancy loss in early gestation with cervical etiology
- Advanced cervical dilation at earlier gestational weeks
- Ultrasound findings: cervix < 25 mm, funneling (beaking), or cervical os effacement
- In utero exposure to DES
- Congenital uterine/cervical structural defects
- Singleton pregnancy
Outcomes/Evaluation
- Pregnancy maintained to term or near-term
- No further cervical shortening on follow-up ultrasound
- No premature cervical dilation
- Successful removal at 36–38 weeks with subsequent vaginal delivery
Nursing Interventions (pre, intra, post)
Preprocedure:
- Confirm singleton pregnancy
- Verify gestational age 12–14 weeks (optimal window)
- Obtain informed consent
- Baseline vitals, FHR, ultrasound to confirm fetal viability
- Evaluate support systems for postoperative bed rest needs
Intraprocedure:
- Provide comfort and emotional support
- Assist provider with cerclage placement
Postprocedure:
- Assess vaginal discharge (color, amount, odor)
- Monitor reports of pressure and contractions
- Check vital signs
- Monitor FHR
- Plan follow-up appointments for observation/supervision
- Plan cerclage removal at 37–38 weeks
Client Education
- Adhere to activity restrictions / bed rest as prescribed
- Increase hydration to promote a relaxed uterus (dehydration stimulates contractions)
- Refrain from sexual intercourse
- Monitor for cervical/uterine changes
- Plan for cerclage removal between 37 and 38 weeks of gestation
- Report immediately: preterm labor, ROM, infection signs, contractions < 5 min apart, severe perineal pressure, urge to push
Potential Complications
- Uterine contractions
- Rupture of membranes
- Infection (chorioamnionitis)
- Bleeding
- Cervical laceration at removal
- Failed cerclage with continued cervical shortening
Nursing Interventions
- Verify gestational age and singleton status preprocedure
- Obtain informed consent
- Establish baseline vitals, FHR
- Postprocedure: monitor for contractions, bleeding, ROM, infection
- Reinforce activity restrictions and hydration
- Educate on red-flag findings requiring immediate report
- Arrange follow-up for surveillance and removal at 37–38 weeks
- Document procedure tolerance, teaching, and discharge instructions
Description of Procedure
Digital examination performed by provider or qualified nurse during labor to assess cervical dilation, effacement, fetal station, presentation, lie, and status of membranes. Insert sterile-gloved index and middle fingers into the client's vagina to palpate landmarks. Frequency depends on labor progress and clinical need — minimize exams when membranes are ruptured to reduce infection risk.
Indications
- Determine cervical dilation and effacement
- Assess fetal station and descent
- Confirm fetal position, presenting part, lie
- Verify status of membranes (intact vs ruptured)
- Assess for prolapsed cord (after ROM)
- Determine progression to next phase or stage of labor
- Confirm full dilation prior to pushing
Outcomes/Evaluation
- Cervical dilation, effacement, and position
- Fetal presenting part, position, and station
- Status of membranes
- Characteristics of amniotic fluid (if membranes ruptured)
- Identification of cord prolapse (palpable cord at introitus or in vagina)
- Confirmation of labor progress (or arrest)
Nursing Interventions (pre, intra, post)
Preprocedure:
- Provide for privacy
- Explain the procedure and obtain client's permission
- Position client to avoid supine hypotension (semi-Fowler's, lateral wedge, or side-lying)
- Cleanse vulva or perineum if needed
Intraprocedure:
- Don sterile glove with antiseptic solution or water-soluble gel for lubrication
- Insert index and middle fingers into the client's vagina
- Palpate cervical dilation, effacement, station
- Identify presenting part and assess membranes
- Limit duration of exam — provide reassurance and breath cues if contraction occurs
Postprocedure:
- Explain findings to the client
- Document findings and report to the provider
- Reassess FHR after exam
- Monitor for ROM if exam disturbed membranes
Client Education
- The exam may feel uncomfortable, especially during a contraction
- Try to relax breathing during the exam
- Findings will be explained to you immediately after
- Frequency of exams may be limited if membranes have ruptured (reduce infection risk)
- Notify the nurse if pain or bleeding occurs after the exam
Potential Complications
- Inadvertent rupture of membranes
- Introduction of infection (especially with ROM)
- Discomfort or anxiety
- Maternal supine hypotension if not properly positioned
- Vasovagal response
Nursing Interventions
- Provide privacy and explain procedure
- Obtain consent prior to exam
- Use sterile technique with appropriate lubricant
- Avoid supine positioning (use lateral tilt)
- Limit exam duration during contractions
- Reassess FHR before and after exam
- Document dilation, effacement, station, position, presentation, membrane status, and amniotic fluid characteristics
- Limit exams when membranes are ruptured
- Communicate findings to provider for clinical decision-making
Description of Procedure
Local anesthetic (bupivacaine) + analgesic (morphine or fentanyl) injected into the epidural space at the L4–L5 level. Eliminates pain from the umbilicus to the thighs — uterine contractions, fetal descent, perineal stretching. May not eliminate pressure sensations. Administered when the client is in active labor and dilated to at least 4 cm. Continuous infusion or intermittent injections via indwelling epidural catheter. Patient-controlled epidural analgesia (PCEA) is a favored method.
Indications
- Pain relief during active labor (≥ 4 cm dilation)
- Suitable for all stages of labor and types of birth
- Cesarean birth (anesthesia level)
- Episiotomy and laceration repair
- Client preference for regional pain management
Outcomes/Evaluation
- Pain relief from umbilicus to thighs
- Client able to rest comfortably during labor
- Stable maternal vitals and FHR
- Client maintains some pressure awareness for pushing efforts
- Successful birth without complications attributable to the block
Nursing Interventions (pre, intra, post)
Preprocedure:
- Verify labor is well-established (active labor, ≥ 4 cm dilation)
- Obtain informed consent
- Establish IV access
- Administer IV fluid bolus to offset hypotension
- Assess baseline maternal vitals and FHR
- Position client sitting or modified Sims' with back curved (widens intervertebral space)
Intraprocedure:
- Help steady client during catheter insertion
- Continuous FHR monitoring
- Assess for orthostatic hypotension
Postprocedure:
- Encourage side-lying position to avoid supine hypotension (vena cava compression)
- Monitor BP and pulse; observe for hypotension, respiratory depression, ↓ O₂ sat
- Continuous FHR monitoring
- Maintain IV; have oxygen and suction available
- Assess bladder for distention; catheterize if needed (full bladder interferes with contractions)
- Coach pushing efforts; request anesthesia evaluation if pushing is ineffective
- Side rails up; do NOT allow unassisted ambulation
- After delivery, monitor for return of sensation and motor control before standing — assist with first ambulation
Client Education
- You'll feel pressure as the catheter is placed
- Pain relief begins within 10–20 minutes
- You may still feel pressure during contractions
- You may not feel the urge to void — a urinary catheter may be needed
- You can use the patient-controlled analgesia button if provided
- Notify nurse if you feel: severe headache, difficulty breathing, severe itching, numbness above your nipples
- Do not get out of bed without assistance
Potential Complications
- Maternal hypotension (most common)
- Fetal bradycardia (secondary to maternal hypotension)
- Fever
- Itching (especially with opioid component)
- Inability to feel urge to void; urinary retention
- Loss of bearing-down reflex → ineffective pushing
- Local hematoma or infection at catheter site
- Inadvertent dural puncture → severe headache
- Allergic reaction
- Respiratory depression (with opioid component)
Nursing Interventions
- Verify ≥ 4 cm dilation and active labor before procedure
- Administer prehydration IV fluid bolus
- Position for catheter placement, then side-lying after
- For hypotension: IV vasopressor (ephedrine), lateral position, ↑ IV rate, oxygen
- Continuous FHR monitoring throughout
- Frequent BP monitoring
- Bladder assessment q1–2h; catheterize if needed
- Coach effective pushing technique despite ↓ sensation
- Educate on safety: no unassisted ambulation until full sensation/motor return
- Document procedure tolerance, vitals, FHR, and effectiveness
Description of Procedure
Delivery of the fetus through a transabdominal incision of the uterus to preserve the life or health of the client and fetus when there is evidence of complications. Incisions are made vertically or horizontally into the lower segment of the uterus, with horizontal being the optimal incision.
Indications
- Malpresentation, particularly breech
- Cephalopelvic disproportion (CPD)
- Nonreassuring fetal heart tones / fetal distress
- Placental abnormalities (placenta previa, abruptio placentae)
- Active genital herpes lesions
- HIV-positive status
- Hypertensive disorders (preeclampsia, eclampsia)
- Diabetes mellitus
- Previous cesarean birth
- Dystocia (failure to progress)
- Multiple gestations
- Umbilical cord prolapse
- Congenital malformations
- Maternal cardiac or respiratory disease
Outcomes/Evaluation
- Successful delivery of healthy neonate
- Stable maternal vitals and hemodynamics
- No surgical site infection or wound dehiscence
- Adequate pain management
- Successful initiation of bonding and feeding
- Intact uterus, no significant blood loss
Nursing Interventions (pre, intra, post)
Preprocedure:
- Assess and record FHR and vital signs
- Assist with ultrasound to determine indication
- Position client supine with a wedge under one hip (prevent vena cava compression)
- Insert indwelling urinary catheter
- Verify signed informed consent
- Apply sequential compression device
- Administer preoperative medications
- Prepare surgical site
- Insert IV catheter and initiate fluids
- Verify NPO status since midnight (notify anesthesiologist if not)
- Ensure preoperative diagnostic tests complete (including Rh-factor test)
- Explain procedure; provide emotional support to client and partner
Intraprocedure:
- Assist in positioning client on operating table
- Continue FHR monitoring
- Continue monitoring vital signs, IV fluids, urinary output
- Conduct instrument and sponge counts per protocol
Postprocedure:
- Monitor for infection and excessive bleeding at incision site
- Assess uterine fundus for firmness or tenderness
- Assess lochia for amount and characteristics
- Tender uterus + foul-smelling lochia → suspect endometritis
- Assess for productive cough or chills (pneumonia)
- Assess for thrombophlebitis: tenderness, pain, heat on palpation
- Monitor I&O and vital signs per protocol
- Provide pain relief and antiemetics as prescribed
- Encourage TCDB (turn, cough, deep breathe) to prevent pulmonary complications
- Encourage splinting of incision with pillows
- Encourage ambulation to prevent thrombus formation
- Assess for burning/pain on urination (UTI)
Client Education
- You will receive spinal or epidural anesthesia (most common); general anesthesia only in emergencies
- You will have a urinary catheter and IV in place
- Splint your incision with a pillow when coughing, sneezing, or moving
- Begin to ambulate as soon as you can — this prevents blood clots
- Use pain medication as prescribed for adequate comfort
- Report fever, increased pain, redness/discharge from incision, foul-smelling lochia, leg pain or swelling
- Skin-to-skin and breastfeeding can begin in recovery as soon as you and the baby are stable
- Avoid heavy lifting (more than the baby) for 6 weeks
- Plan for 4–6 weeks recovery
Potential Complications
Maternal:
- Aspiration
- Amniotic fluid pulmonary embolism
- Wound infection / dehiscence
- Severe abdominal pain
- Thrombophlebitis
- Hemorrhage
- Urinary tract infection
- Injuries to the bladder or bowel
- Anesthesia-associated complications
Fetal:
- Premature birth if gestational age inaccurate
- Fetal injuries during surgery
Nursing Interventions
- Pre: complete preoperative checklist (consent, NPO, IV, Foley, SCDs, type/cross)
- Pre: position with hip wedge to prevent supine hypotension
- Intra: continuous FHR monitoring until delivery
- Post: assess fundus, lochia, vital signs per protocol
- Post: surgical site assessment q-shift
- Post: TCDB, splinting, early ambulation
- Post: monitor for endometritis, pneumonia, DVT, UTI
- Pain management with PCA or scheduled analgesics
- Promote skin-to-skin contact and breastfeeding ASAP
- Document all assessments, teaching, and interventions
Description of Procedure
Therapeutic exposure of newborn skin to specific wavelengths of light (425–475 nm blue-green) to convert unconjugated bilirubin into water-soluble photoisomers that can be excreted in urine and bile without conjugation. First-line treatment for moderate to severe hyperbilirubinemia.
Indications
- Bilirubin levels exceeding age-specific phototherapy thresholds (Bhutani nomogram)
- Visible jaundice in first 24 hours (always pathologic)
- Total serum bilirubin (TSB) approaching exchange transfusion levels
- Rh or ABO incompatibility with rising bilirubin
- Prophylactic use in extremely low birth weight or preterm newborns at risk
Outcomes/Evaluation
- Decline in total serum bilirubin
- Resolution of jaundice (skin returns to baseline color)
- Prevention of bilirubin-induced neurologic dysfunction (kernicterus)
- Maintained hydration and nutritional status
- No skin breakdown
- Normal newborn behavior and feeding pattern
- Discontinuation when TSB drops below threshold (typically < 13–14 mg/dL for term)
Nursing Interventions (pre, intra, post)
- Before initiating:
- Obtain consent and explain procedure to parents
- Verify bilirubin level and provider order
- Measure newborn weight and length
- Remove all clothing except diaper
- Apply eye shields (protect retinas from light damage)
- Position light source 18–24 inches above newborn
- Verify radiometer reading appropriate (8–10 mW/cm²/nm minimum)
- During treatment:
- Maintain newborn naked except diaper and eye shields
- Reposition q2hr to expose maximum skin
- Maintain neutral thermal environment
- Eye shields snug but not too tight
- Post-treatment:
- Bilirubin rebound check 12–24 hr after discontinuation
- Continue close monitoring
Client Education
- Explain the purpose: helps baby get rid of excess bilirubin (causes jaundice)
- Eye shields protect baby's eyes from bright light
- Baby will be naked except diaper for maximum skin exposure
- Baby will continue to eat, sleep, and have diaper changes
- Brief breaks for feeding and parent contact are encouraged
- Baby will be cooler (need warming bed)
- Loose green stools and increased urination are expected (eliminating bilirubin)
- Mild rash or temperature changes possible
- Baby's skin may appear less yellow over 24–48 hr
- Bilirubin may rise slightly after stopping treatment (rebound)
- Follow-up appointment scheduled to recheck bilirubin
Potential Complications
- Dehydration from insensible water loss (increased 25–50%)
- Hyperthermia or hypothermia (temperature instability)
- Loose green stools (normal)
- Skin rash (transient, no treatment needed)
- 'Bronze baby syndrome' — gray-brown discoloration if direct hyperbilirubinemia (cholestasis)
- Eye damage from inadequate eye shielding
- Interruption of bonding and breastfeeding
- Reduced calcium (transient hypocalcemia)
- Burns (rare, equipment malfunction)
Nursing Interventions
- Continuous temperature monitoring
- Daily weights
- Strict I&O — increase fluid intake (10–20% increase)
- Reposition q2hr for even exposure
- Verify eye shields in place every assessment
- Remove eye shields during feedings for visual stimulation and bonding
- Assess skin for breakdown, rash, burns
- Monitor bilirubin levels per provider order (every 6–24 hr)
- Encourage breastfeeding or formula every 2–3 hours
- Brief breaks for parent contact (10–15 min, 2–3 times/day)
- Provide emotional support to parents
- Verify radiometer reading daily
- Document: TSB levels, eye shield status, position changes, intake/output, temperature, skin assessment
Description of Procedure
Deliberate rupture of the amniotic membranes using an amniohook (sterile plastic hook) during a vaginal exam. Used to induce or augment labor, place internal monitors, or check fluid color. Performed by provider with sterile technique.
Indications
- Labor induction when cervix is favorable (Bishop > 6)
- Labor augmentation in slow first stage
- Placement of internal fetal scalp electrode or intrauterine pressure catheter
- Assessment of amniotic fluid color (meconium evaluation)
- Fluid sampling for fetal lung maturity (rare)
- Allow more accurate cervical assessment
Outcomes/Evaluation
- Spontaneous onset or augmentation of contractions within minutes to hours
- Documented fluid color, amount, odor
- FHR remains reassuring after procedure
- No cord prolapse
- Internal monitor successfully placed (if indicated)
- Progressive cervical change
Nursing Interventions (pre, intra, post)
- Pre-procedure:
- Verify fetal presenting part is well-engaged (vertex, station 0 or below)
- Continuous EFM established with reassuring tracing
- Confirm vertex presentation (NOT in breech or unstable lie)
- IV access established
- Document baseline FHR and VS
- Empty maternal bladder
- Position client supine with hips elevated
- During:
- Sterile vaginal exam with amniohook
- Apply gentle pressure to membranes
- Document time of rupture, color, amount, odor of fluid
- Immediately check FHR for variable decels or bradycardia
- Perform vaginal exam to rule out cord prolapse
- Post-procedure:
- Continuous EFM
- Monitor for cord prolapse signs
- Reassess maternal VS
- Document fluid characteristics (color, amount, odor, presence of meconium, blood)
Client Education
- Explain procedure: providers will use a tool to break the bag of water
- Quick procedure with minimal discomfort
- Will hear a 'pop' or feel a gush of warm fluid
- Helps speed up labor by intensifying contractions
- Once water is broken, baby must be born within reasonable time
- Will be on continuous monitoring afterward
- Limited mobility once membranes ruptured (cord prolapse risk)
- Report immediately: cord visible, severe pain, change in baby movement
Potential Complications
- Cord prolapse (if presenting part not engaged)
- Variable decels from cord compression
- Chorioamnionitis (increased risk with each vaginal exam)
- Placental abruption (rare, especially with polyhydramnios)
- Fetal bleeding (if vessel inadvertently lacerated — vasa previa)
- Discomfort or maternal anxiety
- Need for delivery within reasonable timeframe (typically 18–24 hr)
Nursing Interventions
- Verify vertex presentation and engaged presenting part before procedure
- Continuous EFM
- Vaginal exam after rupture to assess for cord prolapse
- Document Time of Rupture (TOR)
- Assess fluid: Color, Odor, Amount, Time (COAT mnemonic)
- Color: clear (normal), green/brown (meconium), bloody (concerning), yellow (chorioamnionitis), port-wine (abruption)
- Temperature q1–2hr (chorio monitoring)
- Limit vaginal exams after ROM (infection risk)
- Watch for prolonged ROM (> 18 hr) — GBS prophylaxis indication
- Position changes to encourage labor progress
- Pain management
Description of Procedure
Direct monitoring of fetal heart rate using a fetal scalp electrode (FSE) attached to fetal scalp via small spiral electrode through the cervix, and/or direct measurement of intrauterine pressure using an intrauterine pressure catheter (IUPC). Requires ruptured membranes.
Indications
- Unable to obtain adequate external monitoring (maternal obesity, fetal position)
- Need for accurate FHR variability assessment (concerning external pattern)
- Need for accurate measurement of contraction strength (oxytocin titration)
- Suspected fetal compromise requiring precise monitoring
- Labor augmentation/induction concerns
- Determine adequacy of contractions in slow labor (Montevideo units)
Outcomes/Evaluation
- Accurate continuous FHR tracing
- Accurate measurement of contraction frequency, duration, and intensity
- Identification of FHR variability and decelerations
- Calculation of Montevideo units (MVUs) for contraction adequacy (≥ 200 = adequate)
- Informed decision-making regarding labor management
- No complications from monitor placement
Nursing Interventions (pre, intra, post)
- Pre-procedure prerequisites:
- Membranes must be ruptured (or AROM performed)
- Cervix dilated > 2 cm (FSE) or 2–3 cm (IUPC)
- Vertex presentation (FSE; or breech with caution)
- Sterile technique
- Continuous EFM during placement
- Placement of FSE:
- Sterile vaginal exam
- Apply electrode to fetal scalp (avoiding face, fontanelles, suture lines, genitalia)
- Attach to leg plate; verify tracing on monitor
- Document time of placement
- Placement of IUPC:
- Sterile vaginal exam
- Insert catheter through cervix into uterus (anterior position safest)
- Attach external tubing to pressure transducer
- Calibrate to 0 mmHg
- Verify accurate contraction tracing
- Both:
- Limit vaginal exams (infection risk)
- Monitor for signs of fetal compromise or infection
Client Education
- Explain procedure to client and partner
- Required for direct monitoring of baby and contractions
- Small electrode attached to baby's scalp — leaves tiny mark
- Tubing inserted into uterus to measure contractions accurately
- Will improve information about labor progress
- Won't hurt the baby; minimal sensation for client
- Maintains mobility within limits
- Removed before delivery
Potential Complications
- Maternal: infection (chorioamnionitis, endometritis), uterine perforation (IUPC)
- Vaginal/cervical laceration
- Fetal: scalp abscess or laceration
- Fetal scalp osteomyelitis (rare)
- Skin tear at electrode site
- Placental abruption (IUPC perforation)
- Bleeding
- Higher infection rates with longer use
Nursing Interventions
- Verify membranes ruptured before placement
- Continuous EFM during and after placement
- Document time of placement and any changes
- Assess FHR tracing for variability and decelerations
- Calculate Montevideo units (peak contraction pressure × frequency in 10 min)
- Adequate labor: 200+ MVUs
- Maintain sterile technique with each contact
- Limit vaginal exams (infection control)
- Monitor temperature q1–2hr (chorio surveillance)
- Remove FSE before delivery (provider responsibility usually)
- Document electrode site after delivery
- Provide perineal care (infection prevention)
Description of Procedure
Operative vaginal delivery using obstetric forceps — paired curved metal instruments applied to fetal head to assist in delivery during second stage of labor. Classified as outlet (head visible at perineum, no rotation), low (station +2 or below, < 45° rotation), or mid (above +2 station, < 45° rotation, rarely used).
Indications
- Prolonged second stage (nulliparous > 3 hr with epidural, > 2 hr without; multiparous > 2 hr with epidural, > 1 hr without)
- Maternal exhaustion or inability to push effectively
- Maternal cardiac or neurologic conditions precluding Valsalva
- Nonreassuring fetal heart pattern at delivery (urgent)
- Failed vacuum delivery (sometimes done with forceps)
- Rotation of fetal head from OP or OT to OA position
Outcomes/Evaluation
- Successful vaginal delivery of healthy newborn
- Apgar > 7 at 5 minutes
- No significant maternal trauma
- Minimal newborn injury (transient bruising acceptable)
- Avoid cesarean delivery in second stage
- Maternal hemodynamic stability
- Adequate maternal pain control
Nursing Interventions (pre, intra, post)
- Prerequisites (ALL must be met):
- Full cervical dilation (10 cm)
- Vertex presentation
- Engaged presenting part (station +2 or below)
- Membranes ruptured
- Empty maternal bladder (Foley)
- Anesthesia adequate (epidural ideal)
- Maternal consent
- Provider skilled in forceps use
- Operating room and team available for backup
- Position fetal head precisely known
- Fetus not macrosomic; no CPD
- During procedure:
- Position client in lithotomy
- Episiotomy may be performed
- Apply forceps during contraction
- Maternal pushing coordinated with forceps traction
- Limit number of attempts (3 max)
- Post-delivery:
- Inspect for lacerations (perineum, vagina, cervix)
- Assess newborn carefully for injury
Client Education
- Explain procedure: spoons placed gently on baby's head to help guide birth
- Used to shorten the pushing stage
- Will continue to push during contractions while doctor applies forceps
- Anesthesia (epidural) recommended for comfort
- Possible newborn bruising or marks where forceps touched (resolves)
- Possible perineal tears or need for episiotomy
- Risk of needing cesarean if forceps unsuccessful
- Discuss recovery: more soreness than spontaneous birth
Potential Complications
- Maternal: perineal lacerations (3rd/4th degree), vaginal/cervical lacerations
- Hematomas, postpartum hemorrhage
- Bladder/rectal injury
- Pelvic floor injury, urinary/fecal incontinence
- Fetal/neonatal: bruising, lacerations to face/head
- Facial nerve palsy (usually transient)
- Skull fracture (rare)
- Cephalohematoma, subgaleal hemorrhage
- Retinal hemorrhage
- Brachial plexus injury (if shoulder dystocia occurs)
- Long-term: no convincing evidence of long-term neurologic effects
Nursing Interventions
- Verify all prerequisites with provider
- Position client in lithotomy with legs in stirrups
- Empty bladder via straight catheter
- Continuous EFM until delivery
- Verify epidural adequacy (test, top off)
- Have neonatal resuscitation team available
- Document time of application, number of attempts, traction force, complications
- Prepare for episiotomy if needed
- Anticipate PPH — establish IV, type and screen
- Postpartum: inspect perineum thoroughly
- Newborn assessment for trauma, facial nerve function
- Ice pack to perineum
- Adequate pain management
Description of Procedure
Operative vaginal delivery using a soft or rigid suction cup (Mityvac, Kiwi) applied to the fetal scalp with negative pressure to assist delivery. Less force than forceps. Mother's pushing efforts combined with vacuum traction during contractions.
Indications
- Prolonged second stage with adequate progress earlier
- Maternal exhaustion
- Maternal cardiac or neurologic conditions precluding Valsalva
- Nonreassuring FHR pattern at delivery
- Failed forceps delivery (rare)
- Preferred over forceps in some institutions due to lower maternal trauma
Outcomes/Evaluation
- Successful vaginal delivery
- Apgar > 7 at 5 min
- Minimal maternal lacerations
- Newborn without significant injury
- Avoid cesarean delivery in second stage
- Adequate maternal recovery
- Newborn caput resolves within days
Nursing Interventions (pre, intra, post)
- Prerequisites (same as forceps):
- Full dilation (10 cm)
- Vertex presentation, head engaged (station +2 or below)
- Ruptured membranes
- Empty bladder
- Adequate anesthesia
- Maternal consent
- Skilled provider
- NOT used in preterm < 34 weeks (skull fragility, IVH risk)
- During procedure:
- Apply cup to fetal head flexion point (3 cm anterior to posterior fontanelle)
- Apply vacuum gradually to 600 mmHg
- Traction during contractions only
- Maternal pushing coordinated with traction
- 3-3-3 rule: 3 cup pop-offs OR 3 pulls OR > 30 min — abandon procedure
- Post-delivery:
- Assess for chignon (artificial caput) — expected, resolves
- Newborn assessment for trauma
Client Education
- Explain procedure: suction cup placed on baby's head to assist birth
- You will still need to push during contractions
- Quicker than forceps in many cases
- Less risk of maternal tearing than forceps
- Baby may have a 'chignon' — bump on head where cup was — resolves in days
- Possible bruising or scrape
- If unsuccessful, may need cesarean
- Recovery similar to spontaneous birth
Potential Complications
- Maternal: Less perineal trauma than forceps but possible lacerations
- Chignon at suction site (resolves)
- Cephalohematoma (10–15%)
- Subgaleal hemorrhage (rare, dangerous)
- Retinal hemorrhage
- Scalp lacerations or abrasions
- Hyperbilirubinemia from cephalohematoma resolution
- Skull fracture (rare)
- Intracranial hemorrhage (rare)
- Shoulder dystocia if macrosomia present
Nursing Interventions
- Verify prerequisites with provider
- Position client (typically lithotomy)
- Empty bladder
- Continuous EFM
- Verify epidural function
- Have neonatal resuscitation team available
- Document carefully: time of application, vacuum pressure, number of pulls, pop-offs, total time on scalp
- Discontinue if 3 pop-offs or 3 pulls without progress
- Postpartum: inspect perineum and lacerations
- Newborn: monitor for signs of intracranial bleed (lethargy, seizures, poor feeding)
- Watch for hyperbilirubinemia (from cephalohematoma absorption)
- Educate parents about chignon resolution
- Document newborn findings clearly
Description of Procedure
Noninvasive continuous monitoring of fetal heart rate (FHR) and uterine activity using two abdominal transducers. Standard of care for high-risk pregnancies and many institutional protocols.
Indications
- All high-risk pregnancies during labor
- Suspected fetal compromise
- Induction or augmentation of labor
- Maternal medical conditions (diabetes, HTN, preeclampsia)
- VBAC/TOLAC
- Multifetal gestation
- Meconium-stained amniotic fluid
- Preterm labor
- Post-term pregnancy
- Decreased fetal movement
- Antepartum testing (NST, CST)
Client Preparation
- Verify informed consent and explain procedure
- Position client semi-Fowler or lateral (avoid supine — vena cava compression)
- Empty maternal bladder
- Use Leopold maneuvers to determine fetal position
- Identify fetal back (best FHR auscultation site)
- Apply ultrasound gel to maternal abdomen
Nursing Actions
- Apply ultrasound transducer over fetal back (best FHR signal)
- Apply tocodynamometer (toco) over the fundus (highest uterine palpation point)
- Secure both with elastic belts
- Adjust to detect good FHR tracing (clear baseline) and contraction pattern
- Verify maternal heart rate is NOT being recorded as FHR (compare to maternal radial pulse)
- Document baseline maternal VS
- Document baseline FHR pattern: baseline rate, variability, accelerations, decelerations
- Document contractions: frequency, duration, intensity (palpation — external EFM cannot measure intensity)
- Reposition transducers as needed for maternal/fetal movement
- Reassess and document FHR per protocol (q15-30 min in active labor)
- Encourage position changes (avoid prolonged supine)
- Document interpretation using ACOG Category I, II, or III
- Notify provider for Category II or III patterns
Potential Complications
- Skin irritation from prolonged elastic belt or gel
- Maternal discomfort from supine position
- Loss of signal with maternal/fetal movement (frequent repositioning)
- Limited mobility (restricts ambulation)
- Difficulty in obese clients
- Cannot measure exact contraction intensity (need IUPC)
- May increase intervention rate (induced cesarean rate without improving outcomes — controversial)
Client Education
- Purpose of monitoring and what's being measured
- Need for position changes (lateral preferred)
- Bathroom needs — can be temporarily disconnected
- Belt should be snug but not painful
- Movement may cause signal loss — repositioning normal
- Father/support person can identify FHR sounds
- Allow questions about findings
- Audible FHR sounds are normal swooshing
Interprofessional Care
- Obstetrician/midwife — interpretation and intervention
- Labor and delivery nurse — primary monitoring
- Anesthesia (if epidural planned)
- Neonatologist (high-risk anticipated)
- Charge nurse (consult for concerning patterns)
Description of Procedure
Single injection of local anesthetic directly into the subarachnoid space (CSF) to provide rapid, complete sensory and motor blockade. Primary use is for scheduled or emergent cesarean delivery.
Indications
- Scheduled cesarean delivery (primary use)
- Emergent cesarean delivery (when rapid anesthesia needed)
- Postpartum tubal ligation
- Postpartum manual placental extraction
- Surgical repair of complex perineal lacerations
- External cephalic version (occasionally)
- NOT used for labor analgesia (no continuous infusion option; single dose)
Client Preparation
- Verify informed consent
- Empty bladder (Foley placement)
- IV access with large-bore catheter
- IV fluid bolus 500-1,000 mL LR or NS before block (prevents hypotension)
- Baseline VS (BP, HR, RR, SpO₂)
- Continuous EFM if antepartum
- Maternal positioning: sitting at edge of bed OR lateral recumbent
- Sterile prep and drape of injection site
- Local anesthesia at injection site
Nursing Actions
- Position client (sitting or lateral) with back curved outward (cat pose) — opens intervertebral spaces
- Apply continuous fetal and maternal monitoring
- Monitor BP every 1-2 min × 15 min, then per protocol
- Watch closely for hypotension (drop in BP > 20% from baseline)
- If hypotension: increase IV fluids, position left lateral, oxygen 10 L/min; administer ephedrine 5-10 mg IV or phenylephrine 100 mcg IV
- Assess block level (sensation, motor function)
- Maintain left uterine displacement (wedge under right hip)
- Reassess FHR pattern continuously
- Pain assessment
- Monitor for: respiratory depression, nausea/vomiting, pruritus, headache
- Post-procedure: assess for return of sensation and motor function
- Strict I&O; assess for urinary retention
- Educate to remain supine 6-12 hours (may help prevent post-dural puncture headache — controversial)
Potential Complications
- Maternal hypotension (most common — more rapid/pronounced than epidural)
- Post-dural puncture headache (PDPH) / spinal headache
- High spinal / total spinal (rare emergency — respiratory paralysis, cardiovascular collapse)
- Urinary retention
- Pruritus (opioid-related)
- Nausea/vomiting
- Backache at injection site (self-limited)
- Infection (rare)
- Bleeding/hematoma (especially if anticoagulated)
- Neurologic injury (extremely rare with proper technique)
- Fetal bradycardia (from maternal hypotension)
Client Education
- Procedure: needle insertion in lower back; pressure sensation but should not be painful
- Onset: rapid (1-2 min)
- Duration: 1-3 hours (sufficient for cesarean delivery)
- Cannot move legs during block — normal
- Numbness from chest down typical
- Report immediately: difficulty breathing, severe headache (especially positional), chest discomfort, severe nausea
- Post-dural puncture headache: severe headache worse when sitting/standing, relieved when lying flat; treatment includes hydration, caffeine, NSAIDs, blood patch if persistent
- Bladder catheter may remain until sensation returns
- Bed rest 6-12 hr post-block (varies)
- Return to normal sensation/movement expected within 1-3 hours
Interprofessional Care
- Anesthesiologist or CRNA — performs procedure
- Obstetrician — coordinates with anesthesia
- OR nurse — assists with positioning, monitoring
- Neonatologist (cesarean delivery — newborn resuscitation)
- Recovery room nurse — postoperative monitoring
- Surgeon (postpartum tubal ligation, etc.)
Description of Procedure
Trial of labor after a prior cesarean delivery (TOLAC), with the goal of VBAC (vaginal birth after cesarean). Success rates 60-80% in appropriate candidates. Reduces overall maternal morbidity vs repeat cesarean. Major risk: uterine rupture (~0.5-1% with one prior low transverse cesarean).
Indications
- Prior low transverse (or low vertical) cesarean
- Single prior cesarean (multiple may still be candidates with careful counseling)
- No other contraindications
- Adequate facility (immediate cesarean capability — anesthesia, OR, blood)
- Maternal desire
- Vertex presentation
- Singleton (some twin VBACs)
Contraindications:
- Prior classical (high vertical) cesarean
- Prior T or J uterine incision
- Prior uterine rupture
- Extensive uterine surgery (myomectomy entering cavity)
- Placenta previa
- Inability to perform emergency cesarean
- Patient refusal
- Other obstetric contraindications to vaginal delivery
Outcomes/Evaluation
Success factors:
- Prior vaginal delivery (especially prior successful VBAC) → high success
- Spontaneous labor
- Adequate cervical dilation at admission
- Maternal BMI < 30
- Younger maternal age
- Estimated fetal weight < 4000g
Reduced success:
- Indication for prior cesarean recurrent (CPD, dystocia)
- Need for labor induction/augmentation
- Maternal obesity
- Macrosomia
Outcomes:
- VBAC successful: 60-80%
- Repeat cesarean during TOLAC: 20-40%
- Uterine rupture: 0.5-1%
- Maternal death rare but slightly higher with failed TOLAC than planned repeat cesarean
Nursing Interventions (pre, intra, post)
Pre-procedure (prenatal):
- Detailed counseling on risks/benefits of TOLAC vs repeat cesarean
- Review prior cesarean operative report (type of incision)
- Informed consent
- Plan for delivery setting with immediate cesarean capability
- Anesthesia consultation
- Blood type and crossmatch
Intra-procedure (during TOLAC):
- Continuous fetal monitoring (most important — fetal distress is most common sign of uterine rupture)
- Continuous maternal monitoring
- IV access
- Type and crossmatch ready
- Watch for signs of uterine rupture:
- - Sudden fetal distress (most common — bradycardia)
- - Sudden severe abdominal pain (may be partially masked by epidural)
- - Loss of fetal station
- - Cessation of contractions
- - Bleeding
- - Maternal hemodynamic changes (tachycardia, hypotension)
- - Palpable defect in uterus
- Avoid prostaglandins (misoprostol) for induction — increases rupture risk
- Mechanical cervical ripening if needed
- Oxytocin acceptable but careful
- OR immediately available
Post-procedure:
- If VBAC: routine postpartum care; monitor for bleeding
- Watch for postpartum hemorrhage
- If rupture: emergent care, possible hysterectomy
- Postpartum counseling about future pregnancies
Client Education
Prenatal:
- VBAC may be option after prior cesarean
- Success rate 60-80%
- Benefits: avoid surgery, shorter recovery, lower risk in future pregnancies, often preferred experience
- Risk: uterine rupture (0.5-1%) — small but serious
- Need facility with 24-hour cesarean capability
- Continuous fetal monitoring during labor
- Plan B is immediate cesarean if needed
During labor:
- Continuous monitoring required
- Tell us immediately: sudden severe pain, sudden change in feeling, dizziness
- Epidural OK (may mask pain of rupture, but allows controlled response)
- Avoid heavy meals
Future pregnancies:
- Successful VBAC: even higher success in future
- Failed VBAC or rupture: repeat cesarean
- Spacing between pregnancies (≥ 18-24 months)
Potential Complications
- Uterine rupture (most serious — 0.5-1% with single prior low transverse)
- Failed VBAC requiring repeat cesarean
- Hysterectomy (with severe rupture)
- Postpartum hemorrhage
- Maternal injury
- Fetal injury, hypoxia
- Fetal death (rare)
- Maternal death (very rare, slightly higher than planned repeat cesarean)
- Bladder injury during emergent surgery
- Need for transfusion
- Infection
- Anesthesia complications
- Disruption of bonding
Nursing Interventions
- Detailed prenatal counseling and informed consent
- Review prior operative reports
- Continuous fetal monitoring during TOLAC
- IV access, type and crossmatch
- Watch for signs of uterine rupture (most importantly: fetal distress)
- OR and anesthesia immediately available
- Avoid prostaglandins for induction
- Cautious oxytocin use
- Frequent vital signs
- Communication with team
- Postpartum hemorrhage prevention
- Discharge counseling about future pregnancies
Description of Procedure
Procedure to manually rotate a fetus from breech (or transverse) to cephalic presentation by external pressure on the maternal abdomen. Performed at 36-37 weeks gestation. Reduces need for cesarean delivery for breech. Success rate ~50-60% overall.
Indications
- Breech or transverse fetal presentation at 36-37 weeks
- Singleton pregnancy (multiple gestation contraindicated)
- Reactive NST before procedure
- Adequate amniotic fluid
- No labor
- Maternal consent
Contraindications:
- Multiple gestation
- Placenta previa
- Prior cesarean (relative — some do it)
- Ruptured membranes
- Labor
- Oligohydramnios
- Hyperextended fetal head
- Fetal anomalies
- Non-reactive NST or fetal distress
- Severe maternal HTN, preeclampsia
- Suspected uterine rupture or scar dehiscence
Outcomes/Evaluation
Success rates:
- Overall: 50-60% (higher in multiparas, transverse lie)
- Higher with: tocolysis (terbutaline), adequate fluid, posterior placenta, non-engaged presenting part, ECV by experienced provider
- Lower with: nulliparas, anterior placenta, engaged presenting part, obesity, frank breech
Outcomes:
- Successful: continue prenatal care; spontaneous reversion ~5%
- Failed: planned cesarean or continue trying selectively; some practitioners attempt vaginal breech for selected cases
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Confirm gestational age (36-37 weeks)
- Ultrasound: confirm presentation, location of placenta, amniotic fluid, position of fetal head
- NST: confirm reactive
- Verify Rh status — RhoGAM if Rh-negative (after procedure)
- Informed consent
- NPO if possible (in case of cesarean)
- IV access
- Empty bladder
- OR ready (in case of emergent delivery)
- Anesthesia available
Intra-procedure:
- Tocolytic (terbutaline 0.25 mg SQ) ~15 min before to relax uterus
- Maternal positioning: supine with slight tilt
- Ultrasound guidance throughout
- Two hands manipulating fetus through abdominal wall
- "Forward roll" attempted first (push head toward chin)
- "Backward roll" if forward fails
- Continuous FHR monitoring
- Procedure usually 5-15 minutes
- Stop if: fetal distress, maternal severe pain, no progress, ROM
Post-procedure:
- Continue fetal monitoring × 30-60 minutes (or longer)
- Verify position by ultrasound
- If Rh-negative: RhoGAM
- Vital signs
- Educate on warning signs
- Spontaneous reversion possible
- Schedule follow-up
- Plan for delivery
Client Education
- Procedure usually performed in hospital setting
- You may have IV, NPO ahead of time
- Ultrasound used to guide procedure
- Medication to relax uterus given
- Provider will press firmly on belly to turn baby
- Some discomfort, brief pain
- Continuous fetal monitoring during and after
- Procedure takes about 15-30 minutes total
- Success rate ~50%
- Rare risks: cord problems, placental abruption, fetal distress requiring emergent cesarean
- If successful: planned vaginal delivery possible
- If unsuccessful: cesarean delivery typically scheduled
- Watch for after: contractions, bleeding, decreased fetal movement, ROM → call provider
Potential Complications
- Failed version (most common)
- Transient fetal heart rate changes (decelerations) — usually resolve
- Cord entanglement or compression
- Placental abruption (rare)
- Fetomaternal hemorrhage (need for RhoGAM if Rh-negative)
- PROM
- Preterm labor
- Fetal distress requiring emergent cesarean
- Spontaneous reversion to breech after success
- Maternal discomfort
- Bruising
Nursing Interventions
- Confirm eligibility (gestational age, presentation, no contraindications)
- Pre-procedure NST
- Ultrasound assessment
- Informed consent
- Rh status — RhoGAM if Rh-negative
- IV access, NPO
- Continuous fetal monitoring throughout
- Tocolytic administration
- Post-procedure monitoring (30-60+ min)
- Verify position by ultrasound
- Discharge instructions
- Plan for delivery
- Watch for warning signs
Description of Procedure
Mechanical methods to soften and dilate the cervix before labor induction. Used when Bishop score is unfavorable (< 6) and pharmacologic methods are contraindicated or in addition to. Most common: Foley balloon or double-balloon catheter (Cook catheter). Alternative to or used with prostaglandins.
Indications
- Cervical ripening needed before induction
- Unfavorable Bishop score (< 6)
- Indications for induction: postdates, GDM, PROM, oligohydramnios, etc.
- VBAC candidates (preferred over prostaglandins which increase rupture risk)
- Prior cesarean
- Pharmacological methods contraindicated or inadequate
Contraindications:
- Active vaginal bleeding
- Placenta previa
- Active infection (chorioamnionitis)
- Ruptured membranes (controversial — some don't place if ROM)
- Suspected cord prolapse
- Vasa previa
- Malpresentation
- Fetal distress
Outcomes/Evaluation
Expected outcomes:
- Mechanical dilation of cervix to ~3-4 cm
- Stimulates endogenous prostaglandin release
- Often expelled at 4 cm dilation
- Improves Bishop score
- Allows progression to active labor or oxytocin administration
Average effects:
- Foley balloon retained 12-24 hours typically
- Some institutions: traction with weight
- Used alone or with oxytocin/misoprostol
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Verify indications, no contraindications
- Informed consent
- Continuous fetal monitoring
- IV access
- Sterile technique
- Speculum exam
- Pelvic exam to assess Bishop score
- Empty bladder
Intra-procedure:
- Visualize cervix with speculum
- Cleanse cervix
- Insert balloon catheter through cervix into uterus
- Inflate balloon (30-60 mL saline)
- Apply gentle traction (taped to thigh) or weighted (per institution)
- Continuous fetal monitoring
- Position changes encouraged
- Pain management as needed
Post-procedure:
- Continuous fetal monitoring × 1-2 hours, then intermittent if reassuring
- Mobility encouraged (walking)
- Pain assessment
- Vital signs
- Watch for: contractions (progress to active labor), expulsion of balloon, ROM, bleeding
- Reassess cervix every few hours or per protocol
- Remove balloon at 12-24 hours OR when expelled (cervix typically dilated 3-4 cm)
- May then proceed with oxytocin or amniotomy
Client Education
- Procedure stretches and softens the cervix to prepare for labor
- You'll have continuous fetal monitoring
- Brief discomfort during insertion (like an exam)
- Pressure or cramping for some time after
- Can walk around (catheter taped to leg)
- Catheter usually falls out on its own when cervix is dilated
- If not, removed in 12-24 hours
- Then we may start labor medication (Pitocin) or break your water
- Tell us if: severe pain, heavy bleeding, water breaks, fever, can't feel baby move
- Goal: prepare cervix for labor
Potential Complications
- Maternal discomfort, cramping
- Bleeding (minor, usually expected)
- Infection (chorioamnionitis with prolonged use, ROM)
- Bladder pressure
- Rupture of membranes
- Cord prolapse if presenting part not engaged
- Hyperstimulation (less common than with prostaglandins)
- Placental abruption (rare)
- Fetal distress
- Failed cervical ripening
- Need for cesarean
Nursing Interventions
- Confirm indications, screen for contraindications
- Informed consent
- Continuous fetal monitoring during insertion
- Sterile technique
- Aseptic vaginal exam
- Document Bishop score
- Encourage ambulation
- Comfort measures
- Watch for ROM, bleeding, infection
- Remove at appropriate time
- Transition to next step of induction
- Communicate with team
Description of Procedure
Surgical incision of perineum during second stage of labor to enlarge vaginal opening. Routine use no longer recommended — restrictive (selective) use preferred. Types: midline (median, vertical) and mediolateral (45-degree angle).
Indications
- NOT routine — only when needed
- Imminent third- or fourth-degree laceration (extending tear anticipated)
- Shoulder dystocia (to allow maneuvers)
- Operative vaginal delivery (vacuum, forceps)
- Breech delivery
- Fetal distress requiring rapid delivery
- Maternal medical condition (cardiac, pulmonary) needing shortened second stage
Outcomes/Evaluation
Episiotomy types:
- Midline (median): Vertical incision toward anus; easier to repair; less blood loss; less postoperative pain; but extends easily into 3rd/4th degree laceration (rectal involvement)
- Mediolateral: 45-degree angle from posterior fourchette; less risk of extension; but more painful, more difficult repair, more blood loss
Expected outcomes:
- Enlarged vaginal outlet for delivery
- Healing in 2-3 weeks for uncomplicated
- Pain management needed
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Informed consent (often during labor)
- Position lithotomy or modified
- Local anesthesia (lidocaine) injected into perineum
- Or pudendal block
- Or epidural (if already in place)
- Sterile field
Intra-procedure:
- Provider performs incision at appropriate time (during contraction, head bulging at perineum)
- Quick straight cut with scissors
- Delivery follows immediately
Post-procedure (repair):
- After placenta delivered
- Inspect for extensions (3rd/4th degree)
- Layered repair with absorbable suture
- Adequate anesthesia for repair
- Aseptic technique
- Document degree of laceration if extended
Postpartum care:
- Ice pack first 24 hours
- Sitz baths after first 24 hours
- Pain management
- Perineal hygiene
- Stool softeners
Client Education
- Episiotomy is no longer routine — only done when necessary
- If recommended, your provider will explain why
- Local anesthesia given to numb area
- Repair after baby and placenta delivered
- Heals in 2-3 weeks typically
- Pain management: ice first 24 hours, then sitz baths
- Stool softeners help with bowel movements
- Perineal care: peri bottle, change pads frequently, wipe front to back
- Avoid: tampons, intercourse until cleared (6 weeks)
- Pelvic floor exercises (Kegels)
- Watch for: increased pain, redness, swelling, drainage, fever → infection signs
- Resume sexual activity after healing and clearance
- Pelvic floor PT helpful
Potential Complications
- Extension to 3rd/4th degree laceration (especially midline)
- Pain (more than spontaneous tears in some studies)
- Infection
- Dehiscence (wound separation)
- Hematoma
- Bleeding
- Dyspareunia
- Pelvic floor dysfunction
- Anal incontinence (if extended)
- Rectovaginal fistula (rare, severe)
- Chronic pain
- Sexual dysfunction
Nursing Interventions
- Restrictive use — only when truly indicated
- Adequate anesthesia for procedure and repair
- Aseptic technique
- Repair carefully in layers
- Pain management postpartum
- Ice first 24 hours, sitz baths after
- Perineal care education
- Stool softeners
- Watch for infection
- Pelvic floor exercises
- Sexual health counseling
- Postpartum follow-up
Description of Procedure
Instillation of warmed sterile saline (or LR) into the uterus through an intrauterine pressure catheter (IUPC) during labor to: relieve variable decelerations from cord compression (oligohydramnios or ROM), dilute thick meconium. Membranes must be ruptured. Used selectively — evidence is mixed for meconium use.
Indications
- Variable decelerations from cord compression with oligohydramnios or after ROM
- Severe oligohydramnios in labor
- Thick meconium-stained amniotic fluid (controversial — less common use now)
- Need to maintain adequate amniotic fluid
Contraindications:
- Intact membranes
- Multiple gestation
- Severe fetal distress requiring immediate delivery
- Active uterine infection
- Vaginal bleeding (placental abruption)
- Severe uterine anomalies
- Polyhydramnios
- Inability to place IUPC
Outcomes/Evaluation
Expected outcomes:
- Resolution of variable decelerations
- Improved fetal heart rate pattern
- Dilution of meconium (if used for this indication)
- Cushion for umbilical cord
- Improved fetal oxygenation
- Decreased need for cesarean for cord compression
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Confirm ROM
- Place IUPC (often by provider)
- Continuous fetal monitoring
- Verify indication, no contraindications
- Document baseline FHR pattern
Intra-procedure:
- Connect warmed (body temperature) sterile saline or LR via IUPC
- Initial bolus of 250-500 mL over 20-30 minutes
- Continuous slow infusion 2-3 mL/min
- Or per protocol
- Monitor: FHR (improvement), maternal vital signs, contractions, uterine resting tone
- Watch for hyperstimulation
- Watch for over-distension (resting tone increase)
- Document infusion volume
- Periodically check IUPC functioning
Post-procedure:
- Document amount infused
- Continued monitoring
- Watch for resolution of decelerations
- Track maternal/fetal status
- Stop if not effective or fetal distress worsens
Client Education
- Fluid will be added to the uterus to help cushion the cord
- You'll have IUPC in place (after water has broken)
- Should reduce dips in fetal heart rate
- Continuous monitoring
- Tell us about new pain or sudden changes
- If improvement, labor can continue safely
- If not, may need cesarean
Potential Complications
- Failed to resolve variable decelerations
- Hyperstimulation
- Over-distention of uterus
- Uterine rupture (rare)
- Placental abruption (rare)
- Infection (chorioamnionitis)
- Sudden fetal distress
- Cord prolapse
- Discomfort
- Need for cesarean delivery
Nursing Interventions
- Verify ROM and indication
- Place or verify IUPC
- Warm fluid to body temperature (prevents cold stress to fetus)
- Continuous fetal monitoring
- Maternal vital signs
- Document fluid volume infused
- Watch for: improvement in decels (positive), hyperstimulation, over-distention
- Pain assessment
- Position changes
- Communicate with provider
- Be prepared for emergent cesarean if not improving
Description of Procedure
Surgical procedure that permanently blocks the fallopian tubes to prevent pregnancy. Most common methods: clipping, banding, cauterization, or salpingectomy (removal of tubes — increasingly preferred for ovarian cancer prevention). Performed via laparoscopy (interval) or minilaparotomy (postpartum). Considered permanent and irreversible. Failure rate ~0.5% (lifetime).
Indications
- Patient desires permanent contraception
- Family complete
- Medical contraindications to pregnancy
- Genetic conditions where pregnancy contraindicated
- Patient unable or unwilling to use other contraceptive methods
Timing:
- Postpartum (within 24-48 hours of vaginal birth or at cesarean)
- Interval (not pregnancy-related, outpatient laparoscopy)
Considerations:
- Permanent — patient must be CERTAIN
- Federal regulations: signed consent 30 days prior (Medicaid)
- Counseling on alternatives (LARC, hormonal methods)
- Partner involvement (but not legally required)
- Mental capacity to consent
- Vasectomy alternative (easier, lower risk for partner)
Outcomes/Evaluation
Effectiveness:
- Failure rate: ~0.5% lifetime (1 in 200)
- Slightly higher with certain methods
- Permanent contraception
If failure occurs:
- ↑ ectopic pregnancy risk (compared to general population)
- Need pregnancy test if missed periods
Reversal:
- Tubal reversal possible but expensive and not always successful
- IVF is alternative for fertility after sterilization
- Salpingectomy (tube removal) is NOT reversible
Bonus benefit of salpingectomy:
- Reduces ovarian cancer risk significantly
- Increasingly recommended over ligation
Nursing Interventions (pre, intra, post)
Pre-procedure:
- Informed consent (often signed 30 days prior for Medicaid)
- Counseling on permanence and alternatives
- NPO 8 hours
- Pregnancy test (especially interval procedure)
- STI screening if indicated
- Routine pre-op labs
- IV access
- Anesthesia consultation
- Allergy verification
Intra-procedure:
- Postpartum: Mini-laparotomy through small infraumbilical incision; tubes brought out and ligated/removed; closed in layers
- Interval (laparoscopy): General anesthesia; CO2 insufflation; small incisions; trocars; tubes occluded (clips, bands, electrocautery, or removed)
- Confirm bilateral tubal occlusion
- Procedure 30-60 min typically
Post-procedure:
- Recovery in PACU
- Vital signs
- Pain management
- Watch for: bleeding, infection, anesthesia complications
- Encourage ambulation early
- Postpartum-specific: monitor postpartum recovery, breastfeeding
- Interval: usually outpatient discharge
- Discharge instructions
Client Education
Pre-op:
- Procedure is permanent — be sure
- Discuss alternatives (LARC like IUD, implant; vasectomy for partner)
- Federal regulation: signed consent 30 days prior (for Medicaid recipients)
- NPO 8 hours
- Arrange transportation home
- Childcare arrangements
Post-op:
- Some abdominal pain, shoulder pain (from CO2 — laparoscopy)
- Return to normal activities in 1-2 weeks
- Avoid heavy lifting, intercourse for 1-2 weeks
- Watch for: severe pain, fever, infection, severe bleeding → call provider
- Resume work as comfortable
- Effective immediately
Long-term:
- You can still get periods normally
- No effect on hormones or sex drive
- Doesn't protect against STIs — use condoms with new partners
- If miss period: pregnancy test (small failure risk; ↑ ectopic if pregnancy occurs)
- If menopause symptoms — discuss with provider
- Doesn't prevent ovarian cancer (ligation); salpingectomy reduces risk
Potential Complications
- Anesthesia complications
- Bleeding
- Infection
- Damage to adjacent structures (bowel, bladder, blood vessels) — rare
- Failure → pregnancy (0.5%)
- ↑ ectopic if pregnancy occurs after
- Persistent pelvic pain (rare)
- Conversion to laparotomy if complications
- Regret (especially in younger women)
- Hospital admission
Nursing Interventions
- Extensive pre-op counseling
- Confirm informed consent (Medicaid: 30-day rule)
- Address ambivalence — postpone if uncertain
- Discuss alternatives in detail
- NPO verification
- Pregnancy test
- Pre-op routine
- Postpartum: time procedure with postpartum recovery
- Post-op monitoring
- Pain management
- Educate on warning signs
- Discharge planning
- Follow-up appointments
- Counseling about non-effect on hormones, periods
- STI prevention reminder
Defining Characteristics
The reciprocal, enduring, and selective emotional and physical connection between the mother (or primary caregiver) and the newborn. Manifests as en face positioning, eye contact, identification by name, comforting touch and voice, protective behaviors, and the mother's preference for her own infant over others. Develops along a continuum: bonding (immediate) → attachment (over weeks to months).
Antecedents
Conditions that must be in place for attachment to occur:
- Anticipation and acceptance of the pregnancy
- Prenatal bonding (felt fetal movement, ultrasound viewing, naming)
- Healthy maternal mental and physical state
- Adequate social support and absence of significant stressors
- Opportunity for early skin-to-skin contact and proximity
- Newborn able to respond (alert, healthy, capable of cuing)
Negative Consequences
Results from impaired antecedents:
- Failure to thrive in the newborn
- Misreading of newborn cues → inadequate response
- Increased risk of neglect and child maltreatment
- Impaired language and social development
- Postpartum depression in mother (bidirectional risk)
- Disorganized attachment patterns in childhood
Exemplars
- Skin-to-skin contact in the delivery room within the first hour
- Breastfeeding initiation within the first 30–60 minutes
- En face positioning during feeding and quiet alert states
- Calling the newborn by name; speaking in "parentese"
- Rooming-in to facilitate proximity and cue recognition
- Father stroking and exploring the newborn's features (engrossment)
Defining Characteristics
Adequate oxygen delivery to tissues via patent vascular supply and gas exchange. In the fetus, perfusion depends on maternal-to-placental-to-fetal oxygen transfer. Reflected in fetal heart rate variability and reactivity, biophysical profile findings, and ultimately by an Apgar score showing vigorous neonatal transition. Impaired fetal perfusion manifests as late or prolonged decelerations, decreased variability, decreased movement, and acidotic cord blood gases.
Antecedents
Conditions that must be in place for adequate fetal perfusion:
- Patent maternal vascular circulation (normotensive, normovolemic)
- Adequate uteroplacental blood flow (absence of supine hypotensive syndrome)
- Functional placenta without infarction, abruption, or insufficiency
- Intact umbilical cord without compression, prolapse, or true knot
- Adequate maternal oxygenation and hemoglobin concentration
- Normal fetal hemoglobin (HbF) for high O₂ affinity
Negative Consequences
Results from impaired antecedents:
- Fetal hypoxemia → hypoxia → metabolic acidosis
- Late decelerations on FHR monitoring (uteroplacental insufficiency)
- Decreased fetal movement and tone
- Low Apgar scores at 1 and 5 minutes
- Hypoxic-ischemic encephalopathy
- Stillbirth or perinatal mortality
Exemplars
- Reactive NST (≥ 2 accelerations of 15 bpm × 15 sec in 20 min)
- Biophysical profile (BPP) score of 8–10
- Negative contraction stress test (no late decels with contractions)
- Category I FHR tracing (baseline 110–160, moderate variability, no late/variable decels)
- Vigorous newborn at delivery (Apgar ≥ 7 at 1 min, ≥ 9 at 5 min)
- Normal cord gas pH (≥ 7.20) at birth